clinical feature	cancer color	cancer type	data type	description	patient or sample	Default value
ADJUVANT_CHEMO	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Adjuvant Chemotherapy	Patient	
ADJUVANT_TX	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Adjuvant treatment.	Patient	
AGE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	NUMBER	Age at which a condition or disease was first diagnosed.	Patient	
CANCER_TYPE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Cancer Type	Sample	Breast Cancer ; Invasive Breast Carcinoma ; Breast Sarcoma ; Breast Invasive Ductal Carcinoma ; Breast Invasive Carcinoma, NOS ; Breast Cancer, NOS ; Skin Cancer, Non-Melanoma
CANCER_TYPE_DETAILED	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Cancer Type Detailed	Sample	Adenoid Cystic Breast Cancer ; Benign Phyllodes Tumor of the Breast ; Borderline Phyllodes Tumor of the Breast ; Malignant Phyllodes Tumor of the Breast ; Infiltrating Ductal Carcinoma ; Ductal Carcinoma In Situ (DCIS) ; Mucinous Carcinoma ; Infiltrating Tubular Carcinoma ; Mixed Carcinoma ; Infiltrating Lobular Carcinoma ; Medullary Breast Carcinoma ; Invasive Breast Carcinoma ; Breast Invasive Ductal Carcinoma ; Breast Mixed Ductal and Lobular Carcinoma ; Breast Invasive Cancer, NOS ; Breast Invasive Lobular Carcinoma ; Breast Invasive Carcinoma, NOS ; Breast ; Breast Invasive Mixed Mucinous Carcinoma ; Metaplastic Breast Cancer ; Breast Invasive Carcinoma ; Breast Neoplasm, NOS ; Breast Invasive Carcinosarcoma, NOS ; Juvenile Secretory Carcinoma of the Breast ; Invasive Breast Cancer ; Breast Ductal Carcinoma In Situ ; Paget Disease of the Nipple ; Basal Cell Carcinoma ; Solid Papillary Carcinoma of the Breast ; Breast Angiosarcoma ; Breast Invasive Carcinoma (NOS)
ER_STATUS_BY_IHC	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	breast carcinoma progesterone receptor status	Sample ; Patient	Negative ; Positive ; Indeterminate
FOLLOWUP_YEARS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	NUMBER	Followup in years	Patient	
FUSION_STATUS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Yes/No indicator of fusion status	Sample	YES
GENOMIC_ALTERATIONS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	NUMBER	Number of genomic alterations	Sample	15 ; 31 ; 33 ; 19 ; 18 ; 25 ; 20 ; 29 ; 9 ; 14 ; 16
IHC_HER2	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	IHC-HER2	Sample ; Patient	Negative ; HR-/HER2- ; HR+/HER2- ; ND ; HER2+ ; equivocal ; Equivocal ; Positive ; Indeterminate
LOCAL_REGIONAL_RECURRENCE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Local Regional Recurrence	Patient	
METASTATIC_SITE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	The anatomic location to which the cancer has spread.	Sample	Lung ; Liver ; Lymph Node ; Soft Tissue ; Heart ; Retroperitoneum ; Chest Wall ; Bone ; Brain ; Ovary ; Pleura ; Adrenal Gland ; Axilla ; Pelvis ; Bone NOS ; Parasternal Mass ; Neck ; Skin ; Uterus ; Scalp ; Cervix ; Peritoneum ; Mediastinum ; Pericardium ; Back ; Stomach ; Epidural ; Fallopian Tube ; Pterygoid Palatine Tissue ; Appendix ; Bladder ; Epidural Mass ; Upper Tract ; Adnexa or Endomterium ; Retroperitenium ; Pleural Fluid ; Colon ; Ipsilateral Breast ; Rib ; Bowel ; Vertebrate ; Spine ; Small Bowel ; Contralateral Breast ; Mediastinal Mass ; Peritoneal Fluid ; Iliac Bone ; Ascites Fluid ; Orbit ; Trachea ; CSF ; Sternum ; Spine (bone) ; Buttock ; Omentum ; Lymph node ; Femur ; Spleen ; Esophagus ; Right Neck ; Cerebellum ; Bone (Femur) ; Orbit - Right ; Intercostal space ; Scapula ; Uterus/Cervix ; Soft tissue, Posterior Left Shoulder ; Groin ; Sacral Mass ; Spine (Bone) ; Abdomen ; Brain and Leptomeninges ; Orbital Floor ; Abdominal Wall ; Humerus ; Transverse Colon ; Pleural Fliud ; Thigh ; Bone|Liver ; Other, specify ; Lung|Bone|Liver|Other, specify
METASTATIC_TUMOR_INDICATOR	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Distant metastasis present ind2	Sample ; Patient	No ; Yes ; NO ; YES
MUTATION_COUNT	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	NUMBER	Mutation Count	Sample	11 ; 23 ; 22 ; 12 ; 19 ; 15 ; 21 ; 18 ; 7 ; 6 ; 16 ; 14 ; 4 ; 10 ; 68 ; 8 ; 3 ; 25 ; 1 ; 13 ; 75 ; 29 ; 59 ; 48 ; 31 ; 51 ; 44 ; 26 ; 9 ; 114 ; 37 ; 28 ; 20 ; 57 ; 76 ; 129 ; 54 ; 104 ; 39 ; 52 ; 27 ; 151 ; 62 ; 102 ; 63 ; 24 ; 65 ; 41 ; 30 ; 50 ; 17 ; 42 ; 36 ; 53 ; 47 ; 101 ; 40 ; 35 ; 234 ; 160 ; 88 ; 58 ; 49 ; 249 ; 940 ; 113 ; 56 ; 92 ; 81 ; 150 ; 33 ; 105 ; 167 ; 165 ; 370 ; 82 ; 108 ; 475 ; 120 ; 69 ; 67 ; 389 ; 131 ; 5 ; 34 ; 147 ; 121 ; 32 ; 38 ; 80 ; 45 ; 232 ; 206 ; 73 ; 43 ; 60 ; 248 ; 100 ; 46 ; 2 ; 74 ; 117 ; 177 ; 112 ; 163 ; 93 ; 782 ; 155 ; 61 ; 72 ; 84 ; 64 ; 107 ; 143 ; 135 ; 348 ; 157 ; 310 ; 99 ; 95 ; 87 ; 698 ; 83 ; 115 ; 66 ; 79 ; 511 ; 127 ; 139 ; 144 ; 103 ; 132 ; 123 ; 122 ; 189 ; 180 ; 305 ; 247 ; 71 ; 78 ; 128 ; 309 ; 86 ; 77 ; 176 ; 90 ; 7908 ; 97 ; 352 ; 383 ; 125 ; 146 ; 800 ; 106 ; 110 ; 655 ; 164 ; 148 ; 1002 ; 126 ; 96 ; 119 ; 85 ; 262 ; 89 ; 140 ; 188 ; 317 ; 91 ; 198 ; 94 ; 456 ; 236 ; 465 ; 133 ; 346 ; 118 ; 172 ; 137 ; 230 ; 179 ; 109 ; 156 ; 223 ; 98 ; 161 ; 70 ; 201 ; 141 ; 284 ; 55 ; 168 ; 174 ; 185 ; 238 ; 447 ; 116 ; 170 ; 314 ; 142 ; 203 ; 192 ; 334 ; 326 ; 718 ; 240 ; 145 ; 233 ; 178 ; 154 ; 1222 ; 275 ; 306 ; 149 ; 372 ; 303 ; 773 ; 124 ; 153 ; 186 ; 220 ; 184 ; 217 ; 243 ; 224 ; 287 ; 402 ; 386 ; 187 ; 175 ; 269 ; 194 ; 313 ; 342 ; 196 ; 183 ; 210 ; 1312 ; 601 ; 111 ; 162 ; 138 ; 221 ; 543 ; 682 ; 290 ; 704 ; 548 ; 3427 ; 130 ; 505 ; 215 ; 282 ; 281 ; 486 ; 270 ; 362 ; 190 ; 989 ; 915 ; 357 ; 4280 ; 1994 ; 557 ; 1073 ; 216 ; 136 ; 556 ; 670 ; 253 ; 1044 ; 258 ; 599 ; 3860 ; 388 ; 861 ; 1086 ; 1136 ; 239 ; 209 ; 250 ; 1053 ; 347 ; 166 ; 885 ; 676 ; 817 ; 1078 ; 181 ; 211 ; 770 ; 604 ; 208 ; 591 ; 459 ; 271 ; 134 ; 212 ; 300 ; 195 ; 227 ; 173 ; 1095 ; 4259 ; 400 ; 5399 ; 1117 ; 288 ; 754 ; 826 ; 276 ; 159 ; 171 ; 256 ; 219 ; 332 ; 832 ; 1251 ; 422 ; 312 ; 633 ; 191 ; 689 ; 785 ; 971 ; 797 ; 813 ; 3080 ; 366 ; 365 ; 3879 ; 436 ; 193
MYB_MYBL1_FUSION	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Description of MYB or MYBL1 fusions identified.	Sample	MYB-NFIB Fusion ; Negative
MYB_NFIB_CNA	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	MYB-NFIB Fusion Gene Copy Number Alterations	Sample	9q13-q34.2 loss ; 17q21-q25.1 gain; 17p13.3-p11.2 loss ; 12q12-q14.1 loss ; 17q21-q25.1 gain
MYB_NFIB_FISH	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	MYB-NFIB FISH.	Sample	Negative ; Positive
MYB_NFIB_NONSYNONYMOUS_COUNT	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Count of non-synonymous mutations in MYB-NFIB Fusion Gene	Sample	11 ; 22 ; 23 ; 10 ; 9 ; 18 ; 14 ; 19 ; 6 ; 7
MYB_NFIB_REARRANGEMENT	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	MYB-NFIB Rearrangement Description	Patient	
NEOADJUVANT_CHEMO	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Neoadjuvant Chemotherapy.	Patient	
ONCOTREE_CODE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Oncotree Code	Sample	ACBC ; BPT ; BLPT ; MPT ; IDC ; DCIS ; IMMC ; BRCA ; ILC ; MDLC ; BRCANOS ; BRCNOS ; BREAST ; MBC ; BNNOS ; CSNOS ; JSCB ; PD ; BCC ; SPC ; PBS
OVERALL_PATIENT_HISTOLOGY	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Overall Patient Histology	Patient	
PLATFORM	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Platform.	Sample	WES
PRIMARY_SITE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Text term to describe the organ sub-division in an individual with cancer.	Sample	Breast ; Breast NOS ; Right Upper Outer Quadrant ; Right Lower Outer Quadrant ; Left Upper Outer Quadrant|Left ; Left Lower Outer Quadrant ; Left ; Right Upper Outer Quadrant|Right ; Right Upper Inner Quadrant|Right ; Left Lower Inner Quadrant ; Right ; Left Lower Outer Quadrant|Left ; Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left ; Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left ; Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right ; Left Upper Inner Quadrant ; Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right ; Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right ; Left Upper Inner Quadrant|Left ; Right Upper Inner Quadrant ; Left Upper Outer Quadrant ; Right Upper Inner Quadrant|Right Lower Inner Quadrant ; Left Lower Inner Quadrant|Left ; Left Upper Inner Quadrant|Left Upper Outer Quadrant ; Right Lower Outer Quadrant|Right ; Right Lower Inner Quadrant ; Right|Right Upper Inner Quadrant ; Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left ; Left Upper Outer Quadrant|Left Lower Outer Quadrant ; Right Upper Inner Quadrant|Right Upper Outer Quadrant ; Left Upper Inner Quadrant|Left Lower Inner Quadrant ; Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant ; Right Lower Inner Quadrant|Right Lower Outer Quadrant ; Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant ; Right Upper Outer Quadrant|Right Lower Outer Quadrant ; Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant ; Left Lower Inner Quadrant|Left Lower Outer Quadrant ; Right|Right Upper Outer Quadrant ; Left|Left Upper Outer Quadrant ; Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left ; Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left ; Left|Left Upper Inner Quadrant ; Right|Right Lower Inner Quadrant ; Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right
PR_STATUS_BY_IHC	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Breast carcinoma progesterone receptor status	Sample ; Patient	Negative ; Positive ; Indeterminate
RADIATION_THERAPY	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Radiation Therapy.	Patient	
SAMPLE_COUNT	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Number of Samples Per Patient	Patient	
SAMPLE_TYPE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	The type of sample (i.e., normal, primary, met, recurrence).	Sample	Primary ; Metastasis ; Unknown
SEX	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Sex	Patient	
SOMATIC_STATUS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Somatic Status	Sample	Matched ; Unmatched ; UnMatched
STUDY	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Study.	Patient	
TIME_TO_MET_MONTHS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	NUMBER	Time to metastasis (months).	Patient	
TMB_NONSYNONYMOUS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	NUMBER	TMB (nonsynonymous)	Sample	0.366666667 ; 0.766666667 ; 0.733333333 ; 0.4 ; 0.566666667 ; 0.466666667 ; 0.7 ; 0.6 ; 0.233333333 ; 0.2 ; 0.533333333333 ; 0.233333333333 ; 0.466666666667 ; 0.133333333333 ; 0.366666666667 ; 0.333333333333 ; 2.26666666667 ; 0.266666666667 ; 0.1 ; 0.833333333333 ; 0.0333333333333 ; 2.53333333333 ; 0.433333333333 ; 0.966666666667 ; 1.96666666667 ; 1.6 ; 0.666666666667 ; 0.566666666667 ; 1.03333333333 ; 0.5 ; 1.7 ; 1.46666666667 ; 0.9 ; 0.3 ; 3.8 ; 1.26666666667 ; 0.766666666667 ; 1.86666666667 ; 1.93333333333 ; 2.5 ; 4.26666666667 ; 0.933333333333 ; 1.83333333333 ; 3.5 ; 1.3 ; 1.73333333333 ; 0.866666666667 ; 5.06666666667 ; 2.06666666667 ; 3.33333333333 ; 2.1 ; 0.8 ; 2.2 ; 1.4 ; 1.0 ; 1.76666666667 ; 0.733333333333 ; 1.56666666667 ; 3.36666666667 ; 1.36666666667 ; 1.2 ; 1.23333333333 ; 7.8 ; 1.8 ; 5.333333333 ; 2.933333333 ; 1.033333333 ; 1.933333333 ; 0.533333333 ; 1.633333333 ; 8.266666667 ; 31.36666667 ; 2.066666667 ; 3.733333333 ; 1.866666667 ; 3.066666667 ; 2.7 ; 1.366666667 ; 1.166666667 ; 5 ; 1.1 ; 3.466666667 ; 5.533333333 ; 5.5 ; 4.3 ; 0.966666667 ; 12.2 ; 2.733333333 ; 3.033333333 ; 0.833333333 ; 1.733333333 ; 3.533333333 ; 15.86666667 ; 4 ; 2.166666667 ; 2.3 ; 0.933333333 ; 12.96666667 ; 1 ; 4.333333333 ; 0.666666667 ; 1.566666667 ; 0.166666667 ; 0.433333333 ; 1.133333333 ; 0 ; 0.866666667 ; 4.9 ; 1.9 ; 1.066666667 ; 1.266666667 ; 2.666666667 ; 2.233333333 ; 2.766666667 ; 1.5 ; 7.7 ; 1.333333333 ; 1.466666667 ; 6.866666667 ; 2.433333333 ; 1.666666667 ; 2 ; 0.133333333 ; 3.333333333 ; 1.533333333 ; 0.066666667 ; 2.466666667 ; 3.9 ; 0.333333333 ; 0.033333333 ; 5.933333333 ; 5.4 ; 1.233333333 ; 3.1 ; 2.533333333 ; 26.03333333 ; 5.166666667 ; 2.033333333 ; 2.4 ; 2.8 ; 2.133333333 ; 4.766666667 ; 4.5 ; 11.6 ; 5.233333333 ; 10.33333333 ; 1.433333333 ; 4.466666667 ; 4.366666667 ; 3.166666667 ; 2.9 ; 23.36666667 ; 4.033333333 ; 3.433333333 ; 3.833333333 ; 2.266666667 ; 3.4 ; 2.633333333 ; 17.03333333 ; 4.233333333 ; 4.666666667 ; 4.8 ; 0.166666666667 ; 0.0666666666667 ; 0.633333333333 ; 1.1091553006 ; 2.2183106012 ; 3.32746590179 ; 7.76408710418 ; 0.0 ; 8.87324240478 ; 12.2007083066 ; 3.45879237993 ; 6.65493180359 ; 4.43662120239 ; 5.54577650299 ; 6.91758475987 ; 9.78719697615 ; 0.978719697615 ; 1.95743939523 ; 8.80847727853 ; 3.91487879046 ; 2.93615909284 ; 7.82975758092 ; 5.87231818569 ; 6.8510378833 ; 11.7446363714 ; 4.89359848807 ; 24.4679924404 ; 8.64698094984 ; 4.32349047492 ; 2.59409428495 ; 1.72939618997 ; 0.864698094984 ; 7.78228285485 ; 6.05288666489 ; 5.1881885699 ; 10.3763771398 ; 21.6174523746 ; 3.16666666667 ; 3.46666666667 ; 3.6 ; 3.43333333333 ; 1.13333333333 ; 1.33333333333 ; 1.16666666667 ; 2.73333333333 ; 4.4 ; 3.76666666667 ; 4.1 ; 3.06666666667 ; 4.06666666667 ; 3.56666666667 ; 6.3 ; 6.0 ; 10.1666666667 ; 8.23333333333 ; 1.53333333333 ; 2.76666666667 ; 2.46666666667 ; 4.03333333333 ; 2.6 ; 1.66666666667 ; 10.3333333333 ; 2.56666666667 ; 5.83333333333 ; 2.13333333333 ; 3.0 ; 264.633333333 ; 3.26666666667 ; 11.7666666667 ; 12.8 ; 4.2 ; 4.93333333333 ; 1.63333333333 ; 26.7666666667 ; 2.63333333333 ; 4.36666666667 ; 3.23333333333 ; 2.23333333333 ; 2.96666666667 ; 2.93333333333 ; 11.6333333333 ; 2.43333333333 ; 3.66666666667 ; 5.2 ; 22.0 ; 5.46666666667 ; 33.5666666667 ; 4.23333333333 ; 3.2 ; 2.03333333333 ; 3.53333333333 ; 4.16666666667 ; 2.83333333333 ; 8.73333333333 ; 1.06666666667 ; 3.03333333333 ; 6.63333333333 ; 5.13333333333 ; 15.4 ; 3.83333333333 ; 7.93333333333 ; 15.7 ; 4.43333333333 ; 5.3 ; 11.6666666667 ; 1.43333333333 ; 2.33333333333 ; 3.7 ; 2.0 ; 3.93333333333 ; 5.76666666667 ; 4.56666666667 ; 2.16666666667 ; 3.13333333333 ; 7.6 ; 6.26666666667 ; 3.63333333333 ; 5.23333333333 ; 4.86666666667 ; 6.23333333333 ; 7.4 ; 3.96666666667 ; 5.43333333333 ; 2.66666666667 ; 6.73333333333 ; 4.66666666667 ; 9.4 ; 5.56666666667 ; 2.86666666667 ; 5.8 ; 6.13333333333 ; 8.0 ; 4.83333333333 ; 14.8333333333 ; 1.71332918708 ; 15.5281742084 ; 9.98239770538 ; 8.56664593538 ; 19.5743939523 ; 0.266666667 ; 0.633333333 ; 2.366666667 ; 3.266666667 ; 4.266666667 ; 3.966666667 ; 3.366666667 ; 5.666666667 ; 10.5 ; 3 ; 6.833333333 ; 1.833333333 ; 1.766666667 ; 7.764087104 ; 4.436621202 ; 3.91487879 ; 6.654931804 ; 5.18818857 ; 5.545776503 ; 9.511679045 ; 8.64698095 ; 36.60212492 ; 15.52817421 ; 1.109155301 ; 5.872318186 ; 3.45879238 ; 2.218310601 ; 28.83803782 ; 12.20070831 ; 8.873242405 ; 9.982397705 ; 4.323490475 ; 3.327465902 ; 7.829757581 ; 19.57439395 ; 2.594094285 ; 4.893598488 ; 11.09155301 ; 1.957439395 ; 7.782282855 ; 6.851037883 ; 8.808477279 ; 0.978719698 ; 2.936159093 ; 6.91758476 ; 0.864698095 ; 17.74648481 ; 6.052886665 ; 13.30986361 ; 21.07395071 ; 17.2939619 ; 29.94719312 ; 43.25705672 ; 10.76591667 ; 14.41901891 ; 23.29226131 ; 46.58452263 ; 31.12913142 ; 26.42543184 ; 16.63732951 ; 29.36159093 ; 14.68079546 ; 9.787196976 ; 21.61745237 ; 32.85852761 ; 11.74463637 ; 25.44671214 ; 24.46799244 ; 20.55311365 ; 27.40415153 ; 16.63823486 ; 15.65951516 ; 1.72939619 ; 43.0636667 ; 12.10577333 ; 15.56456571 ; 17.61695456 ; 13.70207577 ; 14.69986761 ; 11.24107523 ; 18.59567425 ; 28.38287123 ; 36.31731999 ; 10.37637714 ; 45.02110609 ; 22.51055305 ; 39.77611237 ; 12.97047142 ; 23.48927274 ; 25.07624475 ; 18.15865999 ; 19.02335809 ; 13.83516952 ; 19.88805618 ; 16.4292638 ; 31.99382951 ; 25.94094285 ; 23.34684856 ; 22.48215047 ; 34.5879238 ; 33.7232257 ; 69.1758476 ; 3.73333333333 ; 3.86666666667 ; 6.43333333333 ; 6.1 ; 11.1 ; 4.96666666667 ; 3.3 ; 10.93333333 ; 24.06666667 ; 5.6 ; 6.633333333 ; 7.966666667 ; 2.966666667 ; 3.566666667 ; 7.766666667 ; 6.066666667 ; 3.233333333 ; 5.1 ; 2.566666667 ; 5.866666667 ; 4.133333333 ; 2.333333333 ; 7.833333333 ; 3.133333333 ; 40.7 ; 1.966666667 ; 9.1 ; 10.13333333 ; 5.133333333 ; 12.4666666667 ; 10.1333333333 ; 25.9333333333 ; 6.83333333333 ; 5.63333333333 ; 4.0 ; 5.33333333333 ; 6.2 ; 7.46666666667 ; 6.33333333333 ; 7.96666666667 ; 2.36666666667 ; 7.3 ; 8.06666666667 ; 7.66666666667 ; 9.63333333333 ; 13.5 ; 6.96666666667 ; 13.1 ; 5.16666666667 ; 6.16666666667 ; 9.16666666667 ; 6.5 ; 4.73333333333 ; 10.4333333333 ; 11.4666666667 ; 7.26666666667 ; 6.7 ; 7.13333333333 ; 4.13333333333 ; 9.03333333333 ; 44.0 ; 20.3333333333 ; 6.06666666667 ; 4.6 ; 5.36666666667 ; 5.26666666667 ; 7.43333333333 ; 8.2 ; 7.566666667 ; 4.166666667 ; 2.833333333 ; 18.36666667 ; 3.933333333 ; 23.23333333 ; 3.633333333 ; 10 ; 4.633333333 ; 4.066666667 ; 24.2 ; 18.96666667 ; 117.1333333 ; 17.46666667 ; 24.4 ; 5.266666667 ; 7.433333333 ; 9.766666667 ; 9.533333333 ; 2.866666667 ; 16.76666667 ; 3.766666667 ; 3.666666667 ; 9.2 ; 23.8 ; 4.566666667 ; 6.366666667 ; 34.03333333 ; 31.43333333 ; 5.733333333 ; 12.26666667 ; 147.1 ; 69.7 ; 8.766666667 ; 36.56666667 ; 10.8 ; 4.7 ; 18.76666667 ; 23.33333333 ; 11.3 ; 8.6 ; 35.83333333 ; 7.366666667 ; 6.9 ; 7.166666667 ; 8.633333333 ; 19.96666667 ; 128.4333333 ; 5.033333333 ; 4.966666667 ; 12.93333333 ; 5.566666667 ; 28.66666667 ; 36.16666667 ; 37.86666667 ; 6.966666667 ; 8.333333333 ; 9.633333333 ; 6.233333333 ; 12.36666667 ; 35.13333333 ; 11.56666667 ; 29.56666667 ; 5.466666667 ; 6.766666667 ; 22.46666667 ; 27.16666667 ; 35.93333333 ; 6.033333333 ; 7.033333333 ; 25.66666667 ; 20.16666667 ; 8.1 ; 6.933333333 ; 6.6 ; 4.866666667 ; 19.7 ; 2.615035408 ; 1.307517704 ; 5.230070815 ; 6.537588519 ; 3.922553111 ; 9.152623927 ; 10.46014163 ; 14.38269474 ; 18.30524785 ; 11.76765933 ; 7.845106223 ; 16.99773015 ; 27.45787178 ; 13.07517704 ; 28.76538948 ; 15.69021245 ; 36.61049571 ; 20.92028326 ; 30.07290719 ; 23.53531867 ; 33.9954603 ; 26.15035408 ; 31.38042489 ; 22.22780096 ; 19.61276556 ; 52.30070815 ; 60.14581437 ; 39.22553111 ; 24.84283637 ; 104.6014163 ; 40.53304882 ; 45.76311963 ; 15.26666667 ; 9.066666667 ; 4.433333333 ; 7.1 ; 6.133333333 ; 3.866666667 ; 10.6 ; 10.1 ; 6 ; 7.2 ; 6.166666667 ; 6.533333333 ; 5.766666667 ; 8.033333333 ; 36.93333333 ; 142.6666667 ; 27.13333333 ; 180.8333333 ; 37.36666667 ; 5.066666667 ; 9.6 ; 25.26666667 ; 4.533333333 ; 27.96666667 ; 9.3 ; 4.833333333 ; 5.433333333 ; 14.66666667 ; 7.633333333 ; 11.03333333 ; 28 ; 5.7 ; 7.933333333 ; 41.83333333 ; 14.26666667 ; 4.733333333 ; 10.43333333 ; 21.36666667 ; 6.4 ; 7.266666667 ; 23.1 ; 5.966666667 ; 26.6 ; 32.36666667 ; 26.63333333 ; 6.8 ; 103.0666667 ; 11.23333333 ; 12.3 ; 130.3 ; 14.56666667 ; 13.06666667
TUMOR_SIZE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Tumor size.	Sample	40 ; 35 ; 25 ; 45 ; 17 ; 22 ; 15 ; 20 ; 23 ; 24 ; 180 ; 140 ; 120 ; 63 ; 650 ; 90 ; 67 ; 80 ; 95 ; 28 ; 48 ; 190 ; 50 ; 44 ; 32 ; 220 ; 200 ; 1.5 ; 1.3 ; 2.1 ; 3.1 ; 1.8 ; 1.4 ; 1.1 ; 0.9 ; 2.3 ; 1.7 ; 1.6 ; 2.2 ; 3.2 ; 2.7 ; 7 ; 0.7 ; 9 ; 2.5 ; 3.5 ; 4 ; 1.9 ; 5 ; 4.5 ; 6 ; 1.2 ; 2.8 ; 8.4 ; 4.1 ; 2 ; 0 ; 3.8 ; 10 ; 31 ; 65 ; 29 ; 34 ; 16 ; 21 ; 19 ; 36 ; 33 ; 18 ; 12 ; 13 ; 14 ; 55 ; 30 ; 39 ; 70 ; 27 ; 150 ; 60 ; 26 ; 38 ; 52 ; 3 ; 46 ; 11 ; 53 ; 47 ; 43 ; 42 ; 57 ; 100 ; 37 ; 8 ; 160 ; 84 ; 130 ; 5.5 ; 62 ; 1 ; 49 ; 99 ; 68 ; 41 ; 75 ; 51 ; 61 ; 79 ; 71 ; 22.5 ; 17.9 ; 14.5 ; 12.8 ; 18.5 ; 15.5 ; 21.5 ; 16.9 ; 24.4 ; 12.5 ; 40.3 ; 11.8 ; 32.6 ; 17.2 ; 13.8 ; 15.7 ; 182 ; 85 ; 18.3 ; 21.6 ; 28.5 ; 16.2 ; 15.2 ; 31.1 ; 14.3 ; 12.6 ; 25.1 ; 17.6 ; 2.12 ; 21.3 ; 22.32 ; 17.7 ; 15.47 ; 24.15 ; 20.5 ; 69 ; 88 ; 13.6 ; 66 ; 20.8 ; 27.3 ; 21.1 ; 22.8 ; 25.2 ; 26.7 ; 8.9 ; 19.1 ; 11.4 ; 14.9 ; 20.33 ; 17.06 ; 18.95 ; 31.7 ; 21.87 ; 24.6 ; 24.05 ; 17.3 ; 21.4 ; 19.5 ; 58
TUMOR_STAGE	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Tumor stage.	Sample	II ; I ; Stage IIA ; Stage III ; Stage IIB ; Stage IIIA ; Stage IIIB ; Stage IA ; Stage IIIC ; T3 ; T2 ; T1 ; TX ; T4 ; 2 ; 1 ; 4 ; 3 ; 0
TYPE_OF_SURGERY	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	Type of Surgery.	Sample	Breast Conservation/Mastectomy ; Mastectomy ; Breast Conservation
VITAL_STATUS	HotPink	Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)	STRING	The survival state of the person.	Patient	
ETHNICITY	HotPink	Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)	STRING	The text for reporting information about ethnicity.	Patient	
HISTOLOGICAL_DIAGNOSIS	HotPink	Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)	STRING	Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.	Patient	
MEAN_COVERAGE	HotPink	Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)	NUMBER	Mean Coverage (x)	Sample	50 ; 64 ; 68 ; 69 ; 61 ; 58 ; 74 ; 60 ; 79 ; 52 ; 73 ; 57 ; 71 ; 72 ; 54 ; 89 ; 75
NUM_SOMATIC_MUTATION	HotPink	Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)	NUMBER	Total Number of Somatic Mutations	Sample	16 ; 7 ; 14 ; 19 ; 4 ; 11 ; 12 ; 68 ; 10 ; 8 ; 3 ; 22 ; 18 ; 25 ; 1
SURGERY	HotPink	Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)	STRING	Surgery.	Patient	
COUNTRY	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	Country of procurement.	Patient	
ER_STATUS	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	ER Status	Sample	Negative ; Positive ; +ve ; -ve ; Performed but Not Available ; Not Performed ; Indeterminate ; Unk/ND ; Positive low
GRADE	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.	Sample	III ; II ; I ; 2 ; 3 ; 1
HER2_AMPLIFICATION_STATUS	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	HER2 Amplification Status	Sample	Yes ; No
HER2_STATUS	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	HER2 Status	Sample	Negative ; Positive ; -ve ; +ve ; Equivocal
MENOPAUSE_STATUS	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.	Patient	
NONSILENT_RATE	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	NUMBER	Nonsilent Mutation Rate	Sample	2.62 ; 0.44 ; 0.61 ; 1 ; 2.07 ; 0.72 ; 0.87 ; 0.68 ; 1.56 ; 0.37 ; 0.51 ; 0.67 ; 1.05 ; 0.54 ; 1.64 ; 1.47 ; 0.35 ; 4 ; 1.32 ; 0.85 ; 0.62 ; 2.24 ; 1.54 ; 2.02 ; 2.61 ; 0.55 ; 0.94 ; 4.46 ; 0.79 ; 0.49 ; 0.47 ; 0.98 ; 1.85 ; 0.34 ; 0.96 ; 0.31 ; 3.63 ; 0.43 ; 0.82 ; 1.41 ; 0.95 ; 0.8 ; 0.41 ; 5.25 ; 2.19 ; 3.57 ; 2.27 ; 2.35 ; 0.58 ; 1.52 ; 1.06 ; 0.99 ; 1.26 ; 0.52 ; 0.65 ; 0.75 ; 1.89 ; 0.78 ; 0.84 ; 1.62 ; 3.45 ; 0.38 ; 1.22 ; 1.42 ; 0.92 ; 1.28 ; 0.6 ; 0.71 ; 1.74 ; 1.73 ; 8.05 ; 0.91 ; 1.92
PLOIDY	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	NUMBER	Ploidy.	Sample	1.95 ; 2.16 ; 2.01 ; 1.99 ; 1.88 ; 3.24 ; 3.87 ; 3.98 ; 2.04 ; 1.97 ; 3.83 ; 2.12 ; 2.28 ; 1.75 ; 1.92 ; 3.59 ; 3.25 ; 2.09 ; 4.05 ; 3.21 ; 3.81 ; 2.08 ; 2.03 ; 3.96 ; 1.66 ; 1.85 ; 2.1 ; 2.13 ; 2.21 ; 2.05 ; 1.63 ; 1.94 ; 2.27 ; 2.07 ; 2.31 ; 3.12 ; 2.18 ; 2.06 ; 1.9 ; 2.67 ; 1.91 ; 3.44 ; 1.98 ; 3.88 ; 1.79 ; 2 ; 1.89 ; 3.08 ; 3.78 ; 4.17 ; 3.75 ; 3.53 ; 1.96 ; 1.01 ; 3.04 ; 3.56 ; 2.93 ; 3.69 ; 3.79 ; 1.86
PR_STATUS	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	PR Status	Sample	Negative ; Positive ; +ve ; -ve ; Indeterminate ; Performed but Not Available ; Not Performed ; Unk/ND
PURITY	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	NUMBER	Purity	Sample	0.27 ; 0.23 ; 0.52 ; 0.7 ; 0.28 ; 0.43 ; 0.73 ; 0.22 ; 0.6 ; 0.33 ; 0.36 ; 0.8 ; 0.76 ; 0.61 ; 0.72 ; 0.29 ; 0.3 ; 0.82 ; 0.2 ; 0.34 ; 0.79 ; 0.54 ; 0.71 ; 0.25 ; 0.19 ; 0.47 ; 0.62 ; 0.67 ; 0.59 ; 0.44 ; 0.31 ; 0.58 ; 0.5 ; 0.26 ; 0.42 ; 0.56 ; 0.14 ; 0.63 ; 0.68 ; 0.35 ; 0.37 ; 0.89 ; 0.39 ; 0.66 ; 0.65 ; 0.64 ; 0.4 ; 0.53 ; 0.55
SILENT_RATE	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	NUMBER	Silent Mutation Rate	Sample	0.72 ; 0.21 ; 0.17 ; 0.14 ; 0.54 ; 0.13 ; 0.24 ; 0.68 ; 0.1 ; 0.035 ; 0.067 ; 0.34 ; 0.38 ; 0.28 ; 1.09 ; 0.43 ; 0.76 ; 0.59 ; 0.73 ; 0.034 ; 0.31 ; 1.15 ; 0.27 ; 0.82 ; 0.07 ; 1.41 ; 0.11 ; 0.51 ; 0.45 ; 0.2 ; 1.85 ; 0.66 ; 1.27 ; 0.48 ; 0.068 ; 0.9 ; 0.41 ; 0.62 ; 1.47 ; 0.39 ; 0.57 ; 0.58 ; 0.3 ; 0.069 ; 2.43
STAGE	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	Stage	Patient	
SUBTYPE	HotPink	Breast Invasive Carcinoma (Broad, Nature 2012)	STRING	Subtype	Patient	
STUDY_ID	HotPink	Metastatic Breast Cancer (INSERM, PLoS Med 2016)	STRING	Study ID	Patient	
BEST_RESPONSE_TO_THERAPY	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Best Response to Therapy	Patient	
BLOCK_ACCESSION	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	block accession	Patient	
COMMENTS	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Comments.	Patient	
FRACTION_GENOME_ALTERED	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	NUMBER	Fraction Genome Altered	Sample	0.1565 ; 0.2533 ; 0.6218 ; 0.1038 ; 0.3070 ; 0.0364 ; 0.2324 ; 0.2287 ; 0.3847 ; 0.5632 ; 0.1807 ; 0.3038 ; 0.2584 ; 0.3508 ; 0.0664 ; 0.1848 ; 0.3939 ; 0.6389 ; 0.2638 ; 0.6420 ; 0.0433 ; 0.0935 ; 0.0967 ; 0.4888 ; 0.3328 ; 0.5693 ; 0.2282 ; 0.6115 ; 0.1014 ; 0.6313 ; 0.2450 ; 0.2425 ; 0.1328 ; 0.2393 ; 0.0197 ; 0.4175 ; 0.2707 ; 0.1541 ; 0.2331 ; 0.6065 ; 0.0496 ; 0.2071 ; 0.0804 ; 0.1357 ; 0.5070 ; 0.2437 ; 0.2659 ; 0.1077 ; 0.1658 ; 0.0918 ; 0.0781 ; 0.1066 ; 0.4439 ; 0.2606 ; 0.3178 ; 0.5257 ; 0.4827 ; 0.0633 ; 0.4419 ; 0.4294 ; 0.0561 ; 0.1511 ; 0.4225 ; 0.4912 ; 0.2116 ; 0.2344 ; 0.5444 ; 0.3489 ; 0 ; 0.0021 ; 0.0070 ; 0.1644 ; 0.1675 ; 0.5319 ; 0.3956 ; 0.0795 ; 0.2517 ; 0.2728 ; 0.0010 ; 0.4713 ; 0.0271 ; 0.4940 ; 0.2644 ; 0.1904 ; 0.3594 ; 0.2975 ; 0.0867 ; 0.2110 ; 0.3599 ; 0.5844 ; 0.4611 ; 0.2160 ; 0.6769 ; 0.3498 ; 0.1604 ; 0.1220 ; 0.0619 ; 0.1389 ; 0.2804 ; 0.3300 ; 0.0181 ; 0.1924 ; 0.5023 ; 0.3117 ; 0.4096 ; 0.3805 ; 0.4682 ; 0.4717 ; 0.1235 ; 0.0772 ; 0.1594 ; 0.0173 ; 0.3030 ; 0.1957 ; 0.0370 ; 0.0453 ; 0.1401 ; 0.2277 ; 0.0625 ; 0.2094 ; 0.0001 ; 0.2771 ; 0.0192 ; 0.0923 ; 0.5665 ; 0.2479 ; 0.2730 ; 0.1299 ; 0.0238 ; 0.0847 ; 0.1088 ; 0.3919 ; 0.1363 ; 0.3904 ; 0.1261 ; 0.0188 ; 0.1956 ; 0.0071 ; 0.5572 ; 0.2187 ; 0.0373 ; 0.2249 ; 0.3217 ; 0.2509 ; 0.2083 ; 0.3056 ; 0.1287 ; 0.2928 ; 0.5149 ; 0.0028 ; 0.7093 ; 0.1696 ; 0.4260 ; 0.0366 ; 0.1391 ; 0.2652 ; 0.3344 ; 0.5659 ; 0.1210 ; 0.5131 ; 0.2544 ; 0.2498 ; 0.3202 ; 0.4590 ; 0.2521 ; 0.6256 ; 0.2668 ; 0.1471 ; 0.4476 ; 0.3347 ; 0.6571 ; 0.2246 ; 0.3013 ; 0.0110 ; 0.4821 ; 0.3500 ; 0.5945 ; 0.2404 ; 0.3121 ; 0.2589 ; 0.3777 ; 0.2458 ; 0.4510 ; 0.3431 ; 0.3467 ; 0.2773 ; 0.3074 ; 0.3684 ; 0.4453 ; 0.0143 ; 0.1217 ; 0.4931 ; 0.1060 ; 0.4926 ; 0.2748 ; 0.4027 ; 0.6867 ; 0.3140 ; 0.3756 ; 0.2901 ; 0.2414 ; 0.7005 ; 0.3227 ; 0.2811 ; 0.4029 ; 0.4956 ; 0.7094 ; 0.1027 ; 0.3465 ; 0.1555 ; 0.0763 ; 0.2176 ; 0.0340 ; 0.2981 ; 0.0119 ; 0.9463 ; 0.6407 ; 0.4163 ; 0.3928 ; 0.4696 ; 0.4622 ; 0.0288 ; 0.7015 ; 0.7399 ; 0.4274 ; 0.6731 ; 0.0950 ; 0.7824 ; 0.6170 ; 0.4434 ; 0.4998 ; 0.6513 ; 0.7563 ; 0.5222 ; 0.5356 ; 0.4533 ; 0.7810 ; 0.5313 ; 0.7061 ; 0.6677 ; 0.4668 ; 0.4340 ; 0.5025 ; 0.2146 ; 0.0853 ; 0.3822 ; 0.6310 ; 0.6214 ; 0.6936 ; 0.0237 ; 0.1548 ; 0.3991 ; 0.7327 ; 0.3834 ; 0.5981 ; 0.8535 ; 0.5979 ; 0.8331 ; 0.5386 ; 0.0109 ; 0.5144 ; 0.7700 ; 0.3136 ; 0.7041 ; 0.0901 ; 0.0000 ; 0.5152 ; 0.3686 ; 0.4407 ; 0.5378 ; 0.4552 ; 0.6191 ; 0.5381 ; 0.5402 ; 0.4834 ; 0.0895 ; 0.4875 ; 0.4237 ; 0.4452 ; 0.9025 ; 0.4681 ; 0.0657 ; 0.4982 ; 0.5101 ; 0.6161 ; 0.4262 ; 0.3435 ; 0.3953 ; 0.2605 ; 0.6060 ; 0.0710 ; 0.4856 ; 0.0027 ; 0.2303 ; 0.4432 ; 0.5742 ; 0.0848 ; 0.7127 ; 0.3320 ; 0.2263 ; 0.6710 ; 0.4764 ; 0.3468 ; 0.2665 ; 0.0291 ; 0.5383 ; 0.4189 ; 0.4950 ; 0.1791 ; 0.3518 ; 0.1673 ; 0.4491 ; 0.2866 ; 0.4276 ; 0.2130 ; 0.1868 ; 0.7158 ; 0.2907 ; 0.4417 ; 0.2609 ; 0.4975 ; 0.2434 ; 0.3591 ; 0.1065 ; 0.3250 ; 0.0591 ; 0.3619 ; 0.2545 ; 0.6527 ; 0.2783 ; 0.5033 ; 0.5527 ; 0.3844 ; 0.2446 ; 0.6450 ; 0.3997 ; 0.3454 ; 0.5728 ; 0.4871 ; 0.2213 ; 0.0491 ; 0.3390 ; 0.5399 ; 0.2237 ; 0.1253 ; 0.6304 ; 0.6096 ; 0.3385 ; 0.4088 ; 0.2311 ; 0.2697 ; 0.5081 ; 0.2977 ; 0.2233 ; 0.3556 ; 0.2475 ; 0.4986 ; 0.2736 ; 0.3800 ; 0.6421 ; 0.2357 ; 0.4388 ; 0.6024 ; 0.6652 ; 0.0305 ; 0.6192 ; 0.0603 ; 0.1399 ; 0.1179 ; 0.1698 ; 0.1132 ; 0.1516 ; 0.1771 ; 0.0892 ; 0.2325 ; 0.2619 ; 0.4882 ; 0.1988 ; 0.0836 ; 0.2309 ; 0.1143 ; 0.0134 ; 0.3174 ; 0.0493 ; 0.3395 ; 0.2833 ; 0.0924 ; 0.1221 ; 0.0627 ; 0.3296 ; 0.1867 ; 0.1308 ; 0.2724 ; 0.3029 ; 0.0531 ; 0.5843 ; 0.0845 ; 0.1767 ; 0.2171 ; 0.2837 ; 0.1891 ; 0.1036 ; 0.2284 ; 0.1229 ; 0.2568 ; 0.0595 ; 0.1153 ; 0.1161 ; 0.0729 ; 0.3425 ; 0.4003 ; 0.1316 ; 0.0982 ; 0.2922 ; 0.5678 ; 0.1522 ; 0.1108 ; 0.1319 ; 0.3132 ; 0.0724 ; 0.2656 ; 0.2086 ; 0.1967 ; 0.1110 ; 0.5175 ; 0.5078 ; 0.1470 ; 0.1281 ; 0.0056 ; 0.8633 ; 0.2365 ; 0.2305 ; 0.3681 ; 0.3068 ; 0.3623 ; 0.2741 ; 0.1043 ; 0.0790 ; 0.1630 ; 0.1734 ; 0.1178 ; 0.4013 ; 0.6142 ; 0.3585 ; 0.2512 ; 0.1198 ; 0.2206 ; 0.1372 ; 0.0870 ; 0.1535 ; 0.1154 ; 0.1025 ; 0.0862 ; 0.5876 ; 0.3270 ; 0.0661 ; 0.2496 ; 0.2451 ; 0.4705 ; 0.0741 ; 0.1520 ; 0.2386 ; 0.0928 ; 0.2134 ; 0.1003 ; 0.1567 ; 0.1353 ; 0.2474 ; 0.1789 ; 0.4600 ; 0.0945 ; 0.7708 ; 0.3042 ; 0.2136 ; 0.6103 ; 0.2875 ; 0.1612 ; 0.2830 ; 0.1819 ; 0.2758 ; 0.0864 ; 0.6502 ; 0.6432 ; 0.2105 ; 0.1054 ; 0.2863 ; 0.4219 ; 0.1923 ; 0.5104 ; 0.0930 ; 0.0703 ; 0.1170 ; 0.3321 ; 0.1429 ; 0.1633 ; 0.3072 ; 0.0264 ; 0.5374 ; 0.1710 ; 0.0004 ; 0.1049 ; 0.5805 ; 0.1949 ; 0.4504 ; 0.3332 ; 0.5133 ; 0.2092 ; 0.1617 ; 0.3076 ; 0.0851 ; 0.4849 ; 0.2941 ; 0.0817 ; 0.3367 ; 0.2882 ; 0.1378 ; 0.2156 ; 0.1214 ; 0.2853 ; 0.2342 ; 0.0936 ; 0.0180 ; 0.6741 ; 0.1009 ; 0.4653 ; 0.3749 ; 0.1678 ; 0.1869 ; 0.1591 ; 0.2622 ; 0.1608 ; 0.1927 ; 0.1997 ; 0.2195 ; 0.1622 ; 0.0606 ; 0.0838 ; 0.0207 ; 0.0719 ; 0.3048 ; 0.2630 ; 0.1460 ; 0.0757 ; 0.2329 ; 0.1483 ; 0.0053 ; 0.2579 ; 0.0490 ; 0.1835 ; 0.4779 ; 0.1942 ; 0.3826 ; 0.0482 ; 0.1347 ; 0.2998 ; 0.1888 ; 0.1498 ; 0.1094 ; 0.2935 ; 0.1936 ; 0.3571 ; 0.0269 ; 0.0302 ; 0.0002 ; 0.1381 ; 0.4632 ; 0.3799 ; 0.3537 ; 0.4298 ; 0.3127 ; 0.2358 ; 0.5814 ; 0.6033 ; 0.0787 ; 0.6182 ; 0.3453 ; 0.3607 ; 0.0827 ; 0.4345 ; 0.3215 ; 0.6621 ; 0.5461 ; 0.7671 ; 0.5363 ; 0.9470 ; 0.2607 ; 0.3924 ; 0.5648 ; 0.4203 ; 0.2534 ; 0.1794 ; 0.5528 ; 0.2209 ; 0.3154 ; 0.3672 ; 0.6388 ; 0.3856 ; 0.2207 ; 0.3303 ; 0.2489 ; 0.5337 ; 0.2109 ; 0.3023 ; 0.4427 ; 0.2300 ; 0.3929 ; 0.3307 ; 0.3083 ; 0.0756 ; 0.7056 ; 0.1121 ; 0.2643 ; 0.2215 ; 0.5584 ; 0.3914 ; 0.6549 ; 0.5927 ; 0.7074 ; 0.3639 ; 0.4588 ; 0.4787 ; 0.8203 ; 0.1231 ; 0.2398 ; 0.6614 ; 0.5338 ; 0.6372 ; 0.5434 ; 0.0683 ; 0.3867 ; 0.4981 ; 0.2338 ; 0.4565 ; 0.6977 ; 0.5959 ; 0.4749 ; 0.3816 ; 0.1205 ; 0.4832 ; 0.2947 ; 0.3773 ; 0.3265 ; 0.3796 ; 0.6855 ; 0.2818 ; 0.2787 ; 0.2493 ; 0.1509 ; 0.5521 ; 0.1201 ; 0.2488 ; 0.1275 ; 0.3875 ; 0.3859 ; 0.8185 ; 0.1890 ; 0.4255 ; 0.2328 ; 0.2904 ; 0.1500 ; 0.1667 ; 0.3045 ; 0.3503 ; 0.1333 ; 0.5344 ; 0.3504 ; 0.2971 ; 0.3587 ; 0.2376 ; 0.5116 ; 0.4360 ; 0.7348 ; 0.2502 ; 0.3133 ; 0.4767 ; 0.1946 ; 0.1145 ; 0.2774 ; 0.3490 ; 0.1055 ; 0.0338 ; 0.4249 ; 0.2442 ; 0.2679 ; 0.5755 ; 0.4961 ; 0.9462 ; 0.3632 ; 0.9971 ; 0.4715 ; 0.4385 ; 0.0222 ; 0.5273 ; 0.2258 ; 0.0908 ; 0.1545 ; 0.1001 ; 0.6267 ; 0.5352 ; 0.0641 ; 0.1298 ; 0.2346 ; 0.1457 ; 0.6832 ; 0.5787 ; 0.4675 ; 0.0542 ; 0.1163 ; 0.3066 ; 0.0005 ; 0.4859 ; 0.1150 ; 0.4147 ; 0.1074 ; 0.1035 ; 0.3513 ; 0.1273 ; 0.5293 ; 0.5026 ; 0.1086 ; 0.1817 ; 0.5575 ; 0.2858 ; 0.2323 ; 0.3942 ; 0.3918 ; 0.8977 ; 0.4140 ; 0.2687 ; 0.2212 ; 0.0008 ; 0.2015 ; 0.0969 ; 0.3313 ; 0.5518 ; 0.3999 ; 0.6055 ; 0.4239 ; 0.1485 ; 0.1756 ; 0.1531 ; 0.1071 ; 0.1189 ; 0.4302 ; 0.3264 ; 0.2363 ; 0.3373 ; 0.3177 ; 0.2490 ; 0.2219 ; 0.6589 ; 0.3921 ; 0.4019 ; 0.5448 ; 0.5029 ; 0.1676 ; 0.4509 ; 0.3295 ; 0.2038 ; 0.4579 ; 0.2005 ; 0.3426 ; 0.1579 ; 0.1106 ; 0.0332 ; 0.1587 ; 0.6640 ; 0.3412 ; 0.3411 ; 0.2168 ; 0.1646 ; 0.2671 ; 0.0713 ; 0.5036 ; 0.3845 ; 0.6718 ; 0.0162 ; 0.2369 ; 0.6568 ; 0.0082 ; 0.1268 ; 0.2689 ; 0.1605 ; 0.5135 ; 0.5180 ; 0.3198 ; 0.3238 ; 0.3564 ; 0.5880 ; 0.5299 ; 0.2254 ; 0.4187 ; 0.2019 ; 0.1661 ; 0.3008 ; 0.7389 ; 0.1640 ; 0.3573 ; 0.2448 ; 0.3667 ; 0.4688 ; 0.6207 ; 0.3900 ; 0.4374 ; 0.4906 ; 0.3656 ; 0.6736 ; 0.1263 ; 0.4267 ; 0.2815 ; 0.8612 ; 0.2170 ; 0.0566 ; 0.1480 ; 0.6723 ; 0.1533 ; 0.3525 ; 0.5466 ; 0.3387 ; 0.2173 ; 0.9465 ; 0.0342 ; 0.3797 ; 0.3139 ; 0.3560 ; 0.3854 ; 0.5329 ; 0.3094 ; 0.6120 ; 0.6698 ; 0.1084 ; 0.4824 ; 0.0458 ; 0.1113 ; 0.2982 ; 0.2527 ; 0.0485 ; 0.3549 ; 0.3774 ; 0.2631 ; 0.1180 ; 0.3813 ; 0.5139 ; 0.1685 ; 0.4490 ; 0.4112 ; 0.0515 ; 0.1288 ; 0.4586 ; 0.1645 ; 0.0944 ; 0.3391 ; 0.1072 ; 0.5605 ; 0.1889 ; 0.4015 ; 0.0779 ; 0.1846 ; 0.2459 ; 0.7276 ; 0.4243 ; 0.4230 ; 0.1313 ; 0.0132 ; 0.4963 ; 0.0874 ; 0.1230 ; 0.3954 ; 0.1040 ; 0.0970 ; 0.3226 ; 0.3326 ; 0.3172 ; 0.2577 ; 0.4507 ; 0.3827 ; 0.0886 ; 0.6044 ; 0.2996 ; 0.2262 ; 0.5125 ; 0.4068 ; 0.6107 ; 0.4291 ; 0.2557 ; 0.0506 ; 0.1701 ; 0.1635 ; 0.3124 ; 0.2412 ; 0.2295 ; 0.4323 ; 0.8768 ; 0.1039 ; 0.1011 ; 0.3765 ; 0.0345 ; 0.7006 ; 0.4018 ; 0.1266 ; 0.0676 ; 0.0644 ; 0.0078 ; 0.1777 ; 0.9022 ; 0.3884 ; 0.4637 ; 0.5930 ; 0.6261 ; 0.2439 ; 0.2396 ; 0.4697 ; 0.2559 ; 0.0919 ; 0.3026 ; 0.3329 ; 0.1758 ; 0.4664 ; 0.1908 ; 0.1508 ; 0.2122 ; 0.1413 ; 0.2286 ; 0.4130 ; 0.1934 ; 0.2932 ; 0.1815 ; 0.0055 ; 0.0649 ; 0.0343 ; 0.1024 ; 0.0011 ; 0.0024 ; 0.0788 ; 0.5576 ; 0.4456 ; 0.6891 ; 0.6367 ; 0.5093 ; 0.5712 ; 0.3189 ; 0.4238 ; 0.4139 ; 0.5238 ; 0.5938 ; 0.2236 ; 0.2244 ; 0.4178 ; 0.4822 ; 0.1496 ; 0.5082 ; 0.5975 ; 0.4748 ; 0.5073 ; 0.6449 ; 0.6540 ; 0.7120 ; 0.2526 ; 0.2440 ; 0.1436 ; 0.1651 ; 0.1810 ; 0.1537 ; 0.3382 ; 0.5769 ; 0.4742 ; 0.4517 ; 0.4188 ; 0.2302 ; 0.0497 ; 0.3501 ; 0.3394 ; 0.2647 ; 0.2769 ; 0.4736 ; 0.5655 ; 0.0550 ; 0.1954 ; 0.3341 ; 0.1920 ; 0.4218 ; 0.6893 ; 0.1127 ; 0.4728 ; 0.5060 ; 0.1279 ; 0.5508 ; 0.3874 ; 0.4862 ; 0.4473 ; 0.1840 ; 0.1454 ; 0.3545 ; 0.5799 ; 0.2247 ; 0.2471 ; 0.4257 ; 0.3310 ; 0.6342 ; 0.4935 ; 0.6384 ; 0.2379 ; 0.2976 ; 0.4628 ; 0.4073 ; 0.0186 ; 0.2339 ; 0.5447 ; 0.5158 ; 0.6402 ; 0.1598 ; 0.4072 ; 0.4617 ; 0.5865 ; 0.3414 ; 0.2706 ; 0.0526 ; 0.1870 ; 0.0564 ; 0.4235 ; 0.6230 ; 0.5771 ; 0.7763 ; 0.1625 ; 0.1507 ; 0.9194 ; 0.3903 ; 0.3660 ; 0.4999 ; 0.1680 ; 0.8133 ; 0.2889 ; 0.5848 ; 0.0537 ; 0.3962 ; 0.3374 ; 0.2511 ; 0.5412 ; 0.3958 ; 0.3666 ; 0.3057 ; 0.5143 ; 0.3841 ; 0.4386 ; 0.5249 ; 0.3721 ; 0.5080 ; 0.4169 ; 0.4660 ; 0.4437 ; 0.0203 ; 0.2375 ; 0.3375 ; 0.5264 ; 0.4899 ; 0.6458 ; 0.3186 ; 0.4201 ; 0.5783 ; 0.2522 ; 0.4195 ; 0.2052 ; 0.1491 ; 0.3223 ; 0.5314 ; 0.6241 ; 0.1900 ; 0.6598 ; 0.0294 ; 0.3197 ; 0.2573 ; 0.3067 ; 0.4683 ; 0.4661 ; 0.3598 ; 0.3401 ; 0.5807 ; 0.3479 ; 0.6661 ; 0.5382 ; 0.3047 ; 0.3618 ; 0.3569 ; 0.3363 ; 0.0567 ; 0.2726 ; 0.3409 ; 0.4320 ; 0.6379 ; 0.5476 ; 0.1486 ; 0.3738 ; 0.2735 ; 0.3729 ; 0.5372 ; 0.2850 ; 0.4577 ; 0.4550 ; 0.6346 ; 0.2592 ; 0.2827 ; 0.7049 ; 0.1978 ; 0.0067 ; 0.1751 ; 0.3445 ; 0.6873 ; 0.4501 ; 0.6962 ; 0.2909 ; 0.4593 ; 0.4466 ; 0.5083 ; 0.2817 ; 0.1932 ; 0.2292 ; 0.2591 ; 0.2939 ; 0.0445 ; 0.1852 ; 0.6140 ; 0.2042 ; 0.3836 ; 0.4282 ; 0.3100 ; 0.3148 ; 0.3742 ; 0.1693 ; 0.4412 ; 0.4179 ; 0.3910 ; 0.4304 ; 0.1879 ; 0.2484 ; 0.3331 ; 0.4275 ; 0.1725 ; 0.3379 ; 0.0652 ; 0.0846 ; 0.5220 ; 0.7681 ; 0.2112 ; 0.3922 ; 0.6550 ; 0.2010 ; 0.0605 ; 0.0579 ; 0.0466 ; 0.1858 ; 0.5128 ; 0.7993 ; 0.5130 ; 0.2961 ; 0.2570 ; 0.5590 ; 0.3835 ; 0.3327 ; 0.3965 ; 0.4414 ; 0.1674 ; 0.0953 ; 0.3823 ; 0.4794 ; 0.5976 ; 0.4185 ; 0.3049 ; 0.4465 ; 0.5113 ; 0.4801 ; 0.4252 ; 0.3433 ; 0.3293 ; 0.5462 ; 0.7917 ; 0.3528 ; 0.5138 ; 0.2883 ; 0.4714 ; 0.5658 ; 0.5015 ; 0.2405 ; 0.6768 ; 0.7118 ; 0.7599 ; 0.3665 ; 0.2714 ; 0.1894 ; 0.4409 ; 0.5300 ; 0.3635 ; 0.3162 ; 0.6611 ; 0.3689 ; 0.6503 ; 0.1059 ; 0.7011 ; 0.3935 ; 0.1482 ; 0.3539 ; 0.4858 ; 0.5134 ; 0.6858 ; 0.4545 ; 0.5743 ; 0.5948 ; 0.3886 ; 0.2121 ; 0.5163 ; 0.1917 ; 0.2248 ; 0.2064 ; 0.3898 ; 0.6942 ; 0.2279 ; 0.1373 ; 0.5631 ; 0.2432 ; 0.3546 ; 0.8231 ; 0.7237 ; 0.1280 ; 0.5241 ; 0.2272 ; 0.0507 ; 0.9131 ; 0.4110 ; 0.1203 ; 0.7518 ; 0.4335 ; 0.3995 ; 0.3734 ; 0.4892 ; 0.3601 ; 0.7802 ; 0.2335 ; 0.5140 ; 0.0460 ; 0.4064 ; 0.7231 ; 0.1947 ; 0.6119 ; 0.2878 ; 0.2072 ; 0.4381 ; 0.3897 ; 0.4303 ; 0.3153 ; 0.7164 ; 0.1878 ; 0.8165 ; 0.3949 ; 0.3014 ; 0.6920 ; 0.4394 ; 0.1557 ; 0.2917 ; 0.1686 ; 0.5691 ; 0.2756 ; 0.3727 ; 0.8488 ; 0.5816 ; 0.1818 ; 0.0634 ; 0.3876 ; 0.8423 ; 0.1811 ; 0.3448 ; 0.1495 ; 0.1412 ; 0.3625 ; 0.2381 ; 0.2926 ; 0.2214 ; 0.8288 ; 0.7216 ; 0.1812 ; 0.2330 ; 0.0501 ; 0.2472 ; 0.1911 ; 0.3661 ; 0.4155 ; 0.5736 ; 0.4352 ; 0.3583 ; 0.2712 ; 0.3304 ; 0.0732 ; 0.1062 ; 0.3130 ; 0.1475 ; 0.1720 ; 0.2470 ; 0.6308 ; 0.5272 ; 0.6394 ; 0.3436 ; 0.4720 ; 0.3371 ; 0.2691 ; 0.3403 ; 0.1096 ; 0.1058 ; 0.4009 ; 0.2031 ; 0.7186 ; 0.6232 ; 0.5652 ; 0.5898 ; 0.3185 ; 0.3971 ; 0.5231 ; 0.4063 ; 0.5453 ; 0.5196 ; 0.2633 ; 0.2223 ; 0.3019 ; 0.1239 ; 0.1131 ; 0.4424 ; 0.5954 ; 0.2762 ; 0.3937 ; 0.3021 ; 0.3175 ; 0.3702 ; 0.6123 ; 0.4815 ; 0.0630 ; 0.7996 ; 0.2473 ; 0.1833 ; 0.3386 ; 0.4780 ; 0.3336 ; 0.3925 ; 0.3015 ; 0.5847 ; 0.2563 ; 0.2478 ; 0.6300 ; 0.4086 ; 0.2035 ; 0.1073 ; 0.3739 ; 0.3181 ; 0.5640 ; 0.5732 ; 0.1348 ; 0.1166 ; 0.2141 ; 0.3555 ; 0.0057 ; 0.4761 ; 0.9389 ; 0.2285 ; 0.0171 ; 0.2449 ; 0.3406 ; 0.5907 ; 0.5858 ; 0.5955 ; 0.5757 ; 0.5019 ; 0.2884 ; 0.2101 ; 0.2288 ; 0.5672 ; 0.0759 ; 0.6916 ; 0.2394 ; 0.6783 ; 0.1951 ; 0.6146 ; 0.3668 ; 0.6082 ; 0.2079 ; 0.3934 ; 0.4156 ; 0.2925 ; 0.2401 ; 0.5275 ; 0.0240 ; 0.5030 ; 0.5965 ; 0.3170 ; 0.2753 ; 0.3404 ; 0.2345 ; 0.1785 ; 0.3393 ; 0.1305 ; 0.6084 ; 0.4174 ; 0.6185 ; 0.5193 ; 0.2316 ; 0.0287 ; 0.2985 ; 0.4802 ; 0.6025 ; 0.4158 ; 0.1609 ; 0.5115 ; 0.3407 ; 0.4823 ; 0.6496 ; 0.4332 ; 0.6183 ; 0.2795 ; 0.6619 ; 0.5268 ; 0.8258 ; 0.3567 ; 0.3881 ; 0.3693 ; 0.0880 ; 0.0706 ; 0.1832 ; 0.2114 ; 0.0250 ; 0.8613 ; 0.3872 ; 0.1538 ; 0.5499 ; 0.4544 ; 0.8038 ; 0.4723 ; 0.1410 ; 0.1692 ; 0.0504 ; 0.0764 ; 0.2999 ; 0.4123 ; 0.4244 ; 0.4812 ; 0.4327 ; 0.3478 ; 0.0830 ; 0.1464 ; 0.6869 ; 0.1254 ; 0.2564 ; 0.2513 ; 0.3720 ; 0.2886 ; 0.5393 ; 0.5552 ; 0.0511 ; 0.7026 ; 0.1017 ; 0.3752 ; 0.7528 ; 0.7364 ; 0.2469 ; 0.4699 ; 0.2066 ; 0.1752 ; 0.4137 ; 0.0943 ; 0.0668 ; 0.0974 ; 0.2395 ; 0.6355 ; 0.0304 ; 0.5353 ; 0.0960 ; 0.5560 ; 0.4482 ; 0.6399 ; 0.4919 ; 0.6495 ; 0.5324 ; 0.2149 ; 0.0955 ; 0.1755 ; 0.2988 ; 0.2599 ; 0.4941 ; 0.1871 ; 0.2468 ; 0.1284 ; 0.2174 ; 0.6953 ; 0.2418 ; 0.0026 ; 0.3917 ; 0.3851 ; 0.1984 ; 0.4708 ; 0.1218 ; 0.4458 ; 0.4934 ; 0.6276 ; 0.5800 ; 0.5701 ; 0.5013 ; 0.3421 ; 0.3974 ; 0.2315 ; 0.4101 ; 0.2616 ; 0.0642 ; 0.3461 ; 0.3753 ; 0.1551 ; 0.1747 ; 0.8131 ; 0.2899 ; 0.4958 ; 0.3679 ; 0.2043 ; 0.0003 ; 0.3588 ; 0.3801 ; 0.0516 ; 0.2128 ; 0.1070 ; 0.3241 ; 0.2371 ; 0.3062 ; 0.6099 ; 0.3346 ; 0.8650 ; 0.3378 ; 0.4363 ; 0.1082 ; 0.2547 ; 0.0280 ; 0.3906 ; 0.4326 ; 0.6812 ; 0.1926 ; 0.0801 ; 0.1371 ; 0.7568 ; 0.4880 ; 0.7475 ; 0.5418 ; 0.5105 ; 0.5567 ; 0.0587 ; 0.1886 ; 0.5216 ; 0.5664 ; 0.4106 ; 0.2129 ; 0.3973 ; 0.2230 ; 0.4841 ; 0.0157 ; 0.4642 ; 0.2676 ; 0.2245 ; 0.6202 ; 0.2519 ; 0.1716 ; 0.0467 ; 0.2869 ; 0.5789 ; 0.3838 ; 0.1860 ; 0.3840 ; 0.4568 ; 0.6945 ; 0.3168 ; 0.1757 ; 0.5076 ; 0.4543 ; 0.4200 ; 0.5770 ; 0.3469 ; 0.3644 ; 0.0527 ; 0.4339 ; 0.3211 ; 0.1492 ; 0.0372 ; 0.2566 ; 0.5321 ; 0.3035 ; 0.8500 ; 0.1671 ; 0.5248 ; 0.3004 ; 0.6534 ; 0.2731 ; 0.1529 ; 0.0185 ; 0.4301 ; 0.9385 ; 0.6725 ; 0.6117 ; 0.6057 ; 0.2859 ; 0.5680 ; 0.3111 ; 0.0929 ; 0.3911 ; 0.1527 ; 0.2800 ; 0.6223 ; 0.2571 ; 0.6414 ; 0.8935 ; 0.1192 ; 0.2520 ; 0.2460 ; 0.0196 ; 0.4167 ; 0.0897 ; 0.0581 ; 0.5294 ; 0.0258 ; 0.1845 ; 0.2226 ; 0.1602 ; 0.2281 ; 0.5854 ; 0.5836 ; 0.3580 ; 0.4804 ; 0.4367 ; 0.3511 ; 0.7312 ; 0.3405 ; 0.6624 ; 0.5957 ; 0.5751 ; 0.2823 ; 0.5198 ; 0.0915 ; 0.3536 ; 0.9839 ; 0.2060 ; 0.1320 ; 0.3943 ; 0.5142 ; 0.3757 ; 0.8829 ; 0.4777 ; 0.1290 ; 0.5179 ; 0.3036 ; 0.4578 ; 0.0560 ; 0.5643 ; 0.4311 ; 0.6917 ; 0.4576 ; 0.2984 ; 0.6773 ; 0.5642 ; 0.2242 ; 0.0061 ; 0.6029 ; 0.3092 ; 0.6630 ; 0.9594 ; 0.6249 ; 0.7337 ; 0.7263 ; 0.3892 ; 0.1837 ; 0.6625 ; 0.3353 ; 0.0932 ; 0.2028 ; 0.4467 ; 0.5762 ; 0.7051 ; 0.0208 ; 0.2104 ; 0.4428 ; 0.2636 ; 0.5568 ; 0.6089 ; 0.0996 ; 0.6220 ; 0.4817 ; 0.1026 ; 0.7942 ; 0.2717 ; 0.0992 ; 0.5983 ; 0.1142 ; 0.0775 ; 0.3416 ; 0.5120 ; 0.6539 ; 0.2389 ; 0.1340 ; 0.1322 ; 0.3163 ; 0.5616 ; 0.0428 ; 0.0512 ; 0.4922 ; 0.4597 ; 0.5200 ; 0.2234 ; 0.3122 ; 0.3244 ; 0.1432 ; 0.1729 ; 0.2380 ; 0.3160 ; 0.0301 ; 0.4390 ; 0.5667 ; 0.3358 ; 0.0114 ; 0.5210 ; 0.4991 ; 0.4264 ; 0.5679 ; 0.1137 ; 0.2742 ; 0.3690 ; 0.6243 ; 0.0738 ; 0.1057 ; 0.4043 ; 0.9650 ; 0.2515 ; 0.1723 ; 0.5237 ; 0.5856 ; 0.2250 ; 0.0156 ; 0.0131 ; 0.3901 ; 0.4433 ; 0.1728 ; 0.2661 ; 0.5651 ; 0.7723 ; 0.3459 ; 0.4119 ; 0.6255 ; 0.6970 ; 0.8638 ; 0.2733 ; 0.0434 ; 0.0339 ; 0.0463 ; 0.1332 ; 0.6101 ; 0.3297 ; 0.8333 ; 0.0559 ; 0.0251 ; 0.3440 ; 0.6282 ; 0.3458 ; 0.3206 ; 0.0578 ; 0.0727 ; 0.5159 ; 0.3380 ; 0.2775 ; 0.4099 ; 0.1252 ; 0.7735 ; 0.3338 ; 0.1950 ; 0.3966 ; 0.4670 ; 0.0390 ; 0.2699 ; 0.4100 ; 0.5480 ; 0.1982 ; 0.3605 ; 0.0049 ; 0.3337 ; 0.0698 ; 0.3612 ; 0.5031 ; 0.3305 ; 0.2097 ; 0.5225 ; 0.0681 ; 0.3251 ; 0.5802 ; 0.0066 ; 0.1090 ; 0.1128 ; 0.2612 ; 0.1056 ; 0.6378 ; 0.7036 ; 0.1255 ; 0.3398 ; 0.5796 ; 0.5741 ; 0.6062 ; 0.0199 ; 0.0454 ; 0.1970 ; 0.0439 ; 0.6231 ; 0.5387 ; 0.3166 ; 0.2721 ; 1.0000 ; 0.3520 ; 0.1877 ; 0.1730 ; 0.0961 ; 0.3437 ; 0.6016 ; 0.3446 ; 0.5850 ; 0.1136 ; 0.6273 ; 0.3106 ; 0.0396 ; 0.0484 ; 0.4618 ; 0.5420 ; 0.3318 ; 0.3451 ; 0.2781 ; 0.4266 ; 0.3658 ; 0.1034 ; 0.1613 ; 0.2476 ; 0.7300 ; 0.0471 ; 0.3559 ; 0.0913 ; 0.2298 ; 0.6246 ; 0.8609 ; 0.1829 ; 0.1177 ; 0.2698 ; 0.0645 ; 0.8296 ; 0.1853 ; 0.6642 ; 0.0612 ; 0.8922 ; 0.1975 ; 0.9642 ; 0.1561 ; 0.5258 ; 0.1706 ; 0.4398 ; 0.6730 ; 0.2807 ; 0.6515 ; 0.2593 ; 0.2683 ; 0.1202 ; 0.2767 ; 0.3673 ; 0.3286 ; 0.3728 ; 0.7351 ; 0.0814 ; 0.2873 ; 0.4108 ; 0.7040 ; 0.4542 ; 0.2962 ; 0.2150 ; 0.6919 ; 0.6037 ; 0.2879 ; 0.1184 ; 0.2540 ; 0.2791 ; 0.0705 ; 0.6206 ; 0.2778 ; 0.2854 ; 0.1116 ; 0.5496 ; 0.1451 ; 0.0789 ; 0.1005 ; 0.3471 ; 0.2870 ; 0.9158 ; 0.0553 ; 0.4181 ; 0.0060 ; 0.1433 ; 0.3043 ; 0.3361 ; 0.3817 ; 0.1119 ; 0.5176 ; 0.2871 ; 0.4224 ; 0.5904 ; 0.5547 ; 0.0336 ; 0.7286 ; 0.1283 ; 0.0263 ; 0.0159 ; 0.0400 ; 0.0069 ; 0.1903 ; 0.5405 ; 0.6293 ; 0.4737 ; 0.1787 ; 0.1556 ; 0.6987 ; 0.2653 ; 0.2495 ; 0.0881 ; 0.0486 ; 0.0265 ; 0.1623 ; 0.9299 ; 0.4650 ; 0.5147 ; 0.2313 ; 0.1928 ; 0.3399 ; 0.1151 ; 0.6008 ; 0.0007 ; 0.4028 ; 0.2634 ; 0.5545 ; 0.1237 ; 0.0800 ; 0.4030 ; 0.3550 ; 0.2217 ; 0.1013 ; 0.6918 ; 0.7790 ; 0.0530 ; 0.5662 ; 0.6467 ; 0.1101 ; 0.2189 ; 0.2949 ; 0.4581 ; 0.2085 ; 0.6211 ; 0.4497 ; 0.0455 ; 0.0639 ; 0.2819 ; 0.2989 ; 0.0916 ; 0.3155 ; 0.4060 ; 0.6001 ; 0.9350 ; 0.6765 ; 0.5887 ; 0.3883 ; 0.1490 ; 0.0374 ; 0.2444 ; 0.2549 ; 0.1959 ; 0.1739 ; 0.2583 ; 0.0990 ; 0.4904 ; 0.3649 ; 0.4485 ; 0.0988 ; 0.1679 ; 0.4598 ; 0.5004 ; 0.0680 ; 0.2070 ; 0.1000 ; 0.4116 ; 0.1489 ; 0.2124 ; 0.5934 ; 0.2915 ; 0.9202 ; 0.3771 ; 0.2855 ; 0.5505 ; 0.7008 ; 0.0309 ; 0.3064 ; 0.0430 ; 0.5371 ; 0.5281 ; 0.8505 ; 0.3994 ; 0.5558 ; 0.2127 ; 0.1856 ; 0.0316 ; 0.1339 ; 0.2751 ; 0.6573 ; 0.9084 ; 0.6805 ; 0.1996 ; 0.8249 ; 0.3278 ; 0.9239 ; 0.2651 ; 0.3457 ; 0.4855 ; 0.4342 ; 0.2266 ; 0.2542 ; 0.2538 ; 0.1616 ; 0.5206 ; 0.6006 ; 0.5897 ; 0.1233 ; 0.3871 ; 0.3280 ; 0.1547 ; 0.2430 ; 0.4711 ; 0.2424 ; 0.0201 ; 0.0556 ; 0.0241 ; 0.1251 ; 0.0794 ; 0.0655 ; 0.3108 ; 0.4587 ; 0.3120 ; 0.0708 ; 0.1338 ; 0.1719 ; 0.4775 ; 0.0524 ; 0.3309 ; 0.3626 ; 0.1167 ; 0.2740 ; 0.4319 ; 0.3267 ; 0.3242 ; 0.5390 ; 0.3262 ; 0.0547 ; 0.2076 ; 0.0198 ; 0.6102 ; 0.3705 ; 0.3147 ; 0.3763 ; 0.1103 ; 0.6976 ; 0.2703 ; 0.8338 ; 0.4236 ; 0.0583 ; 0.0046 ; 0.9386 ; 0.7776 ; 0.0939 ; 0.3532 ; 0.2794 ; 0.2198 ; 0.3372 ; 0.2062 ; 0.5039 ; 0.3703 ; 0.2068 ; 0.0545 ; 0.3218 ; 0.0777 ; 0.5918 ; 0.0629 ; 0.1769 ; 0.2523 ; 0.3574 ; 0.4299 ; 0.1849 ; 0.4462 ; 0.2075 ; 0.5543 ; 0.0981 ; 0.4927 ; 0.5874 ; 0.4401 ; 0.0972 ; 0.1321 ; 0.0190 ; 0.0948 ; 0.0546 ; 0.5234 ; 0.4117 ; 0.5373 ; 0.7283 ; 0.4515 ; 0.7439 ; 0.2422 ; 0.1352 ; 0.0036 ; 0.0267 ; 0.4223 ; 0.2805 ; 0.0742 ; 0.1207 ; 0.2900 ; 0.3747 ; 0.0776 ; 0.0855 ; 0.2539 ; 0.7370 ; 0.7117 ; 0.1238 ; 0.4184 ; 0.5008 ; 0.2427 ; 0.0508 ; 0.5441 ; 0.3915 ; 0.3450 ; 0.3384 ; 0.1955 ; 0.1503 ; 0.0737 ; 0.6531 ; 0.0025 ; 0.2433 ; 0.6756 ; 0.2896 ; 0.5666 ; 0.8067 ; 0.5219 ; 0.5878 ; 0.1953 ; 0.1702 ; 0.1974 ; 0.0118 ; 0.0421 ; 0.1905 ; 0.6690 ; 0.7705 ; 0.5840 ; 0.0525 ; 0.5221 ; 0.5581 ; 0.6169 ; 0.2253 ; 0.1874 ; 0.1958 ; 0.1805 ; 0.1326 ; 0.2018 ; 0.0834 ; 0.1493 ; 0.0750 ; 0.3462 ; 0.1293 ; 0.0383 ; 0.6200 ; 0.2148 ; 0.6593 ; 0.3977 ; 0.1966 ; 0.4601 ; 0.4148 ; 0.3495 ; 0.1786 ; 0.4572 ; 0.6665 ; 0.2238 ; 0.2806 ; 0.6843 ; 0.4125 ; 0.1487 ; 0.0195 ; 0.6519 ; 0.0261 ; 0.0823 ; 0.4351 ; 0.5690 ; 0.5677 ; 0.6318 ; 0.6743 ; 0.0934 ; 0.1276 ; 0.6960 ; 0.3792 ; 0.0548 ; 0.1753 ; 0.7376 ; 0.8528 ; 0.0753 ; 0.3712 ; 0.4144 ; 0.0622 ; 0.2565 ; 0.4395 ; 0.3497 ; 0.0875 ; 0.3781 ; 0.1656 ; 0.1408 ; 0.1075 ; 0.1649 ; 0.2803 ; 0.1915 ; 0.0252 ; 0.1343 ; 0.1983 ; 0.1061 ; 0.3744 ; 0.0857 ; 0.2041 ; 0.0998 ; 0.2273 ; 0.1614 ; 0.2115 ; 0.0723 ; 0.4034 ; 0.1211 ; 0.2650 ; 0.0882 ; 0.0225 ; 0.0382 ; 0.0205 ; 0.0369 ; 0.4608 ; 0.1219 ; 0.0429 ; 0.2677 ; 0.2649 ; 0.3289 ; 0.1446 ; 0.0137 ; 0.1227 ; 0.6821 ; 0.6459 ; 0.5254 ; 0.4842 ; 0.3784 ; 0.1568 ; 0.0829 ; 0.7142 ; 0.3034 ; 0.5792 ; 0.3427 ; 0.6104 ; 0.4151 ; 0.2829 ; 0.1120 ; 0.0626 ; 0.0770 ; 0.0679 ; 0.0150 ; 0.3167 ; 0.3142 ; 0.2304 ; 0.0448 ; 0.0816 ; 0.1249 ; 0.2340 ; 0.1172 ; 0.1636 ; 0.0586 ; 0.0761 ; 0.4232 ; 0.0745 ; 0.3724 ; 0.3552 ; 0.1042 ; 0.0740 ; 0.3803 ; 0.1697 ; 0.1525 ; 0.0438 ; 0.0832 ; 0.0468 ; 0.4463 ; 0.2312 ; 0.2240 ; 0.0249 ; 0.2877 ; 0.0062 ; 0.4078 ; 0.0809 ; 0.2202 ; 0.0686 ; 0.2709 ; 0.0965 ; 0.0009 ; 0.0736 ; 0.0728 ; 0.1139 ; 0.0577 ; 0.0394 ; 0.1222 ; 0.4810 ; 0.1781 ; 0.4890 ; 0.2179 ; 0.0206 ; 0.0843 ; 0.0230 ; 0.0211 ; 0.5551 ; 0.0450 ; 0.1259 ; 0.3354 ; 0.0015 ; 0.0303 ; 0.3150 ; 0.2506 ; 0.2144 ; 0.3481 ; 0.1575 ; 0.3006 ; 0.0371 ; 0.3760 ; 0.0410 ; 0.0755 ; 0.2504 ; 0.2378 ; 0.1240 ; 0.3905 ; 0.0125 ; 0.4226 ; 0.7181 ; 0.4474 ; 0.0334 ; 0.4204 ; 0.1277 ; 0.5544 ; 0.5697 ; 0.5100 ; 0.3870 ; 0.0762 ; 0.1409 ; 0.2314 ; 0.3578 ; 0.3984 ; 0.0565 ; 0.0876 ; 0.3597 ; 0.0419 ; 0.3334 ; 0.1256 ; 0.4261 ; 0.3775 ; 0.0018 ; 0.0912 ; 0.3171 ; 0.2916 ; 0.1171 ; 0.7305 ; 0.1738 ; 0.2666 ; 0.4673 ; 0.1694 ; 0.2385 ; 0.4644 ; 0.0212 ; 0.2898 ; 0.6164 ; 0.0065 ; 0.3704 ; 0.3885 ; 0.1031 ; 0.4477 ; 0.5170 ; 0.1323 ; 0.1169 ; 0.4164 ; 0.0064 ; 0.0714 ; 0.2188 ; 0.1659 ; 0.0608 ; 0.1447 ; 0.2667 ; 0.1662 ; 0.2535 ; 0.2186 ; 0.3330 ; 0.5964 ; 0.5879 ; 0.5360 ; 0.4814 ; 0.6349 ; 0.2755 ; 0.2093 ; 0.0042 ; 0.5127 ; 0.6839 ; 0.7067 ; 0.3053 ; 0.7140 ; 0.1952 ; 0.1257 ; 0.0602 ; 0.1504 ; 0.0035 ; 0.2106 ; 0.0079 ; 0.4914 ; 0.3196 ; 0.4048 ; 0.2203 ; 0.2306 ; 0.1434 ; 0.3086 ; 0.3824 ; 0.2604 ; 0.0997 ; 0.4864 ; 0.5781 ; 0.3352 ; 0.4495 ; 0.2435 ; 0.3370 ; 0.2888 ; 0.7457 ; 0.5064 ; 0.2351 ; 0.0023 ; 0.5168 ; 0.3129 ; 0.1032 ; 0.1012 ; 0.0440 ; 0.4324 ; 0.1497 ; 0.2402 ; 0.1505 ; 0.3085 ; 0.3986 ; 0.4994 ; 0.4415 ; 0.1654 ; 0.0783 ; 0.0978 ; 0.0038 ; 0.3315 ; 0.1715 ; 0.2768 ; 0.0214 ; 0.5079 ; 0.2765 ; 0.0031 ; 0.2016 ; 0.1524 ; 0.1476 ; 0.2397 ; 0.2797 ; 0.0013 ; 0.1624 ; 0.3302 ; 0.4724 ; 0.4680 ; 0.1140 ; 0.4263 ; 0.2974 ; 0.1147 ; 0.2050 ; 0.3159 ; 0.2986 ; 0.0849 ; 0.2383 ; 0.3410 ; 0.1876 ; 0.2406 ; 0.0966 ; 0.1717 ; 0.6233 ; 0.2349 ; 0.0701 ; 0.0331 ; 0.0734 ; 0.0044 ; 0.1943 ; 0.2098 ; 0.0076 ; 0.5156 ; 0.2507 ; 0.2321 ; 0.1285 ; 0.3709 ; 0.0329 ; 0.2322 ; 0.6121 ; 0.5020 ; 0.0963 ; 0.2259 ; 0.2426 ; 0.3360 ; 0.4694 ; 0.1749 ; 0.7492 ; 0.2078 ; 0.2364 ; 0.2682 ; 0.1182 ; 0.0478 ; 0.0538 ; 0.2529 ; 0.4719 ; 0.2390 ; 0.0473 ; 0.2627 ; 0.6686 ; 0.1468 ; 0.2120 ; 0.1388 ; 0.4575 ; 0.1053 ; 0.0568 ; 0.2680 ; 0.4307 ; 0.1264 ; 0.4546 ; 0.2095 ; 0.3722 ; 0.6086 ; 0.3669 ; 0.0032 ; 0.2708 ; 0.0413 ; 0.4634 ; 0.5432 ; 0.3079 ; 0.2994 ; 0.1909 ; 0.3863 ; 0.2601 ; 0.2727 ; 0.0352 ; 0.0358 ; 0.3340 ; 0.1200 ; 0.1971 ; 0.2861 ; 0.5342 ; 0.0399 ; 0.4214 ; 0.4359 ; 0.2845 ; 0.0146 ; 0.2997 ; 0.0047 ; 0.1759 ; 0.4368 ; 0.1270 ; 0.4525 ; 0.0037 ; 0.3152 ; 0.4953 ; 0.2528 ; 0.2069 ; 0.4566 ; 0.3932 ; 0.2980 ; 0.3182 ; 0.4344 ; 0.5849 ; 0.0147 ; 0.5151 ; 0.3524 ; 0.2844 ; 0.0299 ; 0.1518 ; 0.1045 ; 0.4627 ; 0.1990 ; 0.0153 ; 0.1325 ; 0.3538 ; 0.0149 ; 0.1560 ; 0.2008 ; 0.0087 ; 0.1677 ; 0.2359 ; 0.2621 ; 0.2801 ; 0.1228 ; 0.4036 ; 0.0160 ; 0.2022 ; 0.0259 ; 0.0423 ; 0.5230 ; 0.4676 ; 0.2835 ; 0.4918 ; 0.6280 ; 0.2099 ; 0.8709 ; 0.1989 ; 0.2026 ; 0.3474 ; 0.6636 ; 0.0292 ; 0.1961 ; 0.4309 ; 0.3683 ; 0.4120 ; 0.1376 ; 0.0979 ; 0.0051 ; 0.4562 ; 0.2532 ; 0.0427 ; 0.2480 ; 0.4669 ; 0.0589 ; 0.8403 ; 0.4626 ; 0.2169 ; 0.6981 ; 0.0878 ; 0.5141 ; 0.1590 ; 0.6227 ; 0.2006 ; 0.2096 ; 0.0624 ; 0.2319 ; 0.3534 ; 0.1740 ; 0.3510 ; 0.2785 ; 0.4624 ; 0.3245 ; 0.2353 ; 0.2953 ; 0.4820 ; 0.0805 ; 0.3891 ; 0.5868 ; 0.2400 ; 0.2862 ; 0.2029 ; 0.7750 ; 0.7128 ; 0.5269 ; 0.5707 ; 0.2126 ; 0.2810 ; 0.5430 ; 0.1722 ; 0.3051 ; 0.2923 ; 0.2693 ; 0.5970 ; 0.0246 ; 0.2159 ; 0.5793 ; 0.2268 ; 0.2615 ; 0.5203 ; 0.4480 ; 0.0307 ; 0.1244 ; 0.5760 ; 0.2391 ; 0.2637 ; 0.1761 ; 0.2658 ; 0.6574 ; 0.2360 ; 0.2987 ; 0.2004 ; 0.1774 ; 0.6168 ; 0.6577 ; 0.1421 ; 0.4896 ; 0.1400 ; 0.2809 ; 0.0039 ; 0.0826 ; 0.3819 ; 0.1945 ; 0.1286 ; 0.4286 ; 0.2228 ; 0.1895 ; 0.5277 ; 0.3920 ; 0.3054 ; 0.2750 ; 0.0102 ; 0.0133 ; 0.6610 ; 0.0401 ; 0.5398 ; 0.2014 ; 0.6626 ; 0.2874 ; 0.3642 ; 0.1863 ; 0.2645 ; 0.6114 ; 0.2623 ; 0.5998 ; 0.4050 ; 0.2463 ; 0.3755 ; 0.3487 ; 0.4379 ; 0.2646 ; 0.2745 ; 0.0909 ; 0.0685 ; 0.3983 ; 0.4954 ; 0.0904 ; 0.4229 ; 0.4529 ; 0.5577 ; 0.1670 ; 0.3199 ; 0.5233 ; 0.0574 ; 0.1782 ; 0.2688 ; 0.0380 ; 0.4567 ; 0.2790 ; 0.5615 ; 0.1813 ; 0.1416 ; 0.2280 ; 0.7523 ; 0.1406 ; 0.5289 ; 0.1300 ; 0.6948 ; 0.0730 ; 0.0112 ; 0.0651 ; 0.6036 ; 0.0145 ; 0.6647 ; 0.3025 ; 0.3858 ; 0.3779 ; 0.2789 ; 0.3193 ; 0.8687 ; 0.2705 ; 0.0942 ; 0.2590 ; 0.4750 ; 0.5202 ; 0.3060 ; 0.0029 ; 0.0127 ; 0.0219 ; 0.5223 ; 0.0444 ; 0.3254 ; 0.1866 ; 0.1776 ; 0.1519 ; 0.3842 ; 0.3077 ; 0.7845 ; 0.0359 ; 0.8010 ; 0.5446 ; 0.1558 ; 0.2597 ; 0.5056 ; 0.7222 ; 0.9606 ; 0.5297 ; 0.3878 ; 0.5745 ; 0.8529 ; 0.6408 ; 0.0048 ; 0.6563 ; 0.3183 ; 0.1129 ; 0.1828 ; 0.2832 ; 0.0355 ; 0.3633 ; 0.0030 ; 0.1726 ; 0.0813 ; 0.2891 ; 0.2117 ; 0.1814 ; 0.2518 ; 0.6794 ; 0.3839 ; 0.2757 ; 0.6153 ; 0.0432 ; 0.3515 ; 0.5839 ; 0.7013 ; 0.1940 ; 0.4850 ; 0.3849 ; 0.4247 ; 0.6156 ; 0.1016 ; 0.1050 ; 0.3314 ; 0.0786 ; 0.2719 ; 0.4205 ; 0.2828 ; 0.2702 ; 0.0068 ; 0.0077 ; 0.2770 ; 0.1215 ; 0.3429 ; 0.0596 ; 0.1836 ; 0.4530 ; 0.7224 ; 0.0014 ; 0.1405 ; 0.2162 ; 0.2764 ; 0.1513 ; 0.2193 ; 0.0333 ; 0.4041 ; 0.3544 ; 0.2135 ; 0.4745 ; 0.1993 ; 0.7368 ; 0.1973 ; 0.1291 ; 0.2467 ; 0.4416 ; 0.3444 ; 0.2231 ; 0.5365 ; 0.3216 ; 0.2334 ; 0.5724 ; 0.5777 ; 0.4619 ; 0.4594 ; 0.6204 ; 0.2635 ; 0.2927 ; 0.0554 ; 0.3101 ; 0.0034 ; 0.0858 ; 0.4084 ; 0.0315 ; 0.5301 ; 0.0947 ; 0.1185 ; 0.2903 ; 0.2133 ; 0.2155 ; 0.3923 ; 0.6620 ; 0.4659 ; 0.1015 ; 0.1801 ; 0.0872 ; 0.5972 ; 0.1068 ; 0.5821 ; 0.0058 ; 0.0417 ; 0.0431 ; 0.1370 ; 0.1672 ; 0.1292 ; 0.0760 ; 0.6357 ; 0.0033 ; 0.4338 ; 0.3192 ; 0.1844 ; 0.4610 ; 0.1123 ; 0.3558 ; 0.3356 ; 0.0964 ; 0.5685 ; 0.5424 ; 0.0095 ; 0.6181 ; 0.4684 ; 0.2438 ; 0.0293 ; 0.6391 ; 0.1987 ; 0.1842 ; 0.0245 ; 0.0407 ; 0.4591 ; 0.5565 ; 0.0320 ; 0.5995 ; 0.0006 ; 0.2192 ; 0.0243 ; 0.0019 ; 0.0442 ; 0.2912 ; 0.3365 ; 0.2464 ; 0.6472 ; 0.4121 ; 0.1803 ; 0.0346 ; 0.2461 ; 0.1583 ; 0.4065 ; 0.4909 ; 0.6470 ; 0.0059 ; 0.1099 ; 0.2143 ; 0.7555 ; 0.6052 ; 0.5267 ; 0.2347 ; 0.2165 ; 0.0080 ; 0.0803 ; 0.4870 ; 0.6846 ; 0.0091 ; 0.1397 ; 0.2077 ; 0.2024 ; 0.2569 ; 0.1795 ; 0.2744 ; 0.2419 ; 0.2289 ; 0.1144 ; 0.0365 ; 0.6802 ; 0.3700 ; 0.2204 ; 0.1159 ; 0.4759 ; 0.3512 ; 0.3247 ; 0.2293 ; 0.1797 ; 0.5247 ; 0.1648 ; 0.5754 ; 0.3024 ; 0.6151 ; 0.3663 ; 0.2581 ; 0.2839 ; 0.5359 ; 0.0397 ; 0.2920 ; 0.6986 ; 0.3770 ; 0.4851 ; 0.2048 ; 0.3581 ; 0.2113 ; 0.1784 ; 0.2152 ; 0.3081 ; 0.2227 ; 0.0470 ; 0.1820 ; 0.4532 ; 0.1174 ; 0.2628 ; 0.3735 ; 0.5587 ; 0.3475 ; 0.1631 ; 0.1100 ; 0.5819 ; 0.4481 ; 0.5148 ; 0.0799 ; 0.0377 ; 0.6144 ; 0.1317 ; 0.3156 ; 0.6455 ; 0.4004 ; 0.0022 ; 0.3492 ; 0.6490 ; 0.0569 ; 0.3540 ; 0.3271 ; 0.2211 ; 0.3902 ; 0.0563 ; 0.0873 ; 0.5051 ; 0.2260 ; 0.4001 ; 0.4879 ; 0.0124 ; 0.2831 ; 0.4549 ; 0.0532 ; 0.4161 ; 0.0959 ; 0.2362 ; 0.0831 ; 0.0418 ; 0.2931 ; 0.6483 ; 0.1115 ; 0.2142 ; 0.0529 ; 0.0475 ; 0.3782 ; 0.3652 ; 0.1419 ; 0.3887 ; 0.2936 ; 0.1798 ; 0.1267 ; 0.1714 ; 0.4524 ; 0.0272 ; 0.1194 ; 0.0615 ; 0.5288 ; 0.3188 ; 0.0274 ; 0.4868 ; 0.1092 ; 0.1265 ; 0.3463 ; 0.2001 ; 0.4421 ; 0.1183 ; 0.1297 ; 0.0139 ; 0.1539 ; 0.3402 ; 0.3195 ; 0.3531 ; 0.3312 ; 0.7482 ; 0.2675 ; 0.4596 ; 0.4996 ; 0.2548 ; 0.4758 ; 0.2102 ; 0.6819 ; 0.0239 ; 0.2505 ; 0.6247 ; 0.0854 ; 0.4049 ; 0.0105 ; 0.0802 ; 0.6504 ; 0.5901 ; 0.7930 ; 0.7249 ; 0.9487 ; 0.4075 ; 0.4762 ; 0.6312 ; 0.6877 ; 0.8618 ; 0.0856 ; 0.9395 ; 0.2857 ; 0.9013 ; 0.7764 ; 0.7807 ; 0.6982 ; 0.7075 ; 0.7618 ; 0.1864 ; 0.6085 ; 0.5414 ; 0.6590 ; 0.2270 ; 0.1477 ; 0.7260 ; 0.4171 ; 0.6315 ; 0.2216 ; 0.1770 ; 0.1444 ; 0.1754 ; 0.6834 ; 0.3959 ; 0.4499 ; 0.0090 ; 0.4183 ; 0.4392 ; 0.2560 ; 0.6118 ; 0.3272 ; 0.1426 ; 0.3791 ; 0.4387 ; 0.4348 ; 0.3282 ; 0.1311 ; 0.1991 ; 0.1872 ; 0.4429 ; 0.5086 ; 0.5103 ; 0.3530 ; 0.2178 ; 0.5888 ; 0.3853 ; 0.3284 ; 0.1657 ; 0.2530 ; 0.2241 ; 0.1204 ; 0.2455 ; 0.1384 ; 0.2825 ; 0.5535 ; 0.4472 ; 0.6184 ; 0.5703 ; 0.7354 ; 0.1887 ; 0.4836 ; 0.2578 ; 0.2294 ; 0.3933 ; 0.0323 ; 0.3455 ; 0.0540 ; 0.3895 ; 0.6245 ; 0.3359 ; 0.1390 ; 0.0379 ; 0.2183 ; 0.1224 ; 0.2600 ; 0.1655 ; 0.3979 ; 0.0662 ; 0.5533 ; 0.5005 ; 0.0416 ; 0.0628 ; 0.0696 ; 0.1663 ; 0.2049 ; 0.1465 ; 0.2175 ; 0.1699 ; 0.8102 ; 0.9247 ; 0.2950 ; 0.1463 ; 0.4924 ; 0.2003 ; 0.1711 ; 0.2684 ; 0.5469 ; 0.0922 ; 0.0135 ; 0.1458 ; 0.3758 ; 0.2913 ; 0.1336 ; 0.2626 ; 0.2715 ; 0.1592 ; 0.3087 ; 0.3780 ; 0.1306 ; 0.0514 ; 0.1597 ; 0.0692 ; 0.2553 ; 0.2163 ; 0.4494 ; 0.2822 ; 0.3572 ; 0.4206 ; 0.1404 ; 0.1652 ; 0.4686 ; 0.1469 ; 0.2632 ; 0.3890 ; 0.5784 ; 0.2084 ; 0.4010 ; 0.4054 ; 0.0224 ; 0.4535 ; 0.1621 ; 0.4925 ; 0.4059 ; 0.5596 ; 0.1392 ; 0.4800 ; 0.1695 ; 0.4639 ; 0.7676 ; 0.1570 ; 0.3862 ; 0.3566 ; 0.5058 ; 0.0182 ; 0.5209 ; 0.5419 ; 0.2033 ; 0.6039 ; 0.4604 ; 0.2377 ; 0.6126 ; 0.6781 ; 0.8802 ; 0.5478 ; 0.3037 ; 0.4897 ; 0.1705 ; 0.2044 ; 0.5947 ; 0.3261 ; 0.3018 ; 0.7838 ; 0.6582 ; 0.6364 ; 0.7894 ; 0.3213 ; 0.0962 ; 0.5278 ; 0.8781 ; 0.8846 ; 0.5657 ; 0.0985 ; 0.3281 ; 0.6927 ; 0.5583 ; 0.8305 ; 0.8514 ; 0.7978 ; 0.8791 ; 0.8670 ; 0.3482 ; 0.4122 ; 0.8477 ; 0.4874 ; 0.7241 ; 0.4182 ; 0.8139 ; 0.5422 ; 0.6434 ; 0.8320 ; 0.8391 ; 0.7053 ; 0.7702 ; 0.3103 ; 0.4872 ; 0.6694 ; 0.1653 ; 0.3443 ; 0.4620 ; 0.5706 ; 0.6329 ; 0.6125 ; 0.4067 ; 0.5687 ; 0.2959 ; 0.3716 ; 0.3818 ; 0.0488 ; 0.6900 ; 0.4450 ; 0.7001 ; 0.7821 ; 0.4308 ; 0.2002 ; 0.2554 ; 0.0092 ; 0.6644 ; 0.1627 ; 0.2575 ; 0.0850 ; 0.1862 ; 0.4559 ; 0.3308 ; 0.6187 ; 0.2256 ; 0.7393 ; 0.5339 ; 0.4373 ; 0.6606 ; 0.4948 ; 0.3809 ; 0.6888 ; 0.2586 ; 0.3987 ; 0.4757 ; 0.3820 ; 0.7997 ; 0.3596 ; 0.6303 ; 0.0236 ; 0.3785 ; 0.7774 ; 0.8243 ; 0.3003 ; 0.2040 ; 0.3449 ; 0.2366 ; 0.5204 ; 0.8082 ; 0.7459 ; 0.7509 ; 0.7972 ; 0.6400 ; 0.2990 ; 0.6090 ; 0.7883 ; 0.7226 ; 0.6035 ; 0.8140 ; 0.8336 ; 0.6643 ; 0.6871 ; 0.5725 ; 0.7762 ; 0.4551 ; 0.1499 ; 0.6078 ; 0.3882 ; 0.4242 ; 0.1135 ; 0.2541 ; 0.5109 ; 0.3466 ; 0.1834 ; 0.2940 ; 0.6517 ; 0.7952 ; 0.3707 ; 0.8407 ; 0.2964 ; 0.2017 ; 0.8146 ; 0.6499 ; 0.3825 ; 0.5001 ; 0.2372 ; 0.2639 ; 0.6288 ; 0.8353 ; 0.4154 ; 0.1526 ; 0.5772 ; 0.6833 ; 0.8048 ; 0.1552 ; 0.4808 ; 0.4256 ; 0.0123 ; 0.8379 ; 0.8627 ; 0.2151 ; 0.5240 ; 0.5641 ; 0.5709 ; 0.8631 ; 0.8090 ; 0.1368 ; 0.4221 ; 0.5016 ; 0.6558 ; 0.2291 ; 0.0999 ; 0.0905 ; 0.2166 ; 0.8573 ; 0.7113 ; 0.8681 ; 0.7613 ; 0.7741 ; 0.4792 ; 0.7785 ; 0.7577 ; 0.7633 ; 0.8172 ; 0.6592 ; 0.8032 ; 0.7692 ; 0.8558 ; 0.8442 ; 0.7936 ; 0.7859 ; 0.6395 ; 0.4051 ; 0.3249 ; 0.6212 ; 0.1430 ; 0.7951 ; 0.5729 ; 0.8615 ; 0.7747 ; 0.7927 ; 0.3725 ; 0.3114 ; 0.7064 ; 0.4602 ; 0.7430 ; 0.0669 ; 0.2531 ; 0.3350 ; 0.0949 ; 0.4228 ; 0.0549 ; 0.3948 ; 0.2788 ; 0.6433 ; 0.3717 ; 0.4648 ; 0.2734 ; 0.6995 ; 0.5072 ; 0.5245 ; 0.1456 ; 0.5862 ; 0.6993 ; 0.5566 ; 0.4731 ; 0.5077 ; 0.6201 ; 0.4693 ; 0.6853 ; 0.8301 ; 0.2384 ; 0.3837 ; 0.6418 ; 0.6734 ; 0.6537 ; 0.4176 ; 0.4687 ; 0.3230 ; 0.0678 ; 0.8790 ; 0.3428 ; 0.6026 ; 0.5645 ; 0.5853 ; 0.2261 ; 0.6356 ; 0.6180 ; 0.4921 ; 0.6632 ; 0.8204 ; 0.5479 ; 0.3864 ; 0.0725 ; 0.6188 ; 0.4092 ; 0.2232 ; 0.4915 ; 0.9228 ; 0.4843 ; 0.0938 ; 0.1854 ; 0.1574 ; 0.2021 ; 0.0984 ; 0.2516 ; 0.5065 ; 0.2670 ; 0.0275 ; 0.5900 ; 0.5638 ; 0.1117 ; 0.1329 ; 0.3579 ; 0.1223 ; 0.3754 ; 0.1051 ; 0.1216 ; 0.5445 ; 0.4752 ; 0.0716 ; 0.0443 ; 0.0767 ; 0.4806 ; 0.5550 ; 0.1367 ; 0.1157 ; 0.0325 ; 0.0451 ; 0.1708 ; 0.5715 ; 0.0894 ; 0.6939 ; 0.0052 ; 0.3733 ; 0.0040 ; 0.7743 ; 0.5960 ; 0.6816 ; 0.4149 ; 0.5066 ; 0.4656 ; 0.3151 ; 0.7932 ; 0.0837 ; 0.3713 ; 0.0273 ; 0.0911 ; 0.1517 ; 0.3616 ; 0.5284 ; 0.5906 ; 0.2012 ; 0.1282 ; 0.5951 ; 0.0368 ; 0.1778 ; 0.0570 ; 0.5530 ; 0.7465 ; 0.0041 ; 0.4698 ; 0.6208 ; 0.0489 ; 0.0684 ; 0.4145 ; 0.4799 ; 0.3000 ; 0.1994 ; 0.4090 ; 0.1883 ; 0.4895 ; 0.1324 ; 0.1912 ; 0.0989 ; 0.5613 ; 0.2153 ; 0.0598 ; 0.6020 ; 0.1632 ; 0.3715 ; 0.6645 ; 0.5937 ; 0.6347 ; 0.4614 ; 0.0215 ; 0.1742 ; 0.1481 ; 0.0535 ; 0.1839 ; 0.4194 ; 0.2373 ; 0.1111 ; 0.1209 ; 0.2481 ; 0.2933 ; 0.0120 ; 0.6392 ; 0.1764 ; 0.7787 ; 0.5340 ; 0.0702 ; 0.0798 ; 0.4133 ; 0.0328 ; 0.1344 ; 0.1393 ; 0.0045 ; 0.2749 ; 0.7412 ; 0.1356 ; 0.1821 ; 0.3460 ; 0.5875 ; 0.5014 ; 0.3125 ; 0.0452 ; 0.3342 ; 0.1639 ; 0.5776 ; 0.3009
GENE_PANEL	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Gene panel.	Sample	IMPACT341 ; IMPACT468 ; IMPACT410 ; WES
MONTHS_ON_STUDY	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	NUMBER	months on study	Patient	
MONTHS_ON_TREATMENT	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	NUMBER	Months on Treatment	Patient	
OTHER_PATIENT_ID	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Legacy DMP patient identifier (DMPnnnn)	Patient	
PATIENT_STUDY_ID	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	patient study id	Patient	
PIK3CA_MUTATION	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	PIK3CA mutation is present.	Sample	YES ; NO
REASON_FOR_TX_DISCONTINUATION	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	reason for tx discontinuation	Patient	
SAMPLE_CLASS	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	The sample classification (i.e., tumor, cellline, xenograph).	Sample	Tumor ; Primary Resection ; Biopsy 1 ; Biopsy 2 ; Biopsy 3 ; Biopsy 4 ; cfDNA ; Xenograft
SAMPLE_ORIGIN	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Sample origin	Sample	FFPE
SNAPSHOT_MUTATIONS	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	snapshot mutations	Sample	Not detected ; NE ; PTEN loss/p110a gain (unconfirmed) ; PIK3CA_pE545K ; PIK3CA_pE542K ; PIK3CA_pH1047R
STATUS	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Status.	Patient	
STUDY_ARM	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	study arm	Patient	
THERAPY	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	therapy	Patient	
TREATMENT_BEST_RESPONSE	HotPink	Breast Cancer (MSK, NPJ Breast Cancer 2019)	STRING	Treatment best response	Patient	
ER	HotPink	Juvenile Papillomatosis and Breast Cancer (MSK,J Pathol. 2015)	STRING	ER	Sample	+
HER2	HotPink	Juvenile Papillomatosis and Breast Cancer (MSK,J Pathol. 2015)	STRING	HER2	Sample	-
DX_PSTAGE	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Diagnosis P Stage	Patient	
HISTOLOGY	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Histology	Patient	
MSI_COMMENT	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	MSI Comment	Sample	MICROSATELLITE STABLE (MSS). See MSI note below. ; MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below. ; MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below. ; MICROSATELLITE INSTABILITY-INDETERMINATE. This result is for investigational use only. See MSI note below.
MSI_SCORE	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	NUMBER	MSI Score	Sample	1.68 ; 3.96 ; 0.4 ; 0.89 ; 1.33 ; 0.23 ; 1.62 ; 0 ; 0.48 ; 0.49 ; 0.7 ; 0.25 ; 0.17 ; 0.08 ; 2.68 ; 0.59 ; 1.01 ; 1.17 ; 1.37 ; 1.9 ; 0.93 ; 0.09 ; 2.44 ; 0.79 ; 0.58 ; 1.25 ; 2.51 ; 0.42 ; 5.09 ; 0.36 ; 0.37 ; 0.26 ; 0.34 ; 0.07 ; 0.1 ; 0.2 ; 0.9 ; 0.71 ; 1.07 ; 0.16 ; 0.27 ; 6.23 ; 0.14 ; 0.3 ; 1.86 ; 0.47 ; 2.26 ; 4.37 ; 0.22 ; 3.37 ; 0.18 ; 3.43 ; 0.24 ; 0.76 ; 0.91 ; 1.39 ; 1.77 ; 0.78 ; 5.53 ; 0.45 ; 0.62 ; 0.32 ; 0.51 ; 1.36 ; 1.52 ; 2.07 ; 1.57 ; 1.2 ; 0.06 ; 1.22 ; 1.03 ; 1.21 ; 0.97 ; 0.13 ; 2.23 ; 1.11 ; 2.41 ; 1.61 ; 4.3 ; 1.04 ; 2.49 ; 2.69 ; 1.02 ; 1.85 ; 0.57 ; 3.42 ; 0.99 ; 0.8 ; 1.58 ; 1.53 ; 0.56 ; 0.74 ; 1.16 ; 0.38 ; 1.64 ; 3.99 ; 0.73 ; 1.13 ; 1.41 ; 5.43 ; 1.51 ; 0.05 ; 0.28 ; 2.55 ; -1 ; 18.54 ; 1.15 ; 0.64 ; 0.11 ; 0.68 ; 18.84 ; 2.5 ; 1.08 ; 1.6 ; 1.27 ; 0.63 ; 1.23 ; 0.52 ; 1.12 ; 0.88 ; 1.45 ; 0.19 ; 0.65 ; 0.21 ; 1.3 ; 3.09 ; 0.29 ; 0.33 ; 0.54 ; 3.22 ; 2.13 ; 0.66 ; 1 ; 1.43 ; 0.41 ; 2.45 ; 5.7 ; 0.35 ; 1.98 ; 1.32 ; 2.05 ; 1.87 ; 0.39 ; 1.84 ; 1.4 ; 0.72 ; 0.84 ; 1.05 ; 3.14 ; 8.44 ; 3.12 ; 2.6 ; 0.94 ; 16.68 ; 2.93 ; 2.04 ; 1.96 ; 0.55 ; 1.56 ; 1.79 ; 1.65 ; 5.97 ; 0.61 ; 4.97 ; 2.27 ; 1.34 ; 1.46 ; 3.89 ; 0.31 ; 1.49 ; 0.69 ; 0.82 ; 1.42 ; 1.09 ; 16.88 ; 2.86 ; 0.87 ; 0.15 ; 2.58 ; 1.48 ; 1.7 ; 0.83 ; 0.53 ; 0.44 ; 0.77 ; 2.03 ; 2.1 ; 1.44 ; 3.17 ; 2 ; 2.09 ; 0.67 ; 1.59 ; 1.54 ; 2.12 ; 3.32 ; 0.5 ; 1.92 ; 3.62 ; 2.35 ; 2.43 ; 2.97 ; 3.68 ; 3.73 ; 18.38 ; 3.52 ; 3.33 ; 1.31 ; 2.16 ; 0.6 ; 0.12 ; 1.83 ; 4.36 ; 0.81 ; 1.55 ; 0.95 ; 14.52 ; 1.24 ; 2.99 ; 1.38 ; 0.98 ; 1.06 ; 1.66 ; 4.83 ; 2.02 ; 1.35 ; 1.88 ; 2.31 ; 2.75 ; 2.57 ; 2.36 ; 0.85 ; 4.96 ; 3.9 ; 2.87 ; 6.85 ; 0.43 ; 2.4 ; 4.55 ; 3 ; 2.15 ; 3.04 ; 1.63 ; 4.35 ; 2.08 ; 1.71 ; 5.65 ; 3.85 ; 2.8 ; 3.55 ; 2.22 ; 1.97 ; 3.29 ; 0.86 ; 0.75 ; 2.28 ; 2.29 ; 3.51 ; 1.18 ; 2.33 ; 2.48 ; 2.46 ; 3.76 ; 1.91 ; 0.96 ; 3.91 ; 3.7 ; 3.88 ; 3.93 ; 1.14 ; 3.05 ; 1.72 ; 5.04 ; 3.11 ; 3.01 ; 1.26 ; 2.59 ; 1.28 ; 2.89 ; 2.47 ; 2.78 ; 0.92 ; 3.25 ; 3.44 ; 2.2 ; 1.29 ; 3.06 ; 1.74 ; 3.92 ; 2.17 ; 1.89 ; 1.81 ; 3.5 ; 1.82 ; 3.6 ; 2.21 ; 3.47 ; 5.03 ; 3.69 ; 4.7 ; 2.81 ; 2.9 ; 1.47 ; 1.75 ; 2.54 ; 3.3 ; 3.28 ; 4.4 ; 3.21 ; 1.5 ; 0.46 ; 1.1 ; 4.2 ; 3.02 ; 2.01 ; 1.73 ; 3.98 ; 3.18 ; 2.64 ; 1.99 ; 3.26 ; 1.78 ; 3.27 ; 4.79 ; 2.73
MSI_TYPE	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	MSI Type	Sample	Stable ; Indeterminate ; Do not report ; Instable
OS_MONTHS	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	NUMBER	Overall survival in months since date of sequencing. If patient died before sequencing overall survival in months is set to '0'. If patient is alive and last contact date is before date of sequencing, overall survival in months is set to 'NA'	Patient	
OS_STATUS	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Overall patient survival status.	Patient	
PFS_MONTHS	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	NUMBER	Progress Free Survival (Months)	Patient	
PFS_STATUS	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Progression Free Status	Patient	
RACE	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	The text for reporting information about race.	Patient	
REASON_STOP	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Reason Stop	Patient	
RELIGION	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Religion	Patient	
SAMPLE_COVERAGE	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	NUMBER	Sample coverage	Sample	799 ; 2610 ; 407 ; 887 ; 1057 ; 850 ; 667 ; 446 ; 842 ; 336 ; 389 ; 674 ; 633 ; 1049 ; 234 ; 549 ; 782 ; 902 ; 445 ; 750 ; 476 ; 477 ; 186 ; 520 ; 274 ; 451 ; 737 ; 541 ; 506 ; 405 ; 670 ; 172 ; 433 ; 565 ; 510 ; 669 ; 283 ; 344 ; 556 ; 618 ; 352 ; 188 ; 778 ; 395 ; 502 ; 508 ; 163 ; 797 ; 767 ; 260 ; 772 ; 501 ; 440 ; 402 ; 762 ; 749 ; 960 ; 738 ; 906 ; 1131 ; 535 ; 834 ; 691 ; 1115 ; 922 ; 678 ; 871 ; 704 ; 952 ; 729 ; 714 ; 831 ; 919 ; 851 ; 621 ; 1062 ; 733 ; 908 ; 989 ; 610 ; 1121 ; 765 ; 693 ; 769 ; 999 ; 1043 ; 627 ; 1012 ; 435 ; 760 ; 660 ; 725 ; 828 ; 796 ; 681 ; 1091 ; 994 ; 297 ; 1094 ; 662 ; 844 ; 432 ; 776 ; 526 ; 746 ; 938 ; 970 ; 878 ; 874 ; 664 ; 900 ; 785 ; 741 ; 415 ; 400 ; 413 ; 652 ; 536 ; 781 ; 563 ; 635 ; 211 ; 416 ; 815 ; 739 ; 625 ; 544 ; 697 ; 953 ; 803 ; 425 ; 801 ; 471 ; 592 ; 686 ; 626 ; 671 ; 475 ; 281 ; 928 ; 1008 ; 293 ; 240 ; 1154 ; 1165 ; 840 ; 1259 ; 1031 ; 680 ; 619 ; 757 ; 811 ; 673 ; 468 ; 310 ; 483 ; 452 ; 504 ; 720
SAMPLE_STATUS	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Sample Status	Sample	pre-tx
SO_COMMENTS	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Sign-out comments	Sample	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.    Note: Assessment of the copy number profile is limited by increased background noise. ; Note: The RAD51B, TSHR and DICER1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1q.          Note: The MYC copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clini ; Note: The FGFR1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.        Note: Low sequencing depth of coverage of 172X, negative results should ; Note: The AXIN2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. ; Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution. ; Note: The ERBB2 and RARA copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. ; Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution. ; Note: The HOXB13 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. ; Note: The FYN and ROS1 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. ; Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by FISH has been performed ; Note: The PRKAR1A,  SOX9, RARA and H3F3B copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: Low tumor content (approximately 20% or le ; minor contamination normal ; Note: The PIK3CA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated. ; Note: The ERBB2 p.A37T mutation frequency suggests that the mutation occurs on the amplified allele ; Note: A comparison of variant frequencies suggests the PIK3CA p.E545K mutation is subclonal.    Note: The ERBB2  p.S310F suggests that the mutation occurs on the amplified allele ; Note: The copy number profile is suggestive of an intragenic gain of CDK12 exons7-14. ; Note: Copy number profile is suggestive of a fragmented genome.. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q. Note: Copy number profile is suggestive of broad copy number loss on Chromosome 17q21-25, 6q and 7q. Note: Copy number profile is suggestive of intragenic gain of CDK12 ex ; Note: Copy number profile is suggestive of a fragmented genome. ; Note: The FLCN copy number profile is suggestive of an amplification of exons 4-8 and intragenic deletion of exons 9-14. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 8q and 16p. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 1p32-34. ; Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 5p13, 9p21-24, 12q24, 17p, 17q11, and 17q21-25. Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q and 5q32-35. ; Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 11q14-24 (including ATM and KMT2A), 16q (including CDH1), and 17p (including TP53). Note: Copy number profile is suggestive of broad copy number gain on Chromosome 1q31-4 ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 21q. ; Note: The copy number profile from the MSK-IMPACT assay and an allele specific copy number analysis by FACETS is consistent with a fragmented genome. See M17-16643 for HER2 FISH analysis performed on a different tissue block from the same specimen. ; Note: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q21-24, including MYC. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 17q including ERBB2. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosomes arm 1q32-44. ; Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 8q and 17q22-25. Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms 3p13-21.1 (including BAP1), 6q15-23, 9p (including CDKN2A and CDKN2B ; Note: Copy number profile is suggestive of multiple chromosome level losses.
TMB	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	NUMBER	Total number of mutations divided by the length of the total genomic target region captured (mutations/Mbs)	Sample	1.1 ; 2.2 ; 3.3 ; 7.8 ; 8.9 ; 12.3 ; 3.5 ; 6.7 ; 4.5 ; 5.6 ; 0 ; 7 ; 1 ; 2 ; 3.9 ; 3 ; 7.9 ; 9.8 ; 5.9 ; 11.8 ; 4.9 ; 6.9 ; 24.6 ; 8.8 ; 4.4 ; 2.6 ; 1.8 ; 0.9 ; 6.1 ; 5.3 ; 10.5 ; 21.9
TUMOR_PURITY	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	NUMBER	Tumor Purity	Sample	50 ; 60 ; 70 ; 75 ; 30 ; 40 ; 35 ; 20 ; 90 ; 80 ; 10 ; 85 ; 65 ; 95 ; 100
TX_LINE	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Treatment Line	Patient	
TX_LOCATION	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Treatment Location	Patient	
TX_REG	HotPink	MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)	STRING	Treatment Regimen	Patient	
APOBEC_SIGNATURE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Enriched APOBEC signature	Patient	
CANCER TYPE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Cancer type	Sample	Breast Cancer
CD3_TILS_COUNTS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	CD3+ cell counts	Patient	
CD3_TILS_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	CD3 tumor-infiltrating lymphocytes (TILS) status.	Patient	
CHROMOSOME_INSTABILITY_INDEX_CIN_	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Chromosome instability index as genome wide measure for copy number alterations	Patient	
CIBERSORT_ABSOLUTE_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Level of immune cells inferred from mRNA using the CIBERSORT algorithm	Patient	
ERBB2_GENE_AMPLIFIED	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Significant gene copy number amplification; based on GISTIC2 calls: thresholded == 2 & continuous > 1	Patient	
ERBB2_PROTEOGENOMIC_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Proteogenomic ERBB2 status: gene copy amflification and outlier protein expression	Patient	
ERBB2_UPDATED_CLINICAL_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Updated clinical ERRB2 status (central IHC for 68 tumors)	Patient	
ER_UPDATED_CLINICAL_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Updated clinical ER status (central IHC for 68 tumors)	Patient	
ESTIMATE_IMMUNE_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Level of immune infiltration inferred from mRNA using the ESTIMATE algorithm	Patient	
ESTIMATE_STROMAL_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Level of stromal cells inferred from mRNA using the ESTIMATE algorithm	Patient	
ESTIMATE_TUMORPURITY	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Tumor purity inferred from mRNA using the ESTIMATE algorithm	Patient	
ISCHEMIA_TIME_IN_MINUTES	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Ischemia time in minutes	Sample	0 ; 1 ; 6 ; 8 ; 4 ; 9 ; 10 ; 15 ; 24 ; 12 ; 21 ; 29 ; 30 ; 11 ; 28 ; 20 ; 19 ; 13 ; 22 ; 16 ; 17 ; 14 ; 7 ; 5 ; 18 ; 26 ; 25
NMF_CLUSTER	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	NMF-based multi-omics subtype	Sample	Basal-I ; HER2-I ; LumA-I ; LumB-I
NMF_CLUSTER_MEMBERSHIP_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Cluster Membership score indicating the representiveness of a tumor in its cluster	Sample	1 ; 0.672 ; 0.782 ; 0.958 ; 0.825 ; 0.734 ; 0.55 ; 0.508 ; 0.915 ; 0.913 ; 0.551 ; 0.555 ; 0.409 ; 0.816 ; 0.854 ; 0.634 ; 0.938 ; 0.99 ; 0.6 ; 0.559 ; 0.93 ; 0.791 ; 0.65 ; 0.779 ; 0.586 ; 0.781 ; 0.535 ; 0.607 ; 0.786 ; 0.683 ; 0.898 ; 0.598 ; 0.771 ; 0.863 ; 0.826 ; 0.333 ; 0.604 ; 0.824 ; 0.577 ; 0.799 ; 0.446 ; 0.569 ; 0.423 ; 0.784 ; 0.383 ; 0.776 ; 0.811 ; 0.648 ; 0.814 ; 0.872 ; 0.72 ; 0.941 ; 0.937 ; 0.75 ; 0.962 ; 0.658 ; 0.637 ; 0.414 ; 0.957 ; 0.903 ; 0.934 ; 0.738 ; 0.588 ; 0.78 ; 0.572 ; 0.632 ; 0.606 ; 0.726 ; 0.978 ; 0.638 ; 0.485 ; 0.862 ; 0.418 ; 0.744 ; 0.809 ; 0.641 ; 0.623 ; 0.91 ; 0.79 ; 0.795 ; 0.472 ; 0.484 ; 0.767 ; 0.618 ; 0.871 ; 0.988 ; 0.828 ; 0.849 ; 0.43 ; 0.533 ; 0.612 ; 0.837 ; 0.371 ; 0.615 ; 0.578 ; 0.69 ; 0.757 ; 0.539 ; 0.711 ; 0.728 ; 0.609 ; 0.481 ; 0.536 ; 0.443 ; 0.392 ; 0.402
NUMBER_OF_NON_SYNONYMOUS_MUTATIONS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Total number of somatic mutations (non-synonymous) in the sample	Patient	
ONCOTREE CODE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Oncotree code	Sample	BRCA
PAM50	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	PAM50 classification	Sample	Basal ; Her2 ; LumA ; LumB ; Normal-like
PR_CLINICAL_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Initial clinical PR status	Patient	
STEMNESS_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Stem cell-like phenotype score	Patient	
TMT_CHANNEL	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	TMT10 reporter ion channel	Sample	127C ; 128C ; 129N ; 127N ; 130C ; 128N ; 126 ; 130N ; 129C ; 130C|127N ; 129C|130C ; 128C|129C|130N ; 126|129N ; 129C|126 ; 127C|130C ; 129C|128C
TMT_PLEX	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	TMT10 plex number	Sample	13 ; 12 ; 2 ; 16 ; 17 ; 1 ; 7 ; 9 ; 3 ; 6 ; 5 ; 11 ; 10 ; 8 ; 4 ; 6|17 ; 2|5 ; 10|12|17 ; 3|11 ; 11|16 ; 8|16 ; 3|17
TNBC_UPDATED_CLINICAL_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Triple Negative Breast Cancer (TNBC) status; based on PG ERBB2, updated clinical ER status; initial clinical PR status	Patient	
TOP2A_GENE_AMPLIFIED	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Significant gene copy number amplification; based on GISTIC2 calls: thresholded == 2 & continuous > 1	Patient	
TOP2A_PROTEOGENOMIC_STATUS	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	STRING	Proteogenomic TOP2A status: gene copy amflification and outlier protein expression	Patient	
XCELL_IMMUNE_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Level of immune cells inferred from mRNA using the xCell algorithm	Patient	
XCELL_STROMAL_SCORE	HotPink	Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)	NUMBER	Level of stromal cells inferred from mRNA using the xCell algorithm	Patient	
DISEASE_STATUS	HotPink	Breast Cancer (HTAN, 2022)	STRING	Disease Status	Patient	
PATIENT_GRADE	HotPink	Breast Cancer (HTAN, 2022)	STRING	Patient Tumor Grade	Patient	
SAMPLE_COLLECTION_METHOD	HotPink	Breast Cancer (HTAN, 2022)	STRING	Sample Collection Method	Sample	Surgical Resection ; Biopsy
SPECIMEN_PRESERVATION_TYPE	HotPink	Breast Cancer (HTAN, 2022)	STRING	The method used for preparing the tissue for examination and study.	Sample	Formalin ; Dimidoester
SPECIMEN_SITE	HotPink	Breast Cancer (HTAN, 2022)	STRING	Specimen Site	Sample	Breast NOS ; Liver ; Bone NOS
SPECIMEN_TYPE	HotPink	Breast Cancer (HTAN, 2022)	STRING	The broad cancer phenotype and site information values for a sample to be processed.	Sample	Tissue NOS
TIME_TO_LAST_FOLLOWUP	HotPink	Breast Cancer (HTAN, 2022)	NUMBER	Time to last followup.	Patient	
ABERRANT_CELL_FRACTION	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	NUMBER	Aberrant Cell Fraction	Sample	0.7 ; 0.77 ; 0.72 ; 0.56 ; 0.5 ; 0.71 ; 0.48 ; 0.6 ; 0.43 ; 0.36 ; 0.84 ; 0.61 ; 0.59 ; 0.81 ; 0.54 ; 0.55 ; 0.53 ; 0.46 ; 0.57 ; 0.67 ; 0.58 ; 0.25 ; 0.47 ; 0.37 ; 0.73 ; 0.62 ; 0.63 ; 0.75 ; 0.64 ; 0.3 ; 0.68 ; 0.74 ; 0.49 ; 0.8 ; 0.65 ; 0.42 ; 0.51 ; 0.45 ; 0.83 ; 0.32 ; 0.41 ; 0.76 ; 0.33 ; 0.35 ; 0.52
HISTOPATHOLOGY	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	STRING	Histopathology	Patient	
MITOTIC_COUNT	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	NUMBER	Mitotic Count	Sample	1 ; 6 ; 53 ; 7 ; 40 ; 19 ; 2 ; 18 ; 21 ; 27 ; 13 ; 3 ; 5 ; 20 ; 14 ; 11 ; 110 ; 48 ; 17 ; 28 ; 8 ; 22 ; 46 ; 9 ; 72 ; 32 ; 33 ; 4 ; 31 ; 26 ; 30 ; 36 ; 24 ; 23 ; 16 ; 90 ; 0 ; 58 ; 10
MITOTIC_SCORE	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	STRING	Mitotic Score	Sample	1 ; 3 ; 2
PLEOMORPHISM_SCORE	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	STRING	Pleomorphism Score	Sample	2 ; 3 ; 1
TUBULE_SCORE	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	STRING	Tubule Score	Sample	3 ; 2 ; 1
TUMOR_PLOIDY	HotPink	Breast Invasive Carcinoma (Sanger, Nature 2012)	STRING	Tumor Ploidy	Sample	
CN_CLUSTER	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	CN cluster.	Sample	3 ; 1 ; 4 ; 2 ; 5
CONVERTED_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Converted Stage	Sample	No_Conversion ; Stage IIA ; Stage IIIA ; Stage I ; Stage IIB ; Stage IIIC ; Stage IV ; Stage IIIB ; Stage
INTEGRATED_CLUSTERS_NO_EXP	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Integrated Clusters (no exp)	Sample	2 ; 1 ; 3 ; 5 ; 4
INTEGRATED_CLUSTERS_UNSUP_EXP	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Integrated Clusters (unsup exp)	Sample	2 ; 1 ; 4 ; 3 ; 5
INTEGRATED_CLUSTERS_WITH_PAM50	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Integrated Clusters (with PAM50)	Sample	2 ; 3 ; 1 ; 4
METASTASIS	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Metastasis.	Patient	
METASTASIS_CODED	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Metastasis-Coded	Sample	Positive ; Negative
METHYLATION_CLUSTER	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Methylation cluster.	Sample	5 ; 4 ; 2 ; 3 ; 1
MIRNA_CLUSTER	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	MICRNA cluster	Sample	3 ; 5 ; 4 ; 6 ; 2 ; 1 ; 7
NODES	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Node	Sample	N3 ; N0 ; N2 ; N1
NODE_CODED	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Node-Coded	Sample	Positive ; Negative
PAM50_SUBTYPE	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	PAM50 subtype	Sample	Basal-like ; HER2-enriched ; Luminal A ; Luminal B ; Normal-like ; LuminalB ; Basal ; LuminalA ; Her2 ; Normal ; Other
RPPA_CLUSTER	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	RPPA Cluster.	Sample	Basal ; X ; LumA/B ; ReacII ; ReacI ; Her2 ; LumA
SIGCLUST_INTRINSIC_MRNA	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	SigClust Intrinsic mRNA	Sample	-13 ; -5 ; -2 ; -1 ; -11 ; 0 ; -12 ; -10 ; -9 ; -3 ; -4 ; -8 ; -7 ; -6
SIGCLUST_UNSUPERVISED_MRNA	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	SigClust Unsupervised mRNA	Sample	0 ; -6 ; -12 ; -11 ; -8 ; -10 ; -5 ; -1 ; -3 ; -9 ; -4 ; -7 ; -2
SURVIVAL_DATA_FORM	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Survival Data Form	Sample	followup ; enrollment
TUMOR_T1_CODED	HotPink	Breast Invasive Carcinoma (TCGA, Nature 2012)	STRING	Tumor--T1 Coded	Sample	T_Other ; T1
DFS_EVENT	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Disease Free Event	Patient	
DFS_MONTHS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	Disease free (months) since initial treatment.	Patient	
ER_PCT_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	ER Percent Positivity of the Primary Tumor	Sample	70 ; 0 ; 90 ; 50 ; 80 ; 60 ; 95 ; 100 ; 91 ; 75 ; 1 ; 97 ; 30 ; 65 ; 89 ; 85 ; 86 ; 40 ; 44 ; 1 (weak intensity) ; 5 ; 99 ; 10 ; 98 ; 25 ; 31 ; 87 ; 74 ; 79 ; 96 ; 3 ; 18 ; 93 ; 81 ; 35 ; 84 ; 94 ; 20 ; 9 ; 78 ; 4 ; 42 ; 30-60 ; 14 ; >60 ; 51 ; 77 ; 62 ; 88 ; 29 ; 72 ; 66 ; 57 ; 39 ; 2 ; 11 ; 22 ; 23 ; 13 ; 5 (weak intensity) ; 15 ; 41 ; 67 ; 3 (weak intensity)
ER_STATUS_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	ER Status of the Primary Tumor	Sample	Positive ; Negative ; Unk/ND
HER2_FISH	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 FISH Status of the Sample that Underwent Sequencing.	Sample	Negative ; Positive ; Unk/ND ; Test Failure ; Equivocal ; Negative (outside)
HER2_FISH_RATIO	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 FISH Ratio Value of the Sample that Underwent Sequencing.	Sample	0.24 ; 1.2 ; 1 ; 2 (CN 4.8) ; 4 ; 2.9 ; 1.1 ; 4.0, CN 9.7 ; 1.7 ; 0.88 ; 2.3 ; Not done ; 1.23 ; 2.5 ; 1.4 ; 1.8 (CN 7.5) ; 0.75 ; 4.5 ; 1.5 ; 1.3 ; 3.2 (Heterogenous) ; 1.7 (CN 6.2) ; 0.9 ; 2 (CN 6.4) ; 8.4 ; 6.3 ; 1.6 ; 7 ; Not done (decalcified) ; 2.1 (CN 4.1) ; 1.02 ; 2.6 ; 2.2 ; 3.4 (CN 7.2) ; 2.1 ; 0.74 ; 1.28 ; 3.4 ; 0.94 ; 0.7 ; 1.2 (CN 2.4) ; 0.8 ; 1.9 (CN 4.3) ; 2 ; 3.3 ; 3.29 ; 4.3 (CN 14.3) ; 1.21 ; 6.9 ; 1.37 ; 3.9 ; 2.1 (Heterogenous) ; 3.7 ; 3.6 ; 1.24 ; 16.4 ; 1.8 (CN 5.3) ; 1.3 (OSH, CN 2.0) ; 1.6 (CN 6.6) ; 1.46 ; 2.5 (CN 3) ; 1.3 (OSH CN 4.2) ; 16.6 ; 1.42 ; 1.4 (CN 4.8) ; 4.9 ; 1.9 (CN 4.2) ; 2.4 (heterogenous) ; 3.2 ; 2 (CN 4.6) ; 1.9 ; 0 ; 2.1 (CN 3.7) ; 1.8 ; 2.5 (CN 4.6) ; 1.18 ; 1.39 ; 2.4 (CN 5.9) ; 4.8 ; 1.4 (CN 3.0) (same sample OSH 2.3) ; 1.53 ; 5.4 ; 4.4 ; 1.81
HER2_FISH_RATIO_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 FISH Ratio of the Primary Tumor	Sample	0.7 ; 6.4 ; 1.8 ; 1.2 ; 1 ; 1.4 ; 1.8, MSK failed ; 2.72 ; 0.81 ; 6.5 ; 1.1 ; 2.2 ; 4.1 ; 7.2 ; 0.84 ; 2.8 ; 3.5 ; 1.9 ; 1.7 ; 1.3 ; 1.28 ; 1.33 ; 11.3 ; 7.4 ; 1.43 ; 1.24 ; 1.27 ; 1.6 ; 4 ; 1.15 ; 1.7 (CN 6.2) ; 1.18 ; 1.31 ; 8.9 ; 4.5 ; 2 ; 1.37 ; 5.6 ; 3.3 ; 7 ; 2.3 ; 6.1 ; 6.6 ; 0.6 ; 0.9 ; 2.6 ; 2.7 ; 6.81 ; 6.7 ; 2.5 ; 8.7 ; 2.4 ; 8.6 ; 4.6 ; 4.54 ; 1.7 (Outside: 2.4) ; 6.3 ; 1.4, 1.9 ; 5.02 ; 1.17 ; 5.54 ; 1.13 ; 6 ; 1.9 (CN 4.3) ; 1.5 ; 1.14 ; 11.8 ; 1.91 ; 6.2 ; 3.4 ; 3 ; 8.3 ; 5.11 ; 1.21 ; 2.9 ; 2.1 ; 13.96 ; 4.8 ; 3.6 ; 1.8 (CN 5.3) ; 1.8 (CN 5.6) ; 1.6 (CN 6.6) ; 4.2 ; 1.09 ; 2.1 (CN 6) ; 7.3 ; 1.56 ; 16.6 ; 1.42 ; 1.4 (CN 4.8) ; 1.38 ; 1.77 ; 5.1 ; 1.35 ; 3.2 ; 0.5 ; 1.11 ; 1.23 ; 1.12 ; 4.9 ; 2.4 (heterogenous) ; 2 (CN 4.6) ; 1.69 ; 2.3 (CN 5.4) ; 2.4 (CN 5.9) ; 1.46 ; 1.53 ; 0.8 ; 1.04 ; 4.4 ; 1.34 ; 1.81 ; 1.16
HER2_FISH_STATUS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 FISH Status of the Primary Tumor as per Pathology Report and ASCO/CAP 2013 guideline.	Sample ; Patient	Negative ; Unk/ND ; Positive ; Equivocal ; Indeterminate
HER2_IHC_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 IHC Status of Primary Tumor	Sample	Negative ; Positive ; Unk/ND ; Equivocal ; UNk/ND
HER2_IHC_SCORE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 IHC Value of the Sample that Underwent Sequencing.	Sample ; Patient	0-1+ ; 0+ ; 2+ ; 3+ ; 1+ ; 1-2+ ; 3+ (outside) ; 1+ (focal) ; 2+ (focal) ; 1+ (outside 3+) ; 2-3+ ; 3+ (heterogenous 70-80% pos) ; 1-2+ (outside 3+) ; 2 ; 1 ; 3 ; 0
HER2_IHC_STATUS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 IHC Status of the Sample that Underwent Sequencing.	Sample	Negative ; Equivocal ; Positive ; Unk/ND
HER2_IHC_VALUE_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	HER2 IHC Value of the Primary Tumor	Sample	1+ ; 0-1+ ; 0+ ; 3+ ; 2+ ; 1-2+ ; 3+ (2+ outside) ; 1+ (focal) ; 2+ (3+ outside) ; 1+ (3+ outside)
HER2_STATUS_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall HER2 status of the primary tumor.	Patient	
HR_STATUS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall HR Status of the Sample that Underwent Sequencing.	Sample	Positive ; Negative ; Unk/ND
INVASIVE_CARCINOMA_DX_AGE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	Invasive Carcinoma Diagnosis Age	Sample	37 ; 43 ; 38 ; 49 ; 60 ; 41 ; 48 ; 64 ; 53 ; 50 ; 52 ; 46 ; 42 ; 39 ; 61 ; 51 ; 69 ; 36 ; 62 ; 70 ; 63 ; 32 ; 67 ; 55 ; 31 ; 58 ; 33 ; 47 ; 66 ; 54 ; 45 ; 56 ; 40 ; 44 ; 34 ; 59 ; 25 ; 65 ; 29 ; 57 ; 73 ; 80 ; 71 ; 74 ; 27 ; 72 ; 79 ; 76 ; 35 ; 68 ; 30 ; 28 ; 78 ; 77 ; 26 ; 87 ; 75 ; 23 ; 83 ; 81 ; 91 ; 88 ; 82 ; 84 ; 24 ; 85
INVASIVE_CARCINOMA_DX_TIME	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	Time to Diagnosis Invasive Carcinoma	Sample	444.87 ; 516.48 ; 449.8 ; 513.68 ; 458.36 ; 592.96 ; 518.55 ; 591.12 ; 722.37 ; 487.73 ; 580.33 ; 764.61 ; 635.82 ; 601.81 ; 620.56 ; 556.51 ; 506.61 ; 463.09 ; 488.55 ; 549.38 ; 735.69 ; 734.57 ; 551.58 ; 617.11 ; 604.05 ; 833.95 ; 434.74 ; 745.16 ; 720.69 ; 444.77 ; 576.78 ; 846.55 ; 610 ; 753.03 ; 386.74 ; 805.99 ; 658.45 ; 374.14 ; 590.2 ; 697.37 ; 397.47 ; 561.02 ; 796.05 ; 559.93 ; 558.13 ; 647.11 ; 611.78 ; 541.68 ; 507.76 ; 547.2 ; 800.3 ; 458.68 ; 565.07 ; 628.36 ; 674.38 ; 662.11 ; 637.04 ; 700.36 ; 429.21 ; 760.66 ; 606.32 ; 480.23 ; 727.96 ; 526.64 ; 457.11 ; 761.41 ; 717.63 ; 626.22 ; 392.5 ; 492.04 ; 659.77 ; 480.99 ; 633.22 ; 409.44 ; 504.21 ; 510.23 ; 452.93 ; 825.43 ; 711.68 ; 522.01 ; 302.2 ; 570.53 ; 719.74 ; 622.5 ; 632.2 ; 643.65 ; 561.97 ; 640.95 ; 802.53 ; 410.43 ; 570.2 ; 438.16 ; 479.41 ; 651.38 ; 491.22 ; 795.03 ; 460.46 ; 461.68 ; 676.25 ; 783.45 ; 598.91 ; 645.26 ; 512.6 ; 405.03 ; 581.12 ; 579.44 ; 395.13 ; 554.28 ; 605.3 ; 654.61 ; 466.15 ; 443.95 ; 556.15 ; 612.11 ; 347.14 ; 564.51 ; 655.3 ; 668.95 ; 636.02 ; 585.39 ; 397.01 ; 776.61 ; 629.54 ; 427.8 ; 578.49 ; 368.98 ; 702.83 ; 393.65 ; 603.88 ; 410.46 ; 682.99 ; 873.59 ; 499.7 ; 642.3 ; 492.27 ; 709.74 ; 429.44 ; 958.19 ; 484.34 ; 649.38 ; 672.37 ; 618.91 ; 852.93 ; 563.68 ; 524.87 ; 612.83 ; 684.84 ; 597.14 ; 578.39 ; 561.35 ; 777.01 ; 740.66 ; 554.21 ; 519.51 ; 375.43 ; 615.23 ; 525.86 ; 434.97 ; 604.31 ; 765.72 ; 889.7 ; 569.8 ; 562.8 ; 653.22 ; 604.61 ; 550.95 ; 615.1 ; 590.63 ; 574.44 ; 579.08 ; 322.7 ; 762.99 ; 403.36 ; 530.43 ; 454.38 ; 691.68 ; 536.74 ; 599.18 ; 864.28 ; 548.65 ; 644.97 ; 615.69 ; 745.03 ; 532.43 ; 679.24 ; 646.94 ; 871.68 ; 480.39 ; 757.43 ; 676.78 ; 625.66 ; 466.48 ; 764.97 ; 638.03 ; 662.99 ; 571.38 ; 542.6 ; 533.75 ; 799.7 ; 709.77 ; 639.47 ; 687.73 ; 609.08 ; 710.23 ; 949.7 ; 478.72 ; 628.91 ; 661.84 ; 839.64 ; 802.89 ; 682.47 ; 614.21 ; 465.43 ; 399.8 ; 407.24 ; 502.37 ; 916.41 ; 805.46 ; 418.62 ; 699.44 ; 692.7 ; 507.8 ; 572.17 ; 441.74 ; 661.09 ; 565.2 ; 586.12 ; 731.05 ; 503.68 ; 458.19 ; 798.62 ; 521.51 ; 791.68 ; 558.49 ; 691.18 ; 697.63 ; 532.3 ; 409.14 ; 629.08 ; 548.62 ; 454.97 ; 806.22 ; 691.35 ; 684.97 ; 703.62 ; 508.88 ; 782.63 ; 437.3 ; 775.13 ; 518.72 ; 434.61 ; 619.64 ; 568.62 ; 478.68 ; 685.69 ; 741.22 ; 651.02 ; 816.28 ; 450.36 ; 448.16 ; 702.2 ; 411.51 ; 473.13 ; 460.36 ; 814.31 ; 512.24 ; 693.62 ; 647.07 ; 566.38 ; 539.18 ; 444.34 ; 480.59 ; 582.57 ; 363.42 ; 361.68 ; 848.78 ; 461.12 ; 962.8 ; 494.87 ; 533.42 ; 488.91 ; 602.57 ; 826.88 ; 709.64 ; 570.79 ; 578.88 ; 781.64 ; 351.38 ; 393.88 ; 563.22 ; 696.58 ; 382.8 ; 676.58 ; 578.85 ; 678.36 ; 738.55 ; 487.83 ; 665.86 ; 653.32 ; 633.09 ; 486.18 ; 558.36 ; 757.76 ; 575.92 ; 650.72 ; 494.01 ; 721.15 ; 712.5 ; 748.22 ; 466.64 ; 793.62 ; 720.76 ; 720.26 ; 845.43 ; 530.46 ; 695 ; 502.27 ; 792.43 ; 911.55 ; 722.11 ; 417.17 ; 804.67 ; 669.7 ; 340.56 ; 624.28 ; 442.86 ; 701.35 ; 533.95 ; 614.01 ; 456.81 ; 674.44 ; 320.69 ; 577.04 ; 732.34 ; 714.38 ; 541.48 ; 514.8 ; 494.93 ; 624.57 ; 530.95 ; 550.36 ; 410.36 ; 395.03 ; 586.88 ; 767.66 ; 610.2 ; 573.85 ; 765.36 ; 554.61 ; 703.49 ; 847.86 ; 557.04 ; 676.91 ; 575.26 ; 628.95 ; 442.7 ; 675.49 ; 491.32 ; 675.03 ; 639.61 ; 482.66 ; 574.28 ; 641.88 ; 387.11 ; 799.24 ; 866.84 ; 610.69 ; 501.05 ; 581.05 ; 621.28 ; 396.18 ; 303.82 ; 479.38 ; 672.11 ; 609.67 ; 487.47 ; 615.59 ; 879.84 ; 629.8 ; 608.72 ; 336.48 ; 574.87 ; 684.47 ; 388.91 ; 664.18 ; 608.98 ; 588.32 ; 622.86 ; 711.94 ; 543.49 ; 592.93 ; 461.05 ; 549.9 ; 555.92 ; 520.76 ; 511.22 ; 612.7 ; 515.59 ; 646.48 ; 739.08 ; 559.74 ; 656.74 ; 375.26 ; 618.09 ; 443.55 ; 526.91 ; 963.85 ; 520.33 ; 688.68 ; 454.7 ; 364.08 ; 458.22 ; 496.88 ; 483.03 ; 321.81 ; 735.63 ; 512.99 ; 833.06 ; 441.61 ; 638.98 ; 738.98 ; 597.43 ; 554.41 ; 725.16 ; 716.58 ; 546.41 ; 480.69 ; 415.39 ; 631.38 ; 877.7 ; 781.74 ; 688.82 ; 669.64 ; 886.51 ; 497.43 ; 376.84 ; 649.61 ; 621.51 ; 736.94 ; 408.42 ; 375.92 ; 515.66 ; 698.65 ; 800.66 ; 397.4 ; 680.1 ; 559.44 ; 759.57 ; 524.51 ; 599.47 ; 606.68 ; 758.59 ; 503.91 ; 545.3 ; 463.68 ; 561.91 ; 472.6 ; 606.91 ; 678.59 ; 667.63 ; 541.05 ; 585.79 ; 497.8 ; 381.81 ; 688.75 ; 639.87 ; 735.49 ; 513.75 ; 590.3 ; 644.7 ; 686.64 ; 584.28 ; 562.11 ; 601.78 ; 587.17 ; 519.57 ; 386.71 ; 542.96 ; 626.15 ; 621.15 ; 814.34 ; 745.1 ; 726.05 ; 798.95 ; 395.66 ; 573.36 ; 499.38 ; 465.26 ; 735.13 ; 480.82 ; 587.86 ; 626.48 ; 664.28 ; 713.19 ; 577.4 ; 462.93 ; 654.51 ; 787.04 ; 612.37 ; 696.32 ; 727.6 ; 570.03 ; 571.32 ; 633.62 ; 778.45 ; 758.49 ; 698.45 ; 350.49 ; 934.87 ; 486.55 ; 692.73 ; 871.32 ; 709.51 ; 693.75 ; 384.7 ; 839.9 ; 386.81 ; 385.43 ; 574.24 ; 509.24 ; 836.74 ; 502.76 ; 555 ; 497.34 ; 681.32 ; 739.24 ; 721.91 ; 665.16 ; 546.78 ; 728.62 ; 533.19 ; 857.53 ; 801.02 ; 774.54 ; 420.39 ; 492.11 ; 335.23 ; 555.03 ; 600.13 ; 418.98 ; 622.53 ; 646.41 ; 576.91 ; 508.39 ; 750.03 ; 825.26 ; 605.13 ; 766.64 ; 681.41 ; 417.76 ; 582.07 ; 765.33 ; 659.31 ; 722.99 ; 671.25 ; 427.6 ; 768.16 ; 340.59 ; 540.92 ; 490.07 ; 469.87 ; 927.2 ; 437.01 ; 677.43 ; 517.93 ; 517.43 ; 496.68 ; 472.2 ; 767.53 ; 709.7 ; 542.01 ; 566.61 ; 430.39 ; 917.83 ; 763.49 ; 734.84 ; 699.77 ; 681.61 ; 677.4 ; 729.84 ; 586.64 ; 632.27 ; 437.11 ; 559.38 ; 462.24 ; 655.66 ; 672.17 ; 640.82 ; 790.69 ; 453.45 ; 847.37 ; 653.26 ; 676.71 ; 841.74 ; 693.29 ; 451.61 ; 645.43 ; 335.49 ; 506.97 ; 777.17 ; 618.78 ; 655.16 ; 421.02 ; 571.74 ; 445.46 ; 520.43 ; 612.93 ; 643.39 ; 405 ; 383.68 ; 417.27 ; 811.35 ; 555.56 ; 375.03 ; 500.59 ; 808.45 ; 425.49 ; 497.4 ; 715.49 ; 715.69 ; 469.34 ; 669.54 ; 519.77 ; 591.51 ; 705 ; 687.17 ; 644.47 ; 610.89 ; 477.63 ; 659.87 ; 647.57 ; 634.64 ; 762.93 ; 392.04 ; 604.24 ; 768.78 ; 629.31 ; 491.91 ; 475.07 ; 547.47 ; 487.89 ; 492.66 ; 632.66 ; 667.6 ; 700.26 ; 754.77 ; 507.96 ; 460.39 ; 476.02 ; 494.84 ; 463.98 ; 413.72 ; 739.11 ; 522.93 ; 361.05 ; 418.68 ; 359.01 ; 857.01 ; 418.65 ; 724.77 ; 695.66 ; 481.81 ; 771.02 ; 666.78 ; 552.7 ; 641.78 ; 814.51 ; 320.53 ; 648.06 ; 556.28 ; 558.09 ; 536.61 ; 537.04 ; 713.62 ; 632.76 ; 631.12 ; 789.34 ; 690.66 ; 501.28 ; 805.82 ; 650.95 ; 337.8 ; 314.01 ; 701.15 ; 767.7 ; 428.52 ; 1045.1 ; 734.51 ; 763.75 ; 535.13 ; 462.99 ; 598.85 ; 787.76 ; 529.01 ; 501.41 ; 632.14 ; 493.82 ; 760.07 ; 493.03 ; 675.89 ; 511.84 ; 520.26 ; 477.53 ; 632.93 ; 748.26 ; 531.41 ; 627.37 ; 489.54 ; 680.2 ; 664.31 ; 453.39 ; 687.37 ; 781.22 ; 806.32 ; 386.18 ; 782.14 ; 542.93 ; 592.57 ; 880.79 ; 396.05 ; 496.81 ; 544.28 ; 497.86 ; 651.94 ; 728.06 ; 858.29 ; 758.72 ; 711.74 ; 781.81 ; 619.93 ; 476.97 ; 566.97 ; 583.22 ; 698.55 ; 448.09 ; 676.12 ; 598.98 ; 487.99 ; 882.89 ; 447.7 ; 470.03 ; 762.14 ; 781.97 ; 933.65 ; 601.45 ; 463.65 ; 727.8 ; 630.99 ; 538.36 ; 658.26 ; 547.63 ; 518.16 ; 951.94 ; 803.98 ; 597.83 ; 731.12 ; 360.1 ; 550.72 ; 582.86 ; 660.36 ; 547.83 ; 624.24 ; 431.81 ; 503.13 ; 359.74 ; 901.38 ; 751.84 ; 373.26 ; 448.49 ; 793.72 ; 567.04 ; 639.24 ; 473.95 ; 581.09 ; 613.68 ; 531.91 ; 782.47 ; 639.97 ; 675.56 ; 809.7 ; 772.63 ; 622.01 ; 843.62 ; 754.93 ; 271.51 ; 680.86 ; 654.24 ; 652.04 ; 348.68 ; 374.05 ; 678.45 ; 644.51 ; 672.99 ; 644.87 ; 384.77 ; 561.18 ; 420.59 ; 642.43 ; 492.17 ; 422.34 ; 575.49 ; 482.11 ; 816.64 ; 612.24 ; 874.93 ; 373.19 ; 673.95 ; 459.28 ; 842.47 ; 753.78 ; 354.08 ; 500.46 ; 680.56 ; 504.67 ; 576.74 ; 680.49 ; 605.53 ; 477.27 ; 368.68 ; 562.37 ; 692.17 ; 596.68 ; 831.45 ; 653.85 ; 439.74 ; 491.38 ; 490 ; 837.04 ; 337.4 ; 558.32 ; 372.8 ; 392.24 ; 674.14 ; 752.3 ; 826.51 ; 513.91 ; 362.96 ; 818.98 ; 690.72 ; 494.54 ; 653.03 ; 609.54 ; 920.2 ; 660.16 ; 830.07 ; 673.09 ; 699.28 ; 500 ; 605.33 ; 705.95 ; 533.36 ; 592.7 ; 629.11 ; 607.11 ; 681.97 ; 623.22 ; 604.64 ; 566.35 ; 558.85 ; 660.2 ; 565.86 ; 780.36 ; 555.86 ; 1002.2 ; 566.74 ; 685.76 ; 760.72 ; 488.98 ; 700.43 ; 432.07 ; 731.84 ; 817.14 ; 494.34 ; 551.22 ; 613.26 ; 489.9 ; 636.68 ; 371.32 ; 710.2 ; 450 ; 433.59 ; 630.69 ; 715.43 ; 642.01 ; 518.59 ; 600.72 ; 586.84 ; 484.57 ; 643.98 ; 692.63 ; 575.95 ; 669.31 ; 727.99 ; 848.26 ; 619.05 ; 788.16 ; 445.23 ; 638.45 ; 977.24 ; 785.79 ; 475.26 ; 777.7 ; 932.17 ; 472.07 ; 819.41 ; 457.47 ; 801.32 ; 774.08 ; 565.69 ; 444.47 ; 497.66 ; 541.45 ; 872.11 ; 456.78 ; 925.23 ; 607.43 ; 672.7 ; 520.53 ; 569.38 ; 452.24 ; 408.75 ; 446.94 ; 586.91 ; 743.42 ; 600.16 ; 607.93 ; 528.98 ; 672.07 ; 840.66 ; 436.45 ; 564.05 ; 536.15 ; 436.55 ; 576.22 ; 950 ; 665.1 ; 779.14 ; 862.17 ; 878.39 ; 597.01 ; 537.4 ; 539.21 ; 658.65 ; 803.85 ; 780.66 ; 551.25 ; 703.72 ; 409.47 ; 466.28 ; 470.95 ; 662.17 ; 769.57 ; 635 ; 612.17 ; 781.51 ; 737.43 ; 450.79 ; 612.8 ; 639.64 ; 516.02 ; 487.01 ; 751.61 ; 578.62 ; 641.05 ; 477.89 ; 705.36 ; 574.97 ; 598.55 ; 843.39 ; 758.85 ; 362.5 ; 417.57 ; 679.77 ; 593.49 ; 801.35 ; 402.96 ; 719.14 ; 743.19 ; 492.4 ; 803.75 ; 569.61 ; 322.04 ; 800.76 ; 649.28 ; 704.51 ; 712.99 ; 683.91 ; 421.05 ; 800.07 ; 349.8 ; 613.91 ; 694.54 ; 657.73 ; 789.77 ; 795.43 ; 710.1 ; 637.83 ; 693.45 ; 809.38 ; 650.56 ; 432.34 ; 485.1 ; 627.27 ; 567.66 ; 746.48 ; 689.41 ; 675.07 ; 758.26 ; 567.27 ; 613.03 ; 428.75 ; 432.27 ; 640.56 ; 570.16 ; 718.91 ; 717.07 ; 652.37 ; 570.76 ; 700.2 ; 744.8 ; 615.56 ; 716.32 ; 484.8 ; 634.44 ; 767.2 ; 652.43 ; 656.78 ; 707.01 ; 593.36 ; 389.61 ; 577.99 ; 623.75 ; 573.82 ; 770.23 ; 664.64 ; 421.74 ; 714.51 ; 949.31 ; 556.84 ; 538.78 ; 1092.47 ; 650.49 ; 571.45 ; 672.43 ; 587.93 ; 505 ; 601.32 ; 674.7 ; 491.35 ; 399.41 ; 626.05 ; 497.96 ; 402.4 ; 550.16 ; 534.7 ; 562.86 ; 445.95 ; 704.21 ; 663.09 ; 778.85 ; 664.77 ; 817.8 ; 808.22 ; 929.01 ; 553.49 ; 623.95 ; 600.89 ; 540.72 ; 462.14 ; 750.07 ; 599.57 ; 718.49 ; 951.97 ; 520.36 ; 489.44 ; 708.78 ; 615.89 ; 741.97 ; 401.32 ; 498.85 ; 593.75 ; 473.32 ; 605.66 ; 725.07 ; 577.24 ; 592.4 ; 616.38 ; 403.39 ; 532.89 ; 722.4 ; 813.59 ; 670.26 ; 528.26 ; 787.7 ; 869.38 ; 793.52 ; 408.68 ; 583.62 ; 767.73 ; 812.93 ; 435.46 ; 605.43 ; 707.17 ; 544.84 ; 370.79 ; 741.15 ; 534.41 ; 733.98 ; 838.75 ; 400.76 ; 659.14 ; 661.41 ; 483.65 ; 703.98 ; 1053.39 ; 553.75 ; 750.79 ; 634.47 ; 750.43 ; 574.54 ; 687.24 ; 735.72 ; 627.17 ; 919.38 ; 690.1 ; 555.79 ; 563.06 ; 540.43 ; 472.01 ; 586.78 ; 450.46 ; 328.62 ; 760.56 ; 681.25 ; 699.87 ; 671.74 ; 646.15 ; 723.06 ; 591.25 ; 808.72 ; 420.72 ; 444.93 ; 602.93 ; 496.12 ; 507.34 ; 928.45 ; 746.71 ; 552.11 ; 580.46 ; 478.42 ; 990.13 ; 467.11 ; 580.16 ; 540.66 ; 642.63 ; 730.92 ; 705.26 ; 767.01 ; 836.58 ; 927.04 ; 704.61 ; 687.5 ; 951.32 ; 724.21 ; 1013.32 ; 907.53 ; 416.81 ; 779.44 ; 462.89 ; 432.17 ; 638.88 ; 430.53 ; 799.01 ; 725.3 ; 738.19 ; 421.12 ; 698.32 ; 378.75 ; 865.07 ; 643.59 ; 473.09 ; 678.06 ; 593.29 ; 631.18 ; 849.24 ; 698.06 ; 796.64 ; 726.32 ; 586.18 ; 877.57 ; 589.93 ; 841.64 ; 468.59 ; 721.61 ; 663.32 ; 702.73 ; 828.52 ; 717.11 ; 544.01 ; 633.32 ; 699.8 ; 894.84 ; 425.76 ; 671.18 ; 554.9 ; 839.38 ; 423.75 ; 768.09 ; 491.88 ; 542.76 ; 536.18 ; 389.05 ; 570.43 ; 625.63 ; 346.18 ; 584.7 ; 605.99 ; 915.82 ; 517.01 ; 567.83 ; 552.37 ; 581.25 ; 802.66 ; 593.88 ; 691.71 ; 794.31 ; 670.95 ; 933.72 ; 624.84 ; 631.74 ; 431.25 ; 723.36 ; 387.27 ; 540.23 ; 390.95 ; 472.96 ; 444.51 ; 662.73 ; 532.76 ; 492.01 ; 685.79 ; 595.26 ; 496.28 ; 704.08 ; 517.8 ; 485.66 ; 726.74 ; 651.15 ; 666.81 ; 428.78 ; 881.05 ; 497.04 ; 607.53 ; 621.58 ; 457.73 ; 707.76 ; 508.65 ; 571.22 ; 645.72 ; 697.53 ; 738.75 ; 699.61 ; 846.71 ; 792.57 ; 813.45 ; 779.93 ; 429.8 ; 677.04 ; 787.66 ; 688.32 ; 917.99 ; 728.19 ; 303.03 ; 516.74 ; 528.59 ; 939.01 ; 699.31 ; 493.45 ; 425.33 ; 832.01 ; 555.89 ; 846.88 ; 942.04 ; 693.91 ; 884.31 ; 522.66 ; 716.12 ; 452.76 ; 762.01 ; 793.19 ; 478.59 ; 661.71 ; 740.03 ; 790.13 ; 498.82 ; 758.39 ; 658.78 ; 665.56 ; 954.44 ; 744.77 ; 477.99 ; 792.3 ; 820.56 ; 428.06 ; 951.74 ; 818.03 ; 843.78 ; 447.11 ; 778.32 ; 667.76 ; 820.36 ; 761.35 ; 550.13 ; 472.34 ; 655.23 ; 878.06 ; 816.18 ; 568.65 ; 588.45 ; 723.75 ; 935.33 ; 361.71 ; 637.99 ; 945.13 ; 802.99 ; 495.95 ; 870.76 ; 612.07 ; 580.23 ; 813.65 ; 605.16 ; 825.3 ; 733.09 ; 637.66 ; 618.72 ; 607.76 ; 563.75 ; 647.2 ; 666.35 ; 686.18 ; 649.08 ; 786.35 ; 772.93 ; 463.03 ; 475.2 ; 571.64 ; 551.09 ; 738.65 ; 543.36 ; 606.45 ; 581.74 ; 585.13 ; 498.36 ; 691.12 ; 452.5 ; 653.29 ; 438.19 ; 753.95 ; 910.56 ; 917.17 ; 605.56 ; 368.82 ; 795.89 ; 864.64 ; 772.83 ; 867.6 ; 698.03 ; 922.8 ; 544.77 ; 780.76 ; 785.66 ; 742.99 ; 568.49 ; 373.52 ; 908.65 ; 644.21 ; 728.03 ; 888.55 ; 768.72 ; 556.55 ; 506.78 ; 904.77 ; 399.24 ; 967.73 ; 934.31 ; 613.45 ; 585.07 ; 619.28 ; 649.64 ; 673.26 ; 652.6 ; 569.74 ; 904.84 ; 749.57 ; 536.51 ; 760.26 ; 737.07 ; 626.88 ; 478.75 ; 705.72 ; 555.07 ; 743.06 ; 589.97 ; 814.38 ; 771.81 ; 542.3 ; 531.74 ; 615.82 ; 536.55 ; 903.52 ; 569.9 ; 811.48 ; 798.32 ; 576.88 ; 858.62 ; 453.49 ; 704.64 ; 454.34 ; 785.56 ; 752.93 ; 551.61 ; 761.81 ; 876.94 ; 413.91 ; 610.23 ; 647.34 ; 994.31 ; 511.41 ; 679.7 ; 718.52 ; 609.34 ; 575.13 ; 551.97 ; 719.28 ; 637.86 ; 545.36 ; 393.85 ; 706.48 ; 754.64 ; 909.24 ; 798.09 ; 577.57 ; 562.96 ; 375.72 ; 490.72 ; 928.82 ; 503.78 ; 969.97 ; 677.63 ; 286.68 ; 757.2 ; 369.67 ; 587.37 ; 479.7 ; 757.24 ; 747.93 ; 581.61 ; 498.42 ; 548.03 ; 863.78 ; 630.79 ; 580.3 ; 558.39 ; 539.44 ; 676.51 ; 744.51 ; 455.69 ; 633.52 ; 506.58 ; 656.35 ; 849.61 ; 959.18 ; 635.33 ; 505.3 ; 795.53 ; 695.86 ; 505.36 ; 810.26 ; 693.85 ; 444.7 ; 862.24 ; 594.7 ; 807.11 ; 468.75 ; 737.53 ; 731.64 ; 673.03 ; 714.21 ; 898.16 ; 832.53 ; 614.84 ; 544.08 ; 639.38 ; 654.05 ; 571.09 ; 500.53 ; 480.86 ; 660.03 ; 707.66 ; 772.37 ; 621.84 ; 865.3 ; 592.14 ; 698.26 ; 632.86 ; 870.13 ; 593.06 ; 780.26 ; 769.14 ; 733.52 ; 352.3 ; 892.96 ; 578.19 ; 286.71 ; 587.73 ; 611.51 ; 537.83 ; 621.74 ; 567.2 ; 553.55 ; 887.07 ; 793.45 ; 848.82 ; 855.03 ; 837.01 ; 357.8 ; 539.24 ; 740.49 ; 644.54 ; 693.26 ; 918.36 ; 488.42 ; 502.4 ; 847.96 ; 608.26 ; 588.68 ; 969.77 ; 849.7 ; 458.09 ; 991.45 ; 755.39 ; 697.11 ; 559.8 ; 659.44 ; 677.89 ; 600.03 ; 781.61 ; 925.76 ; 829.28 ; 917.34 ; 623.98 ; 567.4 ; 801.58 ; 927.89 ; 720.92 ; 1025.39 ; 658.68 ; 630.03 ; 724.01 ; 695.16 ; 934.84 ; 1011.61 ; 645.59 ; 646.38 ; 819.44 ; 789.08 ; 822.6 ; 794.61 ; 885.56 ; 690.56 ; 578.13 ; 711.22 ; 458.82 ; 623.49 ; 672.57 ; 813.52 ; 757.89 ; 850.89 ; 457.3 ; 867.89 ; 318.06 ; 803.16 ; 941.94 ; 627.34 ; 640.76 ; 585.26 ; 527.6 ; 869.34 ; 698.85 ; 830.56 ; 519.67 ; 565.1 ; 584.77 ; 821.94 ; 789.51 ; 499.11 ; 690.53 ; 646.78 ; 684.41 ; 344.67 ; 655.76 ; 840.86 ; 615.49 ; 768.55 ; 635.46 ; 871.12 ; 618.59 ; 450.63 ; 564.24 ; 699.67 ; 621.78 ; 897.73 ; 780.33 ; 777.99 ; 736.41 ; 528.65 ; 903.32 ; 633.98 ; 510.46 ; 609.7 ; 674.64 ; 586.15 ; 624.34 ; 762.17 ; 566.68 ; 784.54 ; 742.6 ; 302.86 ; 872.8 ; 377.2 ; 753.52 ; 544.38 ; 793.85 ; 571.25 ; 923.39 ; 530.79 ; 787.8 ; 564.8 ; 735.53 ; 827.53 ; 687.86 ; 879.64 ; 895.53 ; 657.37 ; 742.57 ; 806.41 ; 732.07 ; 903.42 ; 608.36 ; 554.05 ; 781.91 ; 683.95 ; 563.32 ; 785.1 ; 748.42 ; 544.97 ; 711.64 ; 578.55 ; 821.61 ; 764.84 ; 807.7
LAST_CONTACT_DAYS_TO	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	Time of the last follow up in days (reference: date of birth).	Patient	
LATERALITY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	For tumors in paired organs, designates the side on which the cancer originates.	Patient	
MENOPAUSAL_STATUS_AT_DIAGNOSIS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Menopausal Status At Diagnosis	Patient	
METASTATIC_DZ_FUP	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Indicate metastatic disease at last followup.	Patient	
METASTATIC_RECURRENCE_TIME_MONTHS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	Months between diagnosis of the primary tumor and metastatic recurrence.	Patient	
M_STAGE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	M Stage	Patient	
NGS_SAMPLE_COLLECTION_TIME	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	NGS Sample Collection Time Period	Sample	445 ; 517 ; 534 ; 618 ; 489 ; 593 ; 744 ; 761 ; 825 ; 881 ; 567 ; 604 ; 581 ; 765 ; 746 ; 692 ; 723 ; 633 ; 563 ; 578 ; 500 ; 538 ; 576 ; 788 ; 736 ; 627 ; 626 ; 790 ; 875 ; 637 ; 834 ; 480 ; 854 ; 838 ; 836 ; 608 ; 850 ; 615 ; 754 ; 391 ; 815 ; 819 ; 404 ; 398 ; 590 ; 728 ; 621 ; 898 ; 895 ; 726 ; 640 ; 718 ; 755 ; 612 ; 564 ; 591 ; 609 ; 605 ; 575 ; 800 ; 459 ; 565 ; 630 ; 682 ; 671 ; 735 ; 700 ; 762 ; 619 ; 488 ; 729 ; 532 ; 537 ; 504 ; 523 ; 763 ; 724 ; 644 ; 393 ; 492 ; 660 ; 482 ; 634 ; 471 ; 603 ; 556 ; 508 ; 528 ; 303 ; 628 ; 623 ; 720 ; 670 ; 772 ; 571 ; 791 ; 803 ; 411 ; 455 ; 487 ; 666 ; 507 ; 506 ; 677 ; 823 ; 690 ; 648 ; 543 ; 454 ; 583 ; 622 ; 707 ; 413 ; 554 ; 606 ; 681 ; 698 ; 655 ; 467 ; 553 ; 468 ; 743 ; 701 ; 348 ; 405 ; 725 ; 669 ; 636 ; 654 ; 587 ; 805 ; 873 ; 552 ; 884 ; 369 ; 704 ; 415 ; 683 ; 573 ; 600 ; 649 ; 431 ; 1003 ; 652 ; 721 ; 673 ; 717 ; 919 ; 853 ; 802 ; 820 ; 635 ; 561 ; 777 ; 741 ; 804 ; 625 ; 452 ; 857 ; 891 ; 818 ; 687 ; 653 ; 596 ; 520 ; 645 ; 579 ; 323 ; 768 ; 447 ; 693 ; 586 ; 715 ; 909 ; 661 ; 617 ; 745 ; 597 ; 680 ; 647 ; 872 ; 495 ; 486 ; 757 ; 679 ; 748 ; 786 ; 470 ; 639 ; 835 ; 672 ; 535 ; 812 ; 747 ; 771 ; 688 ; 610 ; 975 ; 479 ; 629 ; 848 ; 418 ; 558 ; 916 ; 792 ; 808 ; 774 ; 787 ; 706 ; 607 ; 572 ; 443 ; 810 ; 509 ; 799 ; 656 ; 594 ; 691 ; 712 ; 789 ; 662 ; 549 ; 806 ; 732 ; 826 ; 783 ; 494 ; 519 ; 435 ; 646 ; 514 ; 760 ; 816 ; 501 ; 433 ; 513 ; 589 ; 695 ; 624 ; 372 ; 387 ; 849 ; 978 ; 963 ; 847 ; 842 ; 659 ; 651 ; 613 ; 832 ; 798 ; 696 ; 811 ; 357 ; 394 ; 731 ; 399 ; 864 ; 699 ; 710 ; 560 ; 584 ; 616 ; 827 ; 714 ; 824 ; 473 ; 938 ; 929 ; 793 ; 935 ; 862 ; 807 ; 828 ; 346 ; 674 ; 545 ; 536 ; 676 ; 541 ; 664 ; 531 ; 557 ; 769 ; 750 ; 767 ; 868 ; 675 ; 702 ; 632 ; 524 ; 484 ; 439 ; 813 ; 859 ; 396 ; 440 ; 305 ; 716 ; 778 ; 924 ; 420 ; 441 ; 389 ; 900 ; 739 ; 544 ; 462 ; 658 ; 521 ; 512 ; 751 ; 516 ; 667 ; 780 ; 795 ; 602 ; 432 ; 527 ; 964 ; 546 ; 336 ; 322 ; 547 ; 833 ; 860 ; 540 ; 740 ; 444 ; 887 ; 498 ; 511 ; 709 ; 409 ; 385 ; 559 ; 905 ; 582 ; 474 ; 689 ; 785 ; 642 ; 499 ; 796 ; 641 ; 730 ; 614 ; 958 ; 550 ; 665 ; 503 ; 493 ; 466 ; 844 ; 948 ; 758 ; 580 ; 478 ; 738 ; 759 ; 350 ; 858 ; 694 ; 463 ; 840 ; 412 ; 685 ; 574 ; 631 ; 779 ; 863 ; 548 ; 776 ; 491 ; 663 ; 367 ; 668 ; 650 ; 568 ; 899 ; 713 ; 423 ; 770 ; 708 ; 437 ; 345 ; 490 ; 472 ; 937 ; 477 ; 539 ; 595 ; 1023 ; 801 ; 845 ; 395 ; 408 ; 866 ; 406 ; 456 ; 515 ; 989 ; 421 ; 414 ; 542 ; 809 ; 426 ; 497 ; 910 ; 392 ; 496 ; 817 ; 686 ; 465 ; 525 ; 373 ; 427 ; 457 ; 885 ; 773 ; 814 ; 829 ; 321 ; 657 ; 368 ; 794 ; 1046 ; 893 ; 529 ; 880 ; 585 ; 505 ; 734 ; 453 ; 781 ; 883 ; 397 ; 719 ; 782 ; 620 ; 510 ; 483 ; 917 ; 984 ; 997 ; 742 ; 953 ; 678 ; 598 ; 360 ; 384 ; 901 ; 588 ; 867 ; 475 ; 332 ; 381 ; 533 ; 933 ; 374 ; 843 ; 388 ; 370 ; 903 ; 338 ; 752 ; 363 ; 522 ; 993 ; 611 ; 920 ; 831 ; 705 ; 566 ; 1041 ; 764 ; 869 ; 378 ; 434 ; 643 ; 485 ; 697 ; 851 ; 599 ; 638 ; 1011 ; 784 ; 932 ; 458 ; 775 ; 592 ; 913 ; 925 ; 570 ; 601 ; 889 ; 562 ; 951 ; 878 ; 551 ; 855 ; 797 ; 877 ; 969 ; 417 ; 822 ; 342 ; 970 ; 429 ; 766 ; 912 ; 949 ; 1093 ; 400 ; 403 ; 469 ; 711 ; 451 ; 727 ; 555 ; 448 ; 983 ; 753 ; 1055 ; 971 ; 334 ; 343 ; 424 ; 837 ; 928 ; 1014 ; 861 ; 380 ; 996 ; 722 ; 886 ; 896 ; 839 ; 430 ; 569 ; 1026 ; 530 ; 940 ; 944 ; 365 ; 955 ; 821 ; 954 ; 879 ; 939 ; 1047 ; 737 ; 464 ; 918 ; 907 ; 906 ; 684 ; 995 ; 577 ; 377 ; 930 ; 288 ; 749 ; 856 ; 960 ; 733 ; 830 ; 481 ; 353 ; 888 ; 359 ; 460 ; 926 ; 1013 ; 852 ; 319 ; 943 ; 871 ; 347 ; 307 ; 874 ; 379 ; 756 ; 904
N_STAGE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	N Stage	Patient	
OVERALL_HER2_STATUS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall HER2 Status of the Sample that Underwent Sequencing.	Sample	Negative ; Positive ; Unk/ND ; Equivocal
OVERALL_HER2_STATUS_PATIENT	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall patient tumor HER2 status based on the reivew of the primary and metastatic tumors and the clinical history.	Patient	
OVERALL_HR_STATUS_PATIENT	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall patient tumor hormone receptor status based on the reivew of the primary and metastatic tumors and the clinical history.	Patient	
OVERALL_RECEPTOR_STATUS_PATIENT	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall patient tumor receptor subtype based on the reivew of the primary and metastatic tumors and the clinical history. 	Patient	
OVERALL_TUMOR_GRADE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Overall Primary Tumor Histological Grade.	Sample	II  Intermediate Grade (Moderately Differentiated) ; III High Grade (Poorly Differentiated) ; I  Low Grade (Well Differentiated) ; Unknown
PRIMARY_NUCLEAR_GRADE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Primary Nuclear Grade	Sample	III (High) ; II (Intermediate) ; Unknown ; I (Low) ; I (low)
PRIOR_BREAST_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Prior Breast Primary	Sample	No ; Synchronous Bilateral ; Yes
PRIOR_LOCAL_RECURRENCE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Prior Local Recurrence	Patient	
PR_PCT_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	PR Percent Positivity of the Primary Tumor	Sample	22 ; 0 ; 30 ; 50 ; 60 ; 90 ; 70 ; 95 ; 80 ; 100 ; 85 ; 99 ; 3 (weak intensity) ; 5 ; 1 ; 65 ; 73 ; 21 ; 10 ; 40 ; 20 ; 23 ; 75 ; 15 ; 82 ; 3 ; 25 ; 69 ; 24 ; 98 ; 52 ; 11 ; 59 ; 96 ; 86 ; 74 ; 92 ; 94 ; 91 ; 81 ; 34 ; 4 ; 47 ; >60 ; 43 ; 2 ; 62 ; 35 ; 18 ; 31 ; 33 ; 41 ; 56 ; 89 ; 77 ; 6 ; 49 ; 45 ; <5 ; 28 ; 48 ; 93 ; 37 ; 8 ; 87 ; 36 ; 16 ; 32 ; 61 ; 97
PR_STATUS_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	PR Status of the Primary Tumor	Sample	Positive ; Negative ; Unk/ND
RECEPTOR_STATUS_PRIMARY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Receptor Status of the Primary Tumor	Sample	HR+/HER2- ; Triple Negative ; HR+/HER2+ ; HR+/HER2_Unknown ; HR+/HER2_Equivocal ; Unk/ND ; HR-/HER2+ ; HR-/HER2- ; HR-/HER2_Unknown ; HR-/HER2_Equivocal
SAMPLE_SITE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Sample Site	Sample	Treatment Naive Primary ; Liver ; Breast ; Post-Treatment Primary ; Chest Wall ; Lung ; Brain ; Lymph Node ; Bone ; Post-Neo Primary ; Local Recurrence/Breast ; Soft Tissue ; Ovary ; Uterus ; Skin ; Pleura ; Peritoneum ; Pericardium ; Local Recurrence/Lymph Node ; Epidural Mass ; Bowel ; Stomach ; Appendix ; Bladder/Ureter ; Lymph node ; Parotid ; Orbit ; Trachea ; Local Recurrence ; Spleen ; Esophegus
STAGE_AT_DIAGNOSIS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Stage At Diagnosis	Sample	IV ; IIA ; IB ; IA ; IIIA ; IIIC ; IIB ; IIIB ; unk
TIME_TO_DEATH_MONTHS	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	NUMBER	Time To Death (Months)	Patient	
TUMOR_SAMPLE_HISTOLOGY	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Tumor Sample Histology	Sample	Breast Invasive Ductal Carcinoma ; Breast Mixed Ductal and Lobular Carcinoma ; Breast Invasive Lobular Carcinoma ; Breast Invasive Carcinoma, NOS ; Breast Invasive Mixed Mucinous Carcinoma ; Breast Undifferentiated Carcinoma ; Breast Metaplastic Carcinoma ; Breast Invasive Myoepithelial Carcinoma ; Breast Invasive Carcinosarcoma ; Tubular Carcinoma ; Breast Adenoid Cystic Carcinoma
TUMOR_TISSUE_ORIGIN	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	Tumor Tissue of Origin of the Sequnced Tumor.	Sample	Breast
T_STAGE	HotPink	Breast Cancer (MSK, Cancer Cell 2018)	STRING	T Stage	Patient	
ALPELISIB_DOSE	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Alpelisib Dose (mg)	Patient	
ALPELISIB_SCHEDULING	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Alpelisib Scheduling	Patient	
BREAST_CANCER_SUBTYPE	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Breast Cancer Subtype	Patient	
CLINICAL_BENEFIT	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Clinical Benefit	Patient	
ENDOCRINE_THERAPY	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Endocrine Therapy	Patient	
MEASURABLE_DISEASE	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Measurable Disease	Patient	
OFF_STUDY_REASON	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Off Study Reason	Patient	
PATIENT_DISPLAY_NAME	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Patient Display Name	Patient	
PIK3CA_MUT_PRE_TREATMENT_TUMOR	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	PIK3CA Pre Treatment Tumor Mutation	Patient	
PIK3CA_PRE_TREATMENT_TUMOR	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	PIK3CA Pre Treatment Tumor	Patient	
RECIST_RESPONSE	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	NUMBER	Best RECIST Response	Patient	
SAMPLE_COLLECTION_TIMEPOINT	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Sample Collection Time	Sample	pre-treatment ; post-treatment ; on-treatment
SEQUENCING_PLATFORM	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Tumor Sequencing Platform	Sample	Sequenom ; GUARDANT ; Failed ; MSK-IMPACT ; Foundation
TREATMENT_ARM	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	STRING	Treatment Arm	Patient	
WEEKS_ON_STUDY	HotPink	Breast Cancer (MSK, Nature Cancer 2020)	NUMBER	Weeks on Study	Patient	
CENTER	HotPink	Breast Cancer (SMC 2018)	STRING	Center of sequencing	Patient	
COHORT	HotPink	Breast Cancer (SMC 2018)	STRING	Cohort	Patient	
CYT_SCORE	HotPink	Breast Cancer (SMC 2018)	NUMBER	Cytolytic Activity Score	Sample	11.65587835 ; 61.07734523 ; 11.32946601 ; 5.988873016 ; 6.635088545 ; 12.22376374 ; 18.37942872 ; 6.531531214 ; 10.87578963 ; 3.107812736 ; 4.173631512 ; 0.969948452 ; 13.6511538 ; 23.92983076 ; 5.40684751 ; 8.397309093 ; 6.207431031 ; 17.81248158 ; 11.99947499 ; 13.9044741 ; 12.41317445 ; 3.166528067 ; 4.428182471 ; 7.121404356 ; 1.608664042 ; 15.56099611 ; 1.767710384 ; 16.06974798 ; 2.511374126 ; 6.13908788 ; 2.658683885 ; 19.61536133 ; 12.23147579 ; 12.07445237 ; 5.63505102 ; 5.048999901 ; 19.21193379 ; 20.95642622 ; 2.993325909 ; 3.788799282 ; 1.551450934 ; 6.345833279 ; 28.1967374 ; 17.92877018 ; 22.44930288 ; 2.666720833 ; 8.169632795 ; 12.09462691 ; 9.191082635 ; 5.319962406 ; 24.85146475 ; 32.81156656 ; 25.62811737 ; 3.144709844 ; 14.03122945 ; 4.033088147 ; 3.361249768 ; 14.55244997 ; 3.363881686 ; 4.351068834 ; 7.12240128 ; 2.210972637 ; 8.520176055 ; 15.89213642 ; 14.5556793 ; 10.8402583 ; 5.191338941 ; 23.15651096 ; 9.785192895 ; 6.516977827 ; 2.459268184 ; 3.679252642 ; 11.40545484 ; 19.70427619 ; 0.264952826 ; 3.715992465 ; 1.618023486 ; 4.16449 ; 6.321930085 ; 6.935214488 ; 0.14 ; 1.08 ; 18.03926551 ; 10.91296477 ; 1.434782213 ; 30.06033932 ; 5.065964864 ; 0.105830052 ; 7.89722103 ; 38.91545837 ; 24.852014 ; 4.487983957 ; 5.373890583 ; 0.632771681 ; 13.4771028 ; 4.672654492 ; 12.5824163 ; 1.433631752 ; 6.051396533 ; 7.890145753 ; 0.33763886 ; 7.44908048 ; 7.566042559 ; 1.645904007 ; 4.583579387 ; 5.392012611 ; 4.178420754 ; 5.615051202 ; 2.128097742 ; 27.77383121 ; 4.686683262 ; 3.05995098 ; 6.791237001 ; 50.41132016 ; 13.54467054 ; 2.219594558 ; 17.85763142 ; 13.34164907 ; 30.06456053 ; 53.40613261 ; 5.043153775 ; 9.48372817 ; 4.29036129 ; 5.753033982 ; 8.691202448 ; 3.978844053 ; 6.064948475 ; 14.78549627 ; 1.894069692 ; 5.707363665 ; 8.620812027 ; 1.711782696 ; 1.74198163 ; 3.985599077 ; 7.905744747 ; 0.997246208 ; 5.525667381 ; 3.593744565 ; 7.809897567 ; 3.095044426 ; 2.537242598 ; 0.972728122 ; 14.48830563 ; 1.910157062 ; 9.929994965 ; 8.064192458 ; 7.013401457 ; 4.887698845 ; 2.019900988 ; 1.838124044 ; 3.127906648 ; 2.429485542 ; 5.442499426 ; 6.948856021 ; 17.43124494 ; 4.976102893 ; 63.52414895 ; 6.922138398 ; 14.50875598 ; 19.24128374 ; 2.25166605 ; 6.691621627 ; 73.43173565 ; 4.405995915 ; 9.174213863 ; 4.73894503 ; 36.13813498 ; 17.31991917 ; 2.746998362 ; 12.6736735
HISTOLOGY_SUBTYPE	HotPink	Breast Cancer (SMC 2018)	STRING	Histology of the Cancer Subtype	Patient	
IHC_SUBTYPE	HotPink	Breast Cancer (SMC 2018)	STRING	Immunohistochemistry Subtype	Sample	ER+ ; TN ; ER+HER2+ ; UA ; HER2+
INITIAL_TNM_STAGE	HotPink	Breast Cancer (SMC 2018)	STRING	TNM Stage	Sample	3A ; 2A ; 3C ; 2B ; 1A ; 4 ; 1B
MUTATION_BURDEN	HotPink	Breast Cancer (SMC 2018)	NUMBER	Mutation Burden	Sample	1.30103 ; 0.69897 ; 1.54407 ; 1.75587 ; 1.44716 ; 1.34242 ; 1.11394 ; 1.32222 ; 0.90309 ; 1.07918 ; 0.95424 ; 1.14613 ; 1.6721 ; 1.53148 ; 1.27875 ; 1.85126 ; 1.80618 ; 1.23045 ; 1.64345 ; 1.17609 ; 2.03743 ; 1.49136 ; 0.60206 ; 1.73239 ; 1.85733 ; 1.99564 ; 1.39794 ; 2.15229 ; 1.51851 ; 2.10721 ; 1.70757 ; 1.95904 ; 1.78533 ; 1.4624 ; 1.92428 ; 1.38021 ; 2.07555 ; 2.00432 ; 1.81291 ; 2.07188 ; 2.23045 ; 1.6902 ; 1.50515 ; 2.49969 ; 2.15534 ; 1.81954 ; 1.41497 ; 1.74819 ; 1 ; 1.61278 ; 1.25527 ; 1.57978 ; 0.47712 ; 0.8451 ; 1.72428 ; 1.83251 ; 2.05308 ; 0.77815 ; 1.36173 ; 1.69897 ; 1.68124 ; 1.04139 ; 1.86332 ; 1.5682 ; 1.91908 ; 1.95424 ; 1.90849 ; 1.43136 ; 1.20412 ; 2.14613 ; 1.59106 ; 1.62325 ; 1.79239 ; 1.63347 ; 1.76343 ; 0
SUBTYPE_CONSENSUS	HotPink	Breast Cancer (SMC 2018)	STRING	Subtype Consensus	Sample	ER+ ; TN ; ER+HER2+ ; HER2+
TREATMENT_CHEMOTHERAPY	HotPink	Breast Cancer (SMC 2018)	STRING	Chemotherapy(Yes/No)	Patient	
AGE_AT_SEQ_REPORTED_YEARS	HotPink	Metastatic Breast Cancer (MSK, Cancer Discovery 2022)	NUMBER	Age (in years) at which sequencing was reported	Sample	45 ; 62 ; 63 ; 48 ; 51 ; 61 ; 55 ; 57 ; 46 ; 53 ; 71 ; 73 ; 74 ; 77 ; 72 ; 70 ; 33 ; 34 ; 75 ; 76 ; 67 ; 54 ; 52 ; 50 ; 59 ; 42 ; 44 ; 40 ; 38 ; 56 ; 41 ; 58 ; 35 ; 49 ; 84 ; 60 ; 68 ; 37 ; 65 ; 66 ; 39 ; 47 ; 69 ; 82 ; 43 ; 79 ; 81 ; 83 ; 64 ; 36 ; 80 ; 78 ; 31 ; 86 ; 85 ; 30 ; 87 ; 88 ; 29 ; 32 ; 21
AGE_CURRENT	HotPink	Metastatic Breast Cancer (MSK, Cancer Discovery 2022)	NUMBER	Patient Current Age	Patient	
TUMOR_SITE	HotPink	Metaplastic Breast Cancer (MSK,NPJ Breast Cancer 2021)	STRING	Tumor Site	Patient	
TUMOR_SIZE_CM	HotPink	Metaplastic Breast Cancer (MSK,NPJ Breast Cancer 2021)	NUMBER	Tumor size (cm)	Sample	3.0 ; 1.1 ; 1.4 ; 1.6 ; 2.1 ; 2.9 ; 2.5 ; 5.8 ; 5.2 ; 2.3 ; 1.7 ; 4.5 ; 3.9 ; 3.1 ; 2.2 ; 3
ANGIOLYMPHATIC_INVASION	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	Presence of angiolymphatic invasion.	Patient	
CLIN_M_STAGE	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Patient	
CLIN_N_STAGE	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Patient	
EST_TUMOR_CELLULARITY	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	Estimated tumor cellularity.	Sample	Moderate ; High ; Low
HISTOLOGICAL_TYPE	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	Histological Type	Patient	
IHC_BASAL	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	Basal carcinoma by immunohistochemistry for EGFR and CK5/6	Sample	EGFR-ve/low and/or CK5/6-ve/low ; EGFR+ve and/or CK5/6+ve
IHC_CK5_6	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	IHC_CK5/6	Sample	Negative ; Positive ; Positive low
IHC_EGFR	HotPink	Breast Invasive Carcinoma (British Columbia, Nature 2012)	STRING	IHC_EGFR	Sample	Negative ; Positive ; Positive low
ARCHER	HotPink	Non-CDH1 Invasive Lobular Carcinoma (MSK, 2023)	STRING	Whether or not a supplemental MSK-ARCHER test was performed on the sample in addition to the MSK-IMPACT test.	Sample	NO
INSTITUTE	HotPink	Non-CDH1 Invasive Lobular Carcinoma (MSK, 2023)	STRING	Institute Source	Sample	MSKCC
PAIEN_DISPLAY_NAME	HotPink	Non-CDH1 Invasive Lobular Carcinoma (MSK, 2023)	STRING	Patient Display Name	Patient	
SAMPLE_DISPLAY_NAMW=E	HotPink	Non-CDH1 Invasive Lobular Carcinoma (MSK, 2023)	STRING	Sample Display Name	Sample	P-0000820-T02-IM3 ; P-0003591-T01-IM5 ; P-0004023-T01-IM3 ; P-0004023-T02-IM5 ; P-0005526-T01-IM5 ; P-0005968-T01-IM5 ; P-0007759-T01-IM5 ; P-0008952-T01-IM5 ; P-0009325-T02-IM5 ; P-0010869-T01-IM5 ; P-0011400-T01-IM5 ; P-0014406-T01-IM6 ; P-0017113-T01-IM6 ; P-0019191-T01-IM6 ; P-0019864-T01-IM6 ; P-0024899-T01-IM6 ; P-0024979-T01-IM6 ; P-0025335-T01-IM6 ; P-0026032-T01-IM6 ; P-0026113-T01-IM6 ; P-0026615-T01-IM6 ; P-0031517-T01-IM6 ; P-0034517-T01-IM6 ; P-0034891-T01-IM6 ; P-0056185-T02-IM6
SEQUENCING_TYPE	HotPink	Breast Cancer Xenografts (British Columbia, Nature 2015)	STRING	Sequencing Type	Sample	Targeted ; Whole Genome
ADJ_XRT	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Status of adjuvant radiation therapy. Adjuvant therapy is therapy received after surgery. 	Patient	
AGE_AT_DIAGNOSIS_GROUP	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient's age at the time of primary diagnosis with breast cancer grouped into 5 year intervals.	Patient	
ANY_THERAPY_2YRS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: Since your diagnosis with metastatic breast cancer, have you been on any of your cancer therapies for more than 2 years?	Patient	
BXCEP17_COPY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Copy number of CEP17 in the pathology report. This is the number of copies of the CEP17 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. 	Sample	UNKNOWN ; 3.38 ; 1.8 ; 2.6 ; 1.79 ; 2.16 ; 1.95 ; NOT DONE ; 2.7 ; 3.7 ; 2 ; 1.13 ; 1.68 ; 3.2 ; 1.9 ; 3.1 ; 3.6 ; 1.85 ; 73 ; 1.65 ; 3.8 ; 1.7 ; 2.4 ; 2.57 ; 3.12 ; 3.13 ; 2.5 ; 2.1 ; 2.8 ; 2.12 ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; NOT_DONE ; N/A_BLOOD_SAMPLE ; 2.65 ; 2.88 ; 2.2 ; 2.45
BXHER2_COPY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Copy number of HER2 in the pathology report. This is the number of copies of the HER2 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. 	Sample	UNKNOWN ; 2.09 ; 16.8 ; 13.63 ; 2.3 ; 3 ; 1.9 ; 2.2 ; 22.75 ; 2.26 ; 2.78 ; 2.6 ; NOT DONE ; 1.88 ; 6.1 ; 4.13 ; 2.08 ; 3.6 ; 4.4 ; 6.8 ; 1.5 ; 2.68 ; 1.8 ; 3.2 ; 78 ; 3.65 ; 4.2 ; 1.1 ; 3.5 ; 4.7 ; 5.52 ; 4.25 ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; NOT_DONE ; N/A_BLOOD_SAMPLE ; 6.55 ; 5.45 ; 6.2 ; 3.99 ; 2.5
BXHER2_RATIO	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Ratio of HER2/CEP17 in the pathology report. This is one component of the Flourescence In Situ Hybridization (FISH) test. This ratio is used to determine if the HER2 gene is overexpressed, relative to the CEP17 protein, which acts as a baseline measurement. HER2/CEP17 ratios >2.2 indicate a HER2 Positive tumor.	Sample	UNKNOWN ; 1.1 ; 1.37 ; 3.4 ; 7 ; 1.7 ; 4 ; 1.14 ; 1 ; 1.2 ; 1.4 ; 9.48 ; 1.3 ; 1.29 ; 1.33 ; NOT DONE ; 0.69 ; 1.65 ; 3.67 ; 1.24 ; 5.1 ; 3.2 ; 0.7 ; 15.8 ; 2.2 ; 0.8 ; 1.45 ; 1.94 ; 2.21 ; 1.54 ; 2.9 ; 0.9 ; 1.15 ; 1.83 ; 1.8 ; 1.05 ; 1.5 ; 1.07 ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; NOT_DONE ; N/A_BLOOD_SAMPLE ; 1.38 ; 2.5 ; 1.89 ; 1.9 ; 0.71 ; 1.55 ; 1.47 ; 1.63
BX_DCIS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Notes if Ductal Carcinoma In Situ was reported in the pathology report	Sample	YES ; NO ; N/A_BLOOD_SAMPLE
BX_ER	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Estrogen Receptor (ER) status reported in the pathology report	Sample	POSITIVE ; UNKNOWN ; NEGATIVE ; NOT DONE ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; N/A_BLOOD_SAMPLE
BX_GRADE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Sample grade reported in the pathology report 	Sample	UNKNOWN ; II INTERMEDIATE GRADE (MODERATELY DIFFERENTIATED) ; III HIGH GRADE (POORLY DIFFERENTIATED) ; NOT DONE ; I-II ; I LOW GRADE (WELL DIFFERENTIATED) ; II-III ; NOT_FOUND_IN_RECORD ; N/A_BLOOD_SAMPLE
BX_HER2FISH	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	HER2 Flourescence In Situ Hyrbridization (FISH) results in the pathology report. This is most commonly performed on tumor samples with a HER2 Immunohistochemistry (IHC) score of 2+, or equivocal. This is an additional test that aims to measure whether or not the HER2 gene is overexpressed in a tumor sample.	Sample	UNKNOWN ; NEGATIVE ; NOT DONE ; POSITIVE ; EQUIVOCAL ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; NOT_DONE ; N/A_BLOOD_SAMPLE
BX_HER2IHC	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	HER2 Immunohistochemistry (IHC) results in the pathology report. This test involves staining tissue samples and looking at them under a microscope to determine if the HER2 protein is overexpressed in the sample. Results can be reported as 0+, 1+, 2+, or 3+. 0+ and 1+ indicate a HER2 negative tumor, 2+ is considered equivocal and may require further testing, and 3+ indicates a HER2 Positive tumor.	Sample	UNKNOWN ; 0 ; 1+ ; NOT DONE ; 3+ ; 2+ ; EQUIVOCAL ; 1+ - 2+ ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; NOT_DONE ; N/A_BLOOD_SAMPLE ; 1+-2+
BX_HER2OVERALL	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	HER2 status reported in the pathology report	Sample	UNKNOWN ; NEGATIVE ; NOT DONE ; POSITIVE ; EQUIVOCAL ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; N/A_BLOOD_SAMPLE
BX_HISTOLOGY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	The sample's histology reported in the pathology report (IDC = Invasive Ductal Carcinoma, ILC = Invasive Lobular Carcinoma).	Sample	ADENOCARCINOMA ; IDC ; MIXED IDLC ; ILC ; CARCINOMA NOS ; DCIS ; MIXED_IDLC ; CARCINOMA ; N/A_BLOOD_SAMPLE
BX_KI67	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	The percentage of Ki67 reported in the pathology report	Sample	UNKNOWN ; 19.30% ; 10% ; 52% ; 20% ; 94% ; 31% ; 50% ; 12% ; 60% ; 25% ; >90% ; 28% ; 40% ; 88% ; 4% ; POSITIVE ; 9% ; 14% ; 70% ; NOT DONE ; 45% ; 82% ; 30% ; 15% ; 0 ; 74.50% ; 93% ; 43% ; 5% ; 27% ; 8% ; NOT_FOUND_IN_RECORD ; 19.3 ; 0.1 ; 0.2 ; 0.52 ; 0.4 ; 0.04 ; NOT_DONE ; HIGH ; 94 ; N/A_BLOOD_SAMPLE ; 70%_(HIGH) ; 31 ; 10 ; 0.5 ; 12 ; 60 ; 40 ; 0.45 ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; 0.25 ; 74.5 ; >90 ; 93 ; 0.82 ; 0.3 ; 89 ; 0.12 ; 70 ; 28 ; 0.09 ; 20 ; 0.88 ; 43 ; 5 ; 27 ; 0.15 ; 8 ; 26
BX_LCIS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Notes if Lobular Carcinoma In Situ was reported in the pathology report	Sample	NO ; YES ; N/A_BLOOD_SAMPLE
BX_LOCATION	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	The location in the body where the biopsy or surgery was performed	Sample	BONE ; BREAST ; LIVER ; AXILLARY LYMPH NODE ; LUNG ; CHEST WALL ; OMENTUM ; REGIONAL LYMPH NODE ; AXILLA ; SOFT TISSUE ; BRAIN-CNS ; FALLOPIAN TUBE ; PLEURA ; BRAIN ; BONE MARROW ; CERVICAL LYMPH NODE ; PLEURAL FLUID ; BREAST SKIN ; BLOOD ; LYMPH NODE REGIONAL ; LYMPH NODE DISTANT ; GASTRIC BODY ; ASCENDING COLON
BX_NOTES	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Additional information regarding the sample	Sample	LYMPHOVASCULAR INVASION PRESENT ; ALL HISTOLOGY RESIDUAL ; LYMPHOVASCULAR AND PERINEURAL INVOLVEMENT PRESENT ; LOCATED AT 6:00 ; LOCATED AT 3:00 ; LOCATED AT 6:30 ; PERINEURAL INVASION PRESENT ; TREATMENT EFFECT OBSERVED ; LYMPHATIC INVASION PRESENT ; PERINEURAL TUMOR INVASION PRESENT ; 13/15 AXILLARY LN+ FOR MET CARCINOMA ; EXTENSIVE LYMPHATIC INVASION PRESENT ; LYMPHOVASCUALR INVASION PRESENT ; LYMPHATIC INVASION PRESENT; ER/PR CANNOT BE INTERPRETED ; LYMPH-VASCULAR INVASION PRESENT ; ANGIOLYMPHATIC INVASION PRESENT ; 40% TREATMENT EFFECT ; SUPRACLAVICULAR LN ; LOCATED AT 4:00 ; LOCATED AT 1:00 ; RIGHT INNER QUADRANT ; LOBULAR CANCERIZATION PRSENT ; LOCATION DETAILS: AXILLA ; EQUIVOCAL FISH TEST AND POSITIVE IHC SCORE SUGGESTIVE OF HETEROGENEITY AND CLONAL DIFFERENCES ; SUBTYPE: MUCINOUS ADENOCARCINOMA ; HER2 IHC POSITIVE; HER2 FISH RESULT NEGATIVE ; INVASIVE MICROPAPILLARY CARCINOMA ; LOCATED AT 3:00; LYMPHATIC INVASION PRESENT ; LOCATED AT 11:00 ; TESTING PERFORMED ON DIFFERENT SAMPLE
BX_PERCENT_ER	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Percentage of Estrogen Receptor (ER) reported in the pathology report. A value of >= 1% indicates an ER Positive tumor.	Sample	UNKNOWN ; 0% ; NOT DONE ; 95% ; 90% ; 60% ; 99% ; 30% ; 40% ; 5% ; 50% ; 87% ; 79% ; 80% ; 100% ; 85% ; 98% ; 71.50% ; 70% ; >90% ; > 95% ; <1% ; >95% ; >75% ; 75% ; 93% ; 92% ; 97% ; 74% ; 0 ; 98.80% ; 88% ; >70% ; 57% ; 55% ; 50-60% ; 3% ; 71-80% ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; 95 ; 90 ; 0.56 ; 60 ; 99 ; 30 ; 40 ; 100 ; 71.5 ; 5 ; 50 ; 97 ; N/A_BLOOD_SAMPLE ; 0.4 ; 87 ; >90 ; 79 ; 80 ; >95 ; 70 ; 74 ; 85 ; 98.8 ; <1 ; 98 ; 0.95 ; 0.7 ; >75 ; 88 ; 0.05 ; 0.75 ; 93 ; >70 ; 57 ; 55 ; 1 ; 50-60 ; 0.5 ; 3 ; 0.9 ; 92 ; 71-80 ; 96
BX_PERCENT_PR	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Progesterone Receptor (PR) percentage reported in the pathology report. A value of >=1% indicates a PR Positive tumor.	Sample	UNKNOWN ; 0% ; 100% ; 90% ; 97% ; 75% ; 98% ; 80% ; NOT DONE ; 30% ; 63% ; 53% ; 50% ; 95% ; 1% ; 85% ; 15% ; 69% ; 79.60% ; 13% ; 5% ; 20% ; 4% ; 16% ; <1% ; >90% ; 26-75% ; 65% ; 3-5% ; 10% ; 40% ; 60-70% ; 88% ; 21% ; 72.80% ; 92% ; 70% ; 34% ; <5% ; 60% ; >75% ; 25% ; 70-75% ; 99% ; 71-90% ; >80% ; NOT_FOUND_IN_RECORD ; 0 ; 100 ; 90 ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; 97 ; 2 ; 0.17 ; 75 ; 98 ; 50 ; 79.6 ; 5 ; 13 ; 80 ; N/A_BLOOD_SAMPLE ; 30 ; 63 ; <1 ; 53 ; 1 ; >90 ; 20 ; 95 ; 21 ; 85 ; 72.8 ; 0.5 ; 92 ; 0.16 ; 26-75 ; 0.65 ; 0.05 ; 70 ; 10 ; 69 ; 15 ; 4 ; 3-5 ; 34 ; <5 ; 65 ; 0.1 ; 60 ; >75 ; 0.9 ; 0.4 ; 60-70 ; 88 ; 25 ; 70-75 ; 99 ; 0.95 ; 71-90 ; >80 ; 96
BX_PR	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Progesterone Receptor (PR) status as reported in the pathology report 	Sample	POSITIVE ; UNKNOWN ; NEGATIVE ; NOT DONE ; NOT_FOUND_IN_RECORD ; TESTING_PERFORMED_ON_DIFFERENT_SAMPLE ; N/A_BLOOD_SAMPLE
BX_SIDEDNESS_BREAST	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Left or right sidedness for breast procedures	Sample	LEFT ; RIGHT ; N/A_BLOOD_SAMPLE
BX_TIME_DAYS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	NUMBER	Sample collection time in days from primary diagnosis 	Sample	0 ; 8 ; 10 ; 26 ; 114 ; 16 ; 161 ; 639 ; 3629 ; 17 ; 1525 ; 263 ; 39 ; 512 ; 25 ; 28 ; 110 ; 4031 ; 1 ; 293 ; 1721 ; 3 ; 132 ; 23 ; 40 ; 230 ; 254 ; 936 ; 34 ; 6189 ; 11213 ; 271 ; 908 ; 199 ; 106 ; 4 ; 37 ; 2071 ; 1211 ; 166 ; 143 ; 170 ; 21 ; 6 ; 68 ; 43 ; 38 ; 41 ; 120 ; 45 ; 14 ; 9 ; 467 ; 386 ; 236 ; 15 ; 940 ; 64 ; 3549 ; 1407 ; 3113 ; 400 ; 18 ; 338 ; 44 ; 29 ; 647 ; 30 ; 65 ; 149 ; 652 ; 1842 ; 198 ; 147 ; 57 ; -8 ; 55 ; 42 ; 482 ; 20 ; 12 ; 27 ; 854 ; -3 ; 1235 ; -1 ; 2920 ; 4204 ; 7693 ; 214 ; 232 ; 3764 ; 3257 ; 46 ; 32 ; 12426 ; 186 ; 153 ; 2544 ; 334 ; 48 ; 858 ; 1011 ; 1533 ; 11484 ; 13 ; 1768 ; 1688 ; 6180 ; 1413 ; 1682 ; 5161 ; 1463 ; 1641 ; 7110 ; 2759 ; 160 ; 7265 ; 47 ; 2681 ; 182 ; 7678 ; 70 ; 1189 ; 215 ; 930 ; 1196 ; 5010 ; 7 ; 93 ; 360 ; 5200 ; 3178 ; 3200 ; 194 ; 6470 ; 1325 ; 5244 ; 1835 ; 201 ; 154 ; 3227 ; 4557 ; 2271 ; 3503 ; 2015 ; 2282 ; 2689 ; 1067 ; 3920 ; 1060 ; 350 ; 410 ; 213 ; -21 ; 798 ; 805 ; 5070 ; 500 ; 7902 ; 1587 ; 3582 ; 1700 ; 827 ; 2531 ; 9180 ; 1092 ; 7989 ; 3419 ; 4658 ; 5288 ; 5754 ; 5017 ; 50 ; 2563 ; 3058 ; 2258 ; 519 ; 60 ; 33 ; 325 ; 1715 ; 516 ; 165 ; 481 ; 2585 ; 310 ; 4878 ; 2093 ; 1650 ; 3612 ; 31 ; 211 ; 56 ; 146 ; 2127 ; 22 ; 1888 ; 945 ; 1106 ; 19 ; 2795 ; 4328 ; 217 ; 459
BX_TYPE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	The procedure performed to obtain the sample	Sample	FNA ; CORE ; LUMPECTOMY ; MASTECTOMY ; PUNCH ; OTHER ; EXCISION ; WEDGE ; RE-EXCISION ; DISSECTION ; RESECTION ; UNKNOWN ; BILATERAL SALPINGO-OOPHERECTOMY ; N/A_BLOOD_SAMPLE ; LOBECTOMY ; NOT_FOUND_IN_RECORD ; BILATERAL_SALPINGO_OOPHERECTOMY
CALC_MET_SETTING	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated variable to classify if samples were taken while the patient had metastatic disease, or prior to metastatic disease. Samples taken less than 4 months prior to the diagnosis of metastatic disease are classified as METASTATIC DISEASE PRESENT	Sample	METASTATIC DISEASE PRESENT ; NO METASTATIC DISEASE PRESENT ; UNKNOWN ; METASTATIC_DISEASE_PRESENT ; NO_METASTATIC_DISEASE_PRESENT ; ABSTRACTION_PENDING ; NOT_FOUND_IN_RECORD
CALC_TIME_TO_METS_DX_DAYS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	NUMBER	Calculated elapsed time, in days, between the patient's primary diagnosis with breast cancer and diagnosis with metastatic breast cancer as reported in the medical record	Patient	
CALC_TIME_TO_METS_DX_MONTHS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	NUMBER	Calculated elapsed time, in months, between patient's primary diagnosis with breast cancer and diagnosis with metastatic breast cancer as reported in the medical record	Patient	
CALC_TREATMENT_NAIVE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated variable that is set to YES if a sample was taken prior to the start of any medical therapy	Sample	YES ; NO ; UNKNOWN ; ABSTRACTION_PENDING ; INCONCLUSIVE
DX_CEP17_COPY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Copy number of CEP17 in diagnostic sample. This is the number of copies of the CEP17 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. 	Patient	
DX_ER	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Estrogen Receptor (ER) status of diagnostic sample	Patient	
DX_GRADE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Grade of diagnostic sample	Patient	
DX_HER2FISH	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	HER2 Flourescence In Situ Hyrbridization (FISH) results in diagnostic sample. This is most commonly performed on tumor samples with a HER2 Immunohistochemistry (IHC) score of 2+, or equivocal. This is an additional test that aims to measure whether or not the HER2 gene is overexpressed in a tumor sample.	Patient	
DX_HER2IHC	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	HER2 Immunohistochemistry (IHC) results of diagnostic sample. This test involves staining tissue samples and looking at them under a microscope to determine if the HER2 protein is overexpressed in the sample. Results can be reported as 0+, 1+, 2+, or 3+. 0+ and 1+ indicate a HER2 negative tumor, 2+ is considered equivocal and may require further testing, and 3+ indicates a HER2 Positive tumor.	Patient	
DX_HER2OVERALL	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	HER2 status of diagnostic sample	Patient	
DX_HER2_COPY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Copy number of HER2 in diagnostic sample. This is the number of copies of the HER2 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. 	Patient	
DX_HER2_RATIO	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Ratio of HER2/CEP17 in diagnostic sample. This is one component of the Flourescence In Situ Hybridization (FISH) test. This ratio is used to determine if the HER2 gene is overexpressed, relative to the CEP17 protein, which acts as a baseline measurement. HER2/CEP17 ratios >2.2 indicate a HER2 Positive tumor.	Patient	
DX_HISTOLOGY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Histology of diagnostic sample	Patient	
DX_LOCATION	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Location in the body of initial breast cancer diagnosis 	Patient	
DX_PERCENT_ER	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Percentage of Estrogen Receptor (ER) reported in diagnostic sample. A value of >= 1% indicates an ER Positive tumor .	Patient	
DX_PERCENT_PR	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Progesterone Receptor (PR) percentage reported in diagnostic sample. A value of >=1% indicates a PR Positive tumor.	Patient	
DX_PR	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Progesterone Receptor (PR) status of diagnostic sample	Patient	
DX_SIDEDNESS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Left or right sidedness of diagnostic sample	Patient	
DX_STAGE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV 	Patient	
DX_TYPE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Type of procedure used to obtain diagnostic sample	Patient	
EVER_METS_SITES	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	All locations in the body where breast cancer spread at any point in the patient's treatment	Patient	
GERMLINE_MUTKNOWN_BRCA1	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Reported germline BRCA1 mutation	Patient	
GERMLINE_MUTKNOWN_BRCA2	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Reported germline BRCA2 mutation	Patient	
GERMLINE_MUTKNOWN_PALB2	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Reported germline PALB2 mutation	Patient	
HER2_STATUS_REPORTED	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: At any time, was your breast cancer found to be HER2 positive (HER2+)?	Patient	
HISPANIC	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: Do you consider yourself Hispanic, Latino/a or Spanish?	Patient	
HORMONE_RECEPTOR_STATUS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: At any time, was your breast cancer found to be hormone receptor positive (HR+, ER+ and/or PR+)?	Patient	
INFLAMMATORY_STATUS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: At any time, were you diagnosed with inflammatory breast cancer?	Patient	
METS_SITES_AT_DX	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	All locations in the body where breast cancer spread at the time of diagnosis with metastatic breast cancer.	Patient	
METS_SITES_AT_METS_ABST_ADRENAL_GLAND	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to adrenal gland noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_ASCITES	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to ascites noted during the patient's course of treatment. Ascites is the accumulation of fluid in the abdominal cavity.	Patient	
METS_SITES_AT_METS_ABST_BONE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to bone noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_BRAIN_CNS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to brain or central nervous system noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_CHEST_WALL	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to chest wall noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_DIST_LYMPH	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to distant lymph nodes noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_INTRA_ABDOMINAL	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to intraabdominal area noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_LIVER	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to liver noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_LUNG	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to lung noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_OVARY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to ovary noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_PLEURAL_EFFUSION	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to pleural effusion noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_REG_LYMPH	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to regional lymph nodes noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_SKIN	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to skin noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_SOFT_TISSUE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to soft tissue noted during the patient's course of treatment	Patient	
METS_SITES_AT_METS_ABST_UNKNOWN	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastases unknown or not reported during patient's course of treatment. This is set to YES if metastatic sites could not be determined from available medical records.	Patient	
METS_SITES_AT_METS_DX_ADRENAL_GLAND	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to adrenal gland noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_ASCITES	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to ascites noted at time of diagnosis with metastatic disease. Ascites is the accumulation of fluid in the abdominal cavity. 	Patient	
METS_SITES_AT_METS_DX_BONE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to bone noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_BRAIN_CNS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to Brain or Central Nervous System noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_CHEST_WALL	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to chest wall noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_DIST_LYMPH	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to distant lymph nodes noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_INTRA_ABDOMINAL	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to intraabdominal area noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_LIVER	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to liver noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_LUNG	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to lung noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_OVARY	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to ovary noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_PLEURAL_EFFUSION	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to pleural effusion noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_REG_LYMPH	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to regional lymph nodes noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_SKIN	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to skin noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_SOFT_TISSUE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastasis to soft tissue noted at time of diagnosis with metastatic disease	Patient	
METS_SITES_AT_METS_DX_UNKNOWN	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Metastatic sites unknown or not reported at time of diagnosis with metastatic disease. This is set to YES if metastatic sites could not be determined from available medical records.	Patient	
N_STAGE_REPORTED	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV	Patient	
PATIENT_NOTES	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Additional notes about patient's clinical history	Patient	
RACE_CATEGORIZED	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: What is your race (select all that apply)? Infrequent responses have been categorized as Other for confidentiality. 	Patient	
SAMPLE_TIMEPOINT	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Sample sequential timepoint (T1 = timepoint 1, T2 = timepoint 2, etc.)	Sample	MBCProject_GvHkH2Hk_T1 ; MBCProject_GvHkH2Hk_T2 ; MBCProject_N4srsKsr_T1 ; MBCProject_N4srsKsr_T2 ; MBCProject_4MF1FlFQ_T1 ; MBCProject_4MF1FlFQ_T3 ; MBCProject_wAiri7fp_T1 ; MBCProject_K7f6fdUz_T2 ; MBCProject_xBfJfri9_T1 ; MBCProject_xBfJfri9_T3B ; MBCProject_gKsRsqTR_T1 ; MBCProject_QbiZiytx_T2 ; MBCProject_QbiZiytx_T1 ; MBCProject_VrsMsqTb_T1 ; MBCProject_57iLiJIl_T1 ; MBCProject_ErfKfJt0_T1 ; MBCProject_K0UDUnFE_T1 ; MBCProject_RKf1frsr_T3 ; MBCProject_RKf1frsr_T2 ; MBCProject_RKf1frsr_T1 ; MBCProject_wKuZuQS1_T3 ; MBCProject_kwS1CXSR_T1 ; MBCProject_O8u9SjuW_T1 ; MBCProject_7of5i3hp_T1 ; MBCProject_VbfASefz_T1 ; MBCProject_4DIpSBFV_T1 ; MBCProject_gotjfgf0_T2 ; MBCProject_gotjfgf0_T1 ; MBCProject_bvHXCoTY_T1 ; MBCProject_9JI1fwuX_T1 ; MBCProject_ZdudUNFZ_T1 ; MBCProject_3jhES9fq_T2 ; MBCProject_3LI1TNs3_T1 ; MBCProject_4OIOfAt9_T2 ; MBCProject_7XFmtytw_T3 ; MBCProject_74CYIyHw_T1 ; MBCProject_1ps2hZH8_T1 ; MBCProject_rmSBIguN_T1C ; MBCProject_rmSBIguN_T1A ; MBCProject_KphMt4F9_T1 ; MBCProject_KphMt4F9_T2 ; MBCProject_zyt5TKFB_T1A ; MBCProject_zyt5TKFB_T1B ; MBCProject_JGCBTpH1_T1 ; MBCProject_bAi0Slsx_T2 ; MBCProject_GouMi0U1_T1 ; MBCProject_DxibF0hM_T2 ; MBCProject_P2CMUEiX_T1 ; MBCProject_JBh5TjcM_T1 ; MBCProject_kduys9h5_T1 ; MBCProject_kduys9h5_T2 ; MBCProject_d5CbUNTb_T2 ; MBCProject_d5CbUNTb_T1 ; MBCProject_BOHWtZT8_T1 ; MBCProject_BOHWtZT8_T2 ; MBCProject_epUYsdCE_T1 ; MBCProject_kAFQF3t6_T1 ; MBCProject_5jSPs9fl_T3 ; MBCProject_PASlTyTy_T1 ; MBCProject_pMcWcrtZ_T2 ; MBCProject_rJHBiKTl_T1 ; MBCProject_AqtYu0IW_T2 ; MBCProject_AqtYu0IW_T1 ; MBCProject_PXcjFYIo_T1 ; MBCProject_PXcjFYIo_T2 ; MBCProject_99CdCOHm_T1B_2 ; MBCProject_VQfmS0fK_T1 ; MBCProject_VQfmS0fK_T2 ; MBCProject_gjhMuoha_T1 ; MBCProject_PzUBH7I3_T1 ; MBCProject_PzUBH7I3_T2 ; MBCProject_PzUBH7I3_T3 ; MBCProject_Y7fYC1iG_T1 ; MBCProject_7VFnIqfw_T1 ; MBCProject_ePi1smiM_T3 ; MBCProject_ePi1smiM_T1B ; MBCProject_ePi1smiM_T1C ; MBCProject_ePi1smiM_T1D ; MBCProject_ePi1smiM_T2 ; MBCProject_7JtRIPI2_T1 ; MBCProject_7JtRIPI2_T2 ; MBCProject_1qhlIasw_T1 ; MBCProject_4vC6Fgio_T1 ; MBCProject_NDIbs9i6_T1 ; MBCProject_ZPHRs3Uw_T1 ; MBCProject_BVHET8iq_T1 ; MBCProject_KGs1fxH2_T1A ; MBCProject_KGs1fxH2_T1B ; MBCProject_KGs1fxH2_T1K ; MBCProject_3MUnT7Ty_T1 ; MBCProject_mrhKt1Ue_T1 ; MBCProject_kRC3tlcA_T1 ; MBCProject_lXCmTEuv_T1 ; MBCProject_jEhBHrS2_T1 ; MBCProject_27uAugT4_T1 ; MBCProject_p1CQTdIg_T1 ; MBCProject_70CxiQFk_T1 ; MBCProject_DDUmIZuW_T1 ; MBCProject_7OcOivcV_T1 ; MBCProject_LvS2IvIy_T1 ; MBCProject_EBTBIGFy_T1 ; MBCProject_j2F2sQC0_T1 ; MBCProject_nZHYc4Ie_T1 ; MBCProject_43UpSwhz_T1 ; MBCProject_2pt4t9cA_T2 ; MBCProject_yZSnSluK_T1 ; MBCProject_qmu6TYto_T1 ; MBCProject_qmu6TYto_T2 ; MBCProject_Jeu1F5cz_T1 ; MBCProject_pktAIxFb_T2 ; MBCProject_pktAIxFb_T1 ; MBCProject_eXSVsxUm_T2 ; MBCProject_eXSVsxUm_T1 ; MBCProject_rMHPsbIq_T1 ; MBCProject_bpunhmim_T2 ; MBCProject_LVSjf8h7_T1A ; MBCProject_XmiOUMSm_T1 ; MBCProject_kzuMSZIW_T1 ; MBCProject_BVCVuGhl_T1 ; MBCProject_pyhbI1H5_T3 ; MBCProject_brTys8Hl_T2 ; MBCProject_Y8H6SghO_T2 ; MBCProject_lQtMtjFR_T1 ; MBCProject_lQtMtjFR_T2 ; MBCProject_LDCbC8t9_T1 ; MBCProject_2ViLiZS8_T1 ; MBCProject_2kS5fYc1_T1 ; MBCProject_GKu6TliY_T2 ; MBCProject_wKuwTYhK_T1 ; MBCProject_JKTZhEUe_T1 ; MBCProject_OwuoTVhg_T1 ; MBCProject_oqupfDu7_T1 ; MBCProject_oqupfDu7_T2B ; MBCProject_MYuoCmI7_T1 ; MBCProject_rvULI3TV_T1 ; MBCProject_goSDCjUM_T1 ; MBCProject_RJf1h2Sp_T1 ; MBCProject_BvsPhwI1_T2 ; MBCProject_gdIlF4hG_T1 ; MBCProject_6vTVHzur_T1 ; MBCProject_6vTVHzur_T3 ; MBCProject_0aTBfPcG_T1 ; MBCProject_e4SaTnIW_T1 ; MBCProject_e4SaTnIW_T2 ; MBCProject_e4SaTnIW_T4 ; MBCProject_XVHkUVTb_T1 ; MBCProject_7wCjtKIW_T3 ; MBCProject_mrIQIdsx_T3 ; MBCProject_mrIQIdsx_T1 ; MBCProject_mrIQIdsx_T2 ; MBCProject_LPHKFauY_T1 ; MBCProject_MlheH1iY_T1 ; MBCProject_wzCxuoio_T1 ; MBCProject_6QhZF6ur_T1 ; MBCProject_DximH6Cn_T1 ; MBCProject_briXiduE_T1 ; MBCProject_k4hlFwFg_T1 ; MBCProject_k4hlFwFg_T2 ; MBCProject_gASyuQSl_T2 ; MBCProject_gASyuQSl_T0A ; MBCProject_gASyuQSl_T0B ; MBCProject_gASyuQSl_T0C ; MBCProject_W2CQswiv_T1 ; MBCProject_6JhKimhv_T1 ; MBCProject_ZeTySaU3_T2 ; MBCProject_oZT8clio_T1 ; MBCProject_3vhkhAcY_T1 ; MBCProject_nwIeUoSD_T1 ; MBCProject_GpizsQiW_T1 ; MBCProject_Y7iLIOU0_T1 ; MBCProject_Y7iLIOU0_T1A ; MBCProject_Gxhdtafa_T1 ; MBCProject_glf3CWFa_T1 ; MBCProject_YNTyfDfq_T1B ; MBCProject_EWubi6hd_T1 ; MBCProject_7AC8CoUL_T1 ; MBCProject_QNs8uGhM_T1 ; MBCProject_WYHpfXf1_T1 ; MBCProject_WYHpfXf1_T2 ; MBCProject_2WCGcxuk_T4 ; MBCProject_AwukckTD_T1 ; MBCProject_zatdFvhp_T2 ; MBCProject_W5ceiLi0_T1 ; MBCProject_MmSBTJtJ_T1 ; MBCProject_jmfDfEs8_T1 ; MBCProject_x4cLHdhw_T1 ; MBCProject_x4cLHdhw_T2 ; MBCProject_x4cLHdhw_T3 ; MBCProject_PkTDsOSa_T1 ; MBCProject_PkTDsOSa_T1A ; MBCProject_nkU3hDhB_T1A ; MBCProject_nkU3hDhB_T1B ; MBCProject_nkU3hDhB_T2 ; MBCProject_6zfRF2fl_T2 ; MBCProject_m9SNc1Iq_T1 ; MBCProject_beTYUZij_T1 ; MBCProject_JpCASlSG_T2 ; MBCProject_kQTqIOSP_T2 ; MBCProject_mMhdcrh5_T1 ; MBCProject_NzHBsOtg_T1 ; MBCProject_EkHAIECZ_T1 ; MBCProject_W4FBsLSx_T1 ; MBCProject_W4FBsLSx_T2 ; MBCProject_W4FBsLSx_T3 ; MBCProject_lGCMIGT0_T1A ; MBCProject_lGCMIGT0_T1B ; MBCProject_JGcLUJiA_T2 ; MBCProject_JGcLUJiA_T4 ; MBCProject_JGcLUJiA_T5 ; MBCProject_5vTpUpCv_T1 ; MBCProject_Ali6SAHL_T1 ; MBCProject_9RtxtGUO_T1 ; MBCProject_nEcXsyfj_T2 ; MBCProject_8bfWIQu1_T1 ; MBCProject_8bfWIQu1_T2 ; MBCProject_B7f5hRfD_T0 ; MBCProject_B7f5hRfD_T1 ; MBCProject_AzCnt3sL_T1 ; MBCProject_LnHAS5T0_T1 ; MBCProject_oNI6SXtq_T2 ; MBCProject_2Wf9hPtA_T2 ; MBCProject_xlhkS5CG_T1 ; MBCProject_m1fOs2FL_T1 ; MBCProject_QJFdf8hQ_T2 ; MBCProject_ygcMFgCR_T1A ; MBCProject_ygcMFgCR_T1B ; MBCProject_ygcMFgCR_T1C ; MBCProject_W9hmcWcz_T1 ; MBCProject_5gHasou8_T1 ; MBCProject_5gHasou8_T2 ; MBCProject_DWTkcWCW_T1 ; MBCProject_qQSACYuv_T1 ; MBCProject_lqSlSztO_T2 ; MBCProject_AJF3tVc8_T1 ; MBCProject_6Yt3czsW_T1 ; MBCProject_lJflt3UR_T1 ; MBCProject_y2F3IgIE_T1 ; MBCProject_xBfJfri9_T2 ; MBCProject_xBfJfri9_T3A ; MBCProject_2pt4t9cA_T1 ; MBCProject_VrsMsqTb_T2 ; MBCProject_wKuZuQS1_T2 ; MBCProject_4DIpSBFV_T2 ; MBCProject_qyf8tJUa_T1 ; MBCProject_PltxioCD_BLOOD_P ; MBCProject_3jhES9fq_T1 ; MBCProject_7XFmtytw_T2 ; MBCProject_dPIxCpiZ_T1 ; MBCProject_dPIxCpiZ_T2 ; MBCProject_rmSBIguN_T1_A ; MBCProject_rmSBIguN_T1_C ; MBCProject_1efxSxuz_BLOOD_P ; MBCProject_8juyTguN_BLOOD_P ; MBCProject_nVtEHZi1_BLOOD_P ; MBCProject_R3UpTWFr_T3 ; MBCProject_pwswieUY_BLOOD_P ; MBCProject_MvhNc7Cd_T1 ; MBCProject_nrI4FWfZ_BLOOD_P ; MBCProject_4pfxtQc0_BLOOD_P ; MBCProject_BOHWtZT8_T3 ; MBCProject_GMuyflik_BLOOD_P ; MBCProject_lQtMtjFR_T3 ; MBCProject_9oHNUZUE_BLOOD_P ; MBCProject_MNHjCeCY_BLOOD_P ; MBCProject_odSqHlhG_BLOOD_P ; MBCProject_odSqHlhG_T7 ; MBCProject_DBi1S1cl_BLOOD_P ; MBCProject_rLt0uZhz_BLOOD_P ; MBCProject_LYtpINtB_BLOOD_P ; MBCProject_ZbTlfDcK_BLOOD_P ; MBCProject_WPHlSPTB_BLOOD_P ; MBCProject_axtmcztr_BLOOD_P ; MBCProject_bBIxhQUD_BLOOD_P ; MBCProject_N2HMfxSz_BLOOD_P ; MBCProject_7lC9TJT0_BLOOD_P ; MBCProject_A2TwSMcO_BLOOD_P ; MBCProject_0jUXcgsJ_BLOOD_P ; MBCProject_JYf4UmC7_BLOOD_P ; MBCProject_GjsDCOfR_T1 ; MBCProject_7oIotZSe_T1 ; MBCProject_kNiBiwtL_T2 ; MBCProject_pMcWcrtZ_T1 ; MBCProject_MBIOSgIG_BLOOD_P ; MBCProject_5Rc8S6Iz_BLOOD_P ; MBCProject_xoHAF6s8_T1 ; MBCProject_xoHAF6s8_T2 ; MBCProject_7OTls3Cz_BLOOD_P ; MBCProject_AmUotWsr_BLOOD_P ; MBCProject_JqfQclUP_BLOOD_P ; MBCProject_kPcWtWUk_BLOOD_P ; MBCProject_wlTjfwfB_BLOOD_P ; MBCProject_mrIDsjij_BLOOD_P ; MBCProject_BvsPhwI1_BLOOD_P ; MBCProject_zafPHNuX_BLOOD_P ; MBCProject_BztkUKtA_BLOOD_P ; MBCProject_07t2uAFn_BLOOD_P ; MBCProject_l8UGfecE_BLOOD_P ; MBCProject_OwCgI7fY_BLOOD_P ; MBCProject_XgHGHMUm_BLOOD_P ; MBCProject_lBSVSqup_BLOOD_P ; MBCProject_eQULU6Ug_BLOOD_P ; MBCProject_nYsGsgf7_BLOOD_P ; MBCProject_YXcpfacz_BLOOD_P ; MBCProject_JBcJhKtB_BLOOD_P ; MBCProject_lvCYUbiZ_BLOOD_P ; MBCProject_Mqu7Tacm_BLOOD_P ; MBCProject_DNckSWc3_BLOOD_P ; MBCProject_5wS3unim_BLOOD_P ; MBCProject_W4FBsLSx_BLOOD_P ; MBCProject_x3Tef5t3_BLOOD_P ; MBCProject_LlHlUas0_BLOOD_P ; MBCProject_jWt4f1So_BLOOD_P ; MBCProject_g1hacEF1_T1 ; MBCProject_e4SaTnIW_T3 ; MBCProject_m9uaInfr_BLOOD_P ; MBCProject_kjf7TNhM_BLOOD_P ; MBCProject_kQhvcOSQ_BLOOD_P ; MBCProject_qOFXIAux_BLOOD_P ; MBCProject_jWTAt6t6_BLOOD_P ; MBCProject_knuPtacD_BLOOD_P ; MBCProject_ZgTbHMhN_BLOOD_P ; MBCProject_1mFRTZu0_BLOOD_P ; MBCProject_GeurS8S6_BLOOD_P ; MBCProject_mlhYclhy_BLOOD_P ; MBCProject_eEtEC7IB_T2 ; MBCProject_W7HMcZI4_BLOOD_P ; MBCProject_W7HMcZI4_T1 ; MBCProject_W7HMcZI4_T2 ; MBCProject_W7HMcZI4_T3 ; MBCProject_W7HMcZI4_T4 ; MBCProject_JXUNUQI8_BLOOD_P ; MBCProject_53FkFziE_BLOOD_P ; MBCProject_VkSgSghO_BLOOD_P ; MBCProject_nEcXsyfj_BLOOD_P ; MBCProject_l5S6FdFR_BLOOD_P ; MBCProject_1JSQupur_BLOOD_P ; MBCProject_K9frSgTN_BLOOD_P ; MBCProject_9EHmUJIO_BLOOD_P ; MBCProject_D7U7SNiz_BLOOD_P ; MBCProject_NQIMHkTd_BLOOD_P ; MBCProject_3ehYUAsz_BLOOD_P ; MBCProject_69SPhYf2_BLOOD_P ; MBCProject_eAFkF0s8_BLOOD_P ; MBCProject_oAsLszt0_T1 ; MBCProject_rAs1s0F8_BLOOD_P ; MBCProject_rAs1s0F8_T1 ; MBCProject_4ViNTZSe_T1 ; MBCProject_yWS4imiO_BLOOD_P ; MBCProject_W2CQswiv_BLOOD_P ; MBCProject_nBfYHRSQ_BLOOD_P ; MBCProject_QGI0fOhX_BLOOD_P ; MBCProject_25TAUefB_BLOOD_P ; MBCProject_5gCKFQfm_BLOOD_P ; MBCProject_WzU1HEsr_T2 ; MBCProject_N4HEIRId_BLOOD_P ; MBCProject_4zcacDSB_BLOOD_P ; MBCProject_8YF9FlFx_BLOOD_P ; MBCProject_pzSJS7s4_BLOOD_P ; MBCProject_JxsQiWI9_T3 ; MBCProject_LDH0iycR_T1 ; MBCProject_YEFnulFd_T1 ; MBCProject_YEFnulFd_T2 ; MBCProject_bDH0sbix_T2 ; MBCProject_XWtLC4UZ_BLOOD_P ; MBCProject_G4s2c4fv_BLOOD_P ; MBCProject_ELtvf4UO_BLOOD_P ; MBCProject_nMHqU2Hx_BLOOD_P ; MBCProject_kwseuaHX_BLOOD_P ; MBCProject_l9HwF2io_BLOOD_P ; MBCProject_92frH4SX_T1 ; MBCProject_yNfLhMIW_BLOOD_P ; MBCProject_83Urs6H0_BLOOD_P ; MBCProject_wGFQuEcy_BLOOD_P ; MBCProject_PNursEUY_BLOOD_P ; MBCProject_ELU6IJh0_BLOOD_P ; MBCProject_JwiAIYSe_BLOOD_P ; MBCProject_AgF4uvCq_BLOOD_P ; MBCProject_rYSXcxcV_T1 ; MBCProject_wzUlU9hX_BLOOD_P ; MBCProject_oeubIAFD_T1 ; MBCProject_o5cqTwTa_BLOOD_P ; MBCProject_AesAugs2_BLOOD_P ; MBCProject_GOfliRi4_BLOOD_P ; MBCProject_ewHohEi6_T1 ; MBCProject_gxU5FJhl_BLOOD_P ; MBCProject_7XhrFPT1_T1 ; MBCProject_86HMf8FA_T2
SURGERY_AT_DX	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Surgery performed within 6 months of diagnosis	Patient	
TRIPLE_NEG_STATUS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Patient-reported response to the question: At any time, was your breast cancer found to be triple negative (e.g. NOT ER+, PR+, or HER2+)?	Patient	
T_STAGE_REPORTED	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV	Patient	
X2YR_AIS	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an aromatase inhibitors for more than 2 years.	Patient	
X2YR_ALKYLATING_AGENT	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an alkylating agent for more than 2 years.	Patient	
X2YR_ANTHRACYCLINE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an anthracycline for more than 2 years.	Patient	
X2YR_ANTIHER2	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on anti-HER2 therapy for more than 2 years.	Patient	
X2YR_CAPECITABINE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on capecitabine for more than 2 years.	Patient	
X2YR_CDK46	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a CDK4/6 inhibitor for more than 2 years.	Patient	
X2YR_FULVESTRANT	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on fulvestrant for more than 2 years.	Patient	
X2YR_TAMOXIFEN	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on tamoxifen for more than 2 years.	Patient	
X2YR_TAXANE	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a taxane for more than 2 years.	Patient	
X2YR_VEGF_INHIBITOR	HotPink	The Metastatic Breast Cancer Project (Archived, 2020)	STRING	Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a VEGF inhibitor for more than 2 years.	Patient	
AGE_AT_DIAGNOSIS	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient's age at the time of primary diagnosis with breast cancer grouped into 5 year intervals.	Patient	
ANYTIME_CANCER_LOC_ASCITES	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Ascites	Patient	
ANYTIME_CANCER_LOC_AXILLARY_LYMPH_NODE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Axillary lymph node (lymph nodes in the armpit)	Patient	
ANYTIME_CANCER_LOC_BONE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Bone	Patient	
ANYTIME_CANCER_LOC_BRAIN	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Brain	Patient	
ANYTIME_CANCER_LOC_BREAST	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Breast	Patient	
ANYTIME_CANCER_LOC_CHEST_WALL	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Chest Wall	Patient	
ANYTIME_CANCER_LOC_LIVER	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Liver	Patient	
ANYTIME_CANCER_LOC_LUNG	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Lung	Patient	
ANYTIME_CANCER_LOC_OTHER_LYMPH_NODE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Lymph nodes anywhere other than the axilla/armpit	Patient	
ANYTIME_CANCER_LOC_OVARY	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Ovary	Patient	
ANYTIME_CANCER_LOC_PLEURAL_EFFUSION	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Pleural Effusion	Patient	
ANYTIME_CANCER_LOC_SKIN	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: Please select all of the places in your body that metastatic breast cancer has been found at any time (select all that apply). Listed as TRUE if patient selected Skin	Patient	
CANCER_IDENTIFICATION_IDC	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: At any time since your original diagnosis of breast cancer was it identified as any of the following (select all that apply)? Listed as TRUE if patient selected Invasive Ductal Carcinoma (IDC)	Patient	
CANCER_IDENTIFICATION_ILC	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: At any time since your original diagnosis of breast cancer was it identified as any of the following (select all that apply)? Listed as TRUE if patient selected Invasive Lobular Carcinoma (ILC)	Patient	
CANCER_IDENTIFICATION_MIDLC	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: At any time since your original diagnosis of breast cancer was it identified as any of the following (select all that apply)? Listed as TRUE if patient selected Mixed Invasive Ductal/Lobular Carcinoma	Patient	
CANCER_IDENTIFICATION_RARE_SUBTYPE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: At any time since your original diagnosis of breast cancer was it identified as any of the following (select all that apply)? Listed as TRUE if patient selected Other Rare Subtypes	Patient	
DCIS_SX_BX	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Whether DCIS was present in surgical biopsy	Patient	
DIAGNOSED_BY_SCREENING	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Whether patient was diagnosed by screening	Patient	
DIAGNOSIS_CANCER_BONE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Bone	Patient	
DIAGNOSIS_CANCER_LOC_ASCITES	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Ascites	Patient	
DIAGNOSIS_CANCER_LOC_AXILLARY_LN	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Axillary lymph node (lymph nodes in the armpit)	Patient	
DIAGNOSIS_CANCER_LOC_BRAIN	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Brain	Patient	
DIAGNOSIS_CANCER_LOC_BREAST	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Breast	Patient	
DIAGNOSIS_CANCER_LOC_CHEST_WALL	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Chest Wall	Patient	
DIAGNOSIS_CANCER_LOC_LIVER	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Liver	Patient	
DIAGNOSIS_CANCER_LOC_LUNG	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Lung	Patient	
DIAGNOSIS_CANCER_LOC_OTHER_LN	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Lymph nodes anywhere other than the axilla/armpit	Patient	
DIAGNOSIS_CANCER_LOC_OVARY	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Ovary	Patient	
DIAGNOSIS_CANCER_LOC_PLEURAL_EFFUSION	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Pleural Effusion	Patient	
DIAGNOSIS_CANCER_LOC_SKIN	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient reported response to the question: When you were first diagnosed with metastatic breast cancer, where were all of the places in your body where it was detected (select all that apply)? Listed as TRUE if patient selected Skin	Patient	
DX_BREASTFEEDING	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Whether the patient's initial breast cancer was diagnosed while breast feeding	Patient	
DX_CEP17_COPY_NUMBER	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Copy nubmer of CEP17 in diagnostic sample	Patient	
DX_HER2_COPY_NUMBER	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Copy number of HER2 in diagnostic sample	Patient	
DX_PREGNANT	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Whether the patient's initial breast cancer was diagnosed during pregnancy	Patient	
HER2_POSITIVE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	 Patient-reported response to the question: At any time, was your breast cancer found to be HER2 positive (HER2+)?	Patient	
HR_POSITIVE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	 Patient-reported response to the question: At any time, was your breast cancer found to be hormone receptor positive (HR+, ER+ and/or PR+)?	Patient	
INFLAMMATORY	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	 Patient-reported response to the question: At any time, were you diagnosed with inflammatory breast cancer?	Patient	
LCIS_SX_BX	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Whether LCIS was present in surgical biopsy	Patient	
LOCAL_REGIONAL_RECURRENCE_LOCATION	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient's location of breast cancer at diagnosis of local regional recurrence	Patient	
MENOPAUSAL_STATUS_DX	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Menopausal status of patient at initial diagnosis	Patient	
METS_SITES_AT_METS_ABST	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	All locations in the body where breast cancer spread at any point in the patient's treatment	Patient	
METS_SITES_AT_METS_DX	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	All locations in the body where breast cancer spread at the time of diagnosis with metastatic breast cancer.	Patient	
PT_NOTES	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Additional notable information about  patient not mentioned in previous fields.	Patient	
RACE_CATEGORY	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Patient-reported response to the question: What is your race (select all that apply)? Infrequent responses have been categorized as Other for confidentiality.	Patient	
SX_CEP17_COPY	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	HER2 CEP17 Copy Number of Surgical Biopsy	Patient	
SX_ER	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	ER Status of Surgical Biopsy	Patient	
SX_GRADE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Grade of Surgical Biopsy	Patient	
SX_HER2FISH	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	HER2 FISH Status of Surgical Biopsy	Patient	
SX_HER2IHC	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	HER2 IHC Status of Surgical Biopsy	Patient	
SX_HER2OVERALL	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	HER2 Overall Status of Surgical Biopsy	Patient	
SX_HER2_COPY	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	HER2 Copy Number of Surgical Biopsy	Patient	
SX_HER2_RATIO	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	HER2 Ratio of Surgical Biopsy	Patient	
SX_PERCENT_ER	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	ER Percentage of Surgical Biopsy	Patient	
SX_PERCENT_PR	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	PR Percentage of Surgical Biopsy	Patient	
SX_PR	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	PR Status of Surgical Biopsy	Patient	
SX_STAGE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	Stage of surgical biopsy as recorded in medical record	Patient	
THERAPIES	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	 Patient-reported response to the question: Since your diagnosis with metastatic breast cancer, have you been on any of your cancer therapies for more than 2 years?	Patient	
TRIPLE_NEGATIVE	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	STRING	 Patient-reported response to the question: At any time, was your breast cancer found to be triple negative (e.g. NOT ER+, PR+, or HER2+)?	Patient	
TUMOR_FRACTION	HotPink	The Metastatic Breast Cancer Project (Provisional, December 2021)	NUMBER	Tumor fraction value derived from Ultra Low Pass Whole Genome Sequencing (ULP-WGS) performed on cell-free DNA (cfDNA) from blood samples.	Sample	0.2992 ; 0.2985 ; 0.07889 ; 0.1094 ; 0.1458 ; 0.05484 ; 0.08272 ; 0.27 ; 0.09148 ; 0.6382 ; 0.4004 ; 0.08137 ; 0.4282 ; 0.2379 ; 0.06543 ; 0.255 ; 0.4932 ; 0.2252 ; 0.1972 ; 0.07212 ; 0.1429 ; 0.1634 ; 0.1076 ; 0.08131 ; 0.3765 ; 0.2698 ; 0.3895 ; 0.1386 ; 0.1792 ; 0.06182 ; 0.1284 ; 0.0682 ; 0.2896 ; 0.05773 ; 0.3131 ; 0.05178 ; 0.07764 ; 0.1104 ; 0.2777 ; 0.4222 ; 0.07604 ; 0.1639 ; 0.336 ; 0.06191 ; 0.1063 ; 0.05234 ; 0.2018 ; 0.1363 ; 0.3213 ; 0.1685 ; 0.05103 ; 0.4415 ; 0.3388 ; 0.05365 ; 0.2369 ; 0.2928 ; 0.06483 ; 0.07667 ; 0.08566 ; 0.06811 ; 0.05009 ; 0.1036 ; 0.2079 ; 0.1618 ; 0.06479 ; 0.3112 ; 0.4071 ; 0.09866 ; 0.05518 ; 0.2108 ; 0.07329 ; 0.1498 ; 0.06245 ; 0.08217 ; 0.05679 ; 0.2681 ; 0.1596 ; 0.502 ; 0.3017 ; 0.2964 ; 0.05409 ; 0.2262 ; 0.05815 ; 0.0957 ; 0.05072 ; 0.05163 ; 0.2558 ; 0.277 ; 0.1265 ; 0.3045 ; 0.439 ; 0.05876 ; 0.05225 ; 0.1438 ; 0.1416 ; 0.4101 ; 0.2557 ; 0.3321 ; 0.05766 ; 0.1506 ; 0.3144 ; 0.05247 ; 0.3769
AJCC_METASTASIS_PATHOLOGIC_PM	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	Patient	
AJCC_NODES_PATHOLOGIC_PN	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Patient	
AJCC_PATHOLOGIC_TUMOR_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	Patient	
AJCC_STAGING_EDITION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.	Patient	
AJCC_TUMOR_PATHOLOGIC_PT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	Patient	
BRACHYTHERAPY_TOTAL_DOSE_POINT_A	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Brachytherapy first reference point administered total dose	Patient	
CENT17_COPY_NUMBER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Fluorescence in situ hybridization diagnostic procedure chromosome 17 signal result range	Patient ; Sample	1.1 ; 1.9 ; 4 ; 2.9 ; 160 ; 51 ; 2.98 ; 2.08 ; 2.13 ; 1.8 ; 2 ; 2.2 ; 2.5 ; 1.57 ; 49 ; 74 ; 3 ; 2.3 ; 2.8 ; 2.7 ; 46 ; 1.93 ; 3.7 ; 1.5 ; 4.43 ; 1.45 ; 1.4 ; 3.33 ; polisomy ; 1.7 ; 3.2 ; 5 ; 125 ; 3.1 ; 118 ; 1.67 ; 1.73 ; 2.38 ; 54 ; 35 ; 2.65
CLINICAL_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.	Patient	
CLIN_T_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Patient	
DAYS_TO_COLLECTION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Days to sample collection.	Sample	1416 ; 4330 ; 4242 ; 4137 ; 4106 ; 4103 ; 4230 ; 3879 ; 109 ; 122 ; 120 ; 94 ; 100 ; 88 ; 1240 ; 344 ; 372 ; 198 ; 937 ; 315 ; 338 ; 310 ; 229 ; 69 ; 832 ; 2604 ; 1553 ; 147 ; 617 ; 156 ; 2781 ; 4536 ; 4537 ; 4343 ; 3752 ; 3840 ; 4147 ; 3091 ; 5230 ; 4301 ; 3871 ; 4456 ; 4420 ; 4460 ; 4670 ; 4574 ; 4572 ; 4753 ; 4838 ; 4876 ; 121 ; 116 ; 52 ; 272 ; 211 ; 194 ; 232 ; 201 ; 230 ; 238 ; 203 ; 215 ; 263 ; 226 ; 261 ; 264 ; 243 ; 273 ; 292 ; 212 ; 250 ; 295 ; 938 ; 883 ; 368 ; 1325 ; 912 ; 465 ; 213 ; 590 ; 214 ; 51 ; 155 ; 123 ; 528 ; 764 ; 1648 ; 1581 ; 1267 ; 1091 ; 967 ; 1932 ; 932 ; 679 ; 854 ; 707 ; 423 ; 416 ; 548 ; 581 ; 909 ; 988 ; 63 ; 66 ; 42 ; 37 ; 1030 ; 469 ; 444 ; 550 ; 526 ; 928 ; 1142 ; 919 ; 525 ; 325 ; 249 ; 604 ; 224 ; 220 ; 569 ; 112 ; 44 ; 84 ; 829 ; 335 ; 5041 ; 197 ; 218 ; 251 ; 188 ; 170 ; 169 ; 417 ; 359 ; 136 ; 2998 ; 1051 ; 31 ; 30 ; 21 ; 64 ; 45 ; 53 ; 850 ; 2634 ; 86 ; 62 ; 260 ; 173 ; 141 ; 225 ; 275 ; 282 ; 189 ; 193 ; 158 ; 162 ; 164 ; 144 ; 102 ; 103 ; 76 ; 135 ; 98 ; 104 ; 93 ; 252 ; 65 ; 80 ; 58 ; 77 ; 478 ; 5538 ; 5893 ; 5392 ; 399 ; 2815 ; 176 ; 38 ; 39 ; 1246 ; 56 ; 48 ; 59 ; 183 ; 2441 ; 161 ; 79 ; 40 ; 54 ; 3641 ; 2325 ; 2275 ; 2245 ; 2219 ; 2213 ; 2161 ; 1913 ; 1812 ; 1786 ; 1763 ; 1720 ; 1717 ; 1673 ; 1629 ; 1611 ; 1405 ; 1381 ; 1225 ; 3740 ; 5418 ; 163 ; 435 ; 32 ; 49 ; 41 ; 1238 ; 2927 ; 223 ; 143 ; 142 ; 134 ; 125 ; 168 ; 204 ; 166 ; 132 ; 83 ; 75 ; 50 ; 68 ; 43 ; 2429 ; 101 ; 576 ; 1904 ; 1517 ; 1074 ; 133 ; 99 ; 1833 ; 2051 ; 3755 ; 1340 ; 1315 ; 1339 ; 1490 ; 1372 ; 1464 ; 2109 ; 2464 ; 2436 ; 108 ; 1661 ; 513 ; 486 ; 449 ; 447 ; 4665 ; 1910 ; 6583 ; 1644 ; 1820 ; 2144 ; 2723 ; 2228 ; 2606 ; 91 ; 160 ; 106 ; 1382 ; 986 ; 219 ; 174 ; 299 ; 700 ; 78 ; 1590 ; 97 ; 245 ; 2164 ; 4248 ; 401 ; 146 ; 1015 ; 2979 ; 778 ; 3080 ; 2709 ; 2191 ; 61 ; 67 ; 1506 ; 796 ; 182 ; 3110 ; 2198 ; 3355 ; 2089 ; 184 ; 114 ; 233 ; 1779 ; 1627 ; 306 ; 1148 ; 1143 ; 703 ; 845 ; 87 ; 1954 ; 1610 ; 1935 ; 1563 ; 2467 ; 2677 ; 312 ; 1500 ; 1480 ; 418 ; 505 ; 899 ; 60 ; 567 ; 210 ; 149 ; 159 ; 127 ; 110 ; 639 ; 1871 ; 414 ; 129 ; 140 ; 36 ; 1541 ; 73 ; 1378 ; 1415 ; 1357 ; 1407 ; 2858 ; 2411 ; 2066 ; 154 ; 328 ; 498 ; 85 ; 499 ; 616 ; 131 ; 47 ; 29 ; 826 ; 755 ; 771 ; 561 ; 421 ; 343 ; 279 ; 70 ; 254 ; 595 ; 429 ; 441 ; 1715 ; 1645 ; 981 ; 560 ; 259 ; 128 ; 952 ; 107 ; 237 ; 152 ; 244 ; 350 ; 71 ; 289 ; 74 ; 605 ; 285 ; 139 ; 55 ; 507 ; 869 ; 1493 ; 468 ; 436 ; 191 ; 921 ; 477 ; 231 ; 185 ; 157 ; 126 ; 181 ; 3599 ; 3772 ; 1026 ; 1022 ; 35 ; 1320 ; 1259 ; 742 ; 105 ; 278 ; 216 ; 240 ; 148 ; 92 ; 187 ; 22 ; 656 ; 2928 ; 3020 ; 1316 ; 720 ; 384 ; 167 ; 241 ; 1184 ; 941 ; 759 ; 1276 ; 667 ; 1003 ; 1518 ; 1033 ; 880 ; 453 ; 302 ; 394 ; 180 ; 698 ; 637 ; 606 ; 575 ; 788 ; 484 ; 422 ; 1733 ; 819 ; 2767 ; 2036 ; 363 ; 1153 ; 333 ; 728 ; 769 ; 34 ; 33 ; 2694 ; 2414 ; 587 ; 995 ; 1328 ; 308 ; 2623 ; 2260 ; 1979 ; 1390 ; 756 ; 2546 ; 2445 ; 2310 ; 1911 ; 1274 ; 1204 ; 614 ; 2696 ; 2331 ; 2038 ; 1862 ; 674 ; 358 ; 545 ; 119 ; 27 ; 743 ; 676 ; 28 ; 57 ; 1608 ; 1031 ; 668 ; 554 ; 748 ; 177 ; 1207 ; 118 ; 5305 ; 7820 ; 7362 ; 6372 ; 6687 ; 6664 ; 6660 ; 6475 ; 5557 ; 5836 ; 5350 ; 4754 ; 5073 ; 3278 ; 4565 ; 5238 ; 364 ; 552 ; 946 ; 352 ; 962 ; 1591 ; 1931 ; 644 ; 2456 ; 258 ; 1178 ; 1522 ; 1863 ; 1011 ; 1477 ; 1332 ; 1828 ; 5724 ; 7492 ; 6869 ; 6755 ; 1071 ; 1401 ; 1391 ; 1266 ; 1080 ; 1094 ; 293 ; 301 ; 745 ; 206 ; 583 ; 542 ; 1088 ; 739 ; 549 ; 672 ; 470 ; 1672 ; 1305 ; 1399 ; 1164 ; 1115 ; 1057 ; 958 ; 2348 ; 2597 ; 1317 ; 1513 ; 1337 ; 1177 ; 1083 ; 268 ; 303 ; 280 ; 395 ; 2512 ; 1512 ; 1535 ; 1567 ; 1716 ; 1888 ; 1976 ; 2239 ; 6336 ; 6279 ; 6286 ; 6035 ; 5890 ; 7858 ; 5047 ; 7290 ; 5165 ; 1098 ; 968 ; 190 ; 346 ; 2233 ; 673 ; 572 ; 329 ; 321 ; 205 ; 691 ; 884 ; 1633 ; 2289 ; 2395 ; 2413 ; 5606 ; 5531 ; 4664 ; 4476 ; 5294 ; 5179 ; 5323 ; 5600 ; 906 ; 724 ; 1414 ; 1596 ; 3254 ; 3213 ; 3193 ; 3033 ; 2960 ; 2915 ; 2365 ; 2086 ; 1822 ; 365 ; 3403 ; 6002 ; 1171 ; 1495 ; 715 ; 596 ; 1155 ; 1065 ; 801 ; 1697 ; 2850 ; 1924 ; 1630 ; 1552 ; 2030 ; 1574 ; 1533 ; 670 ; 2793 ; 1948 ; 1578 ; 1017 ; 1549 ; 2141 ; 2301 ; 5388 ; 6821 ; 5113 ; 5243 ; 761 ; 1223 ; 798 ; 1135 ; 1217 ; 1197 ; 1170 ; 1344 ; 1338 ; 1130 ; 997 ; 541 ; 815 ; 89 ; 221 ; 1096 ; 1064 ; 910 ; 792 ; 652 ; 519 ; 461 ; 434 ; 393 ; 360 ; 269 ; 247 ; 2368 ; 1162 ; 891 ; 454 ; 1044 ; 16 ; 3948 ; 4011 ; 2669 ; 3629 ; 3374 ; 2639 ; 3417 ; 3571 ; 2695 ; 2737 ; 2697 ; 3621 ; 965 ; 960 ; 827 ; 722 ; 716 ; 597 ; 506 ; 475 ; 457 ; 426 ; 387 ; 357 ; 287 ; 1939 ; 1744 ; 1528 ; 1463 ; 1471 ; 1450 ; 1424 ; 1331 ; 1233 ; 1157 ; 1140 ; 1085 ; 1008 ; 413 ; 1167 ; 1084 ; 1335 ; 1248 ; 972 ; 267 ; 975 ; 773 ; 675 ; 309 ; 2527 ; 1268 ; 783 ; 729
DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.	Patient	
DAYS_TO_PATIENT_PROGRESSION_FREE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	days_to_patient_progression_free	Patient	
DAYS_TO_SPECIMEN_COLLECTION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Days to sample procurement.	Sample	
DAYS_TO_TUMOR_PROGRESSION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	days_to_tumor_progression	Patient	
DFS_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Disease free status since initial diagnosis	Patient	
DISEASE_CODE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Disease code	Patient ; Sample	FPPP
ER_POSITIVITY_SCALE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Positive finding estrogen receptor other measurement scale text	Patient ; Sample	Strong ; 10-75% ; >75% ; H-Score ; H-SCORE ; Allred Score 8 ; Allred Score 7 ; 0 ; Allred score = 7 ; Allred score = 0 ; Allred score = 8 ; Allred score = 5 ; 7 ; Two-tier ; 8 ; H score ; Allred Score = 7 ; >10% ; Allred score 5 ; Allred score 8 ; Allred score 7 (per outside facility) ; Allred score 7 ; 230 ; Allred ; 80 ; 120 ; 180 ; 250 ; 190 ; 205 ; Intensity=Strong ; Intensity=moderate ; Allred Score 6 ; Allred Score 5 ; Allred Score ; allred score = 8 ; Strong using Weak, Moderate and Strong ; 288 fmol/mg ; Moderate using the scale of Weak, Moderate, Strong ; Moderate using scale of Weak, Moderate, Strong ; STRONG ; allred scrore = 8 ; allred score = 0 ; 49 fmol/mg protein ; allred score = 7 ; Allred score = 2 ; H Score
ER_POSITIVITY_SCALE_USED	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast carcinoma immunohistochemistry er pos finding scale	Patient ; Sample	3 Point Scale ; 4 Point Scale
ER_STATUS_IHC_PERCENT_POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	progesterone receptor level cell percent category	Patient ; Sample	90-99% ; <10% ; 70-79% ; 80-89% ; 50-59% ; 40-49% ; 10-19% ; 30-39% ; 20-29% ; 60-69%
EXTRANODAL_INVOLVEMENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.	Patient	
FIRST_SURGICAL_PROCEDURE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Surgical procedure purpose other text	Patient ; Sample	Total mastectomy with left sentinel lymph node biospy ; Segmental mastectomy ; bilateral total mastectomies with right sentinel node biopsy ; Patey's Surgery ; Right Total Mastectomy and Sentinel Node Biopsy ; Right total mastectomy with lymph node left axillary lymph node excision ; Left segmental mastectomy with axillary lymph node dissection ; Total Mastectomy ; Bilateral Mastectomy ; Total mastectomy ; Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders. ; segmental mastectomy ; Fine Needle aspiration biopsy ; excisional biopsy ; Excisional biopsy ; Wide local excision ; Modified radical mastectomy with left breast biopsy ; total mastectomy ; Wide re-excisional biopsy ; total mastectomy and sentinel node biopsy ; right segmental mastectomy ; needle localized segmental mastectomy ; biopsy ; Wide Local Excision ; right segmental mastectomy witrh axillary node dissection ; Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy ; Left segmental mastectomy with level 1 and level 2 axillary dissection ; Right segmental mastectomy ; Left segmental mastectomy with left axillary lymph node dissection ; total mastectomy with rigth axillary lymph node and sentinel lymph node dissection ; segmental mastectomy with excision of mass on chest wall and axillary node dissection ; segmental mastectomy with axillary lymph node dissection ; needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection ; localized segmental mastectomy with axillary node dissection ; Partial mastectomy ; partial left mastectomy ; Surgical Resection ; Mastectomy ; Surgical resection ; TOTAL MASTECTOMY ; Modified Radical Masectomy ; Pateys surgery ; Excision ; Partial Mastectomy ; breast conserving therapy ; Excisional biospy ; Total mastectomy with retromammary lymph node excision ; Segmental mastectomy with sentinel lymph node biopsy ; Segmental mastectomy with sentinel node biopsy ; Total mastectomy with sentinel lymoh node biopsy ; Total mastectomy with sentinel lymph node biopsy ; segmental mastectomy with right sentinel lymph node biopsy ; partial mastectomy ; total mastectomy with sentinel lymph node biopsy with tissue reconstruction ; left segmental mastectomy with axillary sentinel lymph node biopsy ; left segmental mastectomy with sentinel node dissection ; segmental mastectomy with sentinel lymph node biopsy ; right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP ; Segmental mastectomy with left axillary lymph node dissection ; segmental mastectomy with sentinel lymph node biopsy and wire localization ; Segmental mastectomy with sentinel axillary lymph node biopsy
FORM_COMPLETION_DATE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Form completion date	Patient	
HER2_AND_CENT17_CELLS_COUNT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	HER2 neu and centromere 17 copy number analysis input total number count	Patient ; Sample	60 ; 20 ; 279 ; 389 ; 30 ; 40 ; 330 ; 229 ; 228 ; 569 ; 556 ; 197 ; 561 ; 403 ; 371 ; 200 ; 65 ; 167
HER2_AND_CENT17_SCALE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	HER2 and centromere 17 positive finding other measurement scale text	Patient ; Sample	Vysis AutoVysion System ; HER2 amplification - negative
HER2_CENT17_COUNTED_CELLS_COUNT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	HER2 neu and centromere 17 copy number metastatic breast carcinoma analysis input total number count	Patient	
HER2_CENT17_RATIO	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	HER2 neu chromosone 17 signal ratio value	Patient ; Sample	1.05 ; 1 ; 1.2 ; 1.1 ; 1.6 ; 0.92 ; 16.3 ; 1.5 ; 1.21 ; 2.6 ; 1.9 ; 7.1 ; 1.4 ; 1.03 ; 0.42 ; 1.15 ; 3 ; 3.8 ; 15.12 ; 1.3 ; 4.8 ; 2.2 ; 0.9 ; 1.04 ; 1.7 ; 2.7 ; 1.29 ; 1.65 ; 1.02 ; 1.18 ; 3.2 ; 1.08 ; 1.46 ; 1.11 ; 1.07 ; 1.16 ; 4.05 ; 1.06 ; 1.12 ; 1.32 ; 0.97 ; 1.09 ; 1.33 ; 7 ; 1.22 ; 1.8 ; 1.14 ; 1.41 ; 1.17 ; 0.5 ; 11 ; 2.1 ; 1.13 ; 0.99 ; 0.93 ; 1.23 ; 1.69 ; 1.19 ; 3.4 ; 1.25 ; 1.31 ; 2.83 ; 4.7
HER2_COPY_NUMBER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	HER2 neu breast carcinoma copy analysis input total number	Patient ; Sample	1.1 ; 1.8 ; 4.6 ; 3.2 ; 185 ; 816 ; 3.43 ; 2.2 ; 2.58 ; 1.9 ; 5.8 ; 3.3 ; 3.8 ; 2.8 ; 2.5 ; 2.6 ; 5 ; 2 ; >6 ; 52 ; 114 ; 3 ; 2.4 ; 79 ; not amplified ; 2.23 ; 15 ; 1.67 ; 4.7 ; 1.62 ; 1.57 ; 3.53 ; 1 ; <4.0 ; >6.0 ; 6.4 ; 2.3 ; 21 ; 132 ; 145 ; 1.73 ; 1.85 ; 2.81 ; 2.83 ; 172 ; 118 ; 1.66 ; 4.5 ; 5.65 ; 12.45
HER2_FISH_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	HER2 erbb pos finding fluorescence in situ hybridization calculation method text	Patient ; Sample	PathVysion HER-2 DNA Probe Kit ; PathVysion ; PathVysion HER-2 DNA probe kit. ; Path Vysion HER-2 DNA probe kit ; PathVysion Her-2 DNA ; Pathvysion HER-2 DNA Probe Kit ; ratio > 2.2 is positive ; >=2.0 Positive ; Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified ; Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified ; Pathvysion HER2 DNA Probe Kit ; Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified ; Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified ; Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified ; Path Vysion HER2 DNA Probe Kit ; >2.2 Positive ; Positive >2.2 ; PathVision HER2 DNA Probe Kit
HER2_IHC_PERCENT_POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	HER2 erbb pos finding cell percent category	Patient ; Sample	<10% ; 30-39% ; 10-19% ; 90-99% ; 70-79% ; 40-49% ; 50-59% ; 20-29% ; 60-69% ; 80-89%
HER2_POSITIVITY_METHOD_TEXT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	HER2 erbb method calculation method text	Patient ; Sample	Hecep Test TM DAKO ; Hercep Test  TM Dako ; DAKO Hercep Test TM ; Hercep Test TM DAKO ; 3+ Positive ; dextran coated charcoal ; + or - ; HerceptTest TM Dako ; Venten ; HercepTest TM Dako ; Dako Hercept Test ; DAKOHercepTest TM
HER2_POSITIVITY_SCALE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Pos finding HER2 erbb2 other measurement scale text	Patient ; Sample	Hercep Test  TM Dako ; FISH ; Dako ; 0 ; CISH ; ACIS ; 10-75%
HISTOLOGICAL_SUBTYPE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.	Patient	
HISTORY_NEOADJUVANT_TRTYN	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.	Patient	
HISTORY_OTHER_MALIGNANCY	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.	Patient	
ICD_10	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	10th revision of the International Statistical Classification of Diseases and Related Health Problems.	Patient	
ICD_O_3_HISTOLOGY	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.	Patient	
ICD_O_3_SITE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.	Patient	
IHC_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	IHC Score	Patient ; Sample	1 ; 3 ; 2 ; 0 ; 4
INFORMED_CONSENT_VERIFIED	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Informed consent verified	Patient	
INITIAL_PATHOLOGIC_DX_YEAR	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.	Patient	
IS_FFPE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	If the sample is from FFPE	Sample	NO
LONGEST_DIMENSION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Longest dimension of the sample measured in millimeters	Sample	
LYMPH_NODES_EXAMINED	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.	Patient	
LYMPH_NODES_EXAMINED_HE_COUNT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.	Patient	
LYMPH_NODES_EXAMINED_IHC_COUNT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,	Patient	
LYMPH_NODE_EXAMINED_COUNT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	The total number of lymph nodes removed and pathologically assessed for disease.	Patient	
MARGIN_STATUS_REEXCISION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast cancer surgery margin status	Patient ; Sample	Close ; Negative ; Positive
METASTATIC_SITE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic Site Other	Patient ; Sample	Abdomen ; axilaary node negative but intrammary node positive ; Skin ; skin ; Ovary
METASTATIC_SITE_PATIENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The anatomic location to which the cancer has spread.	Patient	
METHOD_OF_INITIAL_SAMPLE_PROCUREMENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text name of the procedure to secure the tissue used for the original pathologic diagnosis.	Patient	
METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.	Patient	
METHOD_OF_SAMPLE_PROCUREMENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text name of the procedure to secure the tissue used for the original pathologic diagnosis.	Sample	
MICROMET_DETECTION_BY_IHC	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Cytokeratin immunohistochemistry staining method micrometastasis indicator	Patient ; Sample	NO ; YES
NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.	Patient ; Sample	NO ; YES
NTE_CENT17_HER2_OTHER_SCALE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma pos finding other scale measurement text	Patient	
NTE_CENT_17_HER2_RATIO	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Metastatic breast carcinoma HER2 neu chromosone 17 signal ratio value	Patient ; Sample	2.47 ; 1.09
NTE_CENT_17_SIGNAL_NUMBER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma fluorescence in situ hybridization diagnostic proc centromere 17 signal result range	Patient	
NTE_ER_IHC_INTENSITY_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma immunohistochemistry er pos cell score	Patient ; Sample	3
NTE_ER_POSITIVITY_DEFINE_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma estrogen receptor detection method text	Patient	
NTE_ER_POSITIVITY_OTHER_SCALE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text	Patient	
NTE_ER_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma estrogen receptor status	Patient ; Sample	Positive ; Negative
NTE_ER_STATUS_IHC_POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma estrogen receptor level cell percent category	Patient	
NTE_HER2_FISH_DEFINE_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma HER2 erbb pos finding fluorescence in situ hybridization calculation method text	Patient	
NTE_HER2_FISH_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma lab proc HER2 neu in situ hybridization outcome type	Patient ; Sample	Negative
NTE_HER2_POSITIVITY_IHC_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma erbb2 immunohistochemistry level result	Patient ; Sample	2+ ; 1+
NTE_HER2_POSITIVITY_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma HER2 erbb method calculation method text	Patient	
NTE_HER2_POSITIVITY_OTHER_SCALE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma pos finding HER2 erbb2 other measure scale text	Patient	
NTE_HER2_SIGNAL_NUMBER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	HER2 neu metastatic breast carcinoma copy analysis input total number	Patient	
NTE_HER2_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma lab proc HER2 neu immunohistochemistry receptor status	Patient ; Sample	Negative
NTE_HER2_STATUS_IHC_POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma HER2 erbb pos finding cell percent category	Patient	
NTE_PR_IHC_INTENSITY_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Metastatic breast carcinoma immunohistochemistry pr pos cell score	Patient ; Sample	1
NTE_PR_POSITIVITY_DEFINE_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma progesterone receptor detection method text	Patient	
NTE_PR_POSITIVITY_OTHER_SCALE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma pos finding progesterone receptor other measure scale text	Patient	
NTE_PR_STATUS_BY_IHC	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma progesterone receptor status	Patient ; Sample	Negative ; Positive
NTE_PR_STATUS_IHC_POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Metastatic breast carcinoma progesterone receptor level cell percent category	Patient	
OCT_EMBEDDED	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Oct embedded	Sample	TRUE ; FALSE
OTHER_METHOD_OF_SAMPLE_PROCUREMENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The type of procedure or method used to collect the specimen.	Sample	
OTHER_SAMPLE_ID	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Legacy DMP sample identifier (DMPnnnn)	Sample	5fa9998b-deff-493e-8a8e-dc2422192a48 ; 9d501ca9-f50d-45fc-bcc3-fee15f9771cd ; aa1037f4-1414-4e05-b11a-c558a23b7e62 ; 2190d984-3941-41d4-b6de-d0aa76f3570d ; 73af0f78-cc37-43ff-8f46-524a9ba80eda ; 29ac24fb-0065-47f8-b044-f4a66fad2394 ; 50463a25-4292-4bc7-926a-341493e68242 ; f754aa5f-49c8-4e8b-a1fe-f370f807499a ; f2a49aa7-b756-4eaa-a6fd-00f56c7e7851 ; bed56886-f4fe-4917-b32a-18b3d3f47c24 ; f0471d79-d107-4809-976e-fe5b231f0e9d ; fa3f34b7-5f69-41f8-9384-42af0260d7ec ; e3118dbe-9f93-45b0-81d3-2e64f06b7c74 ; fc3fe505-f138-426f-87d3-c7ae138be02d ; caa51a8b-eadc-4d87-b0f8-f6ffc17723b5 ; c2f00c0c-9ad9-4c1d-912c-52eacedcba12 ; 1624f434-259b-4782-afe1-7ac3d13d7807 ; 0dfe13f0-e1f5-4f7e-95b5-e88f9d9e920a ; 71e87611-903b-4b9d-a506-87e58914dc81 ; 3596c171-86d4-48ae-80a5-847c874d4860 ; 159debac-79e0-4727-940c-020e120f8347 ; 81243c1f-affa-4985-ba0e-1f19db52db73 ; e957973b-0b41-484f-9f16-a112bed3107e ; 6a1c2fdb-18ce-40ec-af79-191b489f39a7 ; f4544809-7b92-40bc-b121-0db70c8af314 ; b8718131-47af-4eec-b601-12fa3969ca44 ; 82df814f-5c83-413f-99f5-153aed79161c ; 76f4bdbc-58c8-4424-865b-c6531d908dc3 ; 15c2deaa-1162-4ee8-b698-179bfd67a78d ; 26b0cf7a-584f-46e5-8f83-b6b5f7d542ba ; 09191482-34de-4130-afbe-dd47d481d539 ; 0cc10a1e-a90a-4c55-87a2-a74d47474a4a ; 11678ad0-81ae-4420-8976-52f99c5d7d5d ; ca44a8bf-428e-48b5-ae58-614f9a3e0fd8 ; bea52276-596c-479e-981d-ca9132742098 ; f713031b-b8ee-4195-91b1-ac9cf63d76a4 ; 14193a12-5601-4f0c-90aa-ecd24d6ac41b ; e5c171ac-f700-439c-9e44-6cfed2c9cea7 ; 5cd62b0e-902e-492c-843d-5d8aa6964dc5 ; e5a9fa79-2d0f-4cda-9fea-baab86f78b8e ; 7e598a8a-9fb8-4c2d-94e7-ae1921addcd1 ; 1fc22273-7e02-4193-9fbb-476e0eab6afb ; 3ad0093a-e57a-450a-b0ef-942c9b67a586 ; a0e467f8-79c1-499e-b881-669b4bd55b8c ; 3de73049-e6e7-4ed7-be98-bf174fd37c89 ; 33f49b4e-924e-4590-8afa-e17403602137 ; f0785dc2-a43e-4b59-a21c-ab55c490d441 ; 72367269-4151-4e1f-8636-ff91396ba46c ; 6adbf536-e89b-4148-8ed6-9b9117f78c64 ; cf2b65de-c6a1-4ebc-a62a-c652ce17d2d0 ; ae08dbd6-548a-469c-ba12-b6a87515bce7 ; 0fc347ae-7ad9-4987-887a-d37fe871d6c2 ; f2eac3ac-cb30-4d6d-a85a-4ea1ad3e7301 ; e11024c2-709d-4e47-a9f3-45894a27f2bb ; ca263104-9c70-4b9f-95d1-7a886587eebd ; 6e7092aa-e92c-4d9b-8ed1-f8c32f39fe80 ; 781d285c-5b2a-4d42-b35e-3840d954070b ; ed00a16b-6b8e-44e4-998a-ae4dcca5a93c ; 4584c7e2-8011-4231-a5e6-26a264f6d1b1 ; 940d64bd-8c96-476f-84f9-678d1ed3500f ; 3182e60d-be44-4f03-ba0c-431e0c1f1d5e ; 50111388-1058-413a-ac2a-3fd4f84091aa ; 0d7511fd-b57f-4bba-abc2-38b24ba4a15a ; f642ec37-b771-4b55-a133-a54f3b54ac99 ; 9bd5963e-d8f4-4eed-b32b-2eedb00db268 ; 8d84c9f4-6f19-42a6-9f55-8b4ccafc6117 ; 5a4c0145-86eb-40ae-9983-adb13652a9a2 ; eae4c66c-03a5-4663-a484-a01612602409 ; b32287fb-5ff5-4f5f-a9dc-0c0d514351b4 ; c6ba5d28-97b4-4f07-b91c-997b286dff03 ; 80265a56-75ca-479d-b92b-4fdaeb18ed17 ; bdc13064-e554-4a1e-9037-03187bcb3507 ; aa5103b4-c25d-4ca4-847b-a1ece4c14aff ; f5678056-2dc2-4f1c-87e9-4fba6c78b460 ; a56aa062-cc7f-4ceb-96d6-2a6c251fc9b5 ; 6bbd477d-699c-4988-a27b-0c3233b595eb ; 118fd65d-0b94-4663-a2a3-1f53b278711b ; 24153fe0-2c47-456a-b344-874a0e28de4d ; 5854b639-f677-4ee3-9d68-61b1cdd5a647 ; 91657171-7e5e-4a81-9201-d0b2d5806c04 ; 644c9a14-09da-4382-a6d1-dce67f25a4ff ; bfd30c90-9b30-4e7b-96f5-1f1b2ce23f04 ; d728c743-10a6-4ac4-8725-61c0d2980057 ; ca459603-f477-4ff4-9d47-902b3cbad196 ; af9f631b-2857-48e2-8d77-34f66c1c6149 ; 2556d93d-9252-4248-a044-91deaa7f02df ; 3e2102ac-0d18-4cf5-8617-863245e21b3f ; bf42e8ce-cd3e-46c8-92f9-ea5cda443a6f ; 1e20ead6-a07f-4f0d-962a-a3a240722fb6 ; f66358d4-9319-4c23-983d-ab5056daacf1 ; f4d51ca6-89a6-4571-ae8d-0fad7dde4452 ; 6bfd7e43-77e4-4666-9b28-c5d4cdcd6ad7 ; c5181ae5-bd05-459f-920d-26bd31bd9088 ; 62d2a36e-feb1-4084-8111-7ea38a4e3049 ; 58d073a2-68b8-4f48-ba5e-020258abef71 ; 00a59c97-91b4-413e-8d9e-674753997221 ; 5b62628a-b301-4d60-9213-396e3fc5a3ed ; 5e429dd7-787c-4e7d-b672-b000b7b57929 ; e70a8d1b-f29d-412f-8c90-85862a2b75ad ; 0c61c676-2a72-4dbe-8dcb-284bd112570c ; e2da00f3-fdb9-4ab4-964a-6828568e2e6e ; de6d4267-c1cb-4761-a539-5f83368735af ; 09b414c4-a314-43c5-823a-d91442b6b02b ; cef6023a-2fbf-44ee-a9b3-df78707bd85a ; 26f9a1ab-fa60-47f3-ac29-96acaa68fb4a ; e57574e4-7e01-4e61-bd29-ee4ec63dddd6 ; 50a70e24-2ce8-43fd-87d7-eab2c1fa9a86 ; 28e05d2f-0559-425a-accf-d5b4c1152548 ; e2ef6df2-c375-4c59-ae1b-c8cca22a8387 ; b41b1f04-226e-466c-b5e1-f61e45ad3210 ; 142d082f-444c-4384-97c0-bbc78e228470 ; 684196da-0213-497f-b239-7b5e76b01d0e ; 9f55d963-2c1d-4886-980e-edff099babf5 ; 8ba7248f-69cd-4b16-8900-ad2feec2eab8 ; 22ebe36e-3c42-4ca0-a624-c4219074bab9 ; ac0612f6-3d84-44d5-a224-6cbe65531505 ; f2b7091e-ed85-4546-8f11-307154153d31 ; bbe1e6e5-7c52-44aa-940e-104f07751e11 ; 7a3b5790-35c8-473a-b952-bb603aca5aa1 ; c5eb7bf2-fc4a-497e-ace9-c715fea47e5b ; 174435cc-64d1-4d33-953c-1ada5df46ecd ; 3d164bd9-7416-47af-a102-29954e3efe2c ; bf055644-7bca-43b6-8f5a-e21c42f7cf88 ; 50c357b1-a9fc-44e4-9a7b-937e6d74e081 ; da9dc40b-0350-4b8c-8a7a-15100d5aeb90 ; 9f52ae8b-7fe7-441c-9fb6-c55a9bd1a0d0 ; 0bc7a0cb-2a16-4f63-8188-39fd4c20b8b3 ; b8e11365-4360-4db7-bfe8-a8da3ca4819b ; e216aa55-98fc-4d0d-a24e-cfa05778f973 ; d5d86fc3-a720-43b7-8125-160f3af04de0 ; 438152c8-2d26-4b35-9f68-a4b6c473916e ; ae5c9a58-e3ae-420f-8f72-1e4ffdd3df24 ; 4068463b-8568-4bdb-8db0-19390ec0c7f8 ; 5faa442d-a995-48aa-a52c-a7efe6f56cab ; 7fb4bff6-4385-4503-9016-f9b620af3f8c ; bc220c5a-7255-40be-9c68-2997f0b0d319 ; 3b675bbd-b18e-4b72-b3c3-30527a9c157a ; be145e7b-25ee-409a-8c9c-5e17c9b6c5aa ; a63690bb-5761-47d7-854e-7be44d9b0b3a ; e92843db-568c-496a-bb91-b377b38e252b ; 92058c44-a484-4e08-b1fe-dfe2f03a0aa1 ; c236908e-4814-409b-9fcc-2bedf60aa168 ; cc937913-802f-48cd-a490-e6b90f007c5d ; cc07e1f1-e1e7-4335-ab8b-b7bebef1669f ; 3c2bed9f-2ab5-4623-b631-99e394d7723d ; 0c30cd0e-a2d2-42b0-9ca9-8297de64e4a8 ; fb0b2d84-d982-4d3a-9803-36420f2e7e46 ; 558c43ad-12ad-42dd-94b2-80a607465fcb ; 92b16015-e552-48e3-a095-0197b99b52a8 ; ea78a749-5aee-44e6-9592-b2e20eeb7ff9 ; 061e539b-4cde-4e37-bbcf-30937ce689c9 ; 60cfca96-802d-4a36-8c14-fc0bed308bc3 ; 990eab72-718f-4d71-aa03-892fdfdfa365 ; 652c3b39-d1cb-42e8-98e1-2acb0011bd50 ; f5675b71-ed1b-4fdb-be07-d627dc98ed88 ; a6b12e25-7b2d-460c-876f-02a75a82d7d2 ; 7893162b-3d19-4c54-86ee-aa4884d84e8a ; 8fa798fe-f032-4d77-b362-06261db78e6d ; ae28fd1e-2445-47ad-8c01-1b47d6396694 ; 63963cdd-909a-47d8-bae5-965aa9d1cb99 ; 70d8df1b-251c-4b3d-9de8-c20facd4cad8 ; b4402906-2bfa-4b75-b479-4e660556fbe5 ; 989450c7-cf32-4ed9-a74e-259a9be428ac ; 41af42ec-7521-4783-916e-2c982eef0f98 ; e5053de2-2a3b-4559-a166-35df5386d644 ; 086eac10-6ea8-4cc4-a6e5-91f051e50c54 ; 633ef184-2257-4cbd-90e8-64e92d91abb2 ; 93324982-7cfa-477c-88a0-b6eef61f6ca2 ; a582257d-4bf7-416b-a465-29a3220bc8c3 ; ef5821f3-677a-4bd3-9d99-d9cdd533cdb5 ; b58f47b2-c3ce-49a2-9bd2-f4c2cbda734c ; 4fbe5e67-d18a-48d5-bd88-19a2f4c01c8d ; a9d130f4-84e6-4f3c-982f-69971b5b7a46 ; 48c16c0d-085f-4266-b729-13bfd7aa9dab ; c216cce6-3e13-466e-942d-348f9f803ab2 ; eadfbcf9-0058-4021-8dde-7296d441e42f ; 92f1452b-54af-408f-98a8-cd76191f472b ; 4c7ed667-0015-48e5-a262-cabd54a35244 ; b462982a-4dd0-425e-bce3-0eb8f5527264 ; 8d122839-4167-48b2-9f3a-7ff7c3f134d8 ; 0ca24149-4cc4-4ad1-b448-4cc33fef851e ; 7adf414b-c3f7-4e2c-aa80-81d3edd9764e ; 27c9fa1c-e5e1-40d3-8d25-81f10d27d984 ; 9f6511cf-f17a-48b9-8e58-9c251bd5e8f4 ; 8d9f2037-1c1f-4c73-a993-dc4c2aa67d30 ; dd38ba60-656a-46f7-b22b-bcee3b6d2f19 ; d490330a-de38-478f-9504-a69260ab3967 ; d7e3b628-d5fd-4e79-9c4a-6409330fb8a7 ; a28d9c46-4774-4167-8c1e-ee95436c7b2e ; 723e0934-327e-46f2-94f0-20a65da1ea0e ; fbf64fdd-6787-4647-b0cd-860acc8abce6 ; eee3738e-89d5-41be-8f9d-564e46b4e065 ; 4c6bdfb2-3438-4216-b76d-d87c386bfa96 ; 9ae58006-9650-4494-991a-6ee217331740 ; 55a21e0c-e8a7-43bf-8b28-0e06211114d7 ; 529056f9-7bdf-4675-bff7-a82abddf5734 ; a3ac21e2-b92b-4597-a870-8444ddc6b4d6 ; cb5043e3-c1c1-4b06-9135-1aada484ba4b ; 43993e01-588a-40de-80ec-72c1a66fe70b ; 9eaa7f15-8a97-4a49-9e93-b5790a1fade0 ; d19fe184-84a8-4a49-a4d4-75891670da4d ; d2d7f976-2330-47aa-b1b3-947b3182b0b0 ; ca0d78dc-c860-4835-ad07-052f176804a4 ; c1adf54e-8248-4b44-a9a1-e883fcc4f702 ; 409b906a-5e2c-4ce6-bc85-20a59fa383f4 ; 6d129f34-7de2-4f8a-b150-e6111c5845cc ; c3927b5c-d641-45e5-87ea-9cc18c7ec85e ; 0f0cca8e-770c-45df-a6cc-466cc9328637 ; 3f1e9bda-addf-4e24-a92f-123085bf40bc ; 0d7c1a37-5da1-4257-a118-b7d0717f23da ; 147a9822-8704-4a7f-b856-9a659f4717b3 ; 55e28aaf-8025-4b46-97d3-96cdf512a609 ; 9ff0477c-10cd-47d6-8d0d-4e763ea185a8 ; 2c619641-7849-4837-ab92-0da80342b3e9 ; 9d657232-b6b4-4100-833c-5f94059a9ba7 ; 8da9c00e-1ec3-4657-9511-a2a00b8961cb ; d8b4969f-428d-4bf3-bbd8-883c72e8a934 ; d6023f30-0d07-4839-98d1-0b22b366cc51 ; 0edccd9b-72e9-4c69-899e-4bba4dbacb40 ; f0cf4acd-6b09-4538-b58c-e86c623b6c71 ; 7de9f347-2a8b-4647-bd46-011d74fc48fc ; e2b02d95-df95-48ad-b26f-3eb15201969d ; 31a140ce-bcb7-46b4-8105-626c9db1e183 ; 9cbd4bd6-244b-4274-a230-a7bd02e79571 ; c7f97f19-47ae-48d3-a90a-0162d3975747 ; c9ec05fa-5548-4fe3-8c09-a32c9e599d90 ; f773ae1d-0ad9-42dd-9675-c8b7287fec85 ; 5754d368-87b9-40e5-9a56-bd48ad9a80e3 ; dcc31bf1-9890-4fb1-9677-b5fb77e1fc37 ; 146bd11a-e66a-4d8d-990a-9f1199cdf255 ; d12bd5fd-838e-491b-8949-6a22f78194ad ; 9ff22b6b-ec23-41f5-a887-a59da1639858 ; 7f15f76b-305d-43f7-8d02-34cd0f76340e ; d79df987-e362-43f5-acbd-b19522bace7d ; 3cf5c205-2a3b-4f17-8e56-2078e88f615c ; 17cdb451-9b35-4aab-8bc2-b4a64ef3e3b4 ; 49bfd2cc-fddd-4376-8e53-8008ca075779 ; bc641d07-e041-403a-aa3a-e76279a8a1d1 ; a00cc4fb-6852-4869-89a7-f9f2fc941ccc ; 5cdd3886-898b-4861-a748-d4164ce14a07 ; 0d5c5f1c-d20e-480c-a89b-8feba01caf96 ; 8cf391f9-d743-408f-8891-2c49db90907c ; 30d31924-b87c-4065-a437-00d6033f2979 ; a92b6d90-f7b4-4b17-b56b-b2fb7103b55f ; f9029956-e7fb-447a-9b6a-ea3dd2acadf4 ; 87676c70-e2ad-4103-8bc0-3d3c1e40a790 ; 002997ef-3b93-443a-80a3-bae63e129d99 ; 112649f5-133d-4c45-a66f-4fe9a70bd5b7 ; b692cb10-ff2f-456b-a2c0-706b608d4e7e ; 67d804d7-b6a5-4a70-92cd-f93195d928a4 ; ec76e770-ba6b-4294-a992-993183640ff8 ; 6b1bb382-0103-4207-a0e8-871aa6aae81c ; 7423f6fa-4f31-46b1-a391-b5fc45833c2b ; ae72a901-e7b7-41cf-8eeb-2a7fb51e14f0 ; 51e96168-f2d8-4827-9910-66264b410b4c ; c6f8aca1-259f-48ab-a470-a1afecb8a2a9 ; 02ec11f4-1d26-4d2f-babe-d576ebfff1c7 ; bf8eb507-a277-4f3a-a605-313cd37f18b4 ; 91202959-0b44-43ba-961c-58c9de842d76 ; eb2de640-6c2a-4c8a-87c3-80f9fbdc3d9b ; 57e65074-4dc7-4f55-9638-8d123702305c ; eda0ff5c-84cf-44cb-888f-0aab17441dfa ; 9864f875-05af-4336-b532-a283e4dfeed6 ; 4a299407-b9dc-4500-b6b1-27a474ab4c4a ; 317b72a8-0332-4db8-b9d1-9a26d9907a24 ; 01aeb34a-75e4-446d-97ae-6e32c47158ad ; de71b625-2b73-43a7-9bc0-89d6a13d0d52 ; 5da663cd-e223-41ec-8b2f-796c141ec677 ; 4bdb6c69-67b3-406b-9ac6-9cca2c15f52f ; 7a3cd962-7512-4797-864a-cf374b5cb385 ; 17f2ecdd-59bb-4251-a1b3-2e0a461ea070 ; 0190a751-0a1f-4911-b5dd-26964b7fa5a5 ; 7e9145f7-ccff-4132-b2b7-9b992eebebf4 ; e11babda-c07c-4406-85ed-0b1d45985017 ; b7542984-1410-45e6-b936-8333ff902eb4 ; be694dea-a16a-4841-9588-89bba1b37dc6 ; 9e163b4c-d624-4c71-9d68-8f002aee6fec ; 29ba933a-c5f0-4637-b741-ee9739f02cd2 ; d4371446-8326-4e35-9e86-d8a48393efae ; 4f69c5f3-4e8c-4b71-a5fe-3179412c17e6 ; 6fe6d586-3b5d-4cd4-acb8-5691936441b9 ; b10e80e2-6ded-42f8-beab-b436e0286be1 ; 0f6ed829-a59b-48b7-a2ca-3aa9db40e4c2 ; e1c492c0-cf81-445d-8aa2-a8e8068ead1d ; e61781e7-6c4e-4a6f-8f8d-22896b1243ca ; dc85267a-0ce1-439e-9ecf-e5a13ad06f26 ; 3944bcd6-1a95-4297-8cf3-7e7d38b9390e ; 4a21e922-a294-43f0-89cb-862dabed4f8c ; FABFEC99-220B-4A94-A8FE-01DFD71487F6 ; 7E2ED541-38EE-473F-AC5D-3CAE6F5D9A56 ; 62D4D442-98A0-4540-B22A-4ACF1FBFC40B ; 891365B0-3BB1-4F7C-B351-6191B18EE9D7 ; D32E480B-D1EE-4BAE-AF15-8B5B94C1CC8A ; D92B4202-25D2-40B1-A704-C6BCA0EB5BC3 ; DE8AE7A3-D96B-4B54-9373-8E63F3AC926B ; 7E728799-4C12-451A-AFA9-0B26996F5736 ; 5D7A6563-6E74-48CB-A6A9-6D860759DDAC ; 6AB6C7D7-A0B5-4830-94A3-F16BC11EF953 ; E53D7A9A-3DB0-4A24-8DC1-6DC80428CD24 ; D6F5C34A-0F5C-4AED-977A-74A1E5D50915 ; 2B62733A-FCBD-46B9-B2BE-9397C563E3BD ; 9EBE5223-7566-4026-83AE-812283A8AAEB ; C18A3E05-F8EE-454C-89B2-5659045BA68E ; C6514DEB-3214-4CEB-8DB6-46DACA13911F ; 66760E17-251D-4981-BB02-82C29B315080 ; 1BE16830-BC94-422F-B925-26A772F1ED58 ; 6407B3AB-D159-4700-8E6B-D460411643AC ; 70C927BD-AB54-4E15-8521-5E3A5035DEA5 ; E46B29B9-C697-4739-B292-398674A5ADB9 ; FD735DC5-2EC3-43BD-B1B1-8FA811BE0633 ; 22FF97E9-F168-48BB-9B61-6F50ABA08D27 ; 3F9D6A98-182C-4297-85C5-02CE3B1A3500 ; A189A276-126A-4357-8AEA-9AC6A791A1C5 ; E4F422A0-1142-4BF2-B848-B681295B370E ; 9F55D4C8-5E41-4FFE-B819-1D8BFD06927B ; 571468B9-6FB4-40C6-8830-1FFAD5419B60 ; 6CB73E8A-B788-4EFC-B60E-F33424FC93DE ; 5FCE29D3-4250-4696-B691-D4BC953C21CD ; 07C938AD-70F7-418F-B6C9-EC6E4B1DAE66 ; ED47A919-BE85-4D06-AEE3-87B6485498CC ; 57557C6C-4927-449B-976E-127C0916763B ; 25DE243D-F03E-496B-B5F0-3DD8E61303FE ; 554CD9E3-7BF0-4D5B-A389-D258A8F46073 ; D6E981EE-1AFC-4F84-A3BE-E87E0D1460CD ; B0763E0D-56A7-4953-AD36-C3B218C059B3 ; DAEC3A82-E1F5-4D6F-87DD-90853E48BF29 ; 9439BB31-588C-433B-A7A5-787D8B496F57 ; 8E391BEC-541C-49DC-A0A8-5ECE5F268F1F ; 08F10BB1-6DD4-4F36-86A3-1801F9762187 ; A3AFBB9F-F611-4BF7-A7F7-8DB59022F66F ; 2FA19AF2-6FA0-4164-A0BB-8524D6085D80 ; FCA8DA49-849B-4790-A956-DB7EE97C39E9 ; 930B82A6-A039-4F8F-8487-B0ABB4FE7ABA ; CA3A64DA-CEBC-4451-AD48-5FDB6B9C26CC ; CD8AC496-CD1B-426F-8E17-8F15BA8E94D1 ; 3BC62725-AD6D-4685-BC50-0F1127363D90 ; 8318A9A4-E78E-4DB8-97C7-2CC733D0C512 ; 401D075C-D443-4592-8C03-E675CAAD2B50 ; 8BA93AD6-932D-42C9-8268-DDDA46802057 ; 025EAC6D-539E-4E43-A6F7-4A2D2DEF571D ; 112C8CDD-A187-4D9F-8C71-400848804D32 ; 05BF18CD-2346-4EF9-B6DF-58AA8A67E8A5 ; 96E71B7B-D32B-48BC-858D-20F7C8B7812D ; 122305ED-CA1E-431F-A332-0AC3409CDED2 ; 796DF715-916F-46E4-9DA1-E19C94958E07 ; 4949D427-3B3C-408D-8035-C884BB41E41C ; C685196B-C3CF-49FA-AAE4-F6CCBE04779F ; FC56BE13-C3DD-4DD9-8C34-DC6C7F9D1E16 ; B85BE663-EDBA-4E1E-A10C-D0297744A0E9 ; 8D65B4EE-183B-4767-9091-DEC23A17AF93 ; 42C7E92B-6820-4562-9E32-A424A99A6CBA ; 2A5F4696-6E02-4FE9-B66D-8C2AE93B7C2F ; 668220CE-7E03-4CCF-99F9-99127DDF9806 ; 5D1CB65A-7798-455D-8100-25871CEC5A47 ; FB635F1D-5EE1-4E58-86EA-B1AADA2DE4BA ; 061F9BB8-09F5-4788-B39D-35138A3AA019 ; 143FC27D-E119-48FF-A5EA-BD6AAFC0404E ; 50BD5C91-6557-4456-92D3-AE40CF7A8B9D ; D22E0F16-8D28-467D-AB10-2DD72F7EAB42 ; 9BC1887E-B3ED-4732-B8BC-EF4F4EA59258 ; 7D3DEA42-F18F-4CF6-973D-EA2BAE39BA38 ; 5AE24B78-4C64-4A08-BD13-3D58182215AD ; 2868849C-2BA4-42DE-AEF2-028BF68F4CB3 ; 075393F6-0404-410E-9FD5-7C2C63D3FA84 ; 1F617C60-D09C-4DE3-9973-CF655BEA3046 ; 4EE0389F-33EC-4A69-BC02-1C458D812CB2 ; 70E344F1-A29C-42C7-9FE8-DA9219D45158 ; 083F4985-57C0-4931-BA8A-00F565430DA9 ; 314E66DF-0ADC-4B7F-98E0-A32929192C71 ; ECE8AB6E-9A67-440A-8F3E-C80F3820474F ; 7153D60A-43D2-4A9A-BD8D-C15CD0BD9D75 ; 405B2B8F-7E2E-4D80-89BE-299DA48374EF ; 06239773-A7E3-4262-9B5F-0105E3B1467A ; 27E8B056-063F-4742-A591-B98FB9A948A5 ; 549F03A5-3F91-4975-9EEB-AA062264A602 ; 0B6EE423-04A5-4426-B397-9669FEAE4C44 ; 153D5E35-20A4-40F8-901A-D7208FA2D3D8 ; 66E4ECF2-AF70-46C8-BE47-783E8E3EDECD ; B599719F-F028-45EB-8464-ECF9AD60179F ; 6FAE8A0E-A96A-4895-B40D-C1EB491F0F3E ; A14E7E3D-0593-4D69-B17B-E79DFB065A0F ; 3447BDBF-5177-451E-BB93-736153EA76A9 ; C9E12D18-6092-499F-92AE-6FD6B16F2ACD ; FED3A891-21BE-4196-B9EF-0BF7C8F976AA ; 281F2BE7-7FB2-46F2-9A4A-033DB48329A1 ; 659EE487-4309-4D68-A9BC-9079EE87E4A9 ; 91D2288C-0D88-4A49-A0E4-0A7D2A95CCC6 ; 9D306F32-10BF-4EF7-AC97-91DC07D8EB4A ; 0A1F4A81-38C6-407A-A33B-716A0F9A6B4D ; DA7FE5E0-6AE0-47F0-9B32-FB6B80C4BE38 ; 6B746708-F6EF-45CD-B877-AFA1949D1D78 ; CAA2D510-9024-4D7D-B0EF-80FA4BE1E2EE ; EA7490BF-06AC-43E0-BB61-A2756D027836 ; 38F37F0C-75D2-4A56-B62A-9472A9C3AE13 ; 5012E9C0-A0F3-4F57-8840-FEE059DFE671 ; 4C932085-E46B-4544-A32C-C38B2BAC837A ; 6961FFFE-50B4-4296-8390-196B6070F739 ; EFDDCF44-AC69-436A-BA29-261E8DC6AD55 ; E852C16B-CD36-4551-8CC5-8B59719CA987 ; 287B037A-C32A-49F0-BED6-7674D2E26574 ; CDE5B270-BEC9-40D4-9C59-29F93EF08293 ; 51FB2284-4C63-49D7-9E38-C7D213AB43A6 ; 3374057F-4159-464C-B6C3-276BB12A8902 ; 8518E829-4248-4F12-B32F-F4019F7BA4E2 ; 9E1C48C2-CE8E-4256-8CB2-31B12C523C66 ; 312A82EE-9236-4282-B5EB-EE6063BABF5A ; CEE987EF-2EB6-4CDD-8094-331DE8EC38CA ; 2CF478D5-5400-4724-BF36-89BF1DF26284 ; BA0B6F0B-4E90-40B5-A47B-44ED4EB5DDE2 ; A896CC6D-91D8-4C63-B9C6-2B049E88B8B3 ; 4B4DDC10-5B37-42D2-BBF8-B0CAC95AE1B3 ; B22A4ADB-8D8A-490A-A6F4-CC091B41F56F ; A172DB3E-B6D5-4153-ADEC-9E772D6C1971 ; E0630A0D-D4AA-4C20-87EA-441EA60E6CFE ; E3A1436E-8E38-4CB9-A913-0A50512DB5B3 ; EFEA8F6E-FB7D-42F5-ABCA-3FF47DA3C062 ; 0201CF15-D073-447F-B96E-ECA0800B8CFF ; 5C016B5F-9E0B-4B33-90A0-D8B833DE27D3 ; 6A6B6B80-65C6-413D-94ED-07F13E48D62C ; 74EC0A11-F4F7-4F19-93F9-48674394A885 ; 817DA1B7-E485-496B-B593-2F8422545C6F ; E958EA52-21BC-43CE-9A24-72ACDA04E48D ; 03EB5BA8-0307-49B0-AA05-003007D79107 ; 040438CF-A4BA-4F06-B562-73C79738F53E ; 87845B6D-D3A0-43BF-82CF-A9429759E353 ; DA67ED79-947D-4F49-B1EE-B26B184693CA ; EFE1592D-EF98-40DF-B31E-545BAEF69207 ; 3440B3EB-511E-4904-873D-7A05D88FE879 ; 2C9BB39C-A023-4B44-B8CD-A454E8B60B28 ; 79A531B5-1BF5-442B-BEF7-72B9FC628F5F ; E7BB0755-D706-480D-989D-108B3E817973 ; D36BAC7B-872B-44A8-8C7F-8CB850B49603 ; 076736E4-6B47-40F4-BBD6-3868DFD1B9C5 ; 4C42EC4C-0EBD-41FF-8758-1E6A69CF7EB3 ; EE6B71D0-3596-4669-B138-AF822C2C3C6B ; CC10FEB5-CED7-4C1E-B429-C4AC77236765 ; 8C8D4BD4-3AA9-4AD1-9715-2376EE540A0C ; 764A5732-0B44-4CBE-93F2-7B84FD7D81A1 ; 38CFB491-3A6F-41C7-88B1-62BD97DBA0C5 ; E2EF5D26-F3EE-4F1F-9553-9239548B57D2 ; CEC6AD5E-A8D3-43CD-8A74-2199899F2422 ; E943BA18-21BE-49EC-8D2A-CFAD16E37FA0 ; 2969174B-856A-4BA1-97C3-9038891CF24F ; AD9E6197-47AC-454C-9C33-1988E9B66611 ; C677F76A-9A14-455B-B53B-1DE5CD448678 ; FFFBF817-1853-4783-B3E3-D05261CF2CD8 ; 5B55C210-049A-4835-AC3B-BBA70C72973B ; A4C6B7C7-739F-42E9-A9E0-9B59F1503F16 ; 9F40B937-E6C0-4259-BC0A-5FDCC6549B46 ; A86DD3FC-DE1F-4089-8AD1-95C683F9951F ; 87AAE20E-C532-4D73-AAB6-88BEFC3A2E6F ; DC2E6E86-4A3D-4F9B-BA04-6C0CBAEF94A0 ; 723A715F-02AA-4708-BB61-84A36792EC83 ; 0C7A94A8-4802-4CAA-B59A-6013CE8B3170 ; B9EEEAF9-5A04-4F93-B2FB-897377BD57F4 ; 049340E0-5AC8-4E7F-9C92-971B1200ABAE ; 29D94E70-4462-4FF5-AA91-75D7A412083F ; 3E936C86-FBB5-415D-A657-F96FE5565E34 ; 151A1187-E07E-4B76-B2D2-2DA133B9116B ; D7DC97C6-5819-48EE-99DB-E34F117AB1A3 ; ECE822AF-EA84-419B-99F1-6CE53E4C1E8A ; D5DE71C5-B810-426D-A1F9-7F7FF07B775F ; DA53D0EB-95FD-466A-A7AA-6251CB4CE408 ; 2678D877-E48E-48E3-95C1-65ECCE46308E ; CF5FDA71-8FBA-43FC-91F3-E4BAA36571DD ; 97AD1ECF-7643-461F-B9A2-1AC953825895 ; 2B7230C7-0182-4417-9861-03672629D98D ; 3DC0BC4F-6863-4297-8915-F29E1AA25D26 ; 9E1E6F69-AECE-4672-A059-D27AF0352C84 ; 1DBB21BE-290D-4C22-A6DA-9EB4A0C41EDF ; B280103F-8732-4EE4-9E61-357A9CB3A0A9 ; C26F4FCF-BB96-46BA-80DF-C8F3B926A296 ; 0039A298-3369-4DA5-9BFD-19792E9632BE ; 99095138-B471-48D0-AED9-DD8AFC8DED68 ; 8718F7F1-A95D-4245-9B00-6C061B69A1C6 ; CB7C50BF-C1DF-4B2D-939D-CBE1A4B7B667 ; BC4EF13B-1AB7-4929-953D-45592691394F ; 3D137341-F9A3-4CF0-8F26-ACAD49FA113E ; 5AEEF496-2885-42D7-802E-319B76BBE215 ; A76BC38A-9EEF-4E6C-B021-F940FF5137B8 ; EF196594-35DC-4BA9-8BEB-1EFE72D59E6A ; DA3319A2-F906-495C-B0DE-38CB8672E28F ; 8E324F79-8FBF-4D12-94D2-7B5A978425FC ; CC3A7053-34F6-412F-85B8-DE4C8B481D7E ; E5C7EA3C-3AAA-4409-B10B-372F2F8E30F6 ; 31E39E5F-AF9C-4F34-B065-8363CF9DF39C ; 2B8C960A-3E9A-49BF-8329-7D322DA90326 ; 1889A2AF-AE25-41EC-8A6D-0EC5C5B852CB ; 796B90A8-99D6-4102-81A0-96C6954E9F26 ; 61DB743A-627F-4666-B958-2542DBF3F320 ; 9DE14345-B948-4929-AAD7-8ABC4E2D35BA ; 155DAECE-CD56-4A90-9EE9-2C291C871BFF ; CE4833CA-7926-4C85-9A2D-1DEF273D4F77 ; 0849AA2E-A846-4DE6-8BA3-EB916DC13F35 ; E8811C84-1822-40CB-BA64-10939E29CD35 ; 4D7F3615-8DA4-4702-A84F-EFD533311291 ; B8348B74-69A1-43B1-A7F5-3AB429378EBB ; 3C8913CA-BC61-415B-9C6F-12295328022C ; 34E08E44-8C58-48BD-B682-1EDE7BAEAD3C ; 27BC9F32-2419-4E24-97A1-4136E7BE5A39 ; 1317942A-EF03-4ED9-B418-40A27AA3D6EC ; 31E5BC10-074B-4BB2-92F9-D9217C0EFC3B ; 65842833-68A7-4EFD-A781-19B5DC6BD257 ; D189E6C5-830E-4624-9DF4-CEF3301D0FBC ; 5A1BB598-9A38-452A-9599-365501038A88 ; 569DC2BF-8078-4330-AFAC-F3FF65903249 ; 842AED9A-EF31-404A-B93A-FB8F5FAA0467 ; E6142F96-4B9B-4691-8E7D-47D36BBDF37F ; 0DCB8872-8B48-4100-8AD4-4C89A0D3B9ED ; 25B35473-484C-4908-AE47-B6E6ED2DFB99 ; 468B4AB5-9750-4685-A967-184DA2CFCDB4 ; 62246534-B42C-4D81-B09E-792E55E3CB9A ; C53140B8-0058-4BB2-BE77-5121CD0E5B95 ; 4320C739-978F-4EBF-85C6-23D4735A38C1 ; C7F909CB-2D45-4B58-90BA-180C10E78723 ; 6F1FC322-359B-49FD-AC0D-CC7626F52604 ; 25B06E67-6D9E-4051-87CA-76E1F110B418 ; D763EDF9-B6F2-4814-B263-180ACED12DA2 ; 7091B5BC-E61D-464D-8931-58D9DBEC8CD5 ; 2895FE68-6AD0-4E50-AF50-CEC91436DDD9 ; 32915A08-0985-4232-BB08-A4B0850CB11C ; 4DDA3F93-216C-41D5-B1C0-85EE571D7759 ; 86DE89EF-D62D-4146-BC8A-E138C9EF7555 ; 5D3AF3D2-F86B-4FC5-A56E-381F82B84CD0 ; 4D088B92-CCB7-44FE-A582-F1D9034CD643 ; BFB67AE4-DCFE-4002-8F5A-35DBEC269889 ; 9970C93C-8A6C-4E05-9D2F-4B6BDF087A98 ; 96C72A6B-A6C2-4965-BE92-0910312689F3 ; 7231D76B-0AA1-4614-BDAA-84411618C8C0 ; F472B29C-F85A-422E-8446-453468AB9CC9 ; 98193DAB-86D9-456C-B67F-E3350327A609 ; B8E8E280-C3EA-4757-BB41-1611C95DC868 ; 75E9AD4A-AE3E-4331-9C35-0CE639ED3009 ; A6C10459-25FB-486D-A027-D17F1941B5AE ; BFC636BB-4E93-4E8B-BCC3-C98CF820E6E7 ; CB914F76-BE58-463E-B9DF-C7CB2811BD3C ; B1379238-CFFE-492C-ACAA-F8F0B0F733FF ; 8B7229CB-2578-4A81-8463-407DF893B47C ; C32E8A89-BC6B-4E8A-8719-4509412B5729 ; 8063E0BE-03EA-4A66-8592-DBB2D9F49045 ; 8A384D0C-BE3C-4A35-8B57-2C48DE743EBE ; E24E7C7E-1CD5-4C45-B50C-A731F894CDBE ; 88BFA581-96C7-4D12-B76A-630F44087833 ; ACC34A68-41A6-4C75-8F69-C0CE8727D7E7 ; 421AF19A-AE32-44B3-B91F-FED6A9B99DE1 ; AD431126-BE1F-483F-9333-FA30B2354F43 ; 43623706-5604-4F3D-8746-9BFA0B92C0A9 ; 1422B157-EEC7-460E-96C8-9121847D283B ; 197B76A1-A09A-4659-83AA-2C14FD1023A9 ; 0050D7C9-ECE9-4B6C-8023-1FF2EFCB3C9C ; E355913A-6E4C-4D63-8A53-8BE4C5B003B8 ; 2A532346-0008-4AF8-99BC-D709585DA1D6 ; 685B5DF4-0620-40E2-AA09-0DD736BB5E2B ; 8434F4A2-0EAD-40F6-9B63-9C958A3FB812 ; A31DEC9B-3626-4CB0-8265-1425D5CE1C1E ; 371EE0D6-5C89-4D9E-B57B-D22A0B86987E ; 2BD0E061-F49D-4F0C-A76D-1A647860E0D0 ; 097B9DD5-5617-48BA-8600-EC5A99C75A42 ; 4B35717E-B682-4B39-A5EF-5C9C037E6304 ; B13AB974-E4A4-4926-BD17-17A1E9CA7CE6 ; B884AF8F-FF0C-4CAC-9A26-F4F27B35F8E7 ; 0E20BD04-FDC5-4DBF-B132-5E4562E59413 ; 71CA5ED1-C8D8-4B05-AAA1-C4051976FE1C ; D91EC6E8-CDEA-41B8-A88E-252586D3B9AE ; 1152AD19-6FB1-4DFE-AF73-B74323A47AC7 ; 863804BA-7FCD-49CE-A544-5A98EB3F2857 ; 533D59AB-89CB-485F-934D-F22D8B602EE3 ; 11B582C7-95BF-4A07-8996-EF4D0D4F897E ; 64149D95-1EC6-47EB-985B-0F67252D7F26 ; CB389C7A-50D4-4F2D-9C5C-C1FFF17E442A ; ACC566D9-9CFE-4DEB-B1A0-F04B5A0449F5 ; 9C531ED5-E501-4CBF-9977-202DC1C5E623 ; 6B4D9AE9-5776-4EFA-86AC-3772B179D59F ; A56EE32F-1975-400F-A09E-A747383C9A46 ; A1953616-E244-4A52-B283-2E39D58F2C9A ; F2F2B11F-A4EB-4260-B2B6-822544ADAD60 ; 27DAC66A-E5AC-41B4-95E6-4A9F209261EE ; 4530D39F-1A96-46B3-9964-CBA7C03AD9C9 ; 0692591C-B717-4D4E-B3CE-EA1620EB127E ; 0DE093D5-C752-4E93-A783-EC262B3A3780 ; 081947CF-1635-4A57-9903-0C405EAD6D84 ; 93CE6743-424B-4A1E-8748-E11756399B2B ; 515600AA-A11B-4630-B88D-C59082ED1684 ; d3c85f76-56ed-4f64-9edb-9cdf80526e33 ; 7fd5702e-2d7b-4b79-b2d8-5ca4ca33cf65 ; ace39ef3-1b5e-4ad2-a20d-62957e524281 ; 69886602-a4f1-4ad4-ba56-a0e031c2e295 ; 9dc315ce-3b76-4754-b103-2c2580cde4ab ; f2deda2c-63c8-4b4f-a725-381f00298cd0 ; 1a9f7284-9770-4936-9fa4-500698184680 ; 5c28c3b3-1dfe-46ac-83f6-dd5cdb47d813 ; e8cb34ed-67cb-48b7-83cd-621a1224e781 ; 36cafcfc-cc5e-4203-b018-c2c949e24c12 ; 600df455-fdf4-4955-8d65-236b7b112693 ; 3ee32152-2834-4137-a6e8-254f3cca6b6e ; bdcd6720-fcbf-4c64-8703-b8932472ad19 ; 7fa91f3b-34db-41ba-8447-d745eebac2db ; 7b80a02f-c065-4ec2-95fc-05baf0aa3926 ; d1224e18-6c94-45f7-afb0-d4321150cc8f ; 504ec583-0496-4d64-bcc9-aa52868cc9f2 ; dac9090c-fae9-4d99-b5d7-fc3c8b6a201a ; 993d2cba-b4f8-4a46-994b-b97bb9f10d34 ; 750932d7-0e9d-44e0-bc5a-6031ca4b0448 ; ce2a0734-ea41-4e2c-87dd-516f6e5b83d6 ; 685fa2ea-3dff-450a-8ea6-e97dfe9000a4 ; f411d1ba-697f-4759-afb1-89eaa56e6da7 ; 0d2e50fa-daef-45a3-97b2-5d71ab03cfbf ; e7008896-7348-4b14-a443-d9da1352c80e ; e5bfc024-9ee5-4e37-97ee-45e695489f8d ; 2d80cd9e-8906-4fc9-9645-b3c137d71dc7 ; b16578d4-4d04-430d-8f9c-168ec0288cf1 ; 5d1a5545-6934-41e5-b41b-8e0ee88e6ec6 ; 74fcf73e-30a7-446d-9066-07d2e29ac78f ; 050ec96b-f110-429e-a138-4a41b38a24ae ; 24eaa7eb-502d-4c9a-b390-507b51c53f96 ; 90b93fd6-b94d-4a98-ad7d-dba3428cbb25 ; 3b3eab6c-c039-4c2b-ae4c-18b043d3d810 ; 0dba8c12-0f21-4489-8639-47c156ddfa5f ; 0b2e3720-4a7e-44cd-9e38-7d883f559c1c ; 8e464b23-588b-4d8d-a094-03efeb76789c ; 1964addf-c524-4c72-b596-009235bad133 ; b1de1587-febd-4e50-99ac-eb3dcb23033a ; f4f60d69-6c0d-4a73-90fa-ee369de95fdd ; ea93b70f-c0b6-4063-86a8-cac7d5d99c77 ; 298e1da3-0691-4675-931e-4a36f2ca858d ; 6d462341-cb4a-47bf-8c1b-2ffd6cf5e9ed ; 4c54a99b-a820-4602-9b39-deaca98034a5 ; c385c7fc-0e3e-4fc8-87c1-6db442e5606f ; 3de1ba17-00fc-462f-92a4-096e8112fd89 ; 4ab5f84d-7ba2-49e2-862b-48ff8cff3c34 ; 32b46b33-43d1-4663-bebd-f31673f18a16 ; 5af3de3e-4376-41ab-ae28-4ea9a95dce2d ; 5ebda262-2b64-4495-afec-38d3fa616d9a ; f26df76e-66bc-4e25-8a27-41b6147dc67b ; 8b5c7e4d-a220-4499-9e38-7deacc1776a2 ; 7b2cc917-cd91-486b-bb9b-4c57cf4e86e0 ; a36231aa-f304-4bbf-aa86-b9547916c097 ; 2223917e-5ff9-4726-99be-c73b19522265 ; cc620a1f-7955-43f8-aa30-12e244f89f1b ; 582b2af4-08e5-44d8-996d-d00db1e98413 ; 035ceab2-5468-41d5-9adf-f669225be543 ; 250c0ab4-ef0f-4340-a86d-628b98f8acca ; 0856c285-b57f-47ac-be8b-865dc2ddb58f ; ac9318f5-9e1f-4340-8da6-3815fff8bff5 ; b9140410-1ed1-4012-9637-412b7c688d68 ; 084b2d8f-96a8-41f1-844d-20004cd665e7 ; 6871927f-1488-4366-8545-439557a377aa ; 6d1ce13f-530e-433f-b2a3-f30793b0b003 ; 03115606-c46f-40ef-a95f-cdc1c174797d ; 6f8b48ba-ef24-4d33-a0c3-bc900a6c8cd2 ; 3ed5e5ce-12c3-4d15-9414-0b76f874e43c ; 8df411bb-1d82-4470-84ff-e2d335698d42 ; af859133-ccf5-4157-a260-738c9583c17b ; 5a9087b1-d001-4fcc-b061-f59e7026e711 ; 600a6f89-e714-4258-b4e7-33240123bfc6 ; 7d53f59e-5ae6-4325-9054-c9b1eac7983d ; e315f3f0-664e-47fb-9f3a-c55b3eda826a ; ea748969-579b-43dd-b2cd-1b0ac46b64ea ; 35f3fabc-9939-43a2-8491-c3813a970d13 ; d9e29db0-558c-4bd5-aa94-15d5d57110b1 ; 95c533d3-798c-4aca-8f38-dc4825f254b5 ; b09dcf83-93a7-466b-9414-12896ac7749c ; 1c0714ec-70a9-4902-bd98-8b0fb002c084 ; fe23a254-a0a4-452c-a2ba-685f66738a86 ; 5b9560c4-0632-479a-835f-67d373e59206 ; 108f6aeb-833e-45a1-81fc-4b0b8e3c7163 ; 9d772786-6ac9-4e52-9899-023ffa7247d2 ; ca92f9ad-c58e-41e9-a621-13bab969e94e ; 6408cd12-8623-4205-a757-bd6777a040f6 ; d09d5a48-2dc0-4d0f-8b20-d1f11a08143b ; 8046edc0-e5f9-42ec-85f2-6cc66596633f ; a19fbcc1-a781-4496-97ed-487aa83aae29 ; 05507d2c-3dea-4554-8f06-039fd555309a ; 7f00169e-2572-4158-a453-ccec33cd2159 ; 481cdbff-1f84-4508-ad9f-21a61009d68a ; ce3c01d9-e8c7-4bd6-84f9-741f38b07267 ; 6093f268-1c3f-4fec-bde7-fc3721ecaf8e ; e4dee88b-58d0-4953-ad4a-a2df876f3c95 ; e17e273d-6f53-4419-9f0c-1e4e667c5257 ; 6dd4870f-1ec2-484b-8703-6397d8e67daa ; 5dfab1d0-fed6-47b2-a47d-402e088361ad ; abff5667-7ef4-46c1-ad34-ceabc27e7992 ; 7cd3890a-bac7-42d0-a615-4b0f862200b8 ; ea7fb858-c17b-40d4-9a22-cbd9da614b65 ; 80105f2a-438a-4d44-947d-3f5a50d6cab0 ; 28d6a08d-f73d-4981-882c-aac092fdebb9 ; df545b98-f81f-4e0d-a714-90b406f2a238 ; 673cf36a-0405-4671-a76b-f0607d56beaf ; aa1e0129-d008-4648-8098-24f1981bc386 ; 12ece355-f1d0-446c-84e9-0aed3e6d29f8 ; 72439e36-3c17-4a90-b3e1-8f6ccfd3dcd4 ; 0d9139aa-d829-4ac9-8a65-822dcf79971c ; bd7e34c8-d477-4caf-a44d-aa9a3a4bf7d4 ; 63792ecf-4f55-4eb5-bfbc-78accb4f104a ; 5c703f38-38a5-4543-a964-88cf1d5ba2f1 ; a7e04cc7-3f4c-4986-a336-8083e5653754 ; bf0f55ac-2f35-4f8b-a1d9-c4e283fc7365 ; c8e05740-9d67-4e06-a30f-4298b6523a5a ; 2a3e4dbb-aaff-4b14-bbed-f2d7cf0f8fa3 ; a03cd506-47aa-4333-a9a4-fa1a6815ac75 ; 269af1ab-d92d-42da-bb6b-91929fab99f0 ; 059a543a-4408-4c82-96ef-eae1cc126763 ; 32ed93a7-250a-4fd4-81a8-6d94a6bc9f33 ; 02a0a874-6d4e-4e56-8d74-7952c912fed2 ; 0126489d-c12a-4651-8700-d7090732d7ab ; 7bd968be-14ae-4a63-96d5-814d16072818 ; 0dd8e6c7-9b41-4489-924f-bddf7d189eb3 ; 960d194f-fe39-42a0-831d-5c031cf93544 ; 8deb20df-b01a-40d8-a398-5dbb14786792 ; a09a99f9-33e3-45d5-bfc2-f57ce149a527 ; c6d8d136-3bd3-49d2-8305-3377240a1ce7 ; 9ae522c2-0fbf-493c-b3c7-a6ccd685c787 ; 860baf5b-abcf-4014-8b4b-d0a4b0d15c51 ; b6fe1d5a-f1c0-470d-bf49-b5a13157d2c6 ; 57aff09f-0e97-4e65-a227-3dc7a8516367 ; 1d8f72b7-8596-40e8-afdf-244dd897758c ; 4a7e95e4-58b5-4e96-a029-98f294b3cd54 ; cbf66244-42c8-4df6-aca7-932e77bb5e0e ; 2e4b5ba3-ccc8-40f6-80ac-edaea1685204 ; b2905a3f-810b-4e74-af5c-42d513d91746 ; 439d2ec5-1059-4556-b886-60b42b6db1d7 ; d78ecfd3-1a99-47e6-bb5f-a13c57148a76 ; 27b748ba-fef9-4eaa-96b6-a8ad31b5c478 ; 2f2d2e05-c6ea-4f29-8bed-040bd9c46911 ; c7da9758-e55a-4ed7-984f-cd86e2f6ea20 ; 181ff04b-8315-4069-a4cc-e102796ecde4 ; 071f43e9-e416-453b-a519-c197c5aaf1d1 ; a4910543-8bfd-4cd9-9eab-cf16aead9537 ; 78feb5be-f9d1-4cc6-baba-274136b9487c ; 76c09917-15f9-4908-ab22-ea1401abcb3b ; 199c6271-b0af-489c-99b8-fc76e7e66cf2 ; 46fecdc9-9d0d-41cd-811a-28731f0b7f92 ; 1be0c409-dd2c-4d82-80c4-2a71ec4d17d4 ; a919faa8-0df6-4a94-b12d-46d99df6f26d ; 4f5e142f-d936-469d-abaa-37baf6f045af ; f93c9b46-b07e-4a5f-9b3e-d7cebe34ebed ; cf11642a-eb96-4b37-b914-371c71f8e0ca ; 0bbcc10c-ff75-433b-a58b-7915d27eb7d6 ; 0c12ea89-eeb4-4865-91eb-10cf75884c21 ; efbff161-d65a-4009-8e95-50d7f6cae435 ; c6e14fab-a2a2-4102-8b70-2865757d2f48 ; 0c8df249-80de-4675-93e5-d06ad8ea3001 ; 09d6f42c-5e9f-4adc-bd8c-e5dca597fc01 ; 47436ce0-438f-475b-ac0d-1972d0c5285e ; ca3c9a05-88b7-4d99-abd5-fc557e3929a0 ; 14423610-4958-43f4-9a75-1a61c1293024 ; 2bf07767-58bd-4eb8-a0ff-434a9fdf5c8e ; 43f2cdb0-e5f0-4586-808a-fc0ef3313aa0 ; ef8c35b3-bdab-4a7e-b5ab-a0a99f4db803 ; e405d22f-86a6-4141-ae74-7098d0fdedfd ; 81bebbeb-bdb8-43f4-8113-b8f53425b725 ; 95f2fd0c-9121-47bf-b2c1-dd9ed667a146 ; 4c3d691c-fdf7-46e3-977e-68500c4ac358 ; 9ef8142a-8627-4dcf-8c87-15b1bc2bfea2 ; 74f23f3b-989c-441b-8715-505378d175e3 ; 75103265-c66d-4bd9-8ecf-cfcf66402918 ; 476b6ab5-f108-4280-9d53-7eb75fe17e4a ; 6b1c8010-d4fe-40e7-8e09-7a7dbdde6616 ; 183a47b2-1b00-4a72-adeb-f35b55692ee1 ; 832b8766-0e59-4ad4-b4c9-1e39b2ce4fb1 ; 052e361c-9cf7-4a92-a77d-f3d70f9dec0b ; 5c031f2a-0e98-4ab4-b8c5-3a296fda419d ; 7877c9a9-2002-4d6d-9ca4-f200c1ac00e7 ; 2ee13ed0-cb80-4375-a329-91ff9904bb7c ; e6ff00d4-c0aa-417e-acec-ae4727ae63b0 ; 02c8bf84-4816-49a9-b5d1-0edebb8627c7 ; ef48e806-e31c-4a11-afe8-dcc232357329 ; ba869eea-6e25-4afb-a0ad-73fda57a1d88 ; f76e87a9-4a50-48b4-9527-eac98c38800e ; 3490858a-b2ef-4700-91ea-5e71c71cff67 ; 69dbb2ae-3f19-4c29-9c24-810ae60312f3 ; c144ae50-ed29-4e27-bbee-fa81e79ac7db ; 6c05cfbf-4858-45d1-b5b8-d943a542d196 ; 05415f21-4c6d-4cf4-924c-9c1eb769e696 ; 392933ed-ca0e-458d-b0b1-6ccfe71df1c3 ; 00f81e98-e5c3-43b2-9757-f769ec17f3f8 ; 8e666196-bf9d-4b71-9c66-ee9272b671a5 ; 118021a5-6601-40a5-aef3-53c7fa4ed007 ; 63aa7e64-3d7c-43e8-87fa-f52855faed80 ; 6292ad22-cf2f-4e72-a95d-2441d667a147 ; 0a43ad98-2671-4701-9e5d-35ad63e8ad50 ; ddee0b07-2771-40c7-bdda-c1100958f0d8 ; 630613d2-682f-4a1a-b1fa-95320fb9a9b7 ; 008dafdd-a3d1-4801-8c0a-8714e2b58e48 ; 834d2e25-da72-413b-bb0e-3beb24d46472 ; 7ec2c455-d90f-4cd5-9bbb-aedbf21eca00 ; 357e1eca-0f5c-49d6-b437-0ed0afe3b178 ; 270be245-2239-4e96-a917-79cca40868ba ; b98aa84f-5144-4062-badc-32e89368d684 ; 973ee776-e287-4568-a43d-7b16cc0094a9 ; 18bb30b2-6018-45af-9393-f7a8ea40fa04 ; 31532d08-cb6e-40fa-9dfe-d2c6d037dcb1 ; fc1f0ad4-8412-4143-8ebf-fa6592f396e9 ; 3f6f1066-37f9-464d-872a-f1390eb36f6e ; 8137ffee-bb4f-4e5f-b831-acfc9c5585a8 ; 992d3519-cd51-4f48-880c-81fef52be1bf ; d1991ebd-1cd1-4c2d-ac99-2a6ecd3f90f1 ; 5423b7f8-d2bb-47c8-9af8-3d3e1276888c ; c1898b32-a9c5-410b-a197-572b2a6a2d7a ; 1acae6e0-3100-4de8-a436-e15cdbe1322b ; ffb838b0-db61-4dc9-aadc-41562f677f54 ; a99e45da-6933-4300-9c8a-e9d0f9e9c825 ; 662cc11c-da31-4e31-8e77-46011b38ea96 ; dcf7829e-abaa-435f-b41d-a2bcfde5d66a ; 4c70c0b1-1566-4e39-9dec-5050f62cd0a8 ; a7e71eac-1768-4fc2-8eba-1576d22e0f43 ; 1142b1cf-ebf3-485b-aae2-dcf4d8793212 ; 93a3fc8a-1b50-4da3-9dbb-cf9f582fc22e ; b2921c9d-c655-46f3-86e5-2fc2bed1ed33 ; 69bfa6ce-ed46-4321-a107-347c49d68951 ; 4a7c76a9-c3a2-4b57-a57a-de055152dcf8 ; 19193b8f-1e1b-448c-b934-93f25e60d45b ; 7ea6d404-9d2c-4b69-ac8b-d9ccd2d6cc65 ; 8835b20e-9343-4266-a356-e0343c657130 ; 989c2df5-5183-4daa-a8da-fc9ab18a437c ; 38ac0df0-950e-4c55-9f8a-96fd3f837ee6 ; 2fd1998c-1ea4-42eb-84b9-db352da9cf25 ; 08044da0-8cb7-4bf7-bbb6-b80be4fddd8c ; 9ec60572-39e4-4a0d-b157-cf0ec726fb1d ; dbd8fda0-bdf2-40f0-80b6-daef5ebf9c97 ; 289f5433-4834-401f-9361-efc8e883e630 ; 710257f0-ac05-4fee-b6a3-9c48ecc65b0e ; c0c04ba3-7fdf-47f3-8750-a487639a76df ; c59fa5bd-0b6d-41d5-83ef-7766f0241d70 ; 8da89b04-df25-4ed7-9d9a-e6c9478784e7 ; 46b0a695-f283-4623-a78b-954753e8ee62 ; 7909743a-2bde-48c3-8254-3fbd57ac2e33 ; 9113cf96-0feb-4e13-b1d5-0ddd12c2cab7 ; c0819744-0dad-4597-b9ac-9117497418a8 ; 759a1619-0432-4988-8a6f-5a0ef0956f87 ; e240d339-c042-42dc-b97a-d1effcac44b7 ; c90925f3-2126-478f-b0d4-f3b2c50cfbf9 ; eeb8b594-1bba-4af3-be80-682e261965b4 ; 36ccb542-78a6-4960-8d49-fa02e08fd36f ; bbf837cc-d336-45bc-9024-a018a667f8ec ; f05204c8-8301-4117-b826-b5fa194d28d2 ; dd8ebcff-9598-45db-b762-7ef446159e52 ; d3263082-946d-4420-8a63-8d67eeee09c5 ; e8eda441-d2d9-4708-bb9c-21f7da4e3094 ; 2399b5a8-f089-4a62-b75a-e6c0bd909846 ; e8ff608
PATHOLOGY_REPORT_FILE_NAME	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Pathology Report File Name	Sample	TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf ; TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf ; TCGA-BH-A1ES.9B2253AB-2C41-4E7A-9178-B690FFD9FF78.pdf ; TCGA-BH-A1ET.E66D3DF8-1605-4EFD-AAFA-74F82366FD16.pdf ; TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf ; TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf ; TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf ; TCGA-BH-A1F0.E2EE2397-0F8A-4A71-9B3C-0007F7D00500.pdf ; TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf ; TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf ; TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf ; TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf ; TCGA-C8-A1HM.4DAF6DB8-5429-4B39-B103-D4317166D05B.pdf ; TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf ; TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf ; TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf ; TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf ; TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf ; TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf ; TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf ; TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf ; TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf ; TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf ; TCGA-A7-A13G.50782829-35B6-4A61-A3CE-F105A31EDB42.pdf ; TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf ; TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf ; TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf ; TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf ; TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf ; TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf ; TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf ; TCGA-B6-A1KC.E1FDF8EB-9D75-4629-9C78-6019DAF8190E.pdf ; TCGA-B6-A1KF.40EE8416-9DD8-457D-94AC-A871B5C62873.pdf ; TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf ; TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf ; TCGA-BH-A1EX.FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1.pdf ; TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf ; TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf ; TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf ; TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf ; TCGA-BH-A1F8.BAA6AA92-69C5-454B-A550-246E7DB1EBE3.pdf ; TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A.pdf ; TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf ; TCGA-BH-A1FD.9F838476-4DF1-44D6-989F-33A1D490424B.pdf ; TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf ; TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf ; TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf ; TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf ; TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf ; TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf ; TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26.pdf ; TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf ; TCGA-C8-A1HE.DDB31719-1D2F-4502-B80E-544B684DC16F.pdf ; TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf ; TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf ; TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf ; TCGA-D8-A1J8.E8E799F8-158D-4AEC-8F86-D40F132C071C.pdf ; TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf ; TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf ; TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf ; TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf ; TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf ; TCGA-D8-A1JE.746C603E-FB1F-40D7-BEAF-20ACE27D6C21.pdf ; TCGA-D8-A1JF.03724E51-8430-414F-B483-2CB92D6A878F.pdf ; TCGA-D8-A1JG.E1907A10-207B-41F1-8B8B-24D5B551BD05.pdf ; TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf ; TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf ; TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf ; TCGA-D8-A1JL.156DF753-DB3A-4934-9618-1E18CE46C845.pdf ; TCGA-D8-A1JM.947954F1-4CBA-42D3-99B2-6BE6E44E5239.pdf ; TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf ; TCGA-D8-A1JP.1B61F1C1-8B19-4D9C-B6B9-87EEE350A472.pdf ; TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf ; TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf ; TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf ; TCGA-E2-A1IE.95443906-A63B-4E07-8C4A-ED0A918B88F8.pdf ; TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf ; TCGA-E2-A1IN.CC0B1145-B242-45BD-A946-B14BA5A9E923.pdf ; TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf ; TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf ; TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf ; TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf ; TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf ; TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf ; TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf ; TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf ; TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf ; TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf ; TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf ; TCGA-A1-A0SB.BEC7EEA9-6DEA-4402-A3A1-07EF33D58174.pdf ; TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf ; TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf ; TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf ; TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf ; TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf ; TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf ; TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf ; TCGA-E2-A1IG.ECD02213-B048-4776-B09B-982FE1260F80.pdf ; TCGA-E2-A1II.4F2A288E-8162-4579-BCD2-0FF31B0EEB3C.pdf ; TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf ; TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf ; TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf ; TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf ; TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf ; TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf ; TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf ; TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf ; TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf ; TCGA-E9-A1NA.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf ; TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf ; TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf ; TCGA-EW-A1OV.88E39E13-8ADC-481A-992E-610B3BEBCBD4.pdf ; TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf ; TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf ; TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf ; TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf ; TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf ; TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf ; TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf ; TCGA-EW-A1P5.82771A56-81CA-4414-949F-EFBCAE1C98D4.pdf ; TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf ; TCGA-EW-A1P7.8F35E936-E4DD-4E35-BD9B-6CB7974E2765.pdf ; TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf ; TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf ; TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf ; TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf ; TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf ; TCGA-EW-A1PF.0D24479F-2F86-43AC-AAB1-83AAD99542C4.pdf ; TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf ; TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf ; TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf ; TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf ; TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf ; TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf ; TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf ; TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf ; TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf ; TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf ; TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf ; TCGA-E2-A1IP.021D6868-16EA-4D55-9784-46A0F85C50C8.pdf ; TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf ; TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf ; TCGA-E2-A1LK.6CC4E6EF-6664-448E-933E-FFA9117C7ABF.pdf ; TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf ; TCGA-E9-A1N9.39D6D1DE-2CAE-470F-836B-926242F46E67.pdf ; TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf ; TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf ; TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf ; TCGA-E9-A1R2.5B9C0E4A-3958-4ECF-B8B2-E758E04E7722.pdf ; TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf ; TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf ; TCGA-E9-A1RA.26140CA5-AF22-47DD-BE48-C3C7DE07E5DB.pdf ; TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf ; TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf ; TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf ; TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf ; TCGA-BH-A201.6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8.pdf ; TCGA-BH-A202.57323AE5-3EFE-4492-8522-D9A6DB3F1BE0.pdf ; TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf ; TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf ; TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf ; TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf ; TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf ; TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf ; TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf ; TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf ; TCGA-D8-A1XO.9AAB53EC-89A0-4878-BB9D-D96BC56B54C4.pdf ; TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf ; TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf ; TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf ; TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf ; TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf ; TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf ; TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf ; TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf ; TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf ; TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf ; TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf ; TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf ; TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf ; TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf ; TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf ; TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf ; TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf ; TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf ; TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf ; TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf ; TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf ; TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf ; TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf ; TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf ; TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf ; TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf ; TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf ; TCGA-E2-A1LI.B3A319BE-2230-43E2-91E5-A3B3C76B85BA.pdf ; TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf ; TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf ; TCGA-E9-A1NC.AA1B707B-4DE8-4E0D-87CA-601760F4A6CF.pdf ; TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf ; TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf ; TCGA-E9-A1RD.EDDEB48B-B712-40B0-9DE5-9F5B5791AF4D.pdf ; TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf ; TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf ; TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf ; TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf ; TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf ; TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf ; TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf ; TCGA-E9-A22B.FC896EB8-1CEC-46A0-82E1-E3FBFAAB69F1.pdf ; TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf ; TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf ; TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf ; TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf ; TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf ; TCGA-A2-A25C.1D4CA1BA-B534-4CEA-ABA5-EF9B31694204.pdf ; TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf ; TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf ; TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf ; TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf ; TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf ; TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf ; TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf ; TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74.pdf ; TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf ; TCGA-AR-A24H.C373F2EE-C601-4E17-8E2D-D9BC6AC0301A.pdf ; TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf ; TCGA-AR-A24L.BF82AD23-B40E-459F-83EC-590D392664FD.pdf ; TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf ; TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf ; TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf ; TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf ; TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf ; TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf ; TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf ; TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf ; TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf ; TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf ; TCGA-AR-A24W.0F2464F7-4108-4700-B2EC-17BC6C432D42.pdf ; TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf ; TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf ; TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf ; TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf ; TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf ; TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf ; TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf ; TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf ; TCGA-BH-A203.3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB.pdf ; TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf ; TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf ; TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf ; TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf ; TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf ; TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf ; TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf ; TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf ; TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf ; TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf ; TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf ; TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf ; TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf ; TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf ; TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf ; TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf ; TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf ; TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf ; TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf ; TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf ; TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf ; TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf ; TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf ; TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf ; TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf ; TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf ; TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf ; TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf ; TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf ; TCGA-D8-A27K.6B2ADF84-5CEA-430A-87DD-5C2EC24C6E90.pdf ; TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf ; TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf ; TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf ; TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf ; TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf ; TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf ; TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf ; TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf ; TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf ; TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf ; TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf ; TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf ; TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf ; TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf ; TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf ; TCGA-D8-A27V.E5011BD1-E1DE-4A47-BF3C-66BA1E0B84DC.pdf ; TCGA-EW-A2FS.F273B11F-D3CE-4619-BEC2-15C110567503.pdf ; TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf ; TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf ; TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf ; TCGA-AC-A2FO.5A7EB73F-E681-46CC-B2D6-C87EEAB0AC99.pdf ; TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf ; TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf ; TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf ; TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf ; TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf ; TCGA-GM-A2DD.E7B75FEC-1706-42C1-8906-B17FE4440161.pdf ; TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf ; TCGA-GM-A2DH.C3243207-2190-4435-9AA9-39E3B913E316.pdf ; TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf ; TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf ; TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf ; TCGA-AC-A2QH.C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3.pdf ; TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf ; TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf ; TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf ; TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf ; TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf ; TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf ; TCGA-BH-A2L8.B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD.pdf ; TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf ; TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf ; TCGA-GM-A2DA.F3CD8E6E-B02F-4D5D-B895-6DF063F61603.pdf ; TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf ; TCGA-GM-A2DC.48CB011B-074A-424B-B2D2-E8A2397CF02E.pdf ; TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf ; TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf ; TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf ; TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf ; TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf ; TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf ; TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf ; TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf ; TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf ; TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf ; TCGA-BH-A0B6.06602AD0-AC4D-4674-B4B0-2D207C3E78DC.pdf ; TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf ; TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf ; TCGA-E2-A2P6.E6A21CE6-841D-4D9B-A563-80B9BAF6E682.pdf ; TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf ; TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf ; TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf ; TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf ; TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf ; TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf ; TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf ; TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf ; TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf ; TCGA-E9-A3HO.3EFA8B1E-0FDB-49A4-95FC-4C9C9B15B61A.pdf ; TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf ; TCGA-A7-A3IY.63F5F3D8-6393-4DA7-BB74-7D587199D7FD.pdf ; TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf ; TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf ; TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf ; TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf ; TCGA-C8-A3M7.953ADB1E-77C9-4721-B624-F9CCF040575F.pdf ; TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf ; TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf ; TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf ; TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf ; TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf ; TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf ; TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02.pdf ; TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf ; TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf ; TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf ; TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf ; TCGA-AC-A3QQ.07833A91-F827-4708-AECC-728C708F8E2D.pdf ; TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf ; TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf ; TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf ; TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf ; TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf ; TCGA-AR-A1AM.10C43124-3C21-443C-8268-23BF8A4D317E.pdf ; TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf ; TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf ; TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf ; TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf ; TCGA-GM-A3NW.00C6FB2B-A1C9-4310-B178-740313565A32.pdf ; TCGA-A2-A0EP.F76120C1-B2B2-46EE-AAE1-57B05D258ED1.pdf ; TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf ; TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf ; TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf ; TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf ; TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf ; TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf ; TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf ; TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf ; TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf ; TCGA-A2-A3XV.405B9D03-6200-4DFA-A7D1-C622D3A48AEA.pdf ; TCGA-A2-A3XW.A4621FE7-E898-40BA-B45E-3DC9EF607F37.pdf ; TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf ; TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf ; TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf ; TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf ; TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf ; TCGA-B6-A3ZX.B3CFFF02-89AA-43AE-B19B-BEE6817AA997.pdf ; TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf ; TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf ; TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf ; TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf ; TCGA-B6-A40C.87B150CC-1C5D-42D5-9951-9157A81316D5.pdf ; TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf ; TCGA-JL-A3YW.476488A9-3708-4B11-854A-C91B583C7804.pdf ; TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf ; TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf ; TCGA-B6-A408.F5A14797-6676-4331-9424-D8B820008924.pdf ; TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf ; TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf ; TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf ; TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf ; TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf ; TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf ; TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf ; TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf ; TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf ; TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf ; TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf ; TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf ; TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217.pdf ; TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069.pdf ; TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf ; TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf ; TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf ; TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf ; TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf ; TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf ; TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf ; TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf ; TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf ; TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf ; TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060.pdf ; TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf ; TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf ; TCGA-D8-A4Z1.D77DF136-6F63-48B7-8187-6F8F98CC1F44.pdf ; TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf ; TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf ; TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf ; TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf ; TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf ; TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf ; TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf ; TCGA-AC-A5EI.C0F7848A-DD0B-47B2-956F-A24D597D70BC.pdf ; TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F.pdf ; TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf ; TCGA-BH-A5J0.80DA141E-2752-4464-8D23-06DC7E9B05FE.pdf ; TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf ; TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf ; TCGA-HN-A2OB.32AE5A1A-703B-43C3-948A-719A90DDACC5.pdf ; TCGA-OK-A5Q2.8F2F2141-EC62-4321-B799-054D32FEBA87.pdf ; TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf ; TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf ; TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C.pdf ; TCGA-OL-A5DA.5049C91E-F4BB-4AA7-BE64-837168189379.pdf ; TCGA-PE-A5DC.8693580D-FCB3-4943-9C2F-5F3DABFB5AF0.pdf ; TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf ; TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF.pdf ; TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374.pdf ; TCGA-AC-A5EH.C49EB2B9-A19F-43FC-9A77-18BBB43F5B10.pdf ; TCGA-AC-A5XU.D61D4CCC-2AB5-4268-AEB7-C8928E0AF964.pdf ; TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf ; TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf ; TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf ; TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf ; TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf ; TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf ; TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf ; TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf ; TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf ; TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf ; TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf ; TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf ; TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf ; TCGA-OL-A5RW.86B06754-B000-4F8B-9037-95E7A0BD4D20.pdf ; TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf ; TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf ; TCGA-OL-A5RZ.927C0D4A-327A-4168-80C7-151A4B865CC9.pdf ; TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB.pdf ; TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf ; TCGA-A7-A5ZX.A8834D03-81F5-43BC-A4AB-F215C89CB095.pdf ; TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf ; TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905.pdf ; TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf ; TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf ; TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf ; TCGA-E2-A573.14EB270E-0AAB-4C12-8D71-ED79076C2E93.pdf ; TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf ; TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf ; TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf ; TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf ; TCGA-OL-A66J.D5DE4BB3-81AC-44CB-9336-060F324C7A2F.pdf ; TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf ; TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C.pdf ; TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf ; TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf ; TCGA-E9-A6HE.649E6215-36F9-4BEB-9EE9-683E4FC75C42.pdf ; TCGA-LD-A66U.5FF5CE63-2A8F-4117-A384-A57EED6473D8.pdf ; TCGA-LL-A6FP.D318A0F0-38B2-4DFA-8326-E362603AAC5E.pdf ; TCGA-LL-A6FQ.5C3D9179-7434-4776-A2FF-68CEA0149C68.pdf ; TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf ; TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf ; TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf ; TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf ; TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf ; TCGA-AC-A6IX.3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1.pdf ; TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf ; TCGA-D8-A73X.9B227A4E-6237-4C95-B640-E64AFF0CC5F4.pdf ; TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf ; TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf ; TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf ; TCGA-LL-A73Z.D9FE314C-61F4-4E4D-BB29-4B681C2A8A10.pdf ; TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf ; TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf ; TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf ; TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf ; TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf ; TCGA-A7-A6VW.BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C.pdf ; TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf ; TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf ; TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf ; TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf ; TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf ; TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf ; TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf ; TCGA-EW-A6S9.4FC32F17-7A4D-4FF6-A710-FFFBC610CB56.pdf ; TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf ; TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf ; TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf ; TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf ; TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf ; TCGA-V7-A7HQ.82B46073-10CE-4D05-9421-6308E3FAD1AD.pdf ; TCGA-AC-A7VB.53881871-C36B-4622-BFC6-4DA3635D7B26.pdf ; TCGA-AC-A7VC.A1681334-684E-41E0-B3FA-EFFE1E5A8B7F.pdf ; TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf ; TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf ; TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf ; TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf ; TCGA-LD-A7W5.ADBA741B-AABF-4A33-A61F-C10EE555D175.pdf ; TCGA-LD-A7W6.859561F6-3113-45C8-8FBE-718BF860B582.pdf ; TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf ; TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf ; TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf ; TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf ; TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf ; TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf ; TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf ; TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf ; TCGA-PL-A8LZ.436F3280-98C7-4FA9-BD6F-1B02CAF1D262.pdf ; TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf ; TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf ; TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf ; TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf ; TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf ; TCGA-3C-AALJ.265E5A9A-64FD-4B86-89BC-5E89F253C118.pdf ; TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A.pdf ; TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf ; TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE.pdf ; TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A.pdf ; TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf ; TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf ; TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf ; TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf ; TCGA-AC-A8OS.EEF4E8C6-6D80-4C6A-BFC6-E529692088C1.pdf ; TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf ; TCGA-C8-A9FZ.23B3BAED-E281-4A1D-AB78-51D8D62466FF.pdf ; TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf ; TCGA-LD-A9QF.E8601979-AE05-4E4D-BB39-6B9C5E67D050.pdf ; TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf ; TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf ; TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf ; TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf ; TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B.pdf ; TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA.pdf ; TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf ; TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf ; TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf ; TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf ; TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf ; TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf ; TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf ; TCGA-UL-AAZ6.1AD1E3C4-0D7C-447B-B330-0245F9159FCC.pdf ; TCGA-UU-A93S.821ED144-DF12-4E49-ADC7-27FA5E422B83.pdf ; TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf ; TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf ; TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf ; TCGA-Z7-A8R6.9A5C8EDF-9243-4F55-9036-A400CF3F4CC1.pdf ; TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06.pdf ; TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf ; TCGA-A2
PATHOLOGY_REPORT_UUID	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Pathology report uuid	Sample	747FB91B-F523-4FA0-91DD-6014EF55643D ; A2B755DD-00C4-4349-8E11-C1196EBC91D3 ; 9B2253AB-2C41-4E7A-9178-B690FFD9FF78 ; E66D3DF8-1605-4EFD-AAFA-74F82366FD16 ; FF6BC87F-029E-4565-A35A-6FB968F8EABA ; 16DEA43F-4A61-44E3-854F-6B6575B45628 ; 56EFCA58-2328-4C5C-9618-981447E76B12 ; E2EE2397-0F8A-4A71-9B3C-0007F7D00500 ; 40B07BB9-2CDB-463A-8773-771017E73DBC ; 0813A175-83ED-4F6E-AD7D-FB4135CFF34C ; 04EF4A48-80E1-4567-BB61-2B542F715266 ; ACA6B606-681C-427F-8923-77BAA7390795 ; 4DAF6DB8-5429-4B39-B103-D4317166D05B ; 4C7445ED-B346-4DD7-8AFA-2E95E65364BF ; C972EC08-E1AE-4FCB-B8A1-15000306CDE7 ; FE41053B-16F4-46B0-B243-571F4D5A1665 ; 074223E9-5E1C-47E8-BE40-1C4442CAE9F0 ; 849E9FA7-3420-427B-A310-3346CFA9F0CC ; EAFC71A1-D6FC-46EA-BC47-D054C497D705 ; DA82E751-09C3-466E-A63A-38368D8A2C7C ; E2E6CA22-AFE4-4B8F-90AC-32639687A590 ; 5AD3B697-F097-496C-978B-F73BDA5394A7 ; 02B4C31E-38F0-4AF3-8DAD-527D5F27C11A ; 50782829-35B6-4A61-A3CE-F105A31EDB42 ; 15FB8CBD-85EF-45BE-8065-9F4E922D457E ; 467172CC-6EA1-435D-BDC1-D65FBF8EA0E8 ; EB5199BA-6164-4CFB-AFAA-B41544B83103 ; 0FB93D92-81F6-4241-9094-4AABF70E6A0F ; D9432167-0F2E-4377-9DB4-EA4E59A6C9B9 ; 1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532 ; 6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD ; E1FDF8EB-9D75-4629-9C78-6019DAF8190E ; 40EE8416-9DD8-457D-94AC-A871B5C62873 ; 72996825-1FFA-4C51-8DB0-DA74BCB595EB ; 809F294F-8C48-4719-866B-7169FB1CE24D ; FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1 ; 2ED10396-96FF-4705-93AE-82FB9A80EC28 ; FA781D93-C180-4453-BF95-B2D01B6CDB5C ; F70DE761-F081-4F4C-AD22-9A166CF78CA8 ; 7E9B0BE7-121E-423F-AA37-445BA922FC13 ; BAA6AA92-69C5-454B-A550-246E7DB1EBE3 ; C5D116FF-3193-48A0-B69C-D98831D9976A ; 7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F ; 9F838476-4DF1-44D6-989F-33A1D490424B ; 098BAFB4-94D0-4FC8-B938-D8A410BD8FC1 ; 49927626-EB84-4A79-8073-67818722123A ; 501C3E1B-573B-4A5A-A0ED-3CD15432E6FF ; 8169BE67-03C8-4F4D-9A60-200705B795AE ; 032B81C5-F936-448E-A352-C186DF160B7C ; DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD ; 26F47A4F-B501-4C33-9D49-2039E98DBF26 ; B6E6765F-14BC-4D3D-9266-EF8065354070 ; DDB31719-1D2F-4502-B80E-544B684DC16F ; 11F98715-1482-4D7D-9102-E362634806A7 ; 4D1B4A09-FB4E-45EC-895B-2941D18AED18 ; 24B1FA5C-7D84-4CE5-B094-2358ECE73C10 ; E8E799F8-158D-4AEC-8F86-D40F132C071C ; D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B ; 51A2B7B5-0CDD-427D-BC82-5498810B2641 ; 27376503-A55C-4905-A885-632440EFCED2 ; B4DB830F-BFA4-47F5-94C7-D95984315866 ; 332880ED-FE4E-4EE4-9E96-0A61BFCCA27E ; 746C603E-FB1F-40D7-BEAF-20ACE27D6C21 ; 03724E51-8430-414F-B483-2CB92D6A878F ; E1907A10-207B-41F1-8B8B-24D5B551BD05 ; 49C79E09-2F69-4089-BFB1-53197DA09A46 ; EF2DC6FB-F026-4025-B148-DF07194914AB ; 1841FEE0-EC36-4EC4-8B5E-6D340C80735B ; 156DF753-DB3A-4934-9618-1E18CE46C845 ; 947954F1-4CBA-42D3-99B2-6BE6E44E5239 ; 021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6 ; 1B61F1C1-8B19-4D9C-B6B9-87EEE350A472 ; 0EA57ABF-E3DA-4862-BAB8-A6E36408AC42 ; 72AF26A2-FAD0-42FD-A63C-6E8E2597B84E ; B5074D1A-C617-414F-B349-6096F59E122D ; 95443906-A63B-4E07-8C4A-ED0A918B88F8 ; 12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433 ; CC0B1145-B242-45BD-A946-B14BA5A9E923 ; F23523C7-B6E9-4205-BD36-D76E9EE9C453 ; 9AA68C63-2C14-430A-85C0-5A92F7FCCD36 ; 97B6C43B-4C7D-49FC-BA49-00D2DF41827D ; D4194F52-3E15-4105-9A1A-1326CF128BF8 ; 7C003A4F-DC30-43D0-AC61-ACE6BA118BEE ; F5EF4698-364C-4A5B-A8EC-1CF231BEEF31 ; E8B860F6-F3FD-4FDF-B467-8988646C2F00 ; 0046FACA-9E90-4BA9-B216-258A2A7A2EC6 ; 79C0D757-50BE-4375-AF69-E577629EE0CA ; D92CABBE-8D7E-41E5-B702-9ED07E94E5C4 ; F282122D-C129-4A8B-9A49-78D5267C37CA ; BEC7EEA9-6DEA-4402-A3A1-07EF33D58174 ; 1617B36B-4EFB-445E-95BC-E63B129AAAE7 ; 89A67051-898A-4E2A-A874-E0165F274E63 ; 4CD6BDB7-9629-41C6-8514-7661E3D33A66 ; D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A ; 92EE56BF-AAA0-438E-9244-780DBB2D9835 ; FF188295-E139-4AEE-8EE8-364536F2BBE8 ; 9E2EF2C8-A60D-443D-99B6-205B7053175A ; ECD02213-B048-4776-B09B-982FE1260F80 ; 4F2A288E-8162-4579-BCD2-0FF31B0EEB3C ; 35F7D0D1-BA21-4135-B444-6B10EAF66F25 ; FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D ; A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2 ; E78526AB-D72D-4407-B7E1-2255BB5B2F68 ; 8F401B38-8D91-4F75-ADE5-52521EAA7DFE ; A868EC86-9CB6-445E-B961-5D4C57263548 ; 3327975F-94BE-460E-9900-E063340927BE ; 910A4342-BBC1-47AE-9316-695B0CD0375D ; 4F15F8D6-9F34-4A61-A006-E5E7A2E68207 ; 595BB256-2F3D-493A-AA90-022BE0CC995F ; AC26EE69-27D8-4523-917A-68573F5F614E ; 3CF4FC36-70EF-4EA3-874C-4A514FCDB717 ; 88E39E13-8ADC-481A-992E-610B3BEBCBD4 ; 2153CBCE-6DA9-4E0F-9F41-B9F08FD50647 ; 4C40B309-3178-4E7E-A987-47698E5E364B ; 76358109-41A0-4D5C-8894-F6A63A925961 ; 42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE ; F9FB00C3-9F86-40AC-A5E8-08712CD5002B ; 042304AE-706A-4033-A97F-3765A6AEC649 ; 70C8D54A-9698-4275-BD96-A6EF2E26474B ; 82771A56-81CA-4414-949F-EFBCAE1C98D4 ; 6FEAD496-58BA-42DC-A3F2-2F380EEB1588 ; 8F35E936-E4DD-4E35-BD9B-6CB7974E2765 ; 6CB5A0ED-5569-4FDC-B651-758BFC6B59D8 ; A68B2364-89DA-4DC7-9AA7-A08BBCC85025 ; B3B6DE56-F40C-40BF-B6B3-2BC10F695F16 ; B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD ; F59530A5-7370-4E77-9099-9F38B25A38EB ; 0D24479F-2F86-43AC-AAB1-83AAD99542C4 ; 6197798C-6F04-470E-BA91-922548E2DFAF ; F93E326D-F4E0-4000-8A67-AA19C4D3637A ; 58B02C83-2AF7-4978-A3F7-A8B9E0D914A1 ; 449F70F0-DFE1-40F9-879D-43283CFAF525 ; 9320030D-5E19-4BEE-99DA-366B6762DED1 ; B7367E27-2A40-4E8F-8975-D5665E6506D9 ; E5D2E429-C41C-47E2-96CB-F3B6F412499B ; D5614445-4EBF-4050-8FC6-D34D5CAADD82 ; FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58 ; AA869507-1B46-4812-8EC5-A4E01C588E6E ; E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8 ; 021D6868-16EA-4D55-9784-46A0F85C50C8 ; ACE20EC5-2822-4F50-949E-E194C59F0FCD ; DAB174BB-862D-49BE-9BA4-9C11C4489305 ; 6CC4E6EF-6664-448E-933E-FFA9117C7ABF ; 224A51C8-8EEB-424C-AD88-44C4321050EA ; 39D6D1DE-2CAE-470F-836B-926242F46E67 ; 740CF6E1-C742-47DC-8057-9D73AF4D6171 ; A6248687-C0C0-4DEF-9D92-196CBDB5CBDE ; 3F4F5A98-F6EA-46D5-95E8-6797D419328A ; 5B9C0E4A-3958-4ECF-B8B2-E758E04E7722 ; AA095896-8217-4BEE-97EC-BC79F5C395BA ; 8A865E33-082A-454F-A6DF-89E994206E65 ; 26140CA5-AF22-47DD-BE48-C3C7DE07E5DB ; 59D84893-8946-4C5C-A338-3E33A1F7DE00 ; AE0C51EF-017E-4F53-968C-804110F9A7E6 ; 5BC01981-366E-44EC-A986-087DB7904E5C ; C2711492-0BDD-487E-9C9B-CEF20BBE57C3 ; 6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8 ; 57323AE5-3EFE-4492-8522-D9A6DB3F1BE0 ; 3F1DA529-4967-462D-8966-E634D66EB3E1 ; 880A4D38-40C5-46C3-8EE7-36539DD64773 ; D3EA3547-7E53-442E-A957-B2DD7EBAFBB9 ; 5F1C3B85-5E5C-428B-8779-3A5878DCE1F2 ; EEA126DE-A667-4373-9DC5-96B55E4ABF07 ; B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C ; 762963FB-3D8C-4616-8C8C-0CD3E45FD243 ; 7E48315C-3717-40DB-8773-71D070AFC47B ; 9AAB53EC-89A0-4878-BB9D-D96BC56B54C4 ; 33B6269D-1D59-4184-A786-2BEB73F6D3A8 ; D9A0E659-99BC-4704-AC85-E63098BA731D ; 6C97C157-05A0-45CE-91E9-3DC8946EFEDE ; 99050E48-8DFE-4405-B8D8-7649CE2C9CFF ; 845F8FCF-CF3C-4CEF-B673-A57DE626939C ; D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C ; BD71F606-58BC-46B9-8A03-CB25D5BECA96 ; 9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C ; 1D6EE39C-DE75-4595-943A-CF53873F96BF ; 53ED4388-8CD2-4925-81A9-9C4792C83566 ; 1B198706-8844-452A-8F5B-8880A239717C ; 08A790DE-B01D-4140-BB1C-B4844291D71E ; 64B91C7E-E6D8-4952-B49F-0F5D57332994 ; CF6E29A2-FAE6-45BB-B625-33877887A89E ; 73953A70-DAC0-443A-AC04-28BDA8D5F673 ; BE186852-8596-4CDB-B5C4-AA5838C15B5F ; 141B770B-22DD-4C87-AFF7-04D85FC9C74A ; FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C ; 2E77693B-FAAD-4CCC-BD4F-3D2470C25143 ; C976ACED-7FF8-4287-9D68-C6FD17895FC0 ; A7C7D409-D086-4A9B-8C8F-E7E231D5891D ; 531B1E8E-9936-42E0-B49B-39C61DD4E943 ; 4F943D12-E769-45F3-86BE-75193786DD4E ; E28150CE-E9B6-4C3F-B867-F9A75E2648DC ; E69CF3E3-4799-4892-87E9-4291B14A1B9C ; 4ACD42D6-9520-4DC6-BB40-9187A4D49981 ; E8D4229D-5049-4991-BDE0-AFC2CBC1827E ; B3A319BE-2230-43E2-91E5-A3B3C76B85BA ; A514658A-FB29-4AA0-9451-2A960B3720C1 ; 4F50E811-0743-440B-9094-6BA0F40BD734 ; AA1B707B-4DE8-4E0D-87CA-601760F4A6CF ; 3BE8EA29-3C5F-4339-9CE7-98994B545848 ; D10A419F-B161-4998-97DE-45DF70F4E212 ; EDDEB48B-B712-40B0-9DE5-9F5B5791AF4D ; 80831A1A-95BD-4ECD-B7D9-6DDCD5313B25 ; 50F3690C-2082-4590-A923-656C5F226FAE ; 7C8F01DC-9CD9-4D61-9032-BC9F28A687EE ; 13CA22BB-5EA5-46C9-82D3-77867122D1B4 ; B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC ; 15FA41AE-3A0F-4112-828B-EE8687A6F158 ; BC3061B7-9C99-4270-84EE-B1306FA01AE2 ; FC896EB8-1CEC-46A0-82E1-E3FBFAAB69F1 ; ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA ; 7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC ; E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D ; 672E4D81-DA47-495C-A58B-BD2B4FEA2380 ; FCE29F34-5D13-4A21-A950-A8577C957C10 ; 1D4CA1BA-B534-4CEA-ABA5-EF9B31694204 ; B81555D4-78D9-4235-AABE-F852CA6F15B5 ; AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B ; EA830A26-3DF5-4731-AD0A-F20A61D58817 ; 46A75AD3-BAD1-4A16-873E-0099BD10FA8C ; 6BE810A6-3D30-4F75-89B7-00C866553165 ; 1159E2EF-6407-4D90-8ED6-7AB04CF4FB32 ; CCE33A95-774E-4242-B2A1-05FF002ED1D9 ; 5CC0C09F-70F6-458A-B8E6-18BDC074BE74 ; 926E93B6-EF7C-4F13-824D-13D08B7F7938 ; C373F2EE-C601-4E17-8E2D-D9BC6AC0301A ; BC7B3577-CA6C-41AD-98E2-89D357D29D37 ; BF82AD23-B40E-459F-83EC-590D392664FD ; 56DFBCCE-A9D9-4F08-AC7E-33998F3439B2 ; AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628 ; 887F0E3A-DC70-4CD4-AAAF-3C613195D895 ; 0BF7CB67-49F1-42EA-8B41-988BD7E0DE61 ; CCE8E855-2582-4214-B9B1-25F0431065CB ; C3259BD1-1A2A-40C4-A106-FA2EF0201811 ; C0A8A457-8790-4745-BD5D-AFBE55254A1C ; 226031B3-D9C2-4343-B3F7-4E0C36B901E7 ; B481795F-C52C-4FCE-827A-07991C7A7C2E ; 468CD293-C9F7-43C6-A40A-18FCDD22F6AA ; 0F2464F7-4108-4700-B2EC-17BC6C432D42 ; B537A19C-C7E8-42EB-BA3F-673417F3A9BA ; AD07F611-0EEA-4890-A02C-6DA3F5F57C45 ; 16BE833B-E17B-4B8A-9D71-B0D83D73D9DE ; F5B17108-8904-48E7-9B3D-182F0EA388B7 ; 8C52C92F-26CA-4E72-BE47-CA2ED1746785 ; C026CFCE-1A82-446D-AC78-8CF4788FD9EB ; 492DDF00-858B-4420-A43F-4FED2DF61C15 ; 0FDC2801-71F8-4D45-BFF1-89445E621A41 ; 3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB ; 4F3E197A-9731-427C-A2AB-2D506A1C717B ; 4CC1413A-5D03-4BE4-91E5-80B578CE7DFA ; CD43BA31-A5C6-4C0C-AA07-3171332776CC ; 864BB34A-1008-480C-A3B5-A2C616E95C49 ; FA93BDAA-B56E-4217-9022-4EBE6009FCF7 ; 91303D10-CC36-47CF-BF14-E1DCE0157D1C ; 742A4812-9EB1-4348-996E-3F1AD7FA3E5D ; 4158FEAB-066B-4500-8FD2-3F197438DFB5 ; 61E73960-32B0-413E-AF1D-2EF4582293B3 ; 8950E632-451D-4436-9AA2-740CB08237E8 ; 6272ED78-501A-4055-8C87-430F46F518AA ; 392524F7-B570-4047-A439-71FC15642DC8 ; 33569E07-D7BF-491B-A352-CEEA81556800 ; 3971CA42-F1B0-4D85-9AD3-210B98E76A9C ; BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07 ; 9D040C65-C225-4D41-BA4C-6BB21EC1CD32 ; 929AB6C9-58B0-4E37-A2B4-9FC1F9099437 ; 0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30 ; 8C845114-BBC6-45F2-9135-7E8298E24422 ; B660432A-A67B-40CC-89F8-80648DB8AE98 ; 5E21E07E-BD5F-4AC7-985A-178416D756E2 ; EAB9E75C-2795-4D83-9806-5019DC14256E ; A7FAA4F2-1846-48CF-9FB5-15E98430F6CE ; BDE9E2A9-09E9-49BC-AFBE-BD32916972DC ; 36F6CB19-17FE-47FA-BFCA-3846578C028B ; 976C6F9E-DDCB-42F4-BD2C-A4D715396B47 ; F8B8EEB1-0603-4181-9BD3-209143024EF8 ; 52D7E980-806C-499D-9DB9-40E1D651D9EB ; FAB622C2-3E45-4E72-AA36-9530BB830993 ; 6B2ADF84-5CEA-430A-87DD-5C2EC24C6E90 ; 1281F503-C256-4DFF-A3BD-BD5E51CE4249 ; 85045216-10EC-473C-96A9-268E71D2B566 ; 69007BC0-E1DF-4E68-BA6A-352F6A12F233 ; ACC0A0E7-218F-4112-AC74-9F5D5A512DD3 ; 5E997487-9A03-4723-B1E6-FA0B557D8FDF ; 15237FF6-A56E-4E05-B81D-B87E91B59917 ; 292571E3-D500-4337-B435-834B504F3109 ; DD0ADC20-2059-435E-9EB4-351C87D7CBEB ; 5F2A52E5-2844-4242-8CE4-A87DF9D9C97B ; A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8 ; 4AABCBD1-DF12-45E1-9307-21D6CB0894A9 ; 3D878253-22B3-4A53-AE54-C0D95E085DB1 ; F6CFE506-16BA-475A-A81F-1AC4B2EFE24A ; E6897E14-465A-486A-A6AD-FCFED21629F2 ; C1ABCD83-40EA-4FF7-BEB6-69679589E8E7 ; E5011BD1-E1DE-4A47-BF3C-66BA1E0B84DC ; F273B11F-D3CE-4619-BEC2-15C110567503 ; 335BFEB5-6356-43A3-896D-50BF3830B59E ; 0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E ; 1CF3FA64-EAE6-4A18-9B51-F5980A885371 ; 5A7EB73F-E681-46CC-B2D6-C87EEAB0AC99 ; 95DC80AB-C070-4613-8C11-A124AEDF9754 ; 73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3 ; B2314041-3E85-4E3F-8924-39FC285B08B2 ; F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9 ; 1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95 ; E7B75FEC-1706-42C1-8906-B17FE4440161 ; CA6B733A-6030-422C-9DE9-B9718CBB2FDC ; C3243207-2190-4435-9AA9-39E3B913E316 ; FBD7BD94-2870-431D-A519-DAF72A97845F ; 18D46E96-4E16-4736-AACF-C6BF8AEC9368 ; 8829274B-EB82-4155-A458-CF9F0E60B36E ; C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3 ; 4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D ; 128D4F7D-017D-459F-9664-AF509AE4555E ; E5B6771D-450A-49AD-AEBC-7FC056BFCDBE ; C3537961-4636-4BD1-BC89-892580B36E43 ; C310F4EC-D8B1-45C4-8D55-705A9EE35902 ; EE769039-220E-4158-8999-09F17AFB4C46 ; B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD ; C70325C1-54EB-41BF-B77C-D92FADA8D23E ; C690925E-38A2-48BC-8E2B-4EA383E27FE2 ; F3CD8E6E-B02F-4D5D-B895-6DF063F61603 ; 5A315635-886B-459E-AF5D-079F66E859F0 ; 48CB011B-074A-424B-B2D2-E8A2397CF02E ; D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7 ; 8CF4E53E-924F-4DC6-8748-BC8A1F7D5662 ; 100E842E-0ADD-4E58-B31B-0C67DC175787 ; CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1 ; F694CBD6-880D-40C7-AB17-D0AD02B7F06B ; 83BA3E82-E8E4-4A70-ADEE-A1360940EECE ; 5CF85AF1-D227-430C-99CD-C2A524CFFA29 ; E422C6E8-084F-42B8-84E7-4EF387F098C7 ; 4D864947-076C-4A66-940D-682E75E525A2 ; 5411AC07-09E4-40C3-844F-2DFAA216D947 ; 06602AD0-AC4D-4674-B4B0-2D207C3E78DC ; 42E3E8C1-D18A-4457-B2F0-FE49F4C027D7 ; 85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E ; E6A21CE6-841D-4D9B-A563-80B9BAF6E682 ; 593AF241-8F84-4BA0-8878-7C1CE72A460B ; 3E4717BA-E9AE-45F9-9696-F8928D9FCECC ; 90F83655-038B-412C-91BD-84CC3A4201D4 ; A5AED5F0-A144-4615-AF78-539B8523D15F ; D8EFFB62-6A23-4033-8144-24B751DECB08 ; 810663DD-1718-4FD6-B9C2-77B4C091B3F1 ; F0308FC8-D8B4-487F-A072-05E66D01842A ; 25CD89AC-052F-4B9F-AE1C-B0824A7A5145 ; 3B7CA8ED-58E2-4609-BE41-46525D3732E7 ; 3EFA8B1E-0FDB-49A4-95FC-4C9C9B15B61A ; 3C301346-4594-4071-A754-04F8B3BE894C ; 63F5F3D8-6393-4DA7-BB74-7D587199D7FD ; 3E54B0CE-8863-4728-BC95-A47C1869F52A ; 9F00B6F4-EE91-4A18-B533-127E39EF8554 ; 9F7E2B98-29E7-465F-AE12-33D78FDFD71A ; 1E498731-FE74-493E-A330-477643800305 ; 953ADB1E-77C9-4721-B624-F9CCF040575F ; FE3E1376-1527-42C0-8F5F-8849D0F2743B ; 4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6 ; 792A24F5-065E-4001-97F6-3F9BA121C65D ; ADDE6090-5278-42D5-8E89-E0AB630A4C06 ; 1659798C-9B6A-4DF9-A5B6-79AD2194DF11 ; B065FC65-CD33-4878-AE2C-7E8C04F5ECAB ; 8C440009-E05E-4046-96AB-BAB211CB7D02 ; A3167E2D-3588-41D4-99AA-6DCB660D55A4 ; 642B4B50-E227-4484-904E-E629F7F9DBC1 ; 4AF67A51-97C1-4D58-9E60-03FDFFACD38A ; 3094774B-B764-4D60-BFF3-48FEF39F4BEA ; 07833A91-F827-4708-AECC-728C708F8E2D ; 87DB9AD3-7640-4A78-B401-D5562D03BA76 ; 1A0D203A-BC4B-441F-97F6-D1FF7E959262 ; CA0CD57E-DA92-463E-A004-D554825A22D6 ; B52E150F-5B34-482A-84E7-1739B9AC09B7 ; 3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE ; 10C43124-3C21-443C-8268-23BF8A4D317E ; 12A869FC-7578-4506-BB23-7C25597834EA ; 7E0F430B-B96B-49B1-B4C1-88C1F3A855A7 ; 1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF ; 8652E026-9C4D-4AB6-AADE-29DA3345892E ; 00C6FB2B-A1C9-4310-B178-740313565A32 ; F76120C1-B2B2-46EE-AAE1-57B05D258ED1 ; DD5295D4-3896-4AA5-AF75-30AEA45D1652 ; A614B6B7-256F-4148-8941-6145B2D9B8B5 ; 5018EC57-96C6-4D63-B708-45559B4D8527 ; 14E2FC4E-7205-4929-81B5-7FF3006F08AD ; 0F890724-8554-4B2B-B4EC-6B9B24C757D8 ; 00058FFD-35E6-4891-8B01-DAB3AE9EBF78 ; E8583D11-D6F7-41AC-8CD5-53437CBD8820 ; E9A88E5B-4F50-4683-9C65-56CFCB15405E ; 25782EF0-8786-446E-ADBA-21F489844237 ; 405B9D03-6200-4DFA-A7D1-C622D3A48AEA ; A4621FE7-E898-40BA-B45E-3DC9EF607F37 ; 770EEADF-19CD-4AB9-A7FA-1A05EE17984C ; EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F ; A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0 ; 0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC ; 52CEF542-0F5B-4660-8746-2CF4A27B214E ; B3CFFF02-89AA-43AE-B19B-BEE6817AA997 ; AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD ; D76CF03A-54CD-4769-87AA-466473F41FC7 ; 9BC704DE-0914-49F1-80F9-36CFE52B8484 ; CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB ; 87B150CC-1C5D-42D5-9951-9157A81316D5 ; A8F63D86-37DF-472E-AF29-FB734EAB7E5C ; 476488A9-3708-4B11-854A-C91B583C7804 ; F969E3E4-0053-44E9-85BC-BEFDBD62C512 ; B644AEB6-7D46-4D4D-BA00-D42BCDDCB164 ; F5A14797-6676-4331-9424-D8B820008924 ; CC77BA51-CE5A-4839-A27A-DD8F389A2733 ; 3FFD87C3-1E75-4A8E-AA26-BF7995E42245 ; 25F791D8-27D6-4DC6-8D96-5D5CF68A5F13 ; 5BB5CEFD-CC07-4451-A774-25FB146067C7 ; B16B3335-492B-471B-AEFE-2350EA558BFC ; E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A ; 0BB6CAC8-CE26-461F-A9FE-46E28E96A368 ; EE644ADF-639E-450A-92E6-2A6F1BAD561F ; E76B5204-99E5-42D0-AE7E-ED5525796CCB ; 5577BE88-72ED-43E5-9BB1-83D56C2EA346 ; 1FFDD2E3-02D5-4C38-B6E9-1261EB57835A ; 389044F0-9D90-4639-8C42-C1A6EA816442 ; C1D4D6BB-AF86-4208-A729-C61365941217 ; CA88491F-5572-4B0D-8E3D-D536E3CE5069 ; 2D6815B5-7704-4D67-93D1-78EDD924F131 ; 0118D9AE-B923-4EEF-BBBC-82D559763FF9 ; 041580F0-700A-4A47-83A6-207ED267E844 ; 4A5630FF-0ADC-4E69-B22A-02F1F34F61F9 ; 351D8E38-6E04-4F54-8CB1-975AEB7DB552 ; 2649764C-9566-49DB-B8E9-B4B86DBB763C ; 03B39A59-0068-4276-8340-7B97A1395E68 ; 5E14E7CA-3417-4379-8EE3-7F00D6D4A02B ; 563D1ED2-1A8B-4D90-BD42-AC3790D04913 ; C0C49D41-AA66-435B-9312-FAD8E2DC3305 ; C1B1FAA6-EB15-43BB-B3A3-D11511C76060 ; 9BF0E34A-F78C-4BFD-AC4C-926FA1D60342 ; B3884493-D0D2-445C-B9BB-BC475021EBA4 ; D77DF136-6F63-48B7-8187-6F8F98CC1F44 ; BCDA7E7B-396B-4809-A0B3-2BC2C22DC908 ; 3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74 ; DB0291E6-E371-40F8-BDB3-0F85F015B3DE ; C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9 ; C13D16C9-BAC7-4CA4-B062-D925466F9E2B ; 58D54D1A-3A8D-40DD-A643-846CAF242494 ; D564A7FB-4F0A-4589-AB32-A6CD8B547219 ; C0F7848A-DD0B-47B2-956F-A24D597D70BC ; 4C3E3E5B-E24E-447B-A688-68D6EBE15A9F ; 52B5D974-2653-44CA-937D-5467EE39938B ; 80DA141E-2752-4464-8D23-06DC7E9B05FE ; D346F4E5-4E4A-4161-96FB-7B8ABBB17128 ; 72186F5B-9F97-428C-8E06-9240E17E88DD ; 32AE5A1A-703B-43C3-948A-719A90DDACC5 ; 8F2F2141-EC62-4321-B799-054D32FEBA87 ; AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740 ; A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B ; FD496AFB-43EF-41D8-850F-E57DD53C185C ; 5049C91E-F4BB-4AA7-BE64-837168189379 ; 8693580D-FCB3-4943-9C2F-5F3DABFB5AF0 ; 7A2719FC-1CA2-4D58-9EF7-594926D1FF66 ; 6D2FA4DD-285F-4815-9494-76B297FA04AF ; FA5CF5A2-F44A-4303-9200-32250FAEF374 ; C49EB2B9-A19F-43FC-9A77-18BBB43F5B10 ; D61D4CCC-2AB5-4268-AEB7-C8928E0AF964 ; A9015F6A-F6BB-4AC8-B681-099232A6DFAC ; F2409024-D848-4B02-A371-92BEA1105EC4 ; 511282C5-02AC-4105-8B52-5BBEC8B45D22 ; 6C698240-6557-4F96-BF56-60792693920F ; B50AB6D5-3010-450E-9CCE-E9BFA0202736 ; A616A83A-8D19-4085-B430-1AF80D4F9642 ; E49FAC55-434A-429B-8E61-C5E0FBD7C15C ; B169A5B5-27CD-48A6-A8D7-C14D3824A20A ; 4D4811FB-5BF1-4574-975B-1740602E43D8 ; C5C5D704-2558-4D4B-937B-33BD91132882 ; B6B4DCFE-F044-44D6-BB90-EF71E6981E82 ; 7507AC79-4C8E-4393-92B9-BFA6BEB492D0 ; 0CA74400-1596-4C14-AF02-4F5169D61942 ; 86B06754-B000-4F8B-9037-95E7A0BD4D20 ; 9536A134-A44C-4698-A525-DEEE7FACD144 ; C8297152-7551-49A1-8C9D-6B411391AC77 ; 927C0D4A-327A-4168-80C7-151A4B865CC9 ; EDF80CFD-4115-48E9-BF76-DDE957A97AEB ; A56585F9-9651-472B-BF53-C708A686EB7D ; A8834D03-81F5-43BC-A4AB-F215C89CB095 ; C4F259BA-7C00-4326-ACB2-924C4AE33E87 ; 6BB72835-1002-4B35-9304-495E12A30905 ; 83BCCC3C-0384-45CD-84B4-67E2EDE822EE ; 83AAF7BF-131D-4044-AD3B-670B838A23D6 ; 803922CD-3D37-47DC-8BDC-EF8F4779685A ; 14EB270E-0AAB-4C12-8D71-ED79076C2E93 ; F3FAB505-03FF-4FAA-ABB6-96AD20F47871 ; 17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF ; 3D84D02A-42B1-42E1-84FB-E9AE9381ABB4 ; 800346FC-BC14-4A33-B10C-84224D908481 ; D5DE4BB3-81AC-44CB-9336-060F324C7A2F ; 8A19AA55-9B1F-4325-B730-068F928F1C13 ; BBA96852-E70C-4D37-A185-611F568BE90C ; 5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02 ; 967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27 ; 649E6215-36F9-4BEB-9EE9-683E4FC75C42 ; 5FF5CE63-2A8F-4117-A384-A57EED6473D8 ; D318A0F0-38B2-4DFA-8326-E362603AAC5E ; 5C3D9179-7434-4776-A2FF-68CEA0149C68 ; B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6 ; B8C192A7-E530-4301-B4D3-FF528A230260 ; CDB6A529-DE8B-48F6-A569-D07251D139C3 ; 60ACE33B-BEE2-4A49-85F0-1364D245FCA9 ; 979468F0-6B4A-4759-9CA2-7BA1D1441BC2 ; 3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1 ; 1DB8FAFB-FC4A-4401-8316-30FB5352335D ; 9B227A4E-6237-4C95-B640-E64AFF0CC5F4 ; 9C971870-BA92-4E0C-9861-31C56B7E7D64 ; 6EEF1F11-603E-4196-91AB-724BBEE20CE7 ; 315A77B4-1A2E-468D-9E44-FF0B07697943 ; D9FE314C-61F4-4E4D-BB29-4B681C2A8A10 ; 3AD4AA3C-5F68-43D1-B578-07AB574D4DE3 ; 7B53A0D4-E13E-4573-B0A2-BB55AE54BD62 ; 47D02B80-47DA-4135-A288-21077C5947A9 ; 030860D0-66DF-46FF-95A3-2AE4852D5C19 ; C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8 ; BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C ; 80EDDCAC-B87B-47E6-A48C-F166D227DA6C ; BB85F844-C710-41D5-8620-E246DC9D2C6A ; 5B978086-7443-4721-854B-877CE0FC10C0 ; 302E69E0-39F0-4CDB-97F9-A6CDDB3D7233 ; A81EB5E0-305E-4657-94AD-0922CD1D79C6 ; BF07FF13-D7EE-40E1-9729-8F9CCBD1534F ; 7BA4658F-3343-4176-BDCD-620A1001A032 ; 4FC32F17-7A4D-4FF6-A710-FFFBC610CB56 ; 9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5 ; CA6A13D4-DD80-4424-B5F3-654EE31263AE ; 9A8F7726-D97C-44DE-B72F-6BF0FC2078F8 ; 961547D2-F235-47E9-9A6D-D286758E332E ; 217745AA-6C5A-46C5-AC04-1C6581A96A04 ; 82B46073-10CE-4D05-9421-6308E3FAD1AD ; 53881871-C36B-4622-BFC6-4DA3635D7B26 ; A1681334-684E-41E0-B3FA-EFFE1E5A8B7F ; 2B30A85F-7A5F-46E4-BE22-28C902D5DFA3 ; A2B05D26-AC8E-4439-B32C-B48537D20836 ; 22134EA5-5ED5-47B8-9A33-01E59E58B54C ; 359DB5F2-BD23-42E1-B316-9D908DBACD78 ; ADBA741B-AABF-4A33-A61F-C10EE555D175 ; 859561F6-3113-45C8-8FBE-718BF860B582 ; 3FA5FACA-8A6B-4F42-A557-3B69866859E7 ; 5540DD9C-FA3F-48B6-8243-414616816A76 ; F4F5C477-30BB-41EE-B188-B20DE019F30A ; BC78EC6E-73C6-4234-9369-9A5586CD1A69 ; 581088D6-9F9C-4572-B61D-BAF0F6C79B2F ; 37FA6CD0-E789-44EA-AD78-C195CBB1EDE3 ; CA1E5192-ABB0-45E6-8547-2BA2B035238C ; 79A10C4B-1B5F-47BB-99EA-E694FB341696 ; 436F3280-98C7-4FA9-BD6F-1B02CAF1D262 ; A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA ; EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14 ; 5D85E578-64B4-4238-922E-802B8ED87800 ; 0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8 ; 84E6A935-1A49-4BC1-9669-3DEA161CF6FC ; 265E5A9A-64FD-4B86-89BC-5E89F253C118 ; F43B01E6-E1DB-44B1-8003-93870606346A ; 8894688F-7167-48A1-BB1B-FC219B7675C2 ; F9B6971F-23C0-465F-BFEC-778BF228A1AE ; B5CA42BB-9514-42C6-9FB0-C8889C1DC51A ; 2DB5519B-B36D-4616-94F3-601A01185F22 ; 6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6 ; FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90 ; 1E706FF8-F42C-4FC6-8976-BEB4213BD730 ; EEF4E8C6-6D80-4C6A-BFC6-E529692088C1 ; 3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796 ; 23B3BAED-E281-4A1D-AB78-51D8D62466FF ; E28607CD-0847-46F4-8E69-2D1DC80DE56F ; E8601979-AE05-4E4D-BB39-6B9C5E67D050 ; 2697F2B6-725C-438F-B4D3-3E32DEF86FD6 ; 17C74789-D7B0-4291-A2AC-7A72C5DC58EE ; 1582865E-9294-4D78-8B16-92FB70381D15 ; D35DBECD-5241-4562-85CC-2822BB338279 ; E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B ; 8C97B391-96B4-468D-AAA3-24E196DE03CA ; 6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E ; 6A981CB0-F551-48B1-AB91-5D5585A7F282 ; B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB ; 9F96B0B1-2B88-49AE-8D3C-9FED70F1D950 ; F4B87B89-A066-4BE9-88C9-60C7FB5BF373 ; DD2B9E47-8C67-4599-B0B6-0D30DE727B55 ; D7E24E6B-797F-4FC9-B0FB-794C4D379091 ; 1AD1E3C4-0D7C-447B-B330-0245F9159FCC ; 821ED144-DF12-4E49-ADC7-27FA5E422B83 ; FDB00212-9782-4ACE-AD59-019384297A2F ; B7EB0E0B-46C5-43C0-A78D-FB094290765A ; 7726F7AA-88A8-4DD6-B322-6FC68893E0D2 ; 9A5C8EDF-9243-4F55-9036-A400CF3F4CC1 ; 28AFD5DD-B607-4837-819F-688C9218ED06 ; D8B44020-EC34-4788-B7FB-790B9C12D886 ; 990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1 ; DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C ; 8A853D7F-979F-4112-9659-1FDE84EF5102 ; 2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE ; F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0 ; 019F390D-7479-4CDC-8C82-45A27910E782 ; 511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3 ; 43D912CD-BD3C-4E69-B28B-AB2E173C0BC2 ; 2F0333BC-E9BB-4903-B3E2-8AE241DDDF84 ; EB9B8904-F6CC-451F-8628-50CC71F1F7C3 ; AADFAF8B-92B8-4292-96A3-912D55EB9C31 ; B6B7939C-63AF-4B52-B494-AA09A9C03871 ; 5D888D65-685F-4598-884F-AD057DE5FD1D ; A314FB55-F20A-4485-965D-D7894D070A16 ; 738B601A-24D8-4261-B000-198648213070 ; 5664F531-9D45-4302-A455-63E46B5EDD26 ; 956F45E5-A8C6-4A4A-9D1F-D31912180584 ; DD669244-34D8-4725-A52C-F3AAF59852F9 ; 81ADDBAB-C02F-4DA8-9429-76293FB42E42 ; F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA ; D1456192-83E7-4FC8-B783-90D615830156 ; 5DA3A8E1-7EE6-45EC-89EC-69423E2B866B ; 2243F29C-191C-4D33-8483-09BB3AD36598 ; 5D93AE27-79A0-4809-AE7C-54814CED0851 ; 9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE ; 6C7D956E-1247-4663-9ED5-D406AE6E2959 ; C39563FD-CD7F-47C6-A257-5CB70A01C67C ; DD558354-3BF1-4037-881E-011E6BFC0987 ; DE25BF82-5F7A-489B-BFC1-9386C44E7D62 ; 3E967C4F-B916-4A80-A9A1-A5E94F02322C ; AF0A2220-DEEC-44C8-B15C-B6442D5B7517 ; 6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B ; 64F84FF4-A477-4E1E-B4BB-E5614517229E ; D4E86E20-B75E-4CDA-83F2-22C481D4B9E8 ; 6D2212CE-C80F-4545-A895-3F1B6E4C6DB6 ; 2261B407-340D-4BB3-94BC-F06096FBDA80 ; 6E136F3D-A6E1-4541-AA4B-65BC5872DE06 ; 683AAF99-3B91-4501-B701-C3A4E8439647 ; 6DCA5C2C-F28A-409D-9623-24AB748FB4E7 ; 33188769-D86E-41AD-A74D-31A7C2DD08B7 ; F2077079-D683-4D18-94B9-84C760674AF6 ; C1D59BA7-FC3E-46EA-B095-3B6DF42892B0 ; BC0E0F93-B183-44E8-B551-EA463B2FBCE4 ; 7DB1F816-A55F-449A-8DF9-6724B5100CA1 ; 5780D50C-5BF0-4392-BC9B-894D1369866A ; CA911D90-5DDA-49F1-993F-68FCA77A8558 ; DA7BD84B-C00E-40A0-9AE2-33FCE7995696 ; 549E825B-F206-4FF9-835B-2FBE51C7B831 ; FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7 ; 93D66EAD-B7D3-4688-8EC9-75C4380619D9 ; 9DCF000D-D996-49A6-950A-0CD1E90CC6C7 ; 85288EC6-0BDC-4955-8B88-1DEECBF0E235 ; 41A41A7F-E4DD-4D3A-B97D-B4657CA211E1 ; 91BFC77A-E56F-49F0-A294-A5EE9F266FB6 ; 34499A83-DFCE-4DB8-BAA0-A7590AF8BC07 ; 5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF ; 5D439E4F-F1B7-41F7-BF1D-1F6E93D6427D ; 1E002C47-CEC6-491C-9E67-B289687D5B66 ; C4A1A482-6AE5-4807-BA05-C73AC0898546 ; C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03 ; 2728DB14-66D5-4E67-B9B6-63D93DBF509C ; 56C24ABB-CF1D-447F-A5A8-B762C4B01566 ; EBBF2A70-2773-40FA-823A-E608ABFEF591 ; F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF ; 46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7 ; 5E615F92-6FD0-48C7-AC37-78526974BCFC ; C616E97C-8352-4FED-9E83-558318216FB6 ; B73AF7B0-EED3-413C-B249-C97F27E4EA1C ; F72703A2-2C57-459A-9015-94BD3D302491 ; DF890966-D14E-4EDF-B6E3-E10E40BA5B5D ; 3BC6CE69-2641-4B6D-85DF-E8FE838015D0 ; 25F8F043-2CD0-4344-9B4A-5BBB691B5BF9 ; E306BE26-0358-4BE4-AEF6-AD42CC0DA020 ; 8612388B-3680-4BD8-986C-E7ABE9F92F91 ; 1F6200B4-B53B-4E9F-B01B-12D2C0D4270E ; 76734A82-9137-4DA4-871E-D4EC1BC33831 ; 8C2B719A-D45A-4DF3-BA61-908A2E1F6D1D ; 6E2365F3-0875-4949-8409-7E26BBCDE700 ; 12683FCC-4828-4D9A-9B35-E4B7295CC417 ; 20F4DBD9-02FA-4FFD-AEF5-234910D31263 ; 0E27F140-3D60-4027-A370-68127564DE38 ; 0D1ACC76-910E-4243-A229-5F76B5A3299A ; 59163BD6-41E8-4489-81F0-036484447886 ; 5AEE90E0-A9A1-4944-AD6A-2675764D869D ; FE9C56C4-B6D4-4054-A58C-13642370052E ; 0BFAB667-8B40-46AE-A224-535573E268C7 ; 06905BD3-4D17-4625-8631-46CA81D1B47B ; 00C75246-4343-490D-9782-E6C0068C77B2 ; 7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3 ; 16DE55CE-076E-43D3-84BD-332A79B95EFD ; 0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5 ; 726B60CA-1B1C-440D-82FA-A4C978C4D484 ; 24D42292-B875-4FAF-8C3A-9834414C3A01 ; 7D84A145-19AF-48D0-A5D9-F5724068CB26 ; F114D078-5F03-47F8-82AE-B8A21C2F9D31 ; E4F7064C-9D81-49B5-9992-898155B3F11E ; 2972AB07-2C29-43B8-96DA-1386C5E248EB ; DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B ; 964DFAC8-91EC-4C0E-B499-3ED5F2D70096 ; D503E73D-8B94-46A0-A24F-93069A56DC7D ; CB780DE7-E98C-4F7E-9487-8F25FE80DC21 ; 57153075-9055-4D7E-9CD6-9167D165E860 ; 5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3 ; B0DE3388-7826-40D3-ADEE-0B25FE201F4A ; 454CB5E9-3778-4666-9CED-913E08CB3615 ; 61BC91AE-CD06-432D-BCBA-6FAE2209C610 ; 60569C8B-7209-4A3F-A177-F337085E9146 ; A5D94D02-5423-4055-96E3-B5AA5799DC02 ; E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC ; 2A62DD22-EFE6-48CD-8BE6-59B08168F78A ; 5B82545F-2636-4A8A-88DD-1B387DE678FF ; 61462D57-DF98-4F89-BAEF-E8156A47E2DD ; 8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF ; DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71 ; E20AC0FF-43C4-49EA-9E33-764E553933B7 ; 1ED901DF-BCDC-44C8-A7DF-AB895ECA0952 ; FD75D315-EED7-4350-A890-8FB94648E9FC ; AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A ; 1E7788D8-B5FC-473A-8A10-79910443799A ; FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A ; 0D293DF8-374D-4681-9B2A-ACC98601AA25 ; 5B867CB6-F94D-435D-83E3-0ADB814B8077 ; AF12859A-D67A-488D-8BC2-ED28698F2ACA ; E0B04FB6-9500-4786-B6D9-303165EF9090 ; 6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE ; E4D30B42-383A-40BF-BB91-511A90227655 ; 26C566AF-C710-4856-AC21-83D73370EA84 ; 1304FB17-A20A-4EBC-9CC8-1554808AC1F6 ; 6FB7A794-C3E7-4501-A844-CF65B9C3D32C ; 045B2852-E1FF-4376-8F39-60FC940224D0 ; A3CB59DE-5893-4FA2-B4D5-EDA612480E76 ; 7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7 ; 3E8F2012-A457-4358-9C8B-23292374A743 ; F124155D-6131-47F6-8320-46A41AB125D3 ; 9B4BA15D-A071-4213-AD2C-075A04ED48CD ; 5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB ; 049A2CA6-951A-452F-963A-F54FE87ECA31 ; 6B53F577-5EB6-4AF5-9773-3654D3432BE4 ; 3CD1D537-29E4-479B-99FA-26D27E192948 ; 338D5387-0CFB-4D91-944F-1F054C21C769 ; 03BD8920-CA01-4818-BBD7-925DDD3F6908 ; 0CC079D3-EB90-47B5-B554-599A67C9E12A ; 6C520037-2A9B-41CB-8362-97FFCA2AA6E2 ; 8CC70CDC-01EC-4E2B-84C1-F1C946602CCE ; 08519263-5ADD-4BA3-9BC6-C737ACA7DFE4 ; D779EEF8-C83C-4CCA-A140-9BF15DCF14AE ; D5EF8C37-811E-42B7-84E5-E6ED71217971 ; DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD ; 29C262B5-D49D-4125-9661-19033A8EC6A8 ; 846851BE-3D24-46F0-A6BE-CEB22C7D0F62 ; 5EFC16F4-7FC7-479E-93F7-AEDC2D350A22 ; CE2FF4D3-B82C-4435-AE1C-3E2E6F104271 ; 4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE ; 03C7A677-C223-47D6-869E-E6C3250B0C08 ; 1E3F3136-6D86-4470-85AA-55B11C9E24CD ; 71CEC5F6-16E5-46E1-A91B-B5E0F699B231 ; CA834E5F-30DC-46CF-AF33-AD11226FC09E ; FA43414D-3757-43CC-8949-77F82DF4FA4D ; 2D3D759B-D06A-4FC6-855A-5E9F83ADBED9 ; E958CD3C-EE14-4CE1-B55C-7830E320F6AE ; 291884D2-FDFD-4C98-BA19-1A0824ABB68F ; 55F3F917-E441-4C10-A3E3-0645A4E8374E ; CFC4801B-04BD-4FFC-911A-7B88E2FA4B49 ; 8AABC46F-03C7-4FBF-AC20-2C862E303A8B ; DFCA9C6E-710E-4645-9CFC-A908AAD583F3 ; 4379DEE0-F7CB-4A73-8828-21EA0AA830F5 ; F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD ; 4A86A028-C56D-455E-A5CD-47D8A34B5734 ; 267F1EFD-AB89-4124-B803-00CC0E8E9CD2 ; 9B3F0B22-8442-4720-A21B-7EF12CBCD2CE ; 6C91D49C-9738-4A4F-A480-E71CD8EE5268 ; 0ED7357E-662C-4D65-82ED-29739919068F ; CE70DD1E-BCA4-4F89-AA5B-D90FE18A36FF ; 739E1733-3540-4E82-AC91-F511105DABD5 ; CE32A294-10FC-4DBA-A779-FAEEBE677D38 ; C6B0D463-9389-4BAE-93CA-3EE4717D20EC ; B8664381-386A-44A2-AC3B-D69A4980A8EA ; 79DAEAE5-A177-40E0-9BFC-54DC9F544764 ; C9AD69EB-506A-4442-B1C2-C8F09B519CB2 ; A76A272F-675E-4E56-8761-96B71419A012 ; 1F35A542-2795-4B1F-A846-7097B442C2D9 ; 8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD ; FDF38AA6-DC65-4043-8277-71BAE47902B1 ; 42649B9A-29D4-4D05-A78C-AC801792ADEB ; 7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495 ; 2F102533-4B6B-4411-9080-3697ED3099EA ; 161A2735-C3CF-466D-AE21-C6A2C987BB1E ; BD2AE048-BE93-4421-AD3E-BE6F9646484F ; FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D ; 2E8A1816-E963-4063-B2F0-6289514084A5 ; 6C202D3E-5670-4B63-82A2-9EE7AC385089 ; A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B ; E8A43FF3-3D98-45EE-9567-6EED4DA38274 ; 15CAD156-1E40-4C83-B3ED-484964FE407F ; D58E5D64-B5B9-4487-8E46-225AE3617C14 ; 468411B5-1719-46B4-835D-E469D6AEFF12 ; EB9B6625-6674-4665-9BEE-D4DFD9366A02 ; C2976F78-89AF-4461-8D22-BFEBC0504722 ; 3023C34B-CF59-43EA-9241-33B738D19B05 ; 3A38A97C-2CBB-4802-9528-A4BBD62AEA4A ; 5607C6CE-21D5-495E-9174-85F1E2E0CB9D ; 0429FA9A-AD19-424C-94ED-1A902119E559 ; F2B21F52-74F4-44C5-9991-60EBCC4E43A6 ; D1B30DA1-FF63-4FC7-AB8B-818331EE6D72 ; BAEB6705-FCDC-4B40-B1CB-D926B8287F92 ; A6E2735B-AAD3-48D7-8289-306257CB5B6F ; 11E1BCE2-F246-4930-A97C-A14B34BCF840 ; EB00527B-1E37-420E-85E4-10063DB4BC1C ; 142F03FE-5B60-416D-8DCD-EC34DB5495DB ; A3CDF051-4162-47EC-BE8A-1519A5564518 ; 7F75F15A-2476-4FFD-97B3-313F06568E21 ; 53DD68D0-C2BE-4EC2-907E-3F1F11D31052 ; 1E3F22FC-3D82-4911-9C97-8CB87A3D131C ; F04188AB-51CE-4AA1-B72C-399BE7863235 ; E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E ; 975989FE-8785-42C1-8551-53661B7B16A1 ; 891F4C63-8207-4CB8-AB59-A970CC6F1A1A ; 29EDE507-90BA-4ABE-B3EF-559EBA4CCD56 ; A997FF30-F112-48BE-8FF1-15F8266A5E62 ; C956B4B1-99E6-4823-886A-FA8FCD1E3E4D ; 94CF5704-1BE7-4CCC-870E-FB8527AC47E8 ; 93292768-8C20-4551-8CA8-44AE0FFB487E ; CC7D1177-1638-4A80-A3AA-266ADC260EC9 ; 584E15EE-1C80-4507-8AD3-558DF06DBDF3 ; C7476B2B-0040-4013-8D30-06935E3FB897 ; 71291A56-C2DB-4EB9-8223-DD7563CBBDC9 ; 575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09 ; 8C4FEB77-99B6-4C73-9751-508953A874DC ; E57B4989-102F-44FD-8FB2-0627143FA904 ; CFF567FC-8867-4CA4-85AE-81A7D30095E7 ; 1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6 ; 0C0EEC9F-A715-4769-B58C-99D06C3C91F3 ; 13302EC6-6511-42FE-AA8B-C875B5384FFE ; 4F047F5B-EF3A-4590-8E7A-D90A52860324 ; 6104F94F-BA8F-4435-A839-E1FEA6EFFDF3 ; 01992912-611F-4AA8-8570-B062CBCCAF70 ; 8169AA00-E396-4A3E-A91C-F67B1F0B8E3E ; 1E8B978E-3D1B-46E8-80EE-3A11EE571CEC ; BC75790C-FBC7-4897-B228-762245C48740 ; 161E2817-7DB2-46F8-BFEB-256DBBEFE633 ; 8401DFCF-8793-461A-B17E-E6584CE2423B ; 63F76DB5-8433-4EFE-9054-6C04F065DF2D ; 8E6902A6-A673-46CC-9AEB-3A71EF11099F ; 6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096 ; 7546B7FB-1976-4994-AFB7-6270382D44D7 ; 0DCD80E1-173E-4A1B-BDD8-74C7D12C1313 ; 5B685F7F-917D-41BA-A7AB-D0E15D457BC5 ; 7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F ; 377F7050-F900-4345-A326-568F00050BC3 ; 383EC600-FBF3-4F91-8FAC-41E3DDE6589E ; 6643B290-5D7A-4649-B57D-47A5BA4E8D31 ; 3671D46F-6D69-42DA-9830-24F67EB8B0B6 ; E1A92F92-1DD2-4E33-9C16-3FD0371D1431 ; 6061FCA5-A113-4985-905D-E17020F6933E ; 6535D911-D718-4794-9D5E-6E06553464FF ; E9231B3
PATH_MARGIN	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.	Patient	
PHARMACEUTICAL_TX_ADJUVANT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.	Patient	
PRIMARY_SITE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.	Patient	
PRIMARY_SITE_PATIENT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text term to describe the organ sub-division in an individual with cancer.	Patient	
PROJECT_CODE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Project code	Patient ; Sample	TCGA
PROSPECTIVE_COLLECTION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.	Patient	
PR_POSITIVITY_DEFINE_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Pgr detection method text	Patient ; Sample	manual counting ; H-Score 190 ; H-Score 160 ; H-SCORE 0 ; H-Score 290 ; H-Score 0 ; H-Score 140 ; H-SCORE 250 ; H-SCORE 150 ; H-SCORE 280 ; H-Score 70 ; H-SCORE 7 ; Image Analysis ; Allred score 0+0 = 0 ; Allred score 5+3 = 8 ; Allred score 2+3 = 5 ; Allred score 2+2 = 4 ; Immunohistochemistry ; IHC ; IMAGE ANALYSIS ; Allred score = 8 ; Allred score 4+3 = 7 ; Allred score 5+2 = 7 ; Allred score 3 + 2 = 5 ; image cytometry ; Allred score 0+0=0 ; Allred score 7 per outside facility report ; Allred score 5+3=8 ; Allred score 5+3= 8 ; Allred score 3+3=6 ; dextran coated charcoal ; Allred score 3+2=5 ; %IHC ; Allred 5 = 2+3 ; Allred 8 = 5+3 ; Allred 0 = 0+0 ; Allred (Biocare) ; allred score 5 +3 = 8 ; allred score 5+3+8 ; allred score 4+2=6 ; allred score 3 + 3 = 6 ; allred score 2+2 = 4 ; allred score 4 + 3 = 7 ; allred score 5 + 3 = 8 ; H-SCORE 245 ; H-SCORE 140 ; H-SCORE 1 ; H-SCORE 120 ; H-SCORE 162 ; H-SCORE 15 ; PR Negative H-Score 0 ; H-Score 260 ; H-Score-230
PR_POSITIVITY_IHC_INTENSITY_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast carcinoma immunohistochemistry pos cell score	Patient ; Sample	1+ ; 3+ ; 0 ; 2+ ; 4+
PR_POSITIVITY_SCALE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Pos finding progesterone receptor other measurement scale text	Patient ; Sample	Strong ; 10-75% ; >75% ; <10% ; H-Score ; H-SCORE ; Allred Score 4 ; Allred Score 5 ; Allred Score 7 ; Allred Score 8 ; 0 ; Allred score = 8 ; Allred score = 0 ; Allred score = 5 ; Allred score = 4 ; 7 ; Two-tier ; 8 ; H score ; Allred score = 2 ; Allred score = 7 ; Allred Score 6 ; >10% ; Allred Score 3 ; Allred score 5 ; Allred score 0 ; Allred score 7 per outside facility report ; Allred score 8 ; Allred score 6 ; Allred ; 110 ; 10 ; 230 ; 120 ; Intensity=Strong ; Intensity=weak ; Allread Score 8 ; Allred Score ; allred score = 8 ; Strong using Weak, Moderate and Strong ; 70 fmol/mg ; Strong, using scale of Weak, Moderate and Strong ; MODERATE ; allred score = 6 ; allred score = 4 ; allred score = 7 ; allred score =  8
PR_POSITIVITY_SCALE_USED	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast carcinoma immunohistochemistry progesterone receptor pos finding scale	Patient ; Sample	3 Point Scale ; 4 Point Scale
PR_STATUS_IHC_PERCENT_POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Progesterone receptor level cell percent category	Patient ; Sample	90-99% ; 70-79% ; <10% ; 20-29% ; 60-69% ; 50-59% ; 40-49% ; 30-39% ; 80-89% ; 10-19%
RADIATION_TREATMENT_ADJUVANT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.	Patient	
RETROSPECTIVE_COLLECTION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.	Patient	
SAMPLE_INITIAL_WEIGHT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Sample Initial Weight	Sample	250 ; 100 ; 220 ; 590 ; 410 ; 600 ; 550 ; 180 ; 460 ; 300 ; 490 ; 980 ; 680 ; 280 ; 440 ; 150 ; 640 ; 360 ; 730 ; 710 ; 770 ; 120 ; 580 ; 540 ; 420 ; 200 ; 210 ; 30 ; 20 ; 80 ; 140 ; 290 ; 230 ; 90 ; 130 ; 430 ; 190 ; 260 ; 110 ; 1070 ; 380 ; 310 ; 350 ; 400 ; 270 ; 450 ; 40 ; 50 ; 170 ; 70 ; 160 ; 60 ; 320 ; 740 ; 240 ; 340 ; 370 ; 620 ; 390 ; 470 ; 330 ; 510 ; 650 ; 500 ; 840 ; 1250 ; 700 ; 520 ; 480 ; 990 ; 630 ; 900 ; 670 ; 1300 ; 1100 ; 1460 ; 1650 ; 1270 ; 800 ; 780 ; 158 ; 970 ; 750 ; 560 ; 690 ; 950 ; 850 ; 5 ; 10 ; 1550 ; 920 ; 1180 ; 960 ; 1390 ; 1500 ; 940 ; 530 ; 570 ; 1350 ; 830 ; 610 ; 2190 ; 760 ; 890 ; 1760 ; 910 ; 1740 ; 1020 ; 720 ; 1170 ; 1530 ; 1080 ; 1710 ; 810 ; 1130 ; 1050 ; 1360
SAMPLE_TYPE_ID	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Sample type id	Sample	1 ; 6
SHORTEST_DIMENSION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	Shortest Dimension	Sample	
SITE_OF_TUMOR_TISSUE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Text term that describes the anatomic site of the tumor or disease.	Patient	
SPECIMEN_CURRENT_WEIGHT	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The weight of the specimen.	Sample	
SPECIMEN_FREEZING_METHOD	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The method used to freeze the tissue after removal from the patient.	Sample	
SPECIMEN_SECOND_LONGEST_DIMENSION	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	NUMBER	The second longest dimension of the specimen.	Sample	
STAGE_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Stage Other	Patient	
STAGING_SYSTEM	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Staging System.	Patient	
STAGING_SYSTEM_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Staging System Other	Patient ; Sample	SLN and non-SLN biopsy ; Sentinel lymph node dissection ; Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy ; Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy ; Sentinel lymph node biopsy and non-sentinel lymph node biopsy ; Sentinel lymph node and axillary lymph node biopsy ; sentinel LN and one non sentinel LN ; Sentinel lymph node and non-sentinel lymph node biopsy ; SN+1 non sentinel node ; sentinel + non sentinel ; mastectomy with TLND ; Pateys surgery ; SLN AND NON-SLN BX ; Sentinel lymph node biopsy plus non-sentinel lymph node biopsy ; Sentinel lymph node plus Level I and Level II lymph nodes ; FNA plus axillary lymph node dissection
SURGERY_FOR_POSITIVE_MARGINS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast carcinoma primary surgical procedure name	Patient ; Sample	Mastectomy NOS ; Other ; Modified radical mastectomy ; Lumpectomy
SURGERY_FOR_POSITIVE_MARGINS_OTHER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast neoplasm other surgical procedure descriptive text	Patient ; Sample	Re-excision of the inferior margin ; Re-Excision of Superior Margin ; Left breast reexcision ; Reexcision ; Skin excision ; Margin resection ; Re-excision of original lumpectomy site ; Right Breast Reexcision ; Right Breast reexcision ; surgical resection ; Reexcision of segmental mastectomy
SURGICAL_PROCEDURE_FIRST	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Breast carcinoma surgical procedure name	Patient ; Sample	Modified Radical Mastectomy ; Simple Mastectomy ; Lumpectomy ; Other
TIME_BETWEEN_CLAMPING_AND_FREEZING	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Time between clamping and freezing	Sample	
TIME_BETWEEN_EXCISION_AND_FREEZING	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Time between excision and freezing	Sample	
TISSUE_SOURCE_SITE	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.	Patient ; Sample	LQ ; A2 ; A7 ; D8 ; AC ; BH ; C8 ; AN ; B6 ; E2 ; GM ; A1 ; AR ; EW ; AQ ; E9 ; AO ; GI ; MS ; LL ; A8 ; JL ; HN ; OL ; Columbia University ; Proteogenex, Inc. ; University of Sao Paulo ; Holy Cross ; UCSF ; Walter Reed ; Christiana Healthcare ; Indivumed ; International Genomics Consortium ; Cureline ; MSKCC ; UNC ; Mayo ; Duke ; University of Pittsburgh ; ILSBio ; Greater Poland Cancer Center ; Roswell Park ; Asterand ; University of Miami ; ABS - IUPUI ; MD Anderson ; Ontario Institute for Cancer Research (OICR) ; ABS - Research Metrics Pakistan ; Hartford Hospital ; Candler ; Gundersen Lutheran Health System ; University of Minnesota ; Mount Sinai School of Medicine ; University of Chicago ; Fox Chase ; Institute of Human Virology Nigeria ; Albert Einstein Medical Center ; Boston Medical Center ; Mary Bird Perkins Cancer Center - Our Lady of the Lake ; Medical College of Georgia ; Greenville Health System ; University of Kansas ; Spectrum Health ; John Wayne Cancer Center
TUMOR_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	The state or condition of an individual's neoplasm at a particular point in time.	Patient	
VIAL_NUMBER	HotPink	Breast Invasive Carcinoma (TCGA, Firehose Legacy)	STRING	Vial number	Sample	A ; B
DAYS_TO_BIRTH	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	NUMBER	Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.	Patient	
DAYS_TO_DEATH	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	NUMBER	Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.	Patient	
DAYS_TO_LAST_FOLLOWUP	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	NUMBER	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.	Patient	
NTE_ER_STATUS_IHC__POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	STRING	Metastatic breast carcinoma estrogen receptor level cell percent category	Sample	70-79% ; 90-99% ; <10%
NTE_HER2_STATUS_IHC__POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	STRING	Metastatic breast carcinoma HER2 erbb pos finding cell percent category	Sample	<10%
NTE_PR_STATUS_IHC__POSITIVE	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	STRING	Metastatic breast carcinoma progesterone receptor level cell percent category	Sample	<10%
TUMOR_TISSUE_SITE	HotPink	Breast Invasive Carcinoma (TCGA, Cell 2015)	STRING	Text term that describes the anatomic site of the tumor or disease.	Sample	Breast
BREAST_SURGERY	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Type of Breast Surgery	Patient	
CELLULARITY	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Tumor Content	Patient	
CHEMOTHERAPY	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Chemotherapy.	Patient	
CLAUDIN_SUBTYPE	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Pam50 + Claudin-low subtype	Patient	
ER_IHC	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	ER status measured by IHC	Patient	
HER2_SNP6	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	HER2 status measured by SNP6	Patient	
HORMONE_THERAPY	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Hormone Therapy	Patient	
INFERRED_MENOPAUSAL_STATE	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Inferred Menopausal State	Patient	
INTCLUST	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Integrative Cluster	Patient	
LYMPH_NODES_EXAMINED_POSITIVE	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Number of lymphnodes positive	Patient	
NPI	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	NUMBER	Nottingham prognostic index	Patient	
RADIO_THERAPY	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Radio Therapy	Patient	
RFS_MONTHS	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	NUMBER	Time until last follow-up or relapse (in months)	Patient	
RFS_STATUS	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	Relapse Free Status (Recurred = cases where there was loco-regional relapse, distant relapse or death-specific death)	Patient	
THREEGENE	HotPink	Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)	STRING	3-Gene classifier subtype	Patient	
ANEUPLOIDY_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	Aneuploidy Score	Sample	19 ; 22 ; 13 ; 4 ; 7 ; 3 ; 14 ; 0 ; 11 ; 10 ; 2 ; 15 ; 24 ; 16 ; 18 ; 9 ; 5 ; 21 ; 6 ; 17 ; 8 ; 25 ; 20 ; 26 ; 23 ; 34 ; 31 ; 12 ; 29 ; 27 ; 28 ; 1 ; 33 ; 30 ; 35 ; 32
BUFFA_HYPOXIA_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	mRNA based Buffa Hypoxia Score	Patient	
CANCER_TYPE_ACRONYM	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Text field to hold cancer type acronym used by TCGA PanCanAtlas.	Patient	
DAYS_LAST_FOLLOWUP	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..	Patient	
DSS_MONTHS	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	The time period (months) usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.	Patient	
DSS_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	The time period usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.	Patient	
GENETIC_ANCESTRY_LABEL	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Genetic ancestries were determined using five different methods as described in Carrot-Zhang et al (2020). These consensus calls were created based on the ancestral population that received the majority of assignments for each patient.	Patient	
IN_PANCANPATHWAYS_FREEZE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Patient Part of PanCan Pathway Analysis	Patient	
MSI_SCORE_MANTIS	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	MSI Score reported by MANTIS. The suggested thresholds are MSI: >0.6, Indeterminate: 0.4-0.6 and MSS: <0.4.	Sample	0.3319 ; 0.3449 ; 0.3266 ; 0.3218 ; 0.3411 ; 0.3208 ; 0.3379 ; 0.2829 ; 0.2898 ; 0.4042 ; 0.311 ; 0.4765 ; 0.292 ; 0.2902 ; 0.259 ; 0.3423 ; 0.3308 ; 0.2779 ; 0.2921 ; 0.2911 ; 0.3046 ; 0.2846 ; 0.3005 ; 0.2887 ; 0.294 ; 0.289 ; 0.2769 ; 0.2774 ; 0.293 ; 0.3074 ; 0.2896 ; 0.2823 ; 0.273 ; 0.2894 ; 0.2975 ; 0.2726 ; 0.2932 ; 0.2981 ; 0.2792 ; 0.2663 ; 0.3096 ; 0.2684 ; 0.2742 ; 0.2747 ; 0.2711 ; 0.2606 ; 0.2756 ; 0.2627 ; 0.272 ; 0.2644 ; 0.2529 ; 0.2854 ; 0.2729 ; 0.3283 ; 0.2504 ; 0.2822 ; 0.3273 ; 0.261 ; 0.2844 ; 0.3032 ; 0.2874 ; 0.2956 ; 0.2804 ; 0.2795 ; 0.2768 ; 0.3164 ; 0.2828 ; 0.3097 ; 0.2978 ; 0.3038 ; 0.2793 ; 0.3031 ; 0.3072 ; 0.2855 ; 0.2746 ; 0.3021 ; 0.2845 ; 0.2988 ; 0.3819 ; 0.3028 ; 0.3077 ; 0.3009 ; 0.3124 ; 0.3305 ; 0.3239 ; 0.3362 ; 0.3368 ; 0.2954 ; 0.3082 ; 0.3052 ; 0.3222 ; 0.314 ; 0.333 ; 0.3265 ; 0.3314 ; 0.2961 ; 0.3169 ; 0.3073 ; 0.3179 ; 0.2941 ; 0.2963 ; 0.3153 ; 0.2994 ; 0.3062 ; 0.2918 ; 0.3083 ; 0.2929 ; 0.302 ; 0.2957 ; 0.3033 ; 0.2652 ; 0.281 ; 0.2301 ; 0.2683 ; 0.2619 ; 0.2908 ; 0.298 ; 0.3088 ; 0.321 ; 0.28 ; 0.2762 ; 0.2833 ; 0.3293 ; 0.3251 ; 0.301 ; 0.3156 ; 0.3412 ; 0.3212 ; 0.2964 ; 0.2958 ; 0.2891 ; 0.3081 ; 0.3006 ; 0.2899 ; 0.3188 ; 0.3243 ; 0.313 ; 0.2912 ; 0.2967 ; 0.2904 ; 0.3488 ; 0.3487 ; 0.355 ; 0.3463 ; 0.2642 ; 0.2424 ; 0.3039 ; 0.3035 ; 0.2516 ; 0.2916 ; 0.2615 ; 0.2632 ; 0.2674 ; 0.2806 ; 0.2648 ; 0.267 ; 0.2543 ; 0.2604 ; 0.2784 ; 0.2736 ; 0.2569 ; 0.2776 ; 0.2673 ; 0.2679 ; 0.2971 ; 0.2869 ; 0.2628 ; 0.2701 ; 0.2483 ; 0.2715 ; 0.2599 ; 0.2653 ; 0.2634 ; 0.2544 ; 0.2613 ; 0.271 ; 0.26 ; 0.2989 ; 0.2501 ; 0.266 ; 0.251 ; 0.2517 ; 0.277 ; 0.2734 ; 0.2626 ; 0.2589 ; 0.2437 ; 0.2556 ; 0.2753 ; 0.256 ; 0.2659 ; 0.2422 ; 0.275 ; 0.2519 ; 0.2927 ; 0.2681 ; 0.282 ; 0.2656 ; 0.2509 ; 0.2478 ; 0.7713 ; 0.2575 ; 0.2664 ; 0.2617 ; 0.2919 ; 0.217 ; 0.2865 ; 0.2601 ; 0.3232 ; 0.3013 ; 0.3158 ; 0.3604 ; 0.3186 ; 0.3286 ; 0.322 ; 0.3255 ; 0.3114 ; 0.3027 ; 0.3517 ; 0.3177 ; 0.3069 ; 0.3178 ; 0.3295 ; 0.2907 ; 0.2962 ; 0.2972 ; 0.3129 ; 0.3054 ; 0.3194 ; 0.3228 ; 0.3196 ; 0.3095 ; 0.2942 ; 0.3111 ; 0.3203 ; 0.3059 ; 0.3584 ; 0.3234 ; 0.2991 ; 0.3393 ; 0.3474 ; 0.3363 ; 0.331 ; 0.3405 ; 0.3371 ; 0.3014 ; 0.3364 ; 0.3115 ; 0.3361 ; 0.2731 ; 0.2695 ; 0.2375 ; 0.2812 ; 0.2757 ; 0.252 ; 0.8283 ; 0.2944 ; 0.2819 ; 0.3047 ; 0.2735 ; 0.2694 ; 0.2848 ; 0.3094 ; 0.3024 ; 0.2554 ; 0.3358 ; 0.3678 ; 0.2826 ; 0.2641 ; 0.3135 ; 0.3185 ; 0.2982 ; 0.3016 ; 0.2638 ; 0.2649 ; 0.239 ; 0.2568 ; 0.2639 ; 0.288 ; 0.2752 ; 0.2727 ; 0.2595 ; 0.2677 ; 0.2592 ; 0.2721 ; 0.2755 ; 0.2799 ; 0.2537 ; 0.3181 ; 0.3857 ; 0.2771 ; 0.3132 ; 0.2725 ; 0.3223 ; 0.2922 ; 0.3351 ; 0.3339 ; 0.2685 ; 0.2782 ; 0.3277 ; 0.306 ; 0.3378 ; 0.2926 ; 0.3192 ; 0.3145 ; 0.2818 ; 0.2857 ; 0.2872 ; 0.2892 ; 0.2842 ; 0.2984 ; 0.2682 ; 0.2992 ; 0.2878 ; 0.2496 ; 0.2497 ; 0.283 ; 0.2662 ; 0.2816 ; 0.2861 ; 0.2618 ; 0.2572 ; 0.2995 ; 0.3624 ; 0.3085 ; 0.3199 ; 0.3066 ; 0.3187 ; 0.3262 ; 0.3299 ; 0.3522 ; 0.3249 ; 0.3456 ; 0.3138 ; 0.3248 ; 0.3918 ; 0.3301 ; 0.3337 ; 0.3554 ; 0.3281 ; 0.3291 ; 0.3501 ; 0.3504 ; 0.3011 ; 0.3086 ; 0.3271 ; 0.2864 ; 0.2847 ; 0.3064 ; 0.3312 ; 0.2924 ; 0.3078 ; 0.3139 ; 0.2998 ; 0.2733 ; 0.2882 ; 0.2676 ; 0.278 ; 0.269 ; 0.2791 ; 0.3045 ; 0.2716 ; 0.2945 ; 0.2565 ; 0.2985 ; 0.2781 ; 0.264 ; 0.2783 ; 0.2897 ; 0.2802 ; 0.2622 ; 0.2843 ; 0.2875 ; 0.2824 ; 0.2808 ; 0.263 ; 0.2987 ; 0.2706 ; 0.3311 ; 0.3198 ; 0.3202 ; 0.3137 ; 0.3369 ; 0.3349 ; 0.3131 ; 0.3125 ; 0.2948 ; 0.2977 ; 0.284 ; 0.2952 ; 0.2849 ; 0.2667 ; 0.265 ; 0.2803 ; 0.2567 ; 0.2723 ; 0.2513 ; 0.2827 ; 0.2558 ; 0.2584 ; 0.2933 ; 0.2597 ; 0.2495 ; 0.2835 ; 0.3007 ; 0.2837 ; 0.279 ; 0.2654 ; 0.2675 ; 0.2522 ; 0.2815 ; 0.2724 ; 0.2596 ; 0.2507 ; 0.2493 ; 0.2743 ; 0.2722 ; 0.2546 ; 0.2461 ; 0.2885 ; 0.2585 ; 0.2539 ; 0.2635 ; 0.393 ; 0.2732 ; 0.2482 ; 0.2969 ; 0.2759 ; 0.2787 ; 0.2688 ; 0.2777 ; 0.3023 ; 0.7737 ; 0.2518 ; 0.2534 ; 0.2602 ; 0.2851 ; 0.2785 ; 0.2594 ; 0.3256 ; 0.2593 ; 0.2553 ; 0.2931 ; 0.3148 ; 0.2616 ; 0.3331 ; 0.3214 ; 0.3071 ; 0.3189 ; 0.326 ; 0.305 ; 0.3365 ; 0.4703 ; 0.3396 ; 0.3445 ; 0.29 ; 0.2668 ; 0.2744 ; 0.3141 ; 0.2965 ; 0.3711 ; 0.3017 ; 0.2876 ; 0.3109 ; 0.3586 ; 0.332 ; 0.3253 ; 0.3117 ; 0.2834 ; 0.2814 ; 0.2718 ; 0.2886 ; 0.2745 ; 0.287 ; 0.2636 ; 0.2714 ; 0.2797 ; 0.3348 ; 0.2608 ; 0.3679 ; 0.3767 ; 0.2758 ; 0.3394 ; 0.3101 ; 0.3403 ; 0.3 ; 0.2953 ; 0.3104 ; 0.394 ; 0.2895 ; 0.3167 ; 0.3121 ; 0.3233 ; 0.2838 ; 0.2879 ; 0.2934 ; 0.4316 ; 0.31 ; 0.324 ; 0.3658 ; 0.348 ; 0.3268 ; 0.3136 ; 0.3022 ; 0.3527 ; 0.3103 ; 0.3315 ; 0.4299 ; 0.2839 ; 0.4478 ; 0.3887 ; 0.3219 ; 0.327 ; 0.6238 ; 0.3143 ; 0.3015 ; 0.6331 ; 0.3401 ; 0.2853 ; 0.295 ; 0.312 ; 0.4692 ; 0.3123 ; 0.2936 ; 0.3201 ; 0.3162 ; 0.2925 ; 0.3289 ; 0.3195 ; 0.2559 ; 0.2906 ; 0.2796 ; 0.2884 ; 0.2603 ; 0.253 ; 0.2697 ; 0.2551 ; 0.2705 ; 0.2691 ; 0.2863 ; 0.2772 ; 0.2856 ; 0.2761 ; 0.2831 ; 0.2713 ; 0.2514 ; 0.2645 ; 0.3328 ; 0.3128 ; 0.3225 ; 0.4355 ; 0.3479 ; 0.3354 ; 0.3113 ; 0.329 ; 0.33 ; 0.3296 ; 0.3061 ; 0.3573 ; 0.4091 ; 0.3313 ; 0.2955 ; 0.3341 ; 0.3525 ; 0.3386 ; 0.3674 ; 0.361 ; 0.3531 ; 0.3642 ; 0.3721 ; 0.3237 ; 0.3399 ; 0.3235 ; 0.3184 ; 0.2805 ; 0.2873 ; 0.3146 ; 0.3151 ; 0.3563 ; 0.3227 ; 0.315 ; 0.3053 ; 0.3168 ; 0.2913 ; 0.3466 ; 0.3174 ; 0.3058 ; 0.3205 ; 0.3505 ; 0.3246 ; 0.3325 ; 0.3157 ; 0.4072 ; 0.3397 ; 0.3063 ; 0.3557 ; 0.3905 ; 0.339 ; 0.3216 ; 0.3161 ; 0.2903 ; 0.2997 ; 0.3043 ; 0.3408 ; 0.3778 ; 0.5417 ; 0.3332 ; 0.3472 ; 0.3521 ; 0.3465 ; 0.3431 ; 0.3252 ; 0.335 ; 0.3383 ; 0.3686 ; 0.3663 ; 0.3418 ; 0.2905 ; 0.3338 ; 0.3458 ; 0.3435 ; 0.3424 ; 0.3447 ; 0.3107 ; 0.3191 ; 0.3056 ; 0.299 ; 0.3306 ; 0.2914 ; 0.296 ; 0.2859 ; 0.2809 ; 0.2788 ; 0.3496 ; 0.3065 ; 0.3019 ; 0.3459 ; 0.3334 ; 0.3317 ; 0.304 ; 0.2801 ; 0.2939 ; 0.3564 ; 0.3469 ; 0.3539 ; 0.3583 ; 0.3448 ; 0.3272 ; 0.3499 ; 0.35 ; 0.2937 ; 0.2858 ; 0.3041 ; 0.328 ; 0.2986 ; 0.3036 ; 0.3357 ; 0.3475 ; 0.3342 ; 0.3236 ; 0.3535 ; 0.3793 ; 0.336 ; 0.3453 ; 0.3512 ; 0.3461 ; 0.3284 ; 0.3316 ; 0.341 ; 0.3335 ; 0.3254 ; 0.3562 ; 0.3439 ; 0.3366 ; 0.3434
MSI_SENSOR_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	MSI Score reported by MSIsensor. The suggested thresholds are MSI: >10, Indeterminate: 4-10 and MSS: <10.	Sample	0.55 ; 0.74 ; 0.31 ; 0.03 ; 0.01 ; 0 ; 0.46 ; 0.2 ; 0.02 ; 0.36 ; 0.63 ; 0.37 ; 1.02 ; 0.12 ; 0.57 ; 2.84 ; 0.26 ; 0.18 ; 1.12 ; 0.77 ; 1.39 ; 0.04 ; 0.05 ; 0.1 ; 0.13 ; 0.39 ; 0.07 ; 0.27 ; 1.11 ; 0.06 ; 0.32 ; 0.41 ; 1.96 ; 0.35 ; 0.86 ; 0.08 ; 0.11 ; 0.64 ; 0.24 ; 0.59 ; 1.59 ; 0.28 ; 1.48 ; 0.51 ; 0.14 ; 0.17 ; 0.29 ; 0.47 ; 1.2 ; 0.84 ; 0.21 ; 0.89 ; 0.3 ; 0.61 ; 0.98 ; 1.75 ; 0.38 ; 0.16 ; 0.6 ; 1.68 ; 1.26 ; 0.34 ; 1.1 ; 2.07 ; 4.87 ; 3.15 ; 1.3 ; 0.68 ; 0.91 ; 1.31 ; 0.72 ; 0.85 ; 1.23 ; 0.54 ; 0.87 ; 1.69 ; 0.25 ; 0.95 ; 1.74 ; 0.43 ; 1.33 ; 3.2 ; 0.97 ; 2.61 ; 0.45 ; 1.21 ; 0.49 ; 1 ; 0.19 ; 0.5 ; 1.22 ; 0.42 ; 0.62 ; 0.94 ; 0.52 ; 26.38 ; 0.22 ; 0.09 ; 0.66 ; 1.54 ; 0.92 ; 0.75 ; 1.25 ; 32.92 ; 2.5 ; 1.15 ; 0.67 ; 0.56 ; 0.53 ; 0.73 ; 1.04 ; 0.23 ; 0.88 ; 1.24 ; 0.15 ; 0.96 ; 1.34 ; 2.42 ; 1.03 ; 1.8 ; 1.38 ; 1.08 ; 0.78 ; 1.19 ; 0.58 ; 1.35 ; 0.79 ; 0.69 ; 1.18 ; 1.28 ; 1.71 ; 1.07 ; 1.63 ; 1.79 ; 1.78 ; 4.53 ; 1.05 ; 0.82 ; 2.69 ; 0.93 ; 1.45 ; 0.99 ; 0.48 ; 0.7 ; 0.4 ; 8.53 ; 1.06 ; 0.33 ; 26.46 ; 1.55 ; 0.44 ; 1.53 ; 0.81 ; 0.65 ; 0.8 ; 3.02 ; 4.8 ; 1.09 ; 1.82 ; 0.83 ; 13.12 ; 16.36 ; 6.24 ; 1.46 ; 1.89 ; 1.27 ; 2.89 ; 2.8 ; 2.68 ; 2.08 ; 2.28 ; 0.76 ; 1.16 ; 2.11 ; 1.64 ; 3.51 ; 0.71 ; 8.42 ; 1.86 ; 1.98 ; 3.86 ; 2.02 ; 4.09 ; 1.49 ; 2.05 ; 0.9
PATH_M_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	Patient	
PATH_N_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Patient	
PATH_T_STAGE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	Patient	
PERSON_NEOPLASM_CANCER_STATUS	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Person neoplasm cancer status.	Patient	
PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Primary lymph node presentation assessment.	Patient	
PRIOR_DX	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Prior diagnosis.	Patient	
RAGNUM_HYPOXIA_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	mRNA based Ragnum Hypoxia Score	Patient	
TISSUE_PROSPECTIVE_COLLECTION_INDICATOR	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Tissue prospective collection indicator.	Sample	No ; Yes
TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Tissue retrospective collection indicator.	Sample	Yes ; No
TISSUE_SOURCE_SITE_CODE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Tissue Source Site Code	Sample	3C ; 4H ; 5L ; 5T ; A1 ; A2 ; A7 ; A8 ; AC ; AN ; AO ; AQ ; AR ; B6 ; BH ; C8 ; D8 ; E2 ; E9 ; EW ; GI ; GM ; HN ; JL ; LD ; LL ; LQ ; MS ; OK ; OL ; PE ; PL ; S3 ; UL ; UU ; V7 ; W8 ; WT ; XX ; Z7
TUMOR_TYPE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	STRING	Tumor Type	Sample	Infiltrating Lobular Carcinoma ; Infiltrating Ductal Carcinoma ; Other ; Mixed Histology (NOS) ; Mucinous Carcinoma ; Metaplastic Carcinoma ; Infiltrating Carcinoma (NOS) ; Medullary Carcinoma ; Breast Invasive Carcinoma
WEIGHT	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	Weight measured in kilograms.	Patient	
WINTER_HYPOXIA_SCORE	HotPink	Breast Invasive Carcinoma (TCGA, PanCancer Atlas)	NUMBER	mRNA based Winter Hypoxia Score	Patient	
